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PREFACE  
This is a brief report of a journey of several years. The quest of this journey was to 
answer the fundamental question “what happens to the infants born with a birth weight of 
less than 1500 g in this country?” There are over 500 tertiary care NICUs providing state 
of the art care and the survival of Very low birth and extremely low birth infants are 
comparable to the world’s best centers. However unfortunately there is very little data 
about the long term outcome of these infants. From the published literature over the last 
20 years, the total number of VLBW infants followed up for varying periods of time 
ranging from 1 year to 18 years is less than a thousand in this country! 
Developmental follow up requires a team comprising Pediatricians or Neonatologists, 
Psychologists, therapists (occupational therapists, physical therapists and speech 
therapists) and requires input from other medical specialists. Developmental assessments 
using standardized assessment tools are time consuming and demanding on the child who 
is being assessed, the parents and the assessor. On an average a standardized 
developmental assessment (if the child is cooperative) requires about one hour of 
dedicated time. In children with developmental problems or if the child is inattentive for 
any reason, the demands of time and effort increase considerably. Thus developmental 
follow up is a time consuming, labour intensive and an expensive intervention. This may 
be the reason why there is very little follow-up of preterm children. However 
developmental follow up is of paramount importance.  
The very low birth weight infants are probably the largest group with life-long morbidity. 
Once they survive the life-threatening complications in NICU, many of them develop 
xv 
 
neurological, developmental and sensory impairments. They continue to have learning 
and behavior problems in school. 
This institution where this study on the “Neurodevelopmental Outcomes of Very Low 
Birth Weight Infants born in a Tertiary Health Center” was done has a state of the art 
Neonatal ICU and a well-staffed Developmental Pediatrics Unit with psychologists, 
therapists and Developmental Pediatricians. Therefore this was a unique opportunity to 
do this study. Infants with developmental delay or other complications like cerebral palsy 
when identified could also be provided appropriate therapy. It is our hope that the 
information obtained from this study in addition to contributing to the scientific 
knowledge will improve the health and wellbeing of this very vulnerable and special 
group of children. 
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“Behind every fact is a face;  
behind every statistic there is a story” 
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ABSTRACT 
BACKGROUND:  The very low birth infants (VLBW) are exposed to multiple risk 
factors in the antenatal, perinatal and neonatal periods which result in significant short 
term morbidities and adverse neurodevelopmental outcomes. There is limited data about 
the survival and the long-term neurodevelopmental outcomes of these infants from India.   
OBJECTIVES: The primary objectives of this study were to determine the survival and 
neurodevelopmental outcomes at 18-24 months corrected gestational age, of a cohort of 
very low birth weight infants and to identify the perinatal and neonatal factors associated 
with these outcomes. In addition the study also looked at the growth and development of 
the small for gestational age infants in comparison to appropriate for gestational age 
infants and the relationship between the postnatal growth and the neurodevelopmental 
outcomes of the infants was also explored. 
DESIGN, SETTING AND PARTICIPANTS: This was a longitudinal follow-up of the 
VLBW infants from the time of admission into the NICU of a tertiary level neonatal ICU, 
till their developmental assessment at 18-24 months corrected gestational age. The first 
phase of the study was from admission into the NICU till death or discharge from 
nursery.  The second phase was from the time of discharge till the final 
neurodevelopmental assessment. The Amiel-Tison Neurologic examination and the 
Griffiths Mental Developmental Scales (GMDS) were used to determine the final 
neurodevelopmental outcomes.  
METHODS:  Data regarding the antenatal, perinatal and neonatal periods were collected 
prospectively. The end points of the study were death, cerebral palsy or the 
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developmental outcome determined by the General Quotient (GQ) on the GMDS.  The 
growth status at birth was estimated using the third percentile of the Fenton’s curves 
which was used to categorize the study cohort into small or appropriate for gestational 
age.  The Z-scores of weight, length and head circumference were determined using the 
WHO-ANTRHO software at the time of assessment. 
Logistic regression models were used to identify the following:   antenatal, perinatal and 
neonatal risk factors resulting in death in the NICU; risk factors resulting in poor neuro-
developmental outcome; risk factors which resulted in poor language outcomes and the 
risk factors which were associated with being underweight at two years. 
A sensitivity analysis was done to decide if the infants who did not come for the study 
affected the final results of the study 
RESULTS: The survival in the first phase of the study was 92.26% (89.4%-94.54%, 
95% CI).  Septicemia was the major cause of death. Severe intraventricular hemorrhage 
(IVH-Grades 3 and 4), respiratory distress syndrome (RDS) and ventilation were 
significantly more in the boys. The factors which were significantly associated with death 
on the multivariate logistic regression model were birth weight of less than 1200g, 
perinatal asphyxia, respiratory distress syndrome (RDS), severe necrotizing enterocolitis, 
patent ductus arteriosus and septicemia.  
In the Phase II of the study:  65.6% of the infants completed the neurodevelopmental 
assessment. The incidence of poor neurodevelopmental outcome [General Quotient (GQ) 
<2SD] was 11.37% (8.6%-14.9% 95% CI) and incidence of Cerebral palsy in this study 
was 1.1 (0.39-2.63). The mean GQ was 93.6 (SD + 13.01). There were forty eight 
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children with poor neurodevelopmental outcomes, which included five children with 
cerebral palsy. The neurodevelopmental outcomes of the girls were significantly better 
than that of the boys.  
None of the antenatal, perinatal or neonatal risk factors were related to the poor 
neurodevelopmental outcome (GQ <2SD) on the multivariate logistic regression model,  
but post--natal growth (particularly Z-score of weight below 2 SD) at the time of 
assessment was significantly associated with poor neurodevelopmental outcome. 
Multivariate logistic regression model looking at the reasons for poor language 
development showed that perinatal asphyxia, post-natal weight restriction (Z-score of 
weight below 2 SD) and low maternal education level were associated with poor 
language abilities. 
Multivariate logistic regression models which looked at the cause of post-natal growth 
restriction showed that low maternal education, small for gestational status and neonatal 
hypoglycemia were significantly associated with remaining underweight (Z-score of 
weight below 2 SD) at the time of assessment. 
There was no difference in the survival and neurodevelopmental outcomes between small 
for gestational age (SGA) infant and appropriate for gestational age (AGA) babies. 
However the post-natal growth of SGA babies was significantly worse than that of AGA 
babies. 
Sensitivity analysis using “Best case” and “Worse case scenarios” showed that the 
exclusion of those who did not come for the final assessment (those who did not give 
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consent, those who died and those who were lost to follow up) did not affect the final 
results. 
CONCLUSIONS: The survival and neurodevelopmental outcomes of the VLBW infants 
in this study are the best reported from this country and are comparable to Western data. 
Poor post-natal growth (resulting in being underweight) was associated with poor 
neurodevelopmental outcome. There was no difference in the survival and 
neurodevelopmental outcomes of small for gestational age babies compared to those who 
were born appropriate for gestational age. Social factors particularly socio-economic 
status and maternal educational level play an important role in the neurodevelopmental 
outcomes of the VLBW babies. 
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1. INTRODUCTION 
 
The birth of a new baby is a time of eager anticipation and excitement. However in about 
one-third of the pregnancies in this country, the babies are born too small or born too 
early and the excitement is quickly replaced with trepidation and anxiety.  Most parents 
are not prepared for the weeks and months ahead. Initially the several weeks in NICU 
mean days of uncertainty when the very survival of their newborn is at stake. They are 
overwhelmed by the various terrifying procedures and the often incomprehensible 
medical jargon.  It is also the beginning of one of the most expensive treatments. Finally 
after the weeks of NICU care and the infant surviving the seemingly insurmountable odds 
he is ready to go home. 
Even for parents whose babies are relatively well at discharge, this is the beginning of 
another exhausting roller-coaster period with months of sleepless nights and anxious 
days. After the period of extended stay in the NICU where they could depend on the staff 
for emotional, social and medical support, the parents suddenly feel isolated and alone 
when they come home. Each day is a tension because the babies are still very vulnerable. 
There are challenges in feeding, sleeping and combatting infections. For those parents 
whose infants carry the sequelae of the neonatal complications like intraventricular 
hemorrhage, chronic lung disease, retinopathy of prematurity, this is a seemingly endless 
journey of pain and uncertainty. Their burden is tremendous. Surviving these ordeals and 
maintaining some homeostasis in their lives is a daily struggle. 
This thesis is a study of this journey of a cohort of babies who were born too small and 
the overwhelming odds they had to overcome.  
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 DEFINITIONS 1.1
Low Birth Weight (LBW), which comprises a special group of children in terms of 
mortality, morbidity and long term developmental outcomes has been defined by the 
World Health Organization as weight at birth, of less than 2500 g.1,2 Very Low Birth 
Weight (VLBW) infants have a birth weight of less than 1500 g and Extremely Low 
Birth Weight (ELBW) infants have a birth weight of less than 1000 g. Premature birth 
has been defined as delivery before 37 weeks of gestation.  A baby’s low weight at birth 
is either the result of preterm birth or due to restricted intrauterine growth.3  Small for 
gestational age (SGA) traditionally has been defined as a weight below the 10th percentile 
of birth weight-for-gestational age for a specific reference population.4,5 Though often not 
synonymous, SGA is quite commonly used as proxy for intra uterine growth restriction.6 
 LOW BIRTH WEIGHT INFANTS 1.2
The World Health Organization (WHO) estimates that about 20 million LBW infants are 
born every year and 96.5% of them are born in developing countries. These babies 
comprise about 15.5% of all the births.7 But of the estimated, 4 million babies who die in 
the neonatal period every year, low birth weight contributes to 60–80% of all the neonatal 
deaths and so LBW is an important contributor of neonatal mortality.2,8,9 In countries 
where the prevalence of LBW is very high, it is known that most LBW infants are growth 
restricted rather than preterm.10,11 In addition to being a predictor for the baby’s 
development low birth weight  has long been used as a surrogate indicator of maternal 
malnutrition and poor pregnancy health care.11  
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 BURDEN IN INDIA 1.2.1
India, because of its population, has the dubious reputation of being the largest 
contributor to the global burden of low birth weight infants and neonatal mortality. The 
table below gives the current dismal reality of the newborns in the country - 
Live births:  There are 27 million live births every year in India5  
Low birth weight  
Babies: 
30% of the babies born in India are low birth weight, which amount 
to about 7.5 million low birth weight babies every year.5,12 About 
60% of the LBW babies in India have intrauterine growth 
restriction while the remaining 40% are born preterm.13 
Preterm babies: Every year 3.5 million preterm babies are born in India and this 
contributes to 23.6% of the global burden of preterm births.8 
Small for 
gestational age:  
46.9% of all babies born in the country are small for gestational 
age. (There are babies who weigh more than 2500 g, but are still 
considered growth retarded). Most of the SGA babies are born at 
term and they account for almost 94% of the total number of SGA 
babies born in the country.5 
Neonatal deaths: About 7.6 lakh neonates die every year in India, the highest for any 
country in the world.12 Community based studies indicate that 
LBW infants are 11 to 13 more at risk of dying than normal birth 
weight infants and more than 80% of all neonatal deaths occur 
among LBW and preterm infants.14  
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 The National Neonatal Perinatal Database (NNPD),13 recorded data of over 1.5 lakh 
infants born in 18 perinatal centers all over the country in 2002-03. Of these 31.3% of all 
live births were low birth weight, 3.4% of infants were born with birth weight less than 
1500 g (VLBW), 0.7% of the infants were extremely low birth weight and 14.5% of 
infants were preterm.  This is in contrast to the data of the same period in the United 
States were 7.9% of the live born infants were born low birth weight, 1.45% were born 
very low birth weight and 12.3% of infants were preterm.15 However the statistics of the 
NNPD presented above are likely to be inaccurate, since in India, many infants are born 
at home and therefore not weighed at birth. Thus the estimates of low birth weight 
obtained from most developing countries which are usually compiled from health centers 
are likely to be biased.16 
  MILLENNIUM DEVELOPMENT GOAL-4 1.2.2
At the United Nations Millennium Summit in September 2000, the world leaders 
committed themselves and their nations to achieve the time-bound and quantified targets 
of the Millennium Development Goals (MDG).17 The fourth MDG (MDG-4) is to reduce 
the under-5 mortality rate (U5MR) and neonatal mortality by two thirds by 2015. India is 
a signatory to the UN declaration of the MDG and is obliged to decrease the childhood 
mortality by two-third by 2015. Although India has made has made significant progress 
and the neonatal mortality rate has significantly decreased from 52 (per 1000 live births) 
in 1990 to 29 (per 1000 live births) in 2012, it is still unlikely to achieve its MDG-4 
target.18,19   
Two-thirds of the neonatal deaths occur in the first two weeks and deaths in the first week 
account for 45% of the  total under-five deaths in the country.12  The three major causes 
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of neonatal deaths in India (which account for about 78% of all neonatal deaths) are 
prematurity and low birth weight, neonatal infections and birth asphyxia and birth 
trauma.20,21 
 ETIOLOGY AND OUTCOMES OF LOW BIRTH WEIGHT BABIES  1.2.3
From an etiologic perspective the two different types of LBW (IUGR and Preterm birth) 
are quite heterogeneous in their etiologies and in their long term outcomes.3 The most 
important determinants of IUGR and preterm birth in developing countries are listed 
below 22,23 - 
                        IUGR          PRETERM BIRTH 
• Low energy intake/gestational weight gain • Genitourinary infection 
• Low pre-pregnancy body mass index • Multiple births 
• Short stature • Pregnancy induced hypertension 
• Malaria (in endemic countries) • Low pre-pregnancy body mass index 
• Cigarette smoking  • Incompetent cervix 
• Primiparity • Prior preterm birth 
• Pregnancy induced hypertension • Abruptio placentae 
• Congenital anomalies • Strenuous work 
• Other genetic factors • Cigarette smoking 
IUGR and preterm birth also have important differences with respect to prognosis. 
Preterm infants are at increased risk of infant death, neonatal morbidities and long term 
complications in their growth and development. The immediate neonatal complications 
include respiratory distress syndrome (RDS), patent ductus arteriosus (PDA), 
intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL) and retinopathy 
of prematurity (ROP) while long term complications include psychomotor delay and 
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cerebral palsy.24 Preterm birth also generates high health care costs, particularly for 
neonatal intensive care, which is required for several weeks.25,26  
Severely growth restricted infants are at an increased risk of neonatal death and of 
significant short term morbidity from hypoglycemia, hypothermia, hypocalcaemia and 
polycythemia.27,28 Over the longer term they tend to have permanent deficits in growth 
and neurocognitive outcomes.29 Epidemiologic studies by Barker and colleagues have 
suggested that such infants may be at increased risk for type 2 diabetes, hypertension and 
coronary artery disease when they reach middle age many decades later.30,31 Furthermore 
follow-up of a large longitudinal cohort from India has shown that infants who are small 
and thin at birth, but started becoming obese from childhood are likely to have impaired 
glucose tolerance or diabetes during adulthood.32 
 
 THE VERY LOW BIRTH WEIGHT INFANTS 1.3
The field of Neonatology has witnessed unprecedented advances in the last three decades.  
Currently in developed countries even extremely premature babies of 22-25 weeks 
gestational ages and birth weights of 500-750 grams routinely survive because of 
improved perinatal management, prenatal administration of corticosteroids, surfactant 
replacement therapy, sophisticated fluid and parenteral nutrition delivery systems, 
advances in neuroimaging and innovations in ventilation like the high frequency 
ventilators. Even in India it is now routinely possible to save the lives of the extremely 
small and premature VLBW and ELBW infants. The limits of viability are being 
challenged almost every day. Nevertheless in preterm and low birth weight infants, 
mortality rates and neonatal morbidities increase substantially with the decreasing 
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gestational age and decreasing birth weight.33  
 NEONATAL COMPLICATIONS OF VERY LOW BIRTH WEIGHT 1.3.1
Despite all the advancements of neonatal care, the early days of the VLBW infants are 
fraught with potentially life threatening complications.  Because of the immaturity of the 
organs, the preterm and VLBW infants are vulnerable to many neonatal complications 
and have a higher rate of mortality compared to normal term infants.  
In a report from the National Institute of Child Health and Human Development 
(NICHHD) Neonatal Research Network the following neonatal complications were seen 
in 8515 VLBW and ELBW infants weighing  between 400 g to 1500 g 34 -  
• Respiratory distress 93% 
• Retinopathy of Prematurity 59% 
• Patent ductus arteriosus 46% 
• Bronchopulmonary dysplasia 42% 
• Late onset sepsis 36% 
• Necrotizing enterocolitis 11% 
• Grade III and Grade IV intraventricular hemorrhage 7% and 9% 
• Periventricular leukomalacia 3% 
Survival rates:  The rates of survival to discharge in the above ELBW cohort ranged 
from 6% for babies born at 22 weeks to 92% to babies born at 28 weeks.  
According to the data from the National Neonatal-Perinatal database 2002-3, the survival 
rate for ELBW infants was 45%, for infants between 1000 to 1500 g the survival rate was 
73.4%  and for infants above 3000 g the survival rate was 99.2%.13 
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 LONG TERM COMPLICATIONS OF VLBW INFANTS 1.3.2
Follow-up of VLBW infants have shown they are at increased risk for impaired 
neurodevelopmental outcome compared to term babies with normal birth weight. The 
neurologic, developmental, sensory and functional morbidities increase with decreasing 
birth weight.35  It is well known now that the VLBW infants also have a higher mortality 
and are more likely to have higher rates of cerebral palsy36–39, have greater risk for 
ophthalmic morbidities like impaired visual acuity, strabismus, visual field defects,40–43  
and hearing problems.44 VLBW infants are at greater risk for poor academic performance 
than those born with normal birth weight because of their impaired cognition, 
neurosensory defects, and behavioral and psychological problems45–49 They are also 
likely to have more respiratory illnesses compared to term babies.50 They have specific 
psychological and behavioral problems including attention deficit hyperactivity 
syndrome, general anxiety, and depression.51,52 In addition to the effects of the very low 
birth weight, neonatal complications like bronchopulmonary dysplasia,53 perinatal 
infections,54,55 necrotizing enterocolitis56, retinopathy of prematurity, intraventricular 
hemorrhage, hypoglycemia and the presence of congenital anomalies are all associated 
with an increased risk of poor neurodevelopmental outcome. The development of 
hypertension, insulin resistance, and impaired glucose tolerance in adulthood has also 
been associated with very low birth weight.57 The morbidities which often extend to later 
life, result in an enormous physical, psychological and economic costs for the VLBW 
survivors.25,26 
The incidence of cerebral palsy is generally accepted as 2-4 per 1000 in the general 
population of developed countries.58  In a meta-analysis of over 100 studies which looked 
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at the outcomes of the VLBW infants (all studies were done in developed countries) the 
incidence of cerebral palsy of 7.7% and the incidence of all disabilities was 25%.59 This 
study also reported the relative risk for cerebral palsy among surviving the VLBW infants 
was about 38 times than it is in the general population of these countries. Unfortunately 
there is no data available in India. The table below summarizes the short-term and long-
term complications the VLBW babies60  
Affected Organ or System  Short-Term Problems Long-Term Problems 
Pulmonary  
 
RDS, BPD,  pneumothorax, air leak, 
apnea of prematurity   
 
Reactive airway disease, 
 asthma 
Gastrointestinal or 
nutritional 
Hyperbilirubinemia, feeding 
intolerance, NEC 
Failure to thrive, short-bowel 
syndrome, cholestasis 
Central nervous system  
 
IVH, PVL, hydrocephalus Cerebral palsy, hydrocephalus, 
cerebral atrophy, developmental 
delay, hearing loss 
Ophthalmologic  Retinopathy of prematurity  Blindness, retinal detachment, 
myopia, squint 
Cardiovascular Shock, PDA, pulmonary hypertension Pulmonary hypertension, 
hypertension as adults 
Renal  Water and electrolyte imbalance, 
acid−base disturbances 
Hypertension in adulthood 
 
Endocrine Hypoglycemia, transiently low 
thyroxine levels, cortisol deficiency 
Impaired glucose regulation, 
increased insulin resistance 
 
 SMALL FOR GESTATIONAL AGE BABIES AND THEIR COMPLICATIONS 1.3.3
Western studies have shown that being small for gestational age (SGA) at birth confers 
an additional hazard to survival, growth and neurodevelopmental outcome in preterm 
infants.61 Some studies have demonstrated that SGA is a risk factor for mortality in term 
infants as well. In a systematic review it was shown that a birth weight of less than 1500 
INTRODUCTION 
 
 Page 14 
 
grams in term infants is associated with the greatest risk of mortality (odds ratio of 48.6, 
95% CI 28.6-82.5).62 This is very significant because almost  half of the babies born in 
India are small for gestational age and 94% of them are born at term.5 The outcome of the 
SGA infant is worse than those born preterms who are AGA.63–65   
 IMPORTANCE OF NEURODEVELOPMENTAL FOLLOW-UP. 1.4
It has been almost universally accepted that neurodevelopmental outcome is the most 
important measure of neonatal ICU (NICU) success in preterm and VLBW babies.66 
Since the implications of being born premature or born with a low birth weight are 
lifelong, long term follow-up is required to understand the impact of the risk factors and 
the efficacy of therapeutic measures on the growth and neurodevelopmental outcome of 
high risk infants.  These babies require periodic assessments of their growth and 
nutrition, development, neurologic status and their behavior by a dedicated 
multidisciplinary team.67 The main objective during these assessments is to identify the 
deviant developmental trajectories and initiate early intervention. These infants can also 
have complex medical problems and may require ongoing care from pediatric 
subspecialists.  
There are standardized guidelines laid down by the American Association of 
Pediatricians and  National Neonatal Federation for provision of follow-up services for 
high risk infants (which include VLBW infants).68 As the number of survivors increases 
many clinical and research questions have surfaced that can only be answered by long 
term follow-up. Since many VLBW infants can have cognitive and psychiatric 
morbidities even when they are adults, they may require follow-up for many years.69   
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 IMPORTANCE OF THIS STUDY 1.4.1
There are many multi-centric studies from Western countries describing the 
neurodevelopmental outcome of the VLBW infants. There is only study cohort of LBW 
infants from Pune which has been followed up from birth to adolescence.70–74 There are a 
few hospital based studies which have looked at the Neurodevelopmental outcomes of the 
VLBW infants in India and the longest period of follow-up has been for three years.75–78 
During the last decade there has been a phenomenal increase in the number of neonatal 
intensive care units (NICUs) in the country, especially in the corporatized health care 
sector and to a lesser extent in the public sector health care facilities. In addition 
specialist training programs in Neonatology have been started in many large perinatal 
centers in the country.79 But despite the increase in NICUs and the overall improvement 
in the quality of neonatal care, data is very scarce about the long term outcome of these 
infants in India.  So there are many unanswered questions like - What happens to VLBW 
babies after their discharge? How many of them survive? How many have disabilities? 
What are the antenatal, maternal or neonatal risk factors that lead to poor 
neurodevelopmental outcome?  
It is almost certain that the outcomes of VLBW infants in this country are different from 
their counterparts in Western countries. In India unlike in developed countries, it is likely 
that, intrauterine growth restriction and therefore being small for gestational age, neonatal 
infections, birth asphyxia and neonatal hyperbilirubinemia contribute significantly to 
cerebral palsy and poor neurodevelopmental outcomes Therefore as Escobar et al notes, 
“It is critical to define rigorously the outcome of VLBW survivors… Regionally and 
nationally it is important to monitor the overall outcome of such infants so that plans for 
INTRODUCTION 
 
 Page 16 
 
future services can be made; this is particularly important as care of VLBW infant is one 
of the most expensive items in pediatrics”.59 
Despite having the largest population of VLBW infants and thus the possibly the largest 
cohort of the VLBW survivors, there is only little information about them from this 
country.  The follow-up of these infants also requires significant infrastructure in terms of 
personnel and requires a multidisciplinary team of neonatologists, developmental 
pediatricians, child psychologists, therapists (physical therapists, occupational therapists, 
speech therapists) dieticians, pediatric subspecialists (ophthalmologists, ENT specialist, 
pediatric neurologist, radiologists)  and social workers.80  
This study was a prospective follow-up of the VLBW infants (birth weight <1500 g) 
admitted in a tertiary institute. The VLBW infants were then followed up from the time 
they were discharged from the Neonatal ICU, till at least 18 months corrected gestational 
age. The institution where this study was conducted had the infrastructure and the 
multidisciplinary team required for the   undertaking.   
The incidence of developmental delay from Indian studies range from 10-17%,71,76,81 and 
that of cerebral palsy from 3-5%.76,82–84 This is less than the  incidence of 7.8%  for CP 
and 25% for developmental delay obtained from the meta-analysis of the outcomes of 
VLBW from over 100 studies, done by Escobar and associates.59 Since the VLBW in this 
country are different from that of Western cohorts we therefore decided to test the 
hypothesis, that the occurrence of CP and developmental delay would be different from 
that of Western countries. We also hypothesized that risk factors in the perinatal and 
neonatal period would affect the developmental outcome at 18 months corrected 
gestational age. 
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Thus the study was done to ascertain the factors in the perinatal and neonatal period 
which adversely affected the survival and the developmental outcomes in a cohort of 
VLBW infants. 
 
Thus… 
 
 “As Sean’s parents, we faced the demands of (Sean’s) second year often feeling drained 
and depleted. We were surprised how slowly we recovered from the tension and anxiety 
of the long hospitalization and stressful months that followed. We increasingly turned to 
Sean’s early intervention program team for support and encouragement…” 
“ … the neonatal roller coaster did not stop with Sean’s discharge. The ride just got 
lonelier. At the critical point of discharge, we did not have the time, energy and often, the 
inclination to find out way through the maze of follow-up…” 
(parents of Sean, premature LBW infant who had multiple neonatal complications and 
continued to have significant neurodevelopmental and sensory impairment). 85 
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Dhanushika (800 g) and Dhanushree (850 g) 
2 years old 
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2. AIMS AND OBJECTIVES 
 
Aim of the study 
To determine the survival and neurodevelopmental outcomes of Very low birth weight 
infants (<1500 grams at birth) admitted into a tertiary level Neonatal Intensive Care Unit 
(NICU), and were followed up till the infants reached a minimum corrected gestational 
age of 18 months. 
 
The study had two phases - 
Phase 1:  The first phase was from the time of admission of the VLBW infants into the 
NICU till the time of death or discharge from the NICU.  
Phase 2: The second phase was the follow-up phase which started after discharge of the 
survivors from the NICU till their final neurodevelopmental assessment.  
 
Main objectives  
Phase 1:  
To determine the relationship between the antenatal, perinatal and neonatal factors 
which lead to the mortality in the NICU. 
Phase 2:  
Objective 1: To estimate the incidence of poor neurodevelopmental outcome in the 
survivors who were discharged from the NICU 
Objective 2: To determine the relationship between perinatal and neonatal risk factors 
which lead to poor neurodevelopmental outcomes.   
 
AIMS AND OBJECTIVES 
 
 Page 19 
 
Other objectives 
• To determine the differences in the survival and neurodevelopmental outcomes of 
the Small for gestational age babies (SGA) as compared to the Appropriate for 
gestational age (AGA) babies. 
• To monitor the growth profile of the babies in the cohort and to explore the 
relationship between post-natal growth estimated at the time of the assessment and 
the developmental outcome. 
 
Poor neurodevelopmental outcome was defined as - 
1. Presence of neurologic abnormalities particularly cerebral palsy  
2. The developmental assessment used in this study is the Griffiths Mental 
Developmental Scale and poor neurodevelopmental outcome was estimated as the 
General Quotient (GQ) less than 2 Standard deviations (<2SD) below the mean 
for the age. 
3. Presence of blindness or hearing impairment 
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3. LITERATURE REVIEW 
 
The Literature review is organized in the following manner.  
Section 1 (3.1): Outcomes of VLBW babies in the neonatal period from India and other 
countries is discussed in this sub-section 
Section 2 (3.2):  The importance of Neurodevelopmental follow-up and assessment 
Section 3 (3.3): The Neurodevelopmental outcomes of VLBW babies from India and 
other countries 
Section 4 (3.4): Neonatal complications and their effects on the neurodevelopmental 
outcome 
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3.1: SECTION 1 - OUTCOMES VERY LOW BIRTH INFANTS IN THE 
NEONATAL PERIOD 
 
This section (3.1) is arranged in the following manner - 
3.1.1:  Summary of the Indian studies on the outcomes of VLBW infants 
3.1.2: Summary of some important studies from other countries which have looked at 
the outcomes of VLBW.  
3.1.3: Limitations of the Indian studies 
3.1.4: An alternative to care of the VLBW in tertiary neonatal centers – a community 
intervention program for the VLBW infants is presented in this sub-section. 
 
Survival rates for the VLBW and the ELBW infants have consistently improved during 
the 1980s and the 1990s. Although most early follow-up studies reported the outcomes of 
low birth weight infants weighing less than 2500 g, currently the improvement in survival 
has shifted the focus to the VLBW infants weighing less than 1500 g, the ELBW infants 
weighing less than 1000 g and micro-preemies weighing less than 750 g.66 As the 
methodology for assessing the gestational age has improved, there has been increasing 
number of reports evaluating the effects of prematurity rather than that of low birth 
weight. Preterm delivery is defined as birth before 37 weeks of gestation, very preterm is 
less than 32 weeks and extremely preterm is less than 28 weeks.86 
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3.1.1. STUDIES ON THE OUTCOMES OF VLBW FROM INDIA 
Summarized below are the studies done in India on the outcomes of the VLBW and the 
ELBW infants. Of a total of 415 Indian articles on LBW babies from the PubMed 
database, I chose studies pertaining to the survival of the VLBW or the ELBW infants. 
These have been included and summarized. The studies are arranged in a reverse 
chronologic order, from the latest to earlier studies. 
• Ashtekar (2014)87 
Out of the 134 premature babies in the study, 80% were <1600 g in weight. Their 
survival was inversely related to the birth weight. None of the babies less than 800 g 
survived.  
Survival improved with increasing gestational age - 17% of the babies 800-1000 g, 
48% of the babies 1000 to 1200 g and 64% of the babies 1200 -1400 g survived.  
Mortality:  The main causes of death were RDS and sepsis 
• Mukhopadhyay (2013)88  
This is the largest Indian study involving ELBW infants. In this study 78 of the 149 
(52%) babies survived and 57 (39%) survivors had major morbidities. 
Major morbidities: In this study the major morbidities were bronchopulmonary 
dysplasia in 33% of the infants, severe IVH (Grades III & IV) in 68%, severe NEC in 
7% of the infants. Among the infants with ROP, 3% required laser therapy.   
Causes of Mortality: Death resulted predominantly from septicemia in 46% of the 
infants, perinatal asphyxia in 20% and pulmonary hemorrhage in19% of the infants. 
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• Tagare (2013)89 
This is another major Indian study on ELBW infants and in this study, 47 of the 87 
ELBW infants (56.1%) survived. Mortality rate was higher in the <750 g group. 
Mortality: Pulmonary hemorrhage (25%), RDS (22.5%), IVH (22.5%) and sepsis 
(20%) were the major causes of death. 
• Thakur (2013)90  
This was retrospective study done over 10 years. The survival rate was 61.3% 
(173/283). Only 7.6% of babies with <700 g, 50% of babies with 700-900 g and 75% of 
babies with 900 to1000 g survived. Causes of Mortality:  RDS, Sepsis, IVH and 
pulmonary hemorrhage and asphyxia were the major causes of death 
• Basu (2008)91 
In this study 63.8% of 260 VLBW babies survived. The survival was inversely related 
to the birth weight.  None of babies <700 g survived, 22% of babies with 700-800 g, 
45% of 800-1000 g, 55% of 1000 to 1200 and 74% of 1200 -1500 g survived. 
Mortality: The mains cause of death was RDS in the less than 1000 g and asphyxia in 
the over 1000 g categories. 
• Roy (2006)92 
Out of the 106 (<1500 g) infants in this study, 70 were VLBW and 36 were ELBW. 
The    main morbidities were neonatal jaundice (47.2% in ELBW and 24.2% in VLBW 
babies), RDS (38.8% in ELBW and 17.1% in VLBW).  ROP (33.3% in ELBW vs. 
15.7% in VLBW) and sepsis (25.5% in ELBW vs. 14.2% in VLBW) 
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Mortality: The survival was inversely related to the birth weight. None of babies who 
were less than 700 g survived. 58.4% of the babies who were 700-800 g, 70% of babies 
who were 800-1000 g, 83.4% of babies 1000 to 1200 g and 86% of babies 1200 -1500 g 
survived. The mortality rate was related to the gestational age (which was highest in 
infants less than 30 weeks), birth weight (highest in less than 800 g) and male sex. 
• Narayan (2003)93  
Sixty seven (49%) ELBW infants survived to discharge in this study. Mortality was 
greater in <750 g infants, gestational age <28 weeks infants and in male infants 
Morbidities: Hyperbilirubinemia (65%), RDS (65%), sepsis (52%), IVH (29%), 
pneumonia (25%) and ROP (24%). Mortality causes: Sepsis (41%) extreme prematurity 
(24%) were the main causes of death 
• Sehgal (2003)94 
This cohort had 52 ELBW babies of which 30 (57%) survived.  
Mortality: The contributors to the mortality of the infants were HMD in 63%, pulmonary 
hemorrhage which occurred in 18%, septicemia in 32% and NEC which occurred in 9% 
of the infants.  
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3.1.2  SUMMARY OF STUDIES ON NEONATAL OUTCOMES FROM OTHER 
COUNTRIES 
A. Studies from United States (NICHHD cohorts and Vermont Oxford 
Network) 
• Hack (1991)95 
This study from the NICHHD network looked at the neonatal outcomes of more than 
1700 VLBW infants delivered in 1987-88 at seven participating centers.  
Survival rates: Survival was dependent on the birth weight and 34% of <751 grams birth 
weight infants, 66%  of infants  between 751 and 1000 grams, 87%  of infants between 
1001 and 1250 grams., and 93% of infants between  1251 and 1500 grams survived. 
Morbidities:  RDS (67%), symptomatic PDS (25%), NEC (6%), septicemia (17%), 
meningitis (2%), urinary tract infection (4%), and Grades III & IV intraventricular 
hemorrhage (18%) were the main morbidities. Morbidity increased with decreasing birth 
weight. 
• Lemons (2001)96 
The perinatal data was collected prospectively from January 1995 through December 
1996 by the NICHHD. In this cohort 84% of the infants survived, compared to the 
survival of 80% in the 1991 cohort and the 74% survival of the 1988 cohorts. 
Survival: For infants 401 g-500 g survival rate was 11%, 501 to 750 g birth-weight 
survival rate was 52%, 751 to 1000 g survival rate was 86%, for 1001 to 1250 g survival 
rate was 94% and for those 1251 to 1500 g survival rate was 97%. 
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Morbidities: There was no change in the incidence of CLD, IVH and NEC compared to 
the previous study. There was marked improvement in survival after RDS due to 
surfactant use 
• Fanaroff (2007)97 
This study showed an increase by one percent in the survival of the VLBW babies (from 
84% to 85%) in the NICHHD cohort during the period 1997-2002 when compared with 
that of the previously mentioned cohort (1995-96). Among the infants who were between 
501-750 g, 55% survived; 88% of the 751-1000 g infants survived; 94% of the 1001-
1250 g infants survived and 96% of the 1251–1500 g infants survived. This study showed 
that mortality increased for every decrease of 100 g in the birth weight. Although there 
was some improvement in the survival the major morbidities remained the same.  
• Horbar (2012)98   
This study from the Vermont Oxford Network of 355,806 North American VLBW 
infants looked at the mortality trends between 2000 and 2009. There was a decreasing 
trend in the mortality for infants between 500 g and 1500 g. The mortality of 500-750 g 
babies decreased from 41.7% in 2000 to 36.6% in 2009, in the 751-1000 g infants from 
13% to 11.7%, in the 1001-1250 g infants from 6.5%-5.7% and in the 1251-1500 g 
infants, it remained the same at 3.5%. The study also showed a mild decrease in some of 
the neonatal morbidities – late onset sepsis decreased from 21% in 2000 to 15% in 2009, 
ROP from 10.5% to 6.8%. and CLD from 27.1% to 26%. Other morbidities – NEC, IVH 
and PVL remained almost the same between 2000 and 2009. 
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• Stoll (2010)34 
This NICHHD study reported outcomes on the basis of the gestational age rather than the 
birth weights and reported the outcomes of infants between 22 weeks and 28 weeks. This 
study reported the survival of infants born at 22 weeks.  The rates of survival to discharge 
increased with increasing GA, from 6% at 22 weeks to 92% at 28 weeks (72% overall). 
The infants who were less than 24 weeks had three times higher mortality rate than those 
who were 28 weeks of age. The main morbidities were RDS (93%), PDA (46%), severe 
IVH (16%), NEC (11%) and late onset sepsis (36%). Morbidities increased with 
decreasing gestational age. 
B. United Kingdom (EPICure 1 and EPICure 2  studies)99 
Improved survival rates of increase from 40% to 53%, was also noted in a population-
based British study of extremely premature infants (defined as gestational age between 22 
and 26 weeks) born in two time periods – in 1995 and in 2006. Survival increased from 
1995 to 2006 with each week of gestation (9.5%, 12%, and 16% for 23 weeks, 24 weeks, 
and 25 weeks gestation respectively). The median age of death also increased from two 
days in 1995 to seven days in 2006, which reflected, in part, a shift in the cause of death 
from early respiratory failure to later complications of prematurity including infection 
and necrotizing enterocolitis. 
C. France (EPIPAGE study)100  
In France in a cohort of over 4000 babies between 22 and 32 weeks, survival was directly 
correlated with gestational age; the survival was 97% at 32 weeks of gestation compared 
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to 31% at 24 weeks and 78% at 28 weeks. The mortality rates were high among the SGA 
babies, male infants and those born of multifetal gestations.  
In summary, review of the world literature has shown that survival rates for the VLBW 
varied between perinatal centers and between different regions. The survival at 23 weeks 
gestation was less than 30%, while at 24 weeks gestation, the survival rates were between 
17 and 62%; at 25 weeks gestation survival rates was between 35% and 72% and at 26  
weeks it ranges from 14% to 76%.101,102 Since 2000 the survival rates have stabilized at 
approximately 85% for the VLBW infants and 70% for ELBW infants in most Western 
cohorts.103,104  
 
3.1.3  COMPARING THE SURVIVAL OF VLBW INFANTS IN INDIA TO THAT OF WESTERN 
COHORTS 
From what has been said about the neonatal survival of Indian babies as compared to 
those from Western cohorts the following observations can be summarized: 
• There is limited data on the NICU survival of VLBW and ELBW babies in India. All 
studies are from few tertiary care centers and therefore not representative of the 
situation around the country. It is also obvious, that the survival patterns are different 
in the various centers.  
• The Indian data is from individual centers but the Western data is obtained from 
many collaborating perinatal centers. For example the Vermont Oxford Network 
maintains a database of the VLBW based on the collaboration of over 300 tertiary 
level centers.105 
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• There is only study from a premier perinatal center which has looked at the trends 
in survival between the ELBW infants of different periods (2001-2 and 2009-10).106  
The study showed that survival had improved for ELBW who were 28-30 weeks 
gestation, but not for those who were born earlier. The authors opine that the 
improvement in survival between the two periods was probably due to surfactant 
therapy, non-invasive ventilation and high frequency ventilation.106 However, the 
authors also conclude that although the survival rate is improving it is far below that 
off developed countries.  
• The predominant cause of mortality in Indian studies was septicemia, while in most 
Western studies the main morbidities are RDS, IVH and PDA. This may be due to 
the differences between the Indian and Western cohorts. The Indian cohorts are 
more likely to have SGA children, who have a lesser incidence of morbidities like 
IVH, RDS and PDA. 
• There is no information about the survival of less than 500 g infants in this country.  
• In India, there are tertiary perinatal centers with state of the art technology and 
highly specialized doctors and there are secondary level special care newborn units 
(SCNU) in about 300 districts.79 So the survival rates of these vulnerable infants are 
going to vary depending upon the expertise and the infrastructure of the treating 
centers.  Western studies have shown that the survival of the VLBW and the ELBW 
infants is dependent on the expertise and resources of the centers looking after these 
babies.107  A recent study from UK which looked at the survival of the ELBW 
infants born in level 3 nurseries and those born in level 2 nurseries showed that 
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survival was better for those born in level 3 nurseries, but there was no change in 
the morbidities of those who survived.108 Substandard neonatal care is associated 
with increased mortality as shown in a study which looked at the causes of neonatal 
deaths in infants born at 27 to 28 weeks gestation in Great Britain, during a two 
year period (1998 to 2000).109  
• Another reason in the difference in survival reported from the various Indian studies 
could be the inclusion criteria. Some studies have only looked at the survival of in-
born babies, while others have also included out-born babies who are transferred 
after birth from peripheral centers. Survival rate of the ELBW babies and the 
VLBW babies in Indian NICUs depend not only on the quality of intensive care 
after reaching the NICU but also on the manner and quality of transportation of 
these sick babies to the NICU.110  
 
3.1.4 ALTERNATE MODELS TO IMPROVE SURVIVAL OF LOW-BIRTH WEIGHT INFANTS 
It is very unlikely that highly specialized neonatal care will be available for all the low 
birth weight babies born in this country. The above Indian studies and the available data 
on the LBW infants is just the tip of the iceberg. There are definitely many more LBW 
infants born in the many villages and towns in the country who cannot access neonatal 
care and there is no information about their outcomes. Therefore we have to look for 
alternative models of neonatal care.  
Furthermore a review by  Kramer showed that, in the long run, most interventions 
including food and micronutrient supplementation of pregnant mothers have had very 
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little effect in preventing low birth weight and premature babies.111  This was confirmed 
by a study done at Kanyambadi village in South India which looked at the low birth 
weight and preterm birth rates in 1990 and 2005 and found that there was no decrease 
between the two periods. However the  perinatal mortality and neonatal mortality had 
decreased substantially (by 26%) between the two time periods because of improvements 
in the antenatal and neonatal care.112 The authors have concluded that improving 
infrastructure and training people to look after the consequences of low birth weight may 
be a more effective option than trying to prevent low birth weights.  
Thus despite various interventions the birth rates of LBW babies does not seem to be 
coming down, so improving infrastructure to look after these babies may be a better 
option. But in a country with limited resources, is there an alternative, to specialized 
newborn centers, which can meet the enormous task of improving the survival of low 
birth weight infants? 
THE GADCHIROLI MODEL FOR IMPROVING THE LBW SURVIVAL  
In Gadchiroli a village in Maharashtra, Bang and associates demonstrated that most low 
birth infants can survive in home settings with simple and low cost interventions 
delivered by community health care workers.  They also discovered that only a small 
percentage may require intensive care.92,113–115  In the seven years of interventions in the 
field trial in rural Gadchiroli, more than five thousand newborns (including over two 
thousand low birth weight infants and more than five hundred premature infants) were 
managed at home.  The resident Village Health Worker (VHW) in each village was 
trained to assess the neonates at birth, to identify the LBW and premature babies and 
manage them at home.  The VHW and the mothers were trained in early initiation of 
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respiration and feeding, providing warmth, protection from infections and preventing 
other comorbidities  
Although there was no change in the incidence of preterm births and only a small 
reduction in the incidence of LBW babies, with these simple measures at home the 
mortality rates decreased by more than 60% among the low birth weight and premature 
babies. This proved that a majority of the LBW infants could be effectively managed at 
home and only a small proportion required referral to a larger health center. 
 Three factors contributed to the survival of the infants.  
• The simple but efficient care provided by the mothers and the VHWs resulted in a 
marked decrease in sepsis, asphyxia, hypothermia and feeding problems.  
• Prompt treatment of suspected sepsis with antibiotics 
• Supportive care provided by frequent home visits to encourage breast feeding and 
ensuring thermal care.   
The authors were successfully able to prove their hypothesis that even though the 
incidence of LBW and preterm births could not be prevented, survival could still be 
improved by prevention and management of comorbidities, especially infections.115,116 
So in conclusion, the outcomes of VLBW who are looked after in level 3 NICUs are 
improving in India, although the survival rates are far behind that of Western countries. 
Septicemia remains the main cause of mortality in developing countries.  But in a country 
where 30-40% of births occur at home, it is important to look for alternate forms of 
neonatal care. Models which promote universal access to antenatal care, trained birth 
attendance and effective post-natal care are likely to result in sustained reductions in 
neonatal mortality.112 The Gadchiroli model has shown that promoting optimal neonatal 
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care by training health workers and mothers and home-based management of neonatal 
infections can significantly reduce the LBW mortality and morbidity.116 Other simple 
measures like maternal education during the antenatal period about the importance of 
breastfeeding, rooming-in of the baby after birth  and kangaroo mother care could also go 
a long way in reducing neonatal mortality.118 Meta-analysis and systemic reviews have 
supported the usefulness of community based intervention models in the improving the 
survival  among low birth weights.119,120 
Thus investing in state of the art neonatal ICUs may not help the babies in born in 
villages. It would be more prudent therefore, as envisioned in the National Health rural 
mission (NHRM), to have a stratified approach to newborn care. At the most specialized 
level there can be regional perinatal centers which provide state of the art care for the 
very sick neonates. Preceding that, there should be  specialized care newborn units 
(SCNU) at district level, newborn stabilization units (NBSU) at first referral units, 
newborn care corners (NCC) at all active delivery points in a district and trained 
community health workers to provide home based care.79 This would ensure, accessible 
and affordable health care at the community level, identify high risk mothers who are 
likely to have sick babies and early referral to the appropriate level of care. This stepwise 
care can be the way forward in improving survival of low birth and preterm infants in this 
country.  
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3.2:  SECTION 2 - NEURODEVELOPMENTAL FOLLOW-UP AND 
ASSESSMENT: THE WHY, WHO, WHEN AND WHAT TO ASSESS 
 
This section briefly reviews the neurodevelopmental follow-up of VLBW & ELBW 
infants after their discharge from the NICU. In this section I have addressed the following 
questions about neurodevelopmental assessments and developmental follow-up. 
3.2.1:  What is the prevalence of neurodevelopmental disabilities among VLBW infants?  
3.2.2: Why do the VLBW children require formal neurodevelopmental assessments and 
regular follow-up?  
3.2.3:  Who are the children who require neurodevelopmental assessments?  
3.2.4:  When should the children undergo neurodevelopmental assessments? 
3.2.5:  Which domains require assessment? 
3.2.6:  What are the tools required for developmental assessment? 
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3.2.1 WHAT IS THE PREVALENCE OF NEURODEVELOPMENTAL DISABILITIES AMONG 
VLBW INFANTS? 
There has been a marked improvement in the perinatal care during the last two decades in 
India which has resulted in the survival of 89% of the preterm babies and 70% of the 
VLBW babies.13 This has become possible because of collaboration between the 
Neonatal specialists and obstetricians, successful implementation of the Neonatal 
Advance Life Support (NALS), technologic advances in neonatal care, better 
understanding and management of neonatal problems and the emphasis of  intact survival 
of newborn babies.121 However the improved survival of these infants has resulted in an 
increased number of  VLBW survivors with long-term neurodevelopmental sequelae.122 
Blindness following Retinopathy of prematurity (ROP), deafness, severe developmental 
delay and cerebral palsy are the major neurodevelopmental sequelae of VLBW infants.  
All these disabilities increase with decreasing birth weights and gestational age. In the 
United States, survivors of premature birth account for approximately 45% of the 
children with cerebral palsy, 35% of the children with vision impairment and 25% of the 
children with hearing impairment.123 
In Western populations the incidence of cerebral palsy is 15% to 20% for children with 
birth weights of less than 1,000 grams,124,125 14% to 17% for children with birth weights 
of 1,000 to 1,500 grams and 6% to 8% for children with birth weights of 1,500 to 2,499 
grams.126 Western studies have shown that the prevalence of blindness is 5% to 6%  and 
that of deafness is 2% to 3% among the VLBW population.126–128 
In India about 20-30% of the VLBW infants have ROP.129,130 Although most cases of 
ROP resolve and only few lead to permanent blindness, in view of the large number of 
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VLBW survivors,  ROP must be one of leading causes of blindness in the country.131 The  
incidence of cerebral palsy, obtained from hospital based studies among VLBW infants 
in India, is about 3-4%, 75,81 and that of significant developmental delay is about 8-
10%.76,78,132 Population based studies in this country have shown that the incidence of 
cerebral palsy is about 2.8 per 1000.133,134 Cross sectional studies on two cohorts of 
children with cerebral palsy from North India, about 10 years apart, have shown a change 
in the etiology of cerebral palsy. The more recent cohort showed a rise in the proportion 
of CP associated with prematurity (from 13.2% to 24.3%) and low birth weight (from 
20.4% to 37.87%).135,136   
Studies from the NICHHD137 and EPICure cohorts138 which have compared 
neurodevelopmental outcomes of ELBW infants at 18 to 22 months corrected age, during 
two epochs, have shown a better survival rate in the later cohorts but the rates of cerebral 
palsy and severe developmental disability have remained almost the same between the 
two time epochs. Thus the improvement in survival is at the expense of long-term 
developmental disabilities.  
“High prevalence- low severity” dysfunctions among the non-disabled survivors.  
Majority of the survivors of VLBW are “non-disabled” and do not have any of the major 
neurodevelopmental disabilities mentioned above. But as  the “non-disabled” VLBW or 
ELBW  children join school, many of them are detected to have learning disabilities, 
borderline mental retardation, attention deficit hyperactivity disorders and behavioral 
problems.139 These children are also at increased risk for anxiety, depression, social 
difficulties and conduct disorders.140 Although these are low-severity dysfunctions 
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compared to CP or blindness, their prevalence is much higher and they result in a lasting 
impact on the child and the family.141  
 
3.2.2 WHY DO THE VLBW CHILDREN REQUIRE FORMAL NEURODEVELOPMENTAL 
ASSESSMENTS AND REGULAR FOLLOW- UP? 
Since the sequelae of being born with a very low birth weight can affect the child for 
many years, it is vital that these complications are identified early and the interventions 
started as soon as possible. Therefore the primary responsibilities of the follow-up 
program are68 - 
a. Surveillance: Monitoring the growth and development of the VLBW and 
ELBW infants after discharge from the NICU and facilitating the continuity 
of clinical care. Follow-up programs also provide parental support, 
anticipatory guidance and expedite referrals to the early intervention 
programs. 
b. Information: Follow-up programs are also helpful for the NICUs to audit 
their interventions and provide the information about treatment outcomes. 
Collecting information from individual NICUs is useful in compiling 
regional and national databases which are valuable in guiding national health 
care planners. The information obtained from these databases also help in the 
anticipatory guidance of parents based on actual local scenario, rather than 
relying on information obtained other parts of the globe.142 
c. Research is an important component of follow-up programs. Short term 
outcomes of survival are not sufficient to assess efficacy and safety of 
therapies. Follow-up of these infants enrolled in well-designed cohort studies 
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or clinical trials is essential to evaluate the long term impact of the risk 
factors and interventions in the perinatal period and determine how they 
influence growth and development.68,80,121 A case in point is that of post-natal 
corticosteroids in bronchopulmonary dysplasia. Although initial short-term 
studies showed that corticosteroids were useful in treating the respiratory 
complications, only long term follow-up showed that corticosteroids 
adversely affected neurodevelopmental outcomes.143 
 
3.2.3 WHO ARE THE CHILDREN WHO REQUIRE NEURODEVELOPMENTAL 
ASSESSMENTS?  
A rigorous follow-up of all the neonates discharged from the NICU would not be 
practical or feasible. Therefore it is important to select infants who are at high risk of 
developing adverse neurodevelopmental outcomes.80 There are guidelines laid down by 
the NNF and the American Association of Pediatrics (AAP) for risk stratification of all 
“at risk” infants into “high risk”, “moderate risk” and “mild risk” for developing 
neurodevelopmental disorders. The guidelines for subsequent follow-up of these neonates 
are also laid down.68,121,144 The VLBW and ELBW babies are in the “high risk” category 
for developing adverse neurodevelopmental outcomes. 
 
3.2.4 WHEN SHOULD THE CHILDREN UNDERGO NEURODEVELOPMENTAL 
ASSESSMENTS?  
The age of assessment depends on the purpose of assessment. Long-term assessments (in 
children older than 5 years) are better, and their results are more predictive of the child’s 
future development.68  However, because of the huge costs involved and the difficulties 
in tracking the infants, most studies on the effects of perinatal risk factors or clinical trials 
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involving interventions in ELBW/VLBW infants are limited to 24 months.145  The British 
Association of Perinatal Medicine Working Group and the NICHHD consider that the 
age of two years (corrected for weeks of prematurity), as optimal for the assessment of 
neurodevelopmental outcomes.146 By 24 months of age, at least 90% of preterm infants 
with cerebral palsy, sensory deficits and significant developmental impairment can be 
identified.147 Diagnosis of CP at 24 months is no longer confounded by transient 
neurological syndromes of prematurity.148  Although five-year evaluations provide 
valuable information about school outcomes and behavior disorders, because of the huge 
expenses involved in long term tracking and the need for interim assessments, most 
follow-up studies are limited to 24-36 months. Furthermore since long term assessments 
can be affected by socio-economic and familial influences, the neurodevelopmental 
outcomes may not be due to the perinatal risk factors or NICU interventions.149   
The definitions of neurodevelopmental disability as defined by the British Association of 
Perinatal Medicine (2008) are shown in table 1.146 The severity of the disability is 
decided based on a standardized developmental test score, the presence of severe visual 
impairment, severe hearing loss and cerebral palsy. 
Table 1: British Association of Perinatal Medicine definitions for recommended 
outcome categories 
 
Domain Severe neurodevelopmental disability Moderate neurodevelopmental disability 
Motor Cerebral Palsy with GMFCS level ≥ level 3  Cerebral Palsy with GMFCS level 2 and less 
Cognitive Score less than 3 SD below norm Score -2SD to -3SD below norm 
Hearing More than 90dB (no useful hearing even 
with aids) 
Hearing loss corrected with aids (up to 70dB) 
Speech  & 
Language 
No meaningful words or signs Some but fewer than 5 words or signs 
Vision Blind or perceives light Moderately reduced vision 
LITERATURE REVIEW 
 
 Page 40 
 
Recent change in date of assessment by NICHHD:  Recently the NICHHD  has 
decided to do the assessments at 22-26 months corrected age, rather than 18-22 months 
because the predictive value of the neurologic examination and developmental 
assessments are better when the child is two years of age  despite the increased costs and 
difficulties in long-term tracking of the infants.150   
CORRECTING FOR PREMATURITY 
Application of corrected age (age of the child estimated from the expected date of 
delivery, rather than from the date of birth)151 is controversial but is generally accepted 
and is currently practiced in most studies on preterm infants.68  
Studies in favor of full correction  
Barrera compared two groups of preterm babies (VLBW group <1500 g and the other 
higher birth weight (HBW) group of babies 1500-2000 g) with full term babies by 
assessing their development periodically using the Bayley’s scales. It was found that 
when unadjusted for prematurity the VLBW infants were significantly delayed. However 
there was no significant difference when the groups were adjusted for prematurity.152  
Lems et al from their studies, has suggested that, that correction in motor and mental 
scores be used till the end of the first year.153 
Studies which do not advocate correction   
Siegal found that in the first year of life, corrected scores were more highly correlated 
with three and five year test scores. From 12 months of age on, uncorrected scores were 
more highly correlated. Based on these findings Siegel suggested that use of corrected 
scores is probably most appropriate during the first months of life when development is 
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strongly influenced by biologic factors. As the child matures and environmental factors 
become more important, it is appropriate then to use uncorrected scores.154 
The concept of correcting or not correcting for prematurity, is based on two different 
theoretical viewpoints.155 Those who advocate correcting for gestational age, believe that 
early development is dependent on the time since conception. Therefore premature 
infants lag behind term infants during early childhood temporarily. This is based on the 
idea that development depends on the maturation of central nervous system (CNS) and is 
independent of environment influences. The premature infants would catch up after 
complete maturation of their central nervous system. The preference for chronological 
age (no correction for prematurity) reflects an environmental perspective.155 Those who 
advocate this viewpoint believe that external factors are more important than biologic 
factors like CNS maturity and play a more important role in premature infants. They have 
purported that parental interaction and developmental stimulation are more predictive of 
better developmental outcomes.155  However the relative importance on biologic factors 
and environmental factors is still unclear. Currently there is no consensus about 
correction for prematurity.  
Although short-term conclusions about the outcome of VLBW and ELBW infants will 
differ, depending on whether corrected or uncorrected scores are used, long term 
outcomes are not affected by correction.139 Most clinicians support adjusting for 
prematurity in order to reduce parental anxiety and to prevent over referrals to early 
intervention services. However continued adjustment can lead to delayed diagnosis of 
developmental problems and late referrals.155  In clinical practice it is more important to 
show that the child’s development is progressing by periodic assessments than to make 
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conclusions based on a one-time score on the test. In NICHHD cohorts premature infants 
are corrected till 24-30 months although others recommend correction to 36 months.156 
ASSESSMENTS AFTER 36 MONTHS 
Many studies have shown that the complications of premature birth continue till 
adulthood. So there are now many large cohorts which have been followed into school 
age, adolescence and adulthood. The Pune cohort (table 3B) is the only example of 
dedicated long-term follow-up into adulthood from this country.71,73,74  
Assessments at 36 months to 5 years: Assessments at this age can measure language 
skills, evaluate school readiness and identify behavioral disorders. Intelligence testing to 
obtain the intelligence quotient (IQ) using standardized tests is also possible. Beyond 18 
months to 24 months, environmental factors start influencing the child’s development as 
well, so many studies include measures to evaluate home environments, socio-economic 
status parents and measures of daily functioning.157  
 6-8 years: In addition to IQ, assessment of learning and attention can be done. Specific 
learning deficits start manifesting at this age. Behavior assessments can be done at this 
age. After 8 years, the usual evaluations include those for IQ, specific learning disorders, 
and neuropsychological assessments like testing for executive functions.158  
 
3.2.5 WHICH DOMAINS REQUIRE ASSESSMENT? 
Assessments for VLBW infants are done in the  following categories - neurologic 
assessment (usually Amiel-Tison neurologic assessment), development and intelligence 
testing (using standardized developmental assessments and IQ tests), vision and visual 
motor integration, speech and language assessments, gross motor and fine motor 
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assessments, assessment of functional skills of daily living, school readiness and 
assessment of behavior.159 The AAP68 and the AIIMS (based on NNF guidelines)80,121 
have laid down protocols for assessment of these children at various ages. In addition 
neurologic and developmental assessment and monitoring of growth, VLBW infants 
should be screened for Retinopathy of Prematurity and a detailed assessment of the 
hearing must be done. If hearing loss is suspected the child should have Brainstem 
auditory evoked response or Oto-acoustic emissions to confirm the results. Table 2 
compares the assessments recommended by AAP and the NNF at 24-36 months. 
Table 2: AAP and the NNF - AIIMS protocols for assessment 
Area of 
assessment 
American Association of Pediatrics 
(AAP) Protocol 
NNF & All India Institute of Medical 
Sciences (AIIMS) Protocol 
Growth Weight, Length, Head circumference Weight, Length, Head circumference 
Nutrition Body Mass Index, skin folds, Caloric/protein 
fat intake; energy expenditure 
Mid arm circumference, Triceps skin 
fold thickness, Weight for length ratio, 
Growth velocity, Energy intake and 
energy expenditure, Bone density 
Neurologic 
assessment 
Standard for age; Amiel-Tison neurologic 
examination 
Standard for age; Amiel-Tison 
neurologic examination, Hammersmith 
neonatal neurological examination 
Neuroimaging Conventional As required (Ultrasonograms, CT or 
MRI) 
Development Psychomotor Development Index (PDI) and 
Mental Development Index (MDI) on Bayley’s 
Scale of Infant development (BSID)  
1. Development Observation Card (DOC)  
with CDC grading 
2. Trivandrum Developmental Screening 
Chart (TDSC) 
3. Denver Development Screening Test 
(DDST) / Denver II 
4. Development Assessment scale for 
Indian Infants (DASII) 
Language Parent check list,  
Usually limited at this age 
Language Evaluation Scale Trivandrum 
(0-3, Usually limited at this age 
Functional 
behavior 
Functional Independence measure (WeeFIM) 
, Vineland scales, CBCL 
Vineland Social Maturity Scales, CBCL, 
Screening for autism 
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3.2.6 WHAT ARE THE TOOLS REQUIRED FOR DEVELOPMENTAL ASSESSMENT? 
The gold standard for developmental assessment at 18-24 is the administration of a well-
standardized developmental test which covers motor, language, social and cognitive 
domains.145 The commonly used infant development scales are the Bayley Scales 
[currently the Bayley Scales for Infant and Toddler Development- 3rd edition (BSID-
3)],160 Griffith’s Mental Developmental Scales (GMDS),161,162 and the Developmental 
Assessment Scales for Indian Infants - 2nd edition (DASII).163 In all these scales the 
composite of the various abilities are computed to give the developmental quotient(s). In 
the GMDS this is termed as the General Quotient. The BSID and DASII have two 
components to the developmental quotient - the motor quotient [known as Psychomotor 
developmental quotient (PDI) in the BSID or Motor Developmental Quotient (MoDQ) in 
the DASII] and a mental quotient [called Mental developmental Index (MDI) in BSID or 
Mental developmental quotient (MoDQ) in the DASII]. The composite developmental 
quotient(s) can be compared to that of a normative sample consisting of other children of 
the same age. The results obtained about the developmental abilities should be an 
accurate reflection of the child’s capabilities and predictive of the child’s future 
development.164   
For many years the Griffiths scales were used as the standard “developmental test”. This 
has been now overtaken by the Bayley scales as the developmental assessment tool in 
many parts of the world. Most of the major longitudinal cohort studies (of the NICHHD 
in USA, EPICure in UK, and EPIPAGE in France and Victorian Collaboration in 
Australia) have used the Bayley Scales of Infant Development. However the Griffiths 
scales continues to be used in many of European and Asian countries for assessment of 
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infants and young children. Many studies involving ELBW and VLBW have used the 
GMDS for developmental assessment.165–171  
Developmental tests undergo extensive testing for validity, reliability, and accuracy and 
are standardized using children and families who represent the cultural, linguistic, and 
economic diversity of the intended population in order to be as accurate as possible.172  In 
India the most popular developmental assessment test is the Developmental Assessment 
Scale for Indian Infants.163 Although the DASII is referred to as the “gold standard” for 
assessment of Indian infants, it was standardized on a Marathi speaking population in 
Baroda. In view of the immense heterogeneity of the socio-cultural milieu and because of 
the numerous languages and dialects spoken in different parts of the country, it is likely 
that the current version of the DASII may not be culturally sensitive and appropriate for 
the population of the entire country. Sadly there is no other developmental assessment 
tool in this country. There are studies using the DASII in VLBW, ELBW infants 
(although the sample sizes are small) and in developmentally challenged children or from 
disadvantaged environments.76,173–178 
 
3.2.7 WHAT IS THE PREDICTIVE VALUE OF DEVELOPMENTAL ASSESSMENTS? 
It has been known for some time developmental assessments using the standardized 
developmental scales for infants (BSID and the GMDS) are not sensitive to predict the IQ 
of older children. This is mainly because, the decreased verbal skills in the toddlers 
compared to the older children, limits the comparability of the developmental 
assessments with IQ tests. Sutcliffe and colleagues179 found that the GQ obtained from 
the Griffiths’ scales at one and half year could predict the full scale IQ and the 
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performance IQ obtained from the Wechsler Preschool and Primary Scale of Intelligence-
Revised (WPPSI-R) intelligence test  to some extent, but the GQ could not predict the 
verbal IQ of the WPPSI-R.179 This is because at 18 months the verbal and language skills 
are only emerging and therefore, developmental assessments at this age will not 
accurately predict the verbal capabilities when the child is older. So the Griffiths measure 
is more likely to be useful as a general indicator of subsequent development, but not a 
test for predicting language abilities.  
Hack and colleagues found that Mental Development Index (MDI) on the BSID –II at 20 
months corrected age, was not predictive of cognitive functioning at 8 years in their 
cohort of 330 ELBW children. Although mean MDI at 20 months was 76, mean cognitive 
score at 8 years was 88. The positive predictive value of having a low cognitive score of 
<70 at 8 years given a low cognitive score (<70) at 20 months was only 0.37.180 Ment and 
colleagues had similar findings in a cohort of VLBW infants. Expressive language 
abilities were measured serially using the Peabody Picture vocabulary tests- revised 
(PPVT-R). They found that the scores seemed to improve with age. The median score 
was 88 at 3 years and 97 at 8 years.181  
Bowen and colleagues looked at the relationship between the Griffiths Mental 
Development Scales at 1 and 3 years and the Stanford-Binet Intelligence Scale. They 
found that the GQ at 3 years on the GMDS correlated with IQ score of the Stanford Binet 
IQ test, however the 1 year GQ had poor predictive value.182  
Although these results are encouraging, these findings do not mean that VLBW children 
with early delays routinely have later normal cognitive function. Furthermore in children 
without major neuro-disabilities, low score during infancy could be a marker for 
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subsequent risk of learning and behavior disorders at later school age.183 Therefore it is 
important the child is on regular developmental monitoring and early interventions 
should be provided in case there is a developmental delay detected at the time of the 
developmental assessment. 
 
3.2.8 NEUROLOGIC ASSESSMENT OF VLBW CHILDREN 
 
Severe neurodevelopmental impairments in the VLBW and ELBW survivors are usually 
due to neurologic and sensory (vision and hearing) impairments. Neurologic examination 
is thus an integral part of the neurodevelopmental follow-up.  In infants, unlike older 
children and adults much can be learned by observation of posture, movement, and 
quality of movement and examination of passive and active tone.184,185 So neurological 
examination techniques like the Amiel-Tison Neurologic examination or the 
Hammersmith neurologic examination technique are of immense value. Neurologic 
abnormalities become obvious while doing the motor components of developmental 
assessments, (like the Peabody Developmental Motor scales, Bayley’s, Griffiths or 
DASII) because the gross motor and fine motor skills will be affected if there are any 
abnormalities of tone and power.184 Infants with mild tonal abnormality usually improve 
with time unlike children with severe neurologic abnormality who are likely to develop 
neurodevelopmental disabilities.68  
The Amiel-Tison neurologic assessment is mainly based on the study of tone - active 
tone, passive tone and resting posture and is widely used for assessment of infants in 
India and all over the world.186,187 This is the usual neurologic examination done in the 
NICHHD studies. An Indian study showed that the assessment at three months by this 
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method is a good predictor of outcome at 12 months.185  Since this is a neuro-motor 
assessment, the mental abilities cannot be ascertained from this test and this requires a 
formal developmental assessment.184  
Transient dystonia which occurs in preterm and VLBW infants can confound the 
diagnosis of CP during the first year of life.185 This was first described by Drillien and 
manifests as increased tone of the trunk and lower limbs with persistent primitive reflexes 
leading to extensor posturing, scissoring, head lag and delayed supportive responses.188 
Although in the majority of preterms, the dystonia disappears, some infants go on to 
develop cerebral palsy as was shown in a recent study. The study was done on a cohort of 
children less than 2000 g and showed that in sixty five infants who had dystonia in the 
first year only eight infants were finally diagnosed to have CP at three years of age.189  
Another study from India showed that in a cohort of high risk infants who had increased 
tone, by the end of the first year, the tone had become normal in 87% and only 13% went 
on to have cerebral palsy.190  However presence of transient dystonia can increase the risk 
of cognitive and motor problems and it is not possible to make a confident differentiation 
between transient dystonia and cerebral palsy at 6–8 months of age.191 So meticulous 
follow-up of the child is necessary, for confirmation, till the end of the second year. 
Amiel-Tison Neurologic Assessment (ATNA) was initially developed for the neurologic 
examination of term and preterm infants. However Amiel-Tison and Gosselin have 
further developed this tool, so that with the same examination protocol and the same 
system of scoring, the clinician can detect neurologic abnormalities at term gestational 
age and continue to use the same instrument for follow-up of the child till six years of 
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age187,192  A study showed that infants who had abnormal neurologic signs on the ATNA 
at term gestational age were significantly worse on the Psychomotor and mental 
developmental indices of the Bayley scales at one year, and in another study showed 
infants who had neurologic deficits detected by the ATNA  had a lower general quotient 
(GQ) on the Griffiths’ mental developmental scales at 3 years and 8 month.187  
 
3.2.9 THE ADVANTAGES AND DISADVANTAGES OF USING BIRTH-WEIGHT OR 
GESTATIONAL AGE AS INCLUSION CRITERIA FOR VLBW INFANTS 
Prior to the 1990s infants were primarily grouped by birth weight rather than gestational 
age because of the uncertainty of the obstetric estimation of gestational age. However, 
advances in fetal ultrasonography have improved gestational age estimation.193 Since 
gestational age is a stronger determinant of organ maturation and viability than is birth 
weight,194 most Western studies report their outcomes according to the gestational age.  
Nevertheless reporting birth weights is also important in India, since  60% of the LBW 
babies have intrauterine growth restriction while the remaining 40% are born preterm.13 
So reporting only gestational age will miss the population of late preterm and term 
growth retarded infants. Additionally in most developing countries, because of the lack of 
adequate prenatal care, many women do not have early ultrasonograms which are needed 
for gestational age estimation. Therefore both birth weight and gestational age should be 
considered in outcomes studies.195  
To summarize this section, despite the costs involved in the follow-up of VLBW, this is 
an integral part of the continuum of care which starts at admission into the NICU. Long 
term outcomes determine the success of the interventions in the NICU and detect can 
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unanticipated complications. Although developmental assessments have questionable 
predictive value in predicting intelligence or scholastic performance, there is still much 
usefulness in these assessments. Developmental assessments provide an accurate measure 
of the child’s level of functioning in the pre-school age group, help in identifying 
children who require developmental remediation, and are an effective way of 
communicating with parents about their child’s developmental strengths and 
weaknesses.176 However follow-up should not end with pre-school age and meticulous 
monitoring is required to identify children who will have learning difficulties, attention 
problems and behavior disorders. 
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3.3: SECTION 3 - NEURODEVELOPMENTAL OUTCOMES IN INFANCY 
 
This section discusses briefly about the important studies which have reported on the 
neurodevelopmental outcomes of the VLBW infants in India and around the world. The 
section is arranged as follows - 
3.3.1: Findings of all the important studies which looked at the neurodevelopmental 
outcomes of VLBW babies in India other developing countries have been included. 
3.3.2: Important studies from the developed countries.  
3.3.3: Comparison of the Indian studies with that of the developed countries. 
The NICHHD defines “neurodevelopmental impairment” as – (a) Presence of 
Psychomotor developmental Index (PDI) of less than 70 and Mental developmental index 
(MDI) of less than 70 on the Bayley Scales of Infant development (BSID-3rd edition) (b) 
presence of visual impairment of less than 20/200 (c) hearing impairment requiring 
bilateral amplification (d) cerebral palsy.196 Since BSID-3rd edition is the most popular 
developmental assessment tool this definition is used in most Western studies. 
 
3.2.10 NEURODEVELOPMENTAL FOLLOW- UP OF INDIAN CHILDREN 
There are a few studies done in India which have followed up Very low birth weight 
infants from birth to a corrected age of two or three years. These are summarized in 
tables 3A and 3B.  To maintain continuity table 3B summarizes the studies done on the 
Pune Low birth weight cohort. This is the only cohort which has been followed up till 
adolescence. 
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Table 3A: Summary of Indian studies with longitudinal follow-up of Very Low birth 
infants 
Author (date) Research question Sample size and Tools used Main findings 
 
Nair (2014)
174
 
To assess effectiveness 
of TDSC based early 
intervention in LBW 
240 LBW (<2500 g) babies 
were compared to 260 normal 
controls 
TDSC (Trivandrum 
developmental scales for 
children) and DASII  
No difference in the 
development of LBW babies 
and the normal birth weight 
babies. Rates of CP  and 
developmental delay not 
mentioned. 
 
Lakshmi 
(2013)
197
 
Compare outcomes of 
preterm infants with 
history of absent or 
reversed end-diastolic 
umbilical artery Doppler 
flow (AREDF) vs. infants 
with forward end-
diastolic flow (FEDF). 
103 AREDF very low birth 
weight (<1500 g) (VLBW) 
infants and 117 FEDF VLBW 
infants  
Amiel- Tison Neurologic 
examination 
At 12-18 months corrected 
age, AREDF group had a 
trend towards 
increased risk for cerebral 
palsy (7% vs. 0.1%, P=0.06) 
compared to FEDF group. 
Modi (2012)
75
 Neurodevelopmental 
outcome of  VLBW at 12 
months 
corrected age. 
37 of initial 45  VLBW followed 
up at 1 year, compared to 35 
normal infants 
DASII 
DQ at 12 months was 
significantly lower in VLBW 
infants (91.5+7.8) than NBW 
infants (97.5±5.3) 
Sharma (2011)
82
 To determine 
neurosensory outcomes 
of VLBW (≤32 weeks 
≤1500 g) at corrected 
age (CA) of 18 months 
31 out of initial 64 completed 
assessment 
Amiel- Tison neurologic 
examination and DASII 
3 of 31 (10%) had cerebral 
palsy 
 
3of 31(10%)  had 
developmental delay 
Mukhopadhyay 
(2010)
76
 
 
Neurodevelopmental 
and behavioral 
assessment 
of  VLBW (≤34 weeks,  
≤1500 g) at corrected 
age (CA) of 2 years.. 
71 infants from the initial 
sample of 132 were assessed   
at 18  months. 20  infants 
were ELBW 
DASII and Preschool 
behavioral checklist (PBCL) at 
CA of 2 years. 
83% (of the 71 infants) had 
Mental DQ of ≥70 and 75% 
had motor DQ of ≥70. 
No difference between the 
ELBW and the rest in their 
mean Mental and motor 
Developmental quotients. 
 3% had cerebral palsy 
Paul (1998)
81
 
 
Neurodevelopmental 
outcome of “at risk” 
NICU graduates. 
101 infants were 
followed till 3 years. 
55 of 101 were VLBW. 
Followed up to 3 years CA. 
Bayley Scales of Infant 
Development (BSID) (with 
Phatak's adaptation for Indian 
Children) 
10.9% of VLBW had 
Neurodevelopmental 
impairment 
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Table 3B: Summary of the longitudinal follow-up of Very Low birth infants &  high 
risk infants from Pune71,74,83,84,198 
Author (date) Research question Sample size and Tools used Main findings 
Chaudhari (2013)
74
 To assess the cognitive 
development of non-
handicapped 
low birth weight (LBW) 
infants at 18 years 
161 LBW and 73 normal birth 
weight children 
Assessment of Cognition was 
done by Raven’s Progressive 
Matrices 
The IQ of the study 
group was significantly 
lower than that of 
controls. Preterm SGA 
had lowest IQ 
Chaudhari (2004)
71
 Assessment of IQ,  visuo-
motor skills, learning 
abilities in 12 years old 
children who were less 
than 2000 grams at birth 
180 children followed up of 
which 78 were VLBW. 
IQ test:  Wechsler’s Intelligence 
Scale,  
Visuo-motor:  Bender Gestalt 
test, Draw-a-Person   
Specific learning disability: 
Wide Range Achievement Test 
 
12 (15.4%) mentally 
retarded children in 
VLBW group as 
compared to only 3 
(3.3%) amongst controls.  
The number of children 
with mental retardation 
(IQ <70) had also risen 
form 3.5%  at 6 years to 
13.3% 
Chaudhari (2000)
198
 Study the mortality and 
morbidity in high risk 
infants  
• 286 high risk infants 
assessed. Of these 92 were 
VLBW 
• Stanford Binet IQ test at 6 
years 
Mortality was greater 
(22%) in the VLBW 
group. 16.3% of VLBW 
were ‘slow learners’ 
compared to 5.6% of 
children birth wt. 
>2000g 
Chaudhari (1996)
84
 Determine neurologic 
sequelae in high risk 
infant 
• 336 High risk vs. 70 normal 
controls followed up for 3 
years. 109 (32.4%) were 
VLBW.  
• Amiel-Tison Method, BSID 
and Raval's Scale for social 
maturity were used 
Totally 16 (4.8%) had 
cerebral palsy.  
Six (5.5%) of VLBW had 
CP.  
Sensorineural hearing 
loss was present in 5 
(1.5%) children while 1 
subject had cortical 
blindness. Seizure 
disorders in 3.9%. 
Chaudhari (1991)
83
 Determine the 
development of preterm 
babies. Followed up to 24 
months 
• 171 preterm babies, (of 
these, 75 or 43.7% were 
VLBW). 110 assessed at 18 
months and 81 at 24 
months 
• BSID -2 
7 of 171 (4%) had 
cerebral palsy 
4 of 171 (2.3%) had 
gross developmental 
delay. Morbidities in the 
VLBW subgroup not 
specified. 
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Neurodevelopmental follow-up from other developing countries 
Thailand: A study from Thailand which looked at the outcome of 30 VLBW infants at 
18-22 months. Of these five children (16.67%) had visual defect, one child (3.33%) had 
moderately severe hearing loss, one child  (3.33%) had cerebral palsy and seven children 
(23.33%) had delayed development.199 
South Africa: In this study the 106 of a total of 143 (74%) VLBW infants were 
evaluated using the BSID at 16.48 months (mean age). The mean cognitive subscale was 
88.6 (85.69 - 91.59 95% CI), nine children (8.5%) had developmental delay and cerebral 
palsy was diagnosed in 4 (3.7%) of babies.200      
Bangladesh: This was a study on a cohort of preterm newborn infant survivors (<33 
weeks).. 85 of the initial 159 infants (53.5%) were assessed using the BSID-II at a mean 
of 31 months. Of these 36% of the infants had developmental delay, 12% of the infants 
had CP, 18% of the infants had blindness and 6% of the infants had deafness.201 
 
3.2.11 NEURODEVELOPMENTAL FOLLOW- UP FROM OTHER COUNTRIES 
Table 4 summarizes the details of the recent studies from Western countries which have 
looked at the neurodevelopmental outcomes. Since the 1990s most developed countries 
have stopped looking at the outcomes of VLBW (1000-1500 g)  and most of the recent 
studies only discuss the outcomes of ELBW (less than 1000 g or 750 g) or extreme 
preterms (less than 28 weeks). However I have included a few studies from the 1990s 
which have looked at the neurodevelopmental outcomes of VLBW infants (<1500 g). 
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Table 4:  Summary of the Studies which have looked at the neurodevelopmental outcomes of VLBW and ELBW infants  
Author (year) 
Country 
Inclusion criteria 
(GA/Birth weight) 
Age of 
assessment  
& test 
 
Neurodevelopmental Impairment 
 
Other characteristics 
Serenius (2013)
202
 
(EXPRESS study,  
Sweden) 
All infants born alive or 
stillborn in Sweden before 27 
weeks gestation between 
2004 and 2007. Compared 
with age and sex matched 
controls. 456 of 491 (94%) 
children were evaluated 
2.5 years 
BSID -III 
94% of survivors were followed up. 
44.5% had delay on BSID (20% 
moderate to severe) 
CP: 7% (1.3% severe) 
Visual impairment: 3.7% (0.9% blind) 
Hearing impaired: 0.9% (0.2% deaf)  
Incidence of disability was inversely 
related to the gestational age. 
(60% at 22 weeks; 51% at 23 weeks, 
34% at 24 weeks,27% at 25 weeks,; 
and 17% at 26 weeks). 
 
Ishii (2013)
203
 
Japanese 
Neonatal 
research network 
ELBWs born between 22 and 
25 weeks.   
36-42 
months. 
Kyoto Scale 
of 
Psychological 
Development 
562 of 782 (71.9%) were followed up 
13.7% of survivors had CP 
8.2% had hearing impairment 
1.7% had visual impairment 
35.4% had cognitive delay 
Study with largest number of 
survivors at 22 -23 weeks. 45.5%  of 
22 weeks survivors, 32.8% of 23 
week, 36.6% of 24 weeks and 33.1% 
of 25 weeks  had DQ <70. 
Hintz (2011)
204
 
NCHHD-NRN 
USA 
 
Extremely low birth weights at 
an estimated gestational age 
of <25 weeks during 2 periods: 
1999–2001 (epoch 1) and 
2002–2004 (epoch 2). 
18-22 
months 
BSID-II 
Infant survival was similar between 
epochs (35.4%, vs. 32.3%)  
Moderate-to-severe CP: 11.1%  
(epoch 1) vs. 14.9%  (epoch 2) 
MDI was <70 in 44.9% in epoch 1 and 
51% in epoch 2  
Neurodevelopmental impairment was 
diagnosed in 50.1%  v. 58.7%  
Early-childhood outcomes for infants 
born at <25 weeks' estimated 
gestational age were unchanged 
between the 2 periods. 
Schlapbach 
(2012)
205
 
Switzerland 
Extremely premature infants 
live born between 24 and 27 
weeks from 1/1/2000-
31/12/08  
18-24 
months 
BSID-II 
684/844 (81%) were followed up. 
64% showed good outcome, 24% had 
moderate and 11% severe 
neurodevelopmental impairment. 
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Gargus (2009)
206
 
NICHHD-NRN 
(USA) 
To look for unimpaired ELBW 
survivors in the NICHHD 
cohorts 1998-2001.  
(Unimpaired PDI and MDI in 
BSID  within 1 SD of the mean, 
normal neurologic exam, 
vision, hearing swallowing 
were normal 
18-24 m 
BSID II 
Outcomes of 5250 (84%)  infants 
were known at 18 m.  16% were 
unimpaired 22% had mild 
impairments, 22% had 
moderate/severe 
neurodevelopmental impairments 
(Bailey <70, CP, Bilateral blind or 
deaf) 
Less than 1% of live-born infants of  
500 g survive free of impairment at 
18 months, this increases to almost 
24% for 
infants of 901 to 1000 g. Female 
gender, singleton birth, higher birth 
weight, absence of neonatal 
morbidities, are related to better 
unimpaired outcomes 
Doyle (2010)
207
 
Victorian Infant 
Collaborative 
Study 
Group, Australia 
All live born infants 22-27 
weeks GA were included and 
survivors (n=172) was 
assessed 
2 years 
BSID-III 
94.8% were followed up 
9.8% had CP 
2.5% deaf. None were blind 
Dev. Delay in 47.9% (16% moderate 
to severe delay) 
 
Compared to cohorts in 1991-2 and 
97-98 from the same region survival 
rates for infants born at 22-27 seems 
to be the same but the neurosensory 
outcomes in survivors appear to have 
improved 
Bodeau-Livinec 
(2008)
208
  
EPIPAGE (France) 
and British Isles 
(EPICure) 
 
EPICure and EPIPAGE are 2 
population-based studies, 
from the British Isles and 
France, respectively, that 
included extremely preterm 
infants (<28 weeks) 
2 years BSID 
Kaufman 
Assessment 
Battery for 
Children (K-
ABC) at 5-6 
years 
 
90% (280 infants) followed up.  
CP  at 24 to 30 months 
was 20% in the EPICure study versus 
16% in the EPIPAGE study, whereas 
the risk 
Dev. Delay :<70 (-2SD)  at 5 to 6 years 
was 10% vs. 14%, respectively 
Outcomes between the two studies 
were not significantly different. 
Sommer (2007)
209
 
Austria 
48/53 (91%)  of infants <27  
weeks  GA were assessed 
2 years 
GMDS 
CP in 6% (4% non-ambulant &, 2% 
ambulant)  
Development: 40%  were normal, 6%  
had mild delay, 35% (moderate delay) 
and 19% severe delay (DQ<-3 SD) 
Profound growth failure in weight  in 
39% and head circumference<3rd in 
19% of the infants at 2 years 
Gianni (2007)
210
 
Italy 
141 ELBW infants assessed 
Compared MRI at term 
conceptional age, 
neurofunctional exam at 1 
year and assessment at 36 m 
 
36 months 
GMDS 
CP: Not mentioned 
Developmental delay (GQ≤70): 14.2% 
Abnormal MRI at term conceptional 
age, and poor Neurofunctional 
assessment at 1 year can predict poor 
cognitive outcome at 36 months 
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Hoekstra 
(2004)
211
 
Minnesota (USA) 
Retrospective review of  778 
infants between 23-26 weeks  
BSID – II 
At 36 m 
3-6 y: DDST , 
ELMS, ZPAT  
 
87% were followed up at mean of 
47.5 months. 
CP: Not mentioned 
17% had moderate impairment and 
20% severe impairment 
Proportion of severe impairment 
decreased with increasing age. 
34%, 21%, 20%, 17% for 23, 24, 25, 26 
weeks gestation respectively 
Wood (2000)
125
 
EPICure study 
(UK) 
Prospective longitudinal 
cohort.  283 survivors of 20-25 
completed weeks gestation 
BSID-II 
At 30 months 
92% follow-up. 
CP: 50/280 (18%) 
Blind: 7 (0.03%) 
Deaf : 5 (0.02%) had profound 
deafness 
Many others had less severe degree 
hearing and visual impairments 
 
At 30 months almost 50% of the 
survivors had disabilities in mental 
and psychomotor development, 
neuromotor function, or sensory and 
communication function. About 25% 
of them had severe disability. 
Vohr (2000)
212
 
NICHHD-NRN 
(USA) 
Cohort of 1765 VLBW (<1500 
g) infants in the NICHHD 
network 
BSID-II at 8-
22 months 
corrected 
gestational 
age 
78% were followed up 
17% had CP 
 37% MDI <70, 29% PDI <70,  
vision impairment: 9% 
hearing impairment: 11%. 
CP, developmental delay increased 
with decreasing birth weight. 
 
Ment (1996)
213
 
NICHHD-NRN 
(USA) 
Randomized, trial for 
preventing IVH with low dose 
indomethacin in <1250 g 
infants.  Study group got 
indomethacin and control 
group got saline 
Stanford- 
Binet IQ test 
at 36 month 
343 (89%) children were examined at 
8% each in both groups had CP 
No difference in mean IQ between 
the two groups 
Low dose indomethacin was shown 
not have any neurodevelopmental 
consequence and was found to 
improve survival at 36 months 
Veelken (1991)
214
 
Germany 
Prospective cohort of VLBW 
Babies 
 
GMDS at 18-
20 m 
CP: 14.8% 
8% without neurological 
abnormalities was moderately 
retarded 
5% were severely retarded  
1.5% were blind due to ROP. 
 
ELMS: Early Language Milestone Scale; ZPAT: Zimmerman Preschool Articulation Test. 
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3.2.12 COMPARING THE NEURODEVELOPMENTAL OUTCOMES OF VLBW INFANTS IN 
INDIA WITH THAT OF THE DEVELOPED COUNTRIES. 
 
Let me first summarize the findings of outcomes from the cohorts from the developed 
countries.  
1. Survival has improved and the limits of viability are changing  
In developed countries advances in the last two decades in perinatal and neonatal 
management have resulted in the survival of extremely premature infants who are born at 
the limits of viability (22–25 weeks). The use of prenatal corticosteroids for fetal lung 
maturity, surfactant in respiratory distress syndrome, prophylactic indomethacin for 
prevention of intraventricular hemorrhage, improved nutritional management and 
ventilatory techniques have all contributed to the improved survival.215–217 A 2012 
NICHD study of infants <1000 g and <28 weeks gestation born between 2002 and 2008 
reported a survival rate of 39% for infants less than 24 weeks compared with 81% for 
infants  between 25 and 27 weeks gestation.218  There are studies from Japan which have 
reported infants who were born at the limits of viability (22 weeks) and survived.203 
Currently the survival rates are approximately 85% for VLBW and 70% for ELBW 
infants in developed countries.219 
2. Neurodevelopmental outcomes have not improved much 
As mentioned earlier, improved survival has not resulted in improved 
neurodevelopmental outcomes. There is an inverse relationship between birth weight or 
gestational age and the risk for developmental impairment. There is an increase in the 
level of neurodevelopmental impairment as birth-weight or gestational age (especially in 
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the less than 25 weeks) decreases and this is seen all the studies cited. Although there has 
been some evidence of improvement in neurodevelopmental impairment rates since the 
1990s, rates are high particularly in the between 22 and 25 weeks gestational age 
infants.220 
3.  Differences in survival 
There are significant differences in rates of survival and neurodevelopmental impairment 
by geographic region and neonatal network related to multiple factors including 
population characteristics, perinatal and neonatal management and the follow-up 
protocols  
However it must be emphasized that these studies summarized in the table 4 were done 
in countries where there is relatively easy access to perinatal care, there are regional 
centers  specialized in looking after ELBW babies, provision of life support at delivery 
and near universal admission for infants who are micro-preemies (less than 26 weeks 
gestation). This is not possible in a resource stretched country like India, where the 
enormous costs for perinatal care is borne by the parents and where most people are poor. 
Summarizing the data from Indian studies 
Unfortunately there is a paucity of data. Tables 3A and 3B present the data of all studies 
in India which have looked at the outcome of VLBW infants in the last two decades. 
Combining all the studies, we have information of less than 600 VLBW infants. 
From the available database summarized (tables 3A and 3B) the following relevant 
observations can be made - 
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1. The sample sizes of the individual studies are very small. In addition some studies 
have looked at the outcomes of the VLBW infants as part of the developmental 
follow-up of a heterogeneous group of “high risk infants”. In these mixed cohorts 
the etiologies, risk factors and outcomes are varied and therefore it is difficult to 
make definite conclusions.22  
2. All the Indian studies are hospital based studies from tertiary centers which are 
regional referral centers. Therefore it may not be correct to extrapolate the results 
of these studies to the entire country. The dropouts are also very large (ranging 
from 18% to about 50%) and so it is difficult to estimate the true level of 
incidence of cerebral palsy or other neurosensory impairments.  It is important to 
have information of the all the infants who are recruited since children who 
dropped out may be more affected than children who are followed up.145 
3. It is also not clear if the children who were lost to follow-up were the children 
with good outcomes or the ones with neurodevelopmental impairment. Other 
studies have shown that children who were more difficult to track are likely to 
have higher rates of disability.221,222 Especially among the lower socioeconomic 
groups, untraced survivors may be more handicapped as those who are 
evaluated.223 Even survival of these babies is uncertain.   
4. Moreover the outcomes which were reported were not uniform. Most studies have 
reported cerebral palsy, but not all the studies have reported the incidence of 
global developmental delay or neurosensory impairments. 
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Since there is limited data (regionally and nationally) on the incidence of cerebral palsy 
or developmental delay in the general population, it is difficult to determine the risk of 
having cerebral palsy in the VLBW as compared to the term infants.59  
In spite of the limitations the following can be inferred -   
1. There are significant neurodevelopmental morbidities among VLBW children 
which are evident from early childhood. The main morbidities being cerebral 
palsy, developmental delay, sensory impairments (deafness, blindness) and 
behavior problems. 
2. The incidence of cerebral palsy among the VLBW in all studies ranges between 
3% and 5%, which is comparable to data available from Western studies. In 
Escobar’s meta-analysis of the outcomes of VLBW from about 100  Western 
studies the  median  incidence of cerebral palsy was 7.7% and the estimated 
incidence of disabilities among VLBW survivors was 25%.59 
Thus in order to improve the information about the outcome of VLBW from India, it is 
imperative that all centers which look after these babies in this country, contribute the 
data obtained from their developmental follow-up programs into a national database. This 
information can then be used for counseling parents, for allocation of resources and for 
making national policy decisions. 
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3.4:  SECTION 4 - NEONATAL COMPLICATIONS AND THEIR EFFECTS 
ON THE NEURODEVELOPMENTAL OUTCOME 
 
The complications which occur in VLBW infants are predominantly because of the 
immaturity of their organs to adapt to an extra-uterine environment. The risk of acute 
neonatal illness increases with decreasing gestational age, reflecting the fragility and 
immaturity of the brain, lungs, immune system, kidneys, skin, eyes, and gastrointestinal 
system. These complications which have life-long consequences in terms of the 
neurodevelopmental outcome, are further influenced by the effects of the social factors 
which come into play from early childhood.  
Usually there are three risk categories which decide the developmental outcome of 
VLBW/ELBW babies.68,164 
• Biologic risks: These are perinatal complications which include lower birth 
weight, prematurity, IVH, PVL, NEC, congenital anomalies, CLD, septicemia, 
meningitis etc.  
• Risks of therapeutic interventions: These are adverse effects which occur due to 
treatment modalities like ventilation, parenteral nutrition, oxygen therapy, post-
natal administration of corticosteroids etc. 
• Effects of the social and environmental characteristics: The social and/or 
environmental characteristics of families become more increasingly important as 
the child matures and some of these include socio-economic status (SES), 
maternal education, marital status, income, mother’s age and environmental 
stress. 
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This section refers to some of the important risk factors in the neonatal period and 
interventions which have been shown to affect the neurodevelopmental and cognitive 
outcomes of preterm and low birth weight infants. Since most of the studies have used 
Bayley’s Scales of Infant Development for developmental assessment, developmental 
outcomes are expressed in terms of the Psychomotor developmental index (PDI) and 
Mental developmental index (MDI).  Neurodevelopmental impairment is defined as <70 
on the PDI and <70 on the MDI or presence of cerebral palsy, blindness or hearing 
impairment.  
It is important to realize that neonatal morbidities associated with the adverse outcomes 
and interventions in the NICU do not occur in isolation. A study which looked at the 
influence of multiple morbidities showed that the rate of neurodevelopmental impairment 
(NDI) increases with every added morbidity.224 The morbidities analyzed in this study 
were bronchopulmonary dysplasia, severe brain injury and severe Retinopathy of 
prematurity. For the entire cohort the NDI was 35%. However the rate of NDI was 18% 
for children with no morbidity, 42% for those with one morbidity, 78% for those with 
two morbidities and 88% for those with all three morbidities.  The NDI rate for children 
with three neonatal morbidities was almost five times the rate of children with no history 
of neonatal morbidities. Thus  survival  in the nursery and later neurodevelopmental 
outcomes are the cumulative effect of the multiple morbidities and multivariate analyses 
are required to confirm independent effects of the morbidities.164 
In this section the influence of the following factors on the neurodevelopmental outcomes 
of VLBW infants have been reviewed in the following subsections - 
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Male gender (3.4.1), extreme prematurity (3.4.2), antenatal corticosteroids and RDS 
(3.4.3), bronchopulmonary dysplasia (3.4.4), post-natal corticosteroids (3.4.5), NEC 
(3.4.6), septicemia (3.4.7), PVL (3.4.10), IVH (3.4.11). The outcomes which result in 
neurodevelopmental impairment like visual impairment (3.4.8), hearing impairment 
(3.4.9) and cerebral palsy (3.4.12) are also included. 
 
3.4.1 MALE GENDER 
 
Although male gender is not a “risk factor” for poor neurodevelopmental outcome, most 
studies have demonstrated that male ELBW infants are more likely to have cerebral palsy 
or severe neurodevelopmental impairments compared to female infants.225-227  
In a NICHHD cohort of over 7000 VLBW infants, boys had higher rates of BPD, had 
lower APGAR scores and were less likely to survive.225 In another study which looked at 
the neurodevelopmental outcomes of ELBW babies at 18-22 months corrected gestational 
age, the survival of boys was 58.3% compared to 66.9% in girls, and boys were more 
likely to have BPD, severe IVH and ROP “plus disease”. Boys were more likely to have 
MDI <70 (41.9% vs. 27.1%) compared to girls. Multivariate analyses confirmed the 
independent effect  of male sex on the outcomes in this study.226  The differences in the 
outcomes seem to persist into school age and adulthood. The clinical trial on 
“Indomethacin in IVH prevention”, showed that at eight years of age, boys in the study 
were more likely to have difficulties in reading and lower cognitive scores as compared 
to the girls who took part in the study.228 Another study showed that at 20 years of age, 
VLBW males were shorter compared to their normal birth-weight male peers, but VLBW 
girls had caught up with their normal birth-weight peers.229 However a recent study from 
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Australia demonstrated that, although the mortality and neurologic outcomes at 2-3 years 
were worse in male VLBW infants, these were most pronounced in infants who were less 
than 27 weeks gestation and  gender differences were not significant in infants after 27 
weeks gestation.230 
Fleisher and colleagues looked at four indices of lung profile (lecithin / sphingomyelin 
ratios, percentage disaturated lecithin, phosphatidyl-glycerol, and phosphatidylinositol) 
from the amniotic fluids of male and female fetuses.  They demonstrated that all four 
indices revealed a higher degree of lung maturity in female than in male fetuses during 
the last two months of normal pregnancy.231 Furthermore, in-vitro studies on male rat 
fetuses are have revealed that androgens and Mullerian Inhibiting Factor adversely 
affected surfactant production, which probably contributes to the lung immaturity in 
premature males.221,222 
 Thus, the lung immaturity probably predisposes the male infants to higher rates of RDS, 
intubation, BPD and contributes to the higher rates of IVH, all of which can result in 
higher mortality and adverse neurodevelopmental outcomes. This lung immaturity 
hypotheses is supported by studies which show that the differences in survival are more 
apparent in infants who are more premature.234  
 
3.4.2 EXTREME PREMATURITY 
 
It is well known that the outcomes of ELBW and extremely premature infants are far 
worse than infants who are born at later gestational ages. During the second and third 
trimester there is active brain growth with neuronogenesis, neuronal migration, 
maturation, apoptosis and synaptogenesis.235 During this active period of growth, the 
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immature brain is vulnerable to hypoxia, ischemia, under-nutrition and sepsis which can 
result in a cascade of events increasing the threat of complications like germinal matrix 
hemorrhage, periventricular leukomalacia and ventriculomegaly, all of which lead to 
subsequent neurodevelopmental impairment.164 Much of the poor cognitive outcomes in 
extremely premature babies are due to the sequelae of PVL and IVH. The stress of the 
therapeutic measures during their prolonged NICU stay further increases the vulnerability 
to injury.  
MRI studies have shown that the volumes of grey matter, white matter, basal ganglia and 
cerebellum are much lesser in children who were born preterm compared to their age-
matched peers.236  Even in premature infants  with  no evidence of white matter 
involvement on neonatal cranial ultrasound, diffusion-tensor imaging (DTI) has shown 
microstructural abnormalities in the neural connectivity of premature children compared 
to term controls at 12 years of age which has correlated significantly with cognitive 
outcomes.237  
Extremely premature infants breathe through their terminal bronchioles, since their 
alveoli are still underdeveloped and they lack surfactant. By approximately 30 to 32 
weeks of gestation, the lungs make surfactant which reduces the alveolar surface tension, 
thereby facilitating alveolar expansion and reducing the likelihood of alveolar collapse 
atelectasis.238 Respiratory distress syndrome (RDS), a common complication of 
prematurity, is caused primarily by deficiency of pulmonary surfactant in the immature 
lung.238 RDS  and other pulmonary complications (pneumothorax, hypercapnia, hypoxia) 
predispose to development of intraventricular hemorrhage.239 It has been shown that even 
in children with uncomplicated IVH (no parenchymal involvement or ventriculomegaly) 
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the cognitive outcomes are worse 240 compared to infants without IVH. Furthermore 
studies have also shown that uncomplicated IVH is associated with 16% decrease in 
cortical volume at term gestational age.241 
Thus the grey matter and white matter structures of preterm survivors are different from 
their term counterparts and these structural differences manifest as learning and behavior 
abnormalities later in life. 
 
3.4.3 RESPIRATORY DISTRESS & ADMINISTRATION ANTENATAL CORTICOSTEROIDS  
Respiratory distress syndrome is a major cause of morbidity and mortality in preterm 
infants and its incidence increases with decreasing gestational age. The risk is highest in 
extremely preterm infants, as illustrated by a study from the NICHHD that found a 93 
percent incidence of RDS in a cohort of 9575 extremely preterm infants (gestational age 
28 weeks or below) born between 2003 and 2007.242  
Specific interventions are focused on preventing or decreasing the severity of RDS and 
include the following243 - 
• Administration of antenatal corticosteroids 
• Administration of exogenous surfactant 
• Provision of assisted ventilation 
The administration of antenatal glucocorticoids reduces the risk of RDS in premature 
infants because it improves neonatal lung function by enhancing maturational changes in 
lung architecture and by inducing enzymes that stimulate phospholipid synthesis and 
release of surfactant.244  
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In addition to its benefits in RDS, antenatal corticosteroid administration has been shown 
to decrease mortality, and rates of IVH  and incidence of chronic lung.245,246 The 
Cochrane review on antenatal administration of corticosteroids found that there was 
reduction in the rate of neonatal death (Relative Risk 0.69), Respiratory distress 
syndrome (RR 0.66), respiratory support and intensive care admissions (RR0.80), 
intraventricular hemorrhage (RR 0.54), necrotizing enterocolitis (RR0.46) and early onset 
sepsis (RR 0.56).247 Currently all mothers who are at risk of preterm delivery of less than 
34 weeks gestation are advised corticosteroids.248  
In addition to its benefits in reducing mortality and the incidence of IVH, RDS and BPD, 
antenatal corticosteroids have been shown to significantly improve neurodevelopmental 
outcomes. A large multi-center trial which looked at the neurodevelopmental outcomes of 
nearly five thousand ELBW infants at 18-22 months showed, neurodevelopmental 
impairment (moderate–severe cerebral palsy and psychomotor developmental delay), 
intraventricular hemorrhage and periventricular leukomalacia and necrotizing 
enterocolitis were significantly less in the children who were administered antenatal 
corticosteroids.249  
 
3.4.4 BRONCHOPULMONARY DYSPLASIA (BPD) AND NEURO- DEVELOPMENTAL 
OUTCOMES 
Bronchopulmonary dysplasia (BPD) is a serious morbidity among preterm infants and is 
diagnosed when there is a continued need for supplemental oxygen at 36 weeks 
postmenstrual age.250 The incidence of BPD increases with decreasing gestational age 
(the incidence is  42% for birth weights 501–750 g, 25%  for birth weights 751–1000 g, 
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11%  for birth weights 1001–1250 g and 5% when the birth weights are  1251–1500 g).103 
Infants with a birth weight of less than 1250 g account for 97% of all patients with 
BPD.103 In another 42% of the infants less than 28 week gestational age had BPD.242  
Mortality: Infants with severe BPD have a higher risk of mortality than infants with mild 
disease or unaffected of the same gestational age. Death is usually caused by respiratory 
failure, unremitting pulmonary hypertension with cor pulmonale, or acquired infection.25 
Neurodevelopmental impairment  
BPD increases the risk of neurodevelopmental impairment in the preterm and the VLBW 
infants and this is probably as a result of multiple contributing factors like frequent 
episodes of hypoxia, poor growth, and probably because of use of post-natal 
corticosteroids.251 The spectrum of neurodevelopmental impairment seems to correlate 
well with the severity of BPD and  a large cohort study showed that the incidence of 
cerebral palsy, developmental delay, blindness,  hearing impairment and growth 
outcomes  worsened with the severity of BPD.252  Another study showed that BPD and 
post-natal corticosteroid treatment for BPD were significant risk factors for neurologic 
abnormality and neurodevelopmental impairment (MDI and PDI of <70 on the Bayley 
Scales of Infant Development).212 The effect of BPD on neurodevelopmental outcomes 
persists through school age  as demonstrated in a study which showed that the VLBW 
infants who had BPD, when tested at 8 to 10 years of age, scored poorly in their cognitive 
performance, compared with controls.253 Another study on the survivors of BPD at 10 
years of age, showed that on comparing with unaffected preterm controls, neurological 
abnormalities, including subtle neurological signs, cerebral palsy, microcephaly, and 
behavioral difficulties were highly prevalent in the BPD group (71% compared with 19% 
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in control group, P<0.005).254 Infants with BPD have poor post-natal growth and this 
may be due to increased energy expenditure associated with their respiratory disease, 
difficulty in maintaining full nutrient and mineral intake, and due to diuretic therapy.255  
The long- term effects of BPD on growth are not certain. Previous studies have indicated 
that children with BPD are smaller in size than controls.256 However after taking into 
account possible confounders, some studies have shown that the poor growth in BPD 
may be due to the overall effect of prematurity and perinatal complications because of the 
BPD alone.257,258 
Long term pulmonary complications of bronchopulmonary dysplasia  
Up to 50 percent of children with BPD require re-hospitalization during the first two 
years of life, usually due to viral respiratory illnesses.259,260 Recurrent wheezing episodes 
are very common in children with bronchopulmonary dysplasia, but unlike in asthma 
they are less likely to respond to bronchodilators.261,262.  Pulmonary Artery Hypertension 
(PAH) which occurs in 20–40% of infants with BPD is an important risk factor for 
mortality.263 Airway hyper-reactivity, airway obstruction and emphysema are the 
adulthood consequences of BPD in the neonatal period.264  
 
3.4.5 POST-NATAL CORTICOSTEROIDS IN BRONCHOPULMONARY DYSPLASIA AND 
ITS EFFECT ON NEURODEVELOPMENTAL OUTCOME 
Initial reports indicated that there was significant improvement of BPD in infants 
following the administration of corticosteroids.  However Yeh et al reported that 
although dexamethasone had  reduced the incidence of BPD, infants exposed to 
dexamethasone had higher rates of neuromotor dysfunction (39.7% vs. 17.1%) compared 
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to placebo controls.265 When these survivors were re-evaluated at 8 years of age, children 
who had received dexamethasone were found to have lower verbal, performance and full 
scale IQ in addition to the persistence of poor motor skills. The mean head circumference 
and height were also  lower for the dexamethasone group.266 
A recent Cochrane review on the effects of administering post-natal corticosteroids has 
shown that it reduces the risk of developing bronchopulmonary dysplasia and patent 
ductus arteriosus. However there are short-term adverse effects which include 
gastrointestinal bleeding, intestinal perforation, hyperglycemia, hypertension, 
hypertrophic cardiomyopathy and growth failure. The review found that there is  an 
increased risk of abnormal neurological examination and cerebral palsy with post-natal 
corticosteroid administration.267 
However the in the latest trial using dexamethasone to prevent chronic lung disease, it 
was found that the risk of death, NDI and poor growth were similar between the 
treatment group and the control group. According to the authors this may be because 49% 
of the placebo group had received corticosteroids for other reasons during their NICU 
stay.268 Currently use of post-natal corticosteroids to prevent bronchopulmonary 
dysplasia is not recommended.269   
 
3.4.6 NECROTISING ENTEROCOLITIS AND NEURODEVELOPMENTAL OUTCOMES 
The clinical condition of Necrotizing enterocolitis (NEC) is characterized by ischemic 
necrosis of the intestinal mucosa and affects about 10-15% of the VLBW infants.270,242 
The severity of NEC depends on the staging initially proposed by Bell and modified by 
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Walsh and Kliegman271,272. Although most cases resolve with conservative management, 
advanced NEC which can result in bowel perforation would require surgery.  
Nursery outcomes  
Advances in the neonatal intensive care, earlier diagnosis, and aggressive treatment have 
improved the outcome of infants with necrotizing enterocolitis.  As a result, 
approximately 70 to 80 percent of infants who have NEC survive. 
Survival following NEC depends on the severity of the condition.  In a large Western 
study of about 18,000 infants with NEC there was an overall mortality of 28%, and the 
mortality was higher (35%) among those who required surgery.273  Other studies have 
also shown that mortality is more likely in those who undergo surgical intervention than 
in infants who undergo conservative treatment.274 
The mortality decreases with increasing birth weight. This is evident from the data from 
the Vermont Oxford Network 275 on  over 70,000 premature infants which showed that 
the risk of decreased with increasing birth weight (BW) as follows - 
• Birth weight 501 to 750 g – 12 percent risk, 42 percent mortality with NEC 
• Birth weight 751 to 1000 g – 9 percent risk, 29 percent mortality with NEC 
• Birth weight 1001 to 1250 g – 6 percent risk, 21 percent mortality with NEC 
• Birth weight 1251 to 1500 g – 3 percent risk, 16 percent mortality with NEC 
Neurodevelopmental Outcomes: Hintz et al compared neurodevelopmental and growth 
outcomes of ELBW infants with surgically treated NEC and medically treated NEC, with 
infants without NEC in a retrospective study of over 2500 infants from the NICHHD 
registry. At 18-22 months corrected gestational age, 24% of infants who had surgically 
managed NEC developed CP, and 37% of those children had cognitive disabilities (MDI 
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<70, PDI <70) compared to those who did not have NEC. Regression analysis confirmed 
that surgical NEC was an independent risk factor for neurodevelopmental impairment.276  
Chacko and colleagues277 demonstrated that the ELBW infants who underwent 
laparotomy (majority of which was for NEC) had a poor developmental outcome as 
compared to controls. They speculated that occurrence of NEC and bowel perforations 
are frequently associated with cardiorespiratory failure and sepsis resulting in metabolic 
acidosis and hypotension which are in turn associated with poor neurodevelopmental 
outcomes. Other studies have also confirmed that children with NEC who undergo 
surgery have a poorer developmental outcomes.278,279 
A meta-analysis showed that 45% of children who had neonatal NEC had a higher risk of 
cerebral palsy, visual, cognitive and psychomotor impairment. The infants who have 
Bell’s stage III and those who required surgery had more than twice the risk of 
neurodevelopmental impairment compared to infants who did not require surgery.56,280  
NEC especially those which require surgical intervention is associated with 
neurodevelopmental impairment and so the impact of NEC reaches beyond the 
gastrointestinal system affecting both neuromotor and cognitive outcomes.281 The strong 
association of surgically treated NEC with poor outcome may reflect the fact that the 
sickest infants are the ones who need surgical intervention and therefore are likely to 
have post-operative complications which may independently affect neurodevelopmental 
outcome.270 
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3.4.7 NEONATAL SEPSIS, MENINGITIS AND NEURODEVELOPMENTAL OUTCOMES 
Septicemia is one of the most important causes of mortality and morbidity of infants in 
the NICU.101,103,242,282,283 The VLBW infants are at risk for both early onset (within 72 
hours of birth) and late onset (after 72 hours) sepsis. Rates of infection increase with 
decreasing birth weight and gestational age.283 Neonatal sepsis is a bigger problem in 
Indian NICUs compared to the Western NICUs. Indian studies have shown that sepsis 
affects 30-50% of preterm or low birth weight infants admitted in the 
nursery.89,92,94,106,284,285 In addition to the immediate mortality and morbidity in the NICU, 
sepsis and its complications result in definite neurodevelopmental sequelae.  
Mortality 
Neonatal sepsis continues to be one of the primary causes of mortality in neonatal ICUs 
and particularly among very low birth weight infants. Mortality is almost 25% in early-
onset sepsis (EOS) and 18% percent in late-onset sepsis (LOS).282,286 The Indian studies 
on ELBW infants have shown a mortality of up to 51%88,106  Early-onset sepsis is more 
uncommon than LOS but is a potentially lethal problem among very-low-birth-weight 
infants. The Western studies have noted that the pathogens have changed from gram 
positive Group B streptococcus to predominantly gram-negative organisms.287,288 
Mortality due to gram-negative infections is higher than that due to gram-positive 
infections at all ages of onset of sepsis. Late-onset sepsis that is fulminant (lethal within 
48 hours) is more likely to be caused by gram-negative organisms.289,290 In infants with 
late onset sepsis, intubation, administration of pressor therapy, hypoglycemia, 
thrombocytopenia, and development of necrotizing enterocolitis were independent risk 
factors for sepsis-related death.289 
LITERATURE REVIEW 
 
 Page 75 
 
Morbidity  
Preterm infants with sepsis are at risk for both short-term and long-term complications. 
Short-term complications: The experience from the NICHHD suggests that  sepsis 
worsens the risk of PDA, NEC, BPD and increases the duration of ventilation.291  The 
mean duration of hospital stay and mortality was higher in infants who had late onset 
sepsis compared to the uninfected infants.292  
Neurodevelopmental Sequelae 
Sepsis is a risk factor for long-term neurodevelopmental impairment either by direct 
infection of the central nervous system or indirectly due to inflammation. Infection 
results in the release of inflammatory cytokines.55 Cytokines can damage the 
periventricular white matter directly, or they can destroy the myelin producing cells, or 
they can provoke the onset of preterm labour or they can damage the germinal matrix 
leading to intraventricular hemorrhage.293 So there are multiple ways sepsis can lead to 
brain damage in the premature infant and consequently leading to poor developmental 
outcome.294 Neonatal sepsis is shown to affect the post-natal head circumference in 62% 
of the infants, thus further contributing to the risk of neurodevelopmental impairment.295 
In a meta-analysis which pooled the data on 13,755 very preterm and VLBW infants, 
infants with perinatal infections had poorer mental development (P <0.001) and motor  
development (p<0.001) compared to the very preterm and VLBW infants without 
infections.55 Follow-up studies of the EPIPAGE cohort showed that, 9% of the infants 
who had sepsis, developed cerebral palsy and 12% had cognitive impairment when 
assessed at five years of age.  The risk of developing cerebral palsy after early onset and 
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late onset sepsis was almost the same (odds ratio of 1.7), however the risk was higher in 
combined early and late onset sepsis (OR= 2.33).296 
Another meta-analysis showed that Sepsis in VLBW infants was associated with an 
increased risk of one or more long-term neurodevelopmental impairments (odds ratio 
(OR) 2.09).54 
In a prospective study from the Neonatal Research Network of the NICHHD of over six 
thousand ELBW infants, survivors who had sepsis as neonates were more likely to have 
an adverse neurodevelopmental outcome at 18 to 22 months of corrected gestational age. 
This included higher rates of cerebral palsy, lower Bayley scales Infant Development II 
scores, and increased vision impairment compared with uninfected infants. In 
multivariate analyses after adjusting for confounders, children with infection remained at 
increased risk of MDI <70, PDI <70, CP and NDI.295 
There is overwhelming evidence that sepsis in newborns particularly in the 
VLBW/ELBW infants is associated with a high risk of neurodevelopmental impairment 
and cerebral palsy. The most effective way of avoiding sepsis is to prevent them to the 
extent possible. The WHO and AAP have recommended measures to reduce infections in 
the ICU, many of which are simple and cost effective.297-299  So measures like hand 
hygiene, judicious use of antibiotics, maintaining sterility while doing invasive 
procedures, early initiation of breast feeding, kangaroo mother care, surveillance of 
nosocomial infections and avoiding overcrowding can go a long way in preventing 
cerebral palsy and neurodevelopmental impairment. 
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3.4.8 VISION IMPAIRMENT, RETINOPATHY OF PREMATURITY & 
NEURODEVELOPMENTAL OUTCOME 
Retinopathy of prematurity (ROP) is due to the proliferation of aberrant retinal vessels in 
response to the interruption of normal neuronal and vascular development in preterm 
infants.300  
ROP affects a substantial number of premature infants worldwide and its incidence and 
severity is inversely related to the gestational age.301  In a population-based cohort study 
from New Zealand and Australia the overall incidence of severe ROP among infants born 
at less than 32 weeks’ gestation was 10 percent. Severe ROP increased from 3 to 34 
percent as gestational age decreased from 27 to 24 weeks, respectively.301 Multivariate 
analyses from Western studies have shown decreasing gestational age and birth-weight, 
prolonged ventilation, surfactant use for RDS and hyperglycemia requiring insulin are 
strongly associated with ROP.302–304  
However there is enough epidemiologic evidence which shows that the mean birth weight 
and the mean gestational age of infants with severe ROP is greater in developing 
countries compared to that of developed countries.305–308 A multi-centered study showed 
that the mean gestational age of infants from developed countries who developed severe 
ROP was less than 800 grams and that of infants from developing countries was more 
than 1000 g, suggesting that the  risk factors of ROP in developing countries are different 
from that of developed countries.307  
The incidence of ROP in India is about 11-44%, the incidence of severe ROP is 8-12%, 
and the mean birth weight age of Indian babies with ROP is around 1500 g.131,305,308–310 
The National Neonatology Forum therefore, recommends screening of all preterm 
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neonates who are less than 34 weeks at birth and have a birth weight of less than 1750 g;  
as well as babies 34–36 weeks of gestation or 1,750–2,000 g birth weight if they have 
risk factors for ROP.311 Multivariate analysis from an Indian study has revealed the 
following risk factors having an independent effect on ROP - respiratory distress 
syndrome (adjusted OR=8.1), PDA requiring medical or surgical management (adjusted 
OR=3.2), and meningitis.308  
Neurodevelopmental Outcomes  
ROP is strongly associated with neurodevelopmental impairment and cerebral palsy.281 In 
the multicenter Cryosurgery for Retinopathy of Prematurity Study, a longitudinal cohort 
of children with ROP was followed up and was assessed at 5½ years of age. Rates of 
severe disability increased from 3.7% for those children with no ROP to 19.7% for those 
with threshold ROP.312 The subgroup of children with threshold ROP in the cohort was 
reassessed at 8 years. The assessments revealed that children with unfavorable vision had 
more developmental disability (57% vs. 22%), required special education services (63% 
vs. 27%), had lower academic levels (39% vs. 15.8%) and cerebral palsy (84% vs. 48%) 
compared to children with a favorable visual outcome313 In a study  by Schmidt et al on 
ELBW infants with severe ROP (unilateral or bilateral stages 4 or 5), who were assessed 
at 18 months 10% children had died, 24% children had cerebral palsy, 49% children had 
MDI <70 and 3.8% children were deaf and 15% were blind.224 
There are no Indian studies which have looked at the neurodevelopmental outcomes of 
children with ROP.  
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3.4.9 HEARING IMPAIRMENT AND NEURODEVELOPMENTAL OUTCOMES 
About 1-3% of the infants admitted into the NICU are likely to develop hearing 
impairment.314 In a nested case-control Norwegian study, children with birth weights less 
than 1500 g had a six-fold greater risk for hearing loss compared with children with birth 
weights 3500 and 3999 g.315 In Kochi, a community based hearing screening of all infants 
showed that the incidence of hearing loss among the high risk children was about 1%.316 
Newborn infants with hearing impairment who are not rehabilitated early, will steadily 
worsen in their language skills, cognitive abilities, and their social skills.317 
The use of drugs like aminoglycosides & loop diuretics, exposure to the constant 
background noise generated by life support systems, hyperbilirubinemia, 
cytomegalovirus (CMV) infection and hypoxia are the main causes of hearing loss in 
VLBW infants.44 Hearing loss requiring amplification is more likely to occur in the 
presence of other  neonatal morbidities like sepsis, NEC, brain injury and ROP.164 
Early detection and rehabilitation of hearing impairment by 6 months of age has a 
definite advantage for acquiring normal language compared to detection of hearing 
impairment after 6 months of age. It has also been shown that universal hearing screening 
in the NICUs in USA has led to earlier diagnosis and intervention and improved language 
and learning abilities.318 
 
3.4.10 PERIVENTRICULAR LEUKOMALACIA 
Periventricular leukomalacia is a unique white matter injury which occurs predominantly 
in the premature infants and subsequently results in cerebral palsy, cognitive impairment 
and visual disturbances.319  PVL is more common in premature than in term infants.320 
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The injury of PVL comprises has a focal component which may be cystic or non-cystic 
and a more diffuse component. The focal component results in localized necrosis of all 
cellular elements in the deep white matter resulting in cyst formation. If the cysts are 
visible on conventional MRI or cranial ultrasound it is termed “cystic PVL” and if the 
cysts are not visible, it is termed “non-cystic PVL”. The diffuse component is more cell-
specific and involves injury to the pre-oligodendrocytes cells which results in astrocytosis 
and microgliosis.321,322 
PVL is a consequence of the unique vascular anatomy of the immature brain, its 
diminished capacity of autoregulation and the inadequate response to free radical 
damage. The pathogenesis of Periventricular leukomalacia involves the following 
processes323 -  
• Ischemia322: The white matter in the premature infant in supplied by two sets of 
arteries – short penetrating (which penetrate the subcortical white matter) and 
long penetrating arteries (that supply the deep white matter). In the premature 
infants the distal fields of these vessels which supply the periventricular white 
matter are not well developed. So the regions around the ventricles are vulnerable 
to reduced blood flow because of the diminished vascularization. A decrease in 
the cerebral blood flow predisposes these areas in severe ischemia.322 In addition 
Positron emission tomography (PET) studies have confirmed that the cerebral 
white matter blood flow in the preterm brain  is much less than that of mature 
infants or adults.324 So there is a minimal level margin of safety for blood flow to 
cerebral white matter in premature infants.  
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• Impaired cerebral autoregulation321: In mature infants and adults, cerebral 
blood pressure is maintained despite blood pressure variation due to cerebral 
autoregulation. However this is not well developed in preterms and so there is 
reduced perfusion of the brain in times of systemic hypotension. Impaired 
autoregulation is worsened by perinatal asphyxia, hypotension, hypocarbia and 
hypoxemia which further aggravate the ischemic damage in preterm brains. 
• Damage of Pre-oligodendrocytes325,326: The pre-oligodendrocyte cells (pre-OLs) 
mature to form the oligodendrocytes - the myelin producing cells of the White 
matter. Ischemia (due to the impaired vascular autoregulation and the anatomic 
factors mentioned above), inflammation and asphyxia result in release of 
cytokines. The pre-OLs are selectively destroyed by the cytokines through free 
radical mediated mechanisms. Thus loss of the pre-OLs prevents formation of 
myelin which results in. reduction of white matter volume causing 
ventriculomegaly.  
• Role of Maternal/fetal infections, inflammation and cytokines: 
Chorioamnionitis leads to cytokine production, particularly Tumor Necrosis 
Factor (TNF-α), which can access the fetal brain and directly damage the pre-OLs 
of the white matter, or activate microglia and lead to production of oxygen free 
radicals which also contribute to white matter injury.293,327 Numerous studies on 
maternal chorioamnionitis has proven this fact, since chorioamnionitis is very 
strongly associated with periventricular leukomalacia and cerebral palsy.328,329  
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Neurodevelopmental impairment – Cerebral palsy and cognitive deficits secondary 
to PVL 
Periventricular leukomalacia is strongly associated with cerebral palsy,330,331 visual 
insufficiency332 and cognitive impairments. Studies have shown that the stage of cystic 
PVL graded according to the de Vries staging, corresponds to the extent of the 
neuromotor deficit and visual insufficiency, and almost all stage III PVL infants develop 
CP.333 The spasticity which characterizes cerebral palsy is due to the necrosis of the 
periventricular long tracts. The extent of the periventricular white matter loss corresponds 
to the topography of CP.  Children with only posterior periventricular white matter 
involvement are likely have spastic diplegic type of CP with communicative abilities, 
while those with periventricular white matter loss extending till the anterior 
periventricular region are likely to be severely disabled with quadriplegia, visual 
insufficiency and seizures.334   
 
Cognitive impairment in PVL 
The periventricular white matter damage explains the spasticity present in cerebral palsy 
but is not sufficient to explain the existence of grey matter (GM) disease which manifests 
as cognitive and behavioral deficits.  
Cognitive deficits in PVL are related to injury to the thalamus, thalamocortical pathway 
and cortical grey matter. Pathologic studies have shown that there is greater neuronal loss 
in the thalamus (38%) as compared to the cerebral cortex in the children who have 
PVL.335 It has also been shown that thalamic reduction correlates with the deficits in 
working memory and intelligence in school going children with PVL.336 
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In addition to thalamic volume loss, cognition is also dependent on the extent of the grey 
matter involvement which occurs concomitantly with the white matter injury. Grey 
matter loss in the frontal and temporal regions correlates with decreased verbal IQ and 
grey matter volume loss in temporal and occipital regions corresponds to decreased 
diminished performance IQ.337 In addition to cognitive impairment, thalamic injury also 
contributes to spasticity since damage to the thalamocortical pathway is hypothesized to 
alter the connections between the sensory and motor cortex and the cortico-spinal tracts. 
Cortico-spinal tract injury leads to spasticity.338 During the third trimester, when PVL is 
most likely to occur, the thalamocortical system is also developing, thus thalamic and 
cortical injury during this critical period could explain the cognitive deficits  in the 
children with PVL.320 
 
3.4.11 INTRVENTRICULAR HEMORRHAGE 
Intraventricular hemorrhage is a life-threatening complication of premature infants. In a 
large cohort of the NICHHD, 16% of the babies less than 1500 g had severe IVH. The 
incidence of IVH increases as the gestational age decreases and the incidence was 38% in 
infants of 22 weeks compared to 7% in infants of 28 weeks.34 In a study in South 
America using a multiple logistic regression model the following risk factors were found 
to be predictive of severe IVH – decreasing gestational age, mechanical ventilation, non-
administration of antenatal corticosteroid, male gender and presence of respiratory 
distress syndrome.339  
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The pathogenesis of IVH in preterm infants is because of two main factors – the fragility 
of the germinal matrix system and disturbances in the cerebral blood flow (lack of 
autoregulation). 
• Fragility of germinal matrix340,341: IVH usually starts in the sub-ependymal 
germinal matrix which is located between the caudate and thalamus. This highly 
vascular region contains glial and neuronal precursor cells. Unlike the other blood 
vessels in the brain the capillaries of the germinal matrix are very fragile and thin 
walled, because they lack pericytes, have poorly developed basal lamina, have 
deficient endothelial tight junctions and lack astrocyte end-feet ensheathing.239 
These fragile capillaries drain into the venous system. When the cerebral blood 
flow increases in response to hypoxia, hypercapnia or when there is a venous 
stasis due to hypotension, the fragile germinal matrix capillaries rupture.  When 
there is a large bleed the ventricles fill with blood. 
• Lack of autoregulation323,325: Unlike term infants, preterms lack the capacity of 
cerebral autoregulation and therefore are vulnerable to changes in the systemic 
blood pressure. So increase or decrease in systemic blood pressure can injure the 
capillaries in the germinal matrix causing bleeding into the ventricles. IVH is thus 
a progression of germinal matrix hemorrhage 
The short term complications of IVH are post hemorrhagic hydrocephalus (PHH), 
periventricular leukomalacia and death. PHH occurs because the small blood clots caused 
by the IVH block CSF reabsorption.342 About 5% of infants with Grade 1 and 2 IVH die 
and PHH develops in about 7%; in contrast severe IVH has a mortality of 20% and PHH 
develops in about 75% of the infants.343 Intraventricular hemorrhage releases large 
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amount of iron moieties which generate free oxygen radicals which can cause injury to 
the  pre-oligodendrocytes.322  and IVH also results in ischemia. Both these can lead to 
periventricular leukomalacia.327  
Long term complications: Intraventricular hemorrhage is an important cause of 
neurodevelopmental impairment. More than 75% of children who have severe IVH have 
cognitive impairments and cerebral palsy.327 Studies have also shown that the odds ratio 
of developing cerebral palsy after surviving severe IVH is about 15.9 and that of mental 
retardation is between 9.97 and 19.344,345 Although it is seen among the more premature 
infants, IVH is a stronger predictor of poor long term neurodevelopmental outcomes than 
gestational age.346 Another large cohort study which looked at the cognition of children at 
8 years found that, the adverse outcomes depended on the type of the intracranial lesion 
(PVL or IVH) rather than on the  gestational age,347again highlighting that the 
neurodevelopmental outcomes depend more on the presence of IVH or PVL rather than 
the gestational age. 
 
3.4.12 CEREBRAL PALSY 
Cerebral palsy is a group of heterogeneous, non-progressive disorders of tone and posture 
due to injury to the developing brain. The Executive Committee for the Definition of 
Cerebral palsy in 2005 defined CP as “group of disorders of the development of 
movement and posture, causing activity limitations that are attributed to non-progressive 
disturbances that occurred in the developing fetal or infant brain. The motor disorders of 
cerebral palsy are often accompanied by disturbances of sensation, cognition, 
communication, perception, and/or behavior and/or by a seizure disorder”.348  
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Epidemiology 
• Europe:  According to information obtained from a large database comprising 
more than 6000 children with CP, obtained from 13 different regions of Europe, 
the overall prevalence of CP was 2.08/1000 between 1980 and 1990.349  
• USA: A population-based American study reported that the prevalence of CP at 
eight years of age was 3.6 per 1000 children.350  
• Surveillance of Cerebral Palsy in Europe (SCPE) which is an European 
collaborative network of cerebral palsy registers reported a prevalence of 72.6 per 
1000 infants (who were alive at one month) among VLBW infants, compared to 
1.2 per 1000 among infants of birth weights more than 2500 g.351  
• India: There is only one population based study from India and the prevalence of 
CP in less than 10 years of age is believed to be about 2.27/1000.134  
Etiology of cerebral palsy 
The etiology of cerebral palsy (CP) is multifactorial. The known causes account for only 
a small proportion of cases.352 Prenatal, perinatal and post-natal etiologies are known to 
result in the clinical syndrome of CP. Prematurity is a common association in Western 
countries. In developing countries the most common causes are perinatal asphyxia, 
perinatal and neonatal infections, kernicterus and prematurity.  
Table 5 shows the multifactorial etiology from a study of 213 children diagnosed to have 
CP in Australia, compared to the two studies from India by P. Singhi et al in 2002 and 
2013. Some of the children had more than one associated pathology. There is an increase 
in the prevalence of CP due to VLBW and prematurity in the later (2013) cohort. 
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Table 5: Etiology of Cerebral Palsy in India compared to Australia 
 Strijbis EM et al 
353
 
P.Singhi et al 
135
 P. Singhi et al 
136
 
No. of cases 213 1000 1212 
Prematurity  78% 13.2% 24.3% 
Multiple pregnancy  20% 1.2% 3.4% 
IUGR  34% Not mentioned Not mentioned 
Intrauterine infection  28% Not mentioned Not mentioned 
Antepartum hemorrhage 27% Not mentioned Not mentioned 
Severe placental pathology 21% Not mentioned Not mentioned 
Kernicterus 0% 21.6% 35.1% 
Neonatal seizure    Not mentioned 25.2% 26.9% 
Neonatal sepsis Not mentioned 14.6% 30.6% 
Low birth wt. Not mentioned 20.4% 37.8% 
Asphyxia 2% 45.3% 51.98% 
 
Cerebral Palsy in the VLBW infants 
Cerebral palsy in the VLBW infants is due to brain damage which occurs due to antenatal 
factors, or complications of prematurity or  probably a combination of both.36  
A study which compared the VLBW children with CP to VLBW children without CP the 
following factors were associated with CP 354 - 
• Place of delivery: Odds ratio of developing CP was 6.3 in children born in 
primary care (level 1 neonatal center) compared to a specialized level 3 neonatal 
center 
• Pre-eclampsia and exposure to Magnesium sulphate was associated with a 
reduced risk of developing CP (OR 0.08) 
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• Maternal chorioamnionitis and neonatal seizures were strongly associated with 
CP.  
• Notably asphyxia was not associated with CP in this study, 
• Other factors which showed significant associations with the presence of CP were 
short inter-birth intervals and antepartum hemorrhage  
Germinal matrix/ intraventricular hemorrhage and its sequelae and periventricular 
leukomalacia are the most common pathologies associated with CP in the very low birth 
weight infants and white matter damage is the most important antecedent of cerebral 
palsy.355,356  
The rate of CP is much higher in preterm than term infants and this is illustrated by the 
following studies -  
1. In a population-based study from Sweden of 216 children with CP born between 
1987 and 1990, the gestational-age specific prevalences were 80/1000 for 
extremely preterm, 54/1000 for very preterm, 8/1000 for moderately preterms and 
1.4/1000 for term infants. Birth weight-specific prevalences from the same study 
were 57/1000 for birth weights <1000 g, 68/1000 for 1000-1499 g, 14/1000 for 
1500-2499 g and 1.4/1000 for ≥2500 g.357  
2. Multiple studies from various large cohorts have shown that the incidence of CP 
is 18-23% in extremely premature infants125,358-360 and the incidence increases as 
the gestational age decreases.  Very low birth weight infants are hundred times 
more likely to develop cerebral palsy compared to infants whose birth weight are 
more than 3000 g.361   
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However in India it is likely that perinatal factors like perinatal asphyxia and neonatal 
factors like meningitis and kernicterus also contribute substantially to CP in VLBW 
infants.136 A much smaller contribution may be because of prenatal factors like cerebral 
dysgenesis and possibly chromosomal factors Although VLBW infants only contribute to 
3.4% of the total births13 in India, with the improving survival rate among the VLBW, it  
is probably one of the largest causes of cerebral palsy and disability.  
The important findings of this population-based study 
This concludes the Literature review. In the above four sections – the first section was 
about the survival and the third section was about the neurodevelopmental outcomes of 
VLBW infants from India and other countries. The Indian studies were compared to 
Western countries. There is limited data from India about the survival and 
neurodevelopment of very low birth weight infants. The second section reviewed the 
need and the components of a dedicated follow-up program.  Finally in the fourth 
section, some of the important complications in the neonatal period which affect the 
survival and the neurodevelopmental outcomes of VLBW infants were highlighted. With 
this information we went ahead to do the study to look at the incidence of death and poor 
neurodevelopmental outcomes of our cohort of VLBW infants and to see if the 
aforementioned neonatal factors influenced their survival and long term outcomes.   
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4 PATIENTS AND METHODS 
 
(The information presented in this section is as per the STrengthening the Reporting of 
OBservational studies in Epidemiology (STROBE) guidelines.362,363) 
 
4.1  STUDY DESIGN  
This study was an observational study - the longitudinal follow-up of a cohort of very 
low birth infants who were admitted into Neonatal Intensive Care Unit (NICU) of the 
Christian Medical College (CMC) hospital, a tertiary level referral hospital. 
4.2  PARTICIPANTS 
There were 776 VLBW infants in the study with birth weights equal and less than 1500 
g. (Although by definition, VLBW infants are less than 1500 g, those who were equal to 
1500 g were also included since most major studies include babies weighing 1500 g in 
their cohorts) 
4.3 SETTINGS 
The recruitment of the study cohort was done between the time period September 1, 2010 
and 31st March 2012 and the follow-up phase concluded in November 2014. The study 
was conducted using the facilities of the Neonatal ICU (Nursery), the High Risk Infant 
Clinic and the Developmental Pediatrics Unit of the Christian Medical College, Vellore.  
4.4 FOLLOW-UP PROTOCOL and OUTCOMES 
The infants were recruited after consent from the parents. They were followed up until 
the final neurodevelopmental assessment. 
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The study had two phases - 
Phase 1:  The first phase was from the time of admission to the NICU till the time of 
death or discharge from the NICU.  
Phase 2: The second phase was the follow-up phase which started after discharge from 
the NICU till their final neurodevelopmental assessment.  
For the first phase death in the NICU was the outcome. For the second phase the 
neurodevelopmental outcome gauged by the General quotient (GQ) obtained on the 
neurodevelopmental assessment scale – Griffith’s Mental Developmental Scales (GMDS) 
was the outcome. 
 
4.5 INCLUSION & EXCLUSION CRITERIA 
The inclusion and exclusion criteria for Phases 1 and 2 are presented below: 
 
 
INCLUSION  CRITERIA 
 
EXCLUSION CRITERIA 
 
Phase 1 
1. All live VLBW infants born at the 
Christian Medical College 
 
2. Out – born infants who were referred 
for the NICU care within 24 hours of 
birth, with birth weight <1500 
VLBW infants who were born with 
significant anomalies which were 
incompatible with survival beyond 
few hours  
 
Phase 2 
 
Infants who were discharged from the 
neonatal ICU after phase 1, whose parents 
were willing to bring them, for regular 
follow-up till the period of final 
assessment  
Infants whose parents were not 
willing to come for subsequent 
follow-up.  
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4.6 PLAN OF THE STUDY 
4.6.1 Phase 1:  NICU PHASE 
During their stay in the NICU the following details of the infants were recorded.  
Details of the mother and her antenatal period:  The demographic details of the 
mother, her prior pregnancies, previous medical and obstetric complications, details of 
the antenatal period were collected by interviewing the mother and from the Obstetric 
records 
 
Details of the perinatal period – Details pertaining to the infant’s birth, resuscitation, 
APGAR score, progress in the NICU and the neonatal complications were obtained by 
reviewing the Neonatal records. The treatment and interventions during the period of stay 
in the neonatal ICU were as per the existing treatment protocols of the Neonatal ICU. 
 
Gestational age estimation: Gestational age was estimated from the early ultrasound 
scans or in the absence of ultrasonography was calculated from the mother’s last 
menstrual period. In exceptional cases when both of the above were unavailable or 
unreliable, the gestational age was estimated post-natally using the Dubowitz 
examination technique.  
Small for gestational age was defined as weight less than the  3rd percentile of gestational 
age using the fetal growth curves of Fenton et al.364 
Definitions: The definitions of the antenatal factors, perinatal, neonatal and other 
variables used in the study are presented in the Appendix section. 
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Screening of the eyes for the evidence of retinopathy of prematurity was done by the 
same ophthalmologist. The screening and subsequent follow-up were done according to 
the protocols of the Pediatric Ophthalmology department and the National guidelines.311  
 
The Hearing screening was done as part of the neonatal hearing screening that exists in 
the Institution. All infants admitted in the NICU were screened for their hearing at 35 dB 
on both sides, using Neonatal automated Auditory Brainstem Response (ABR). In infants 
who failed the first screening, a second screening was done after two weeks. If the infant 
failed the second assessment then a detailed hearing assessment which involved 
Brainstem Auditory Evoked Response (BAER) and Oto-acoustic Emissions (OAE) was 
done. 
Serial Cranial ultrasound examinations (Neurosonogram) were done in all the very 
low birth infants to look for any evidence of intra-ventricular hemorrhage, periventricular 
leukomalacia and ventricular enlargement, as per the usual protocol practiced for all the 
VLBW babies. The existing practice of the NICU was that two serial scans are done, the 
first scan within 72 hours of birth and the second between days 7 and 10. A third scan 
was done 4-8 weeks after birth. 
Counseling the parents for consent to participate in the follow-up phase of the study 
During the hospital stay, the parents were counseled about the need for careful follow-up 
of the infants after discharge and signed consent was obtained from the either of the 
parents. Although what was done during the period of the study was the standard of care 
in this institution, informed consent for participation was obtained prior to discharge from 
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the NICU from one of the parents.  By institutional policy most infants are discharged 
only after they had attained a weight of 1800 grams. 
4.6.2 Phase 2:  CONDUCT OF THE FOLLOW-UP PHASE 
The infants were recruited into the study during their stay in the Nursery. Parents who 
had given their signed consent could withdraw from the study at any point. The usual 
practice of the institution is that all high risk infants (which include the VLBW infants) 
are followed up regularly at the High risk infant clinic (HRIC) run by the Neonatology 
department until they reach one year of age. At any point if they are detected to have 
developmental delay and they require developmental stimulation or early intervention, 
they are then referred to the Developmental Pediatrics Unit.  Infants who were recruited 
into the study were seen by me (the Principal Investigator) on a regular basis in the High 
risk infant clinic during their follow-up visits.  
 
During the High risk Infant Follow-up visit 
• The anthropometric measurements was recorded, and the neurologic examination 
was done as described by Amiel-Tison187,365 during every visit.  
• Weight was measured using electronic weighing machines which were regularly 
calibrated. Supine length was measured using an Infantometer and the head 
circumference was measured using a non-stretchable tape. 
• The neurological examination was performed as described by Amiel-Tison187,192 
and this included evaluation of the muscle tone, power, Amiel-Tison angles and 
posture. The infants were considered neurologically normal if there was no 
abnormality on the examination. The diagnosis of cerebral palsy was made based 
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on the definition of Bax and associates.348 A child was considered to have CP if 
there was abnormal muscle tone (spasticity, dystonia) at least in one limb and if 
there was abnormal control of movement and posture. 
• Children with CP were classified as per the Surveillance of Cerebral Palsy in 
Europe (SCPE) algorithm.366 Functional classification was done according the 
Gross Motor Functional Classification System (GMFCS) described by Palisano et 
al.367 
• At any point during the follow-up, if there was any indication of developmental or 
cognitive delay, early intervention was commenced by the psychologists and the 
therapists of the Developmental Pediatrics Unit.  
• Children were referred to other Pediatric specialists for further evaluation as and 
when required. 
 
4.7 NEURO-DEVELOPMENTAL ASSESSMENTS 
A. Amiel-Tison Neurological Assessment 
Amiel-Tison Neurological assessment (ATNA) is a simple and time-tested neurological 
assessment method which can be performed as part of the routine examination of an 
infant.186,192,365 The assessment includes assessment of the head growth, neurosensory 
function and spontaneous motor activity, the passive muscle tone, the primitive reflexes, 
assessment of the baby’s adaptation to manipulation during examination and feeding 
autonomy. The Amiel-Tison neurologic examination is the standard examination 
technique in many of the studies on the neurodevelopmental outcomes of high risk 
infants (which include VLBW babies). The great advantage of this neurologic 
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examination is that the same procedures can be used for examination from term 
gestational age till the school going age. Therefore the child can be followed up with the 
same protocol.192  
Depending on the child’s abilities in the various functions, the child is scored from 0 to 2. 
A score of “0” indicates that the function is judged to be optimal. A score of “1”, 
indicates a minor to moderate grade of neurologic abnormality and a score of “2” 
indicates a severe grade of neurologic abnormality. 
For a child between 10-24 months the table below, defines normal and mild, moderate 
deficit and severe deficit.  
Table below was taken from, Amiel-Tison C and Gosselin J “Neurologic development 
from Birth to Six years”192.  
SECTIONS ( or FUNCTIONS) SCORE 
.  
1. Head growth (Head circumference, palpable sutures) 
2. Social interactions (alertness & attention, visual tracking and excitability) 
3. Passive muscle tone (limbs and trunk) 
• Trunk imbalance 
• Stretch Reflex in limbs 
Hypotonia of rigidity 
4. Involuntary movements 
5. Parachute reflex (scored according to age of acquisition) 
6. Gross motor skills (scored according to age of acquisition) 
• Head control 
• Sitting position 
7.Independent walking 
 
 
Scoring  
Severe deficit: Score of 2 in at least six of seven sections; Moderate deficit: Score of 1 in 
five of seven sections; Normal or Mild deficit if the scores are mainly 0  
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B. Peabody developmental Motor Scales368  
At one year corrected age, the infants recruited for the study were assessed using the 
Peabody Developmental Motor Scales (PDMS) by the Occupational therapist involved 
with the study.   
The Peabody Developmental Motor Scales - Second Edition (PDMS-2) is a standardized 
and norm-referenced test of the gross motor and fine motor skills for American children. 
The PDMS is composed of six subtests that measure the fine and gross motor abilities of 
children from birth through five years. The six sub-tests are - 
Reflexes sub-test:  measures the appropriateness of the primitive reflexes in infants less 
than one year. 
Stationary sub-test: checks the ability of the infant to maintain equilibrium. 
Locomotor sub-test: Looks at the development of ambulation – crawling, creeping, 
walking and running 
Grasping sub-test: Looks at the development of grasp from the primitive palmar grasp 
to the development of complex action with the fingers (like buttoning etc.) 
Object manipulation sub-test: this scale checks the ability of infants to handle objects 
appropriate for their developmental age. 
Visual-Motor Integration sub-test:  this scale measures the ability of the children to use 
their hands and their eyes in activities like building blocks, catching and the hand-eye co-
ordination.  
Based on the performance in the above six sub-tests a gross motor quotient (GMQ), a 
fine motor quotient (FMQ) and a total motor quotient (TMQ) can be estimated. The 
TMQ is a composite of the overall motor abilities of the child. 
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Although PDMS is not validated in the Indian population, it has been used in India. A 
study showed that there were differences in the performance of Indian children compared 
to the American norms but the differences were within 0.5 SD.369 According to the 
administration manual less than 1 SD (TMQ of <90) on the American norms is 
considered abnormal.   
In our study the TMQ which is a continuous variable was collapsed to a categorical 
variable and TMQ of >90 was considered normal and TMQ of less than 90 was 
considered abnormal. We used the PDMS for the interim assessment of the motor 
development of the study cohort at one year of corrected gestational age.  The 
Occupational Therapist who was involved with the administration of the PDMS has 
several years of experience in assessment of newborns and infants. 
C. The Griffiths Mental Development Scales161  
The Griffiths Mental Developmental Scales (GMDS) are used to measure the 
developmental abilities of children from birth to 8 years of age.  Currently there are two 
sets of Scales - for the age group 0-2 years (Griffiths Mental Developmental Scales, 0-2 
years) and for the ages 2-8 years (Griffiths Mental Developmental Scales Extended 
Revised).162,370  
In the first scale (the Griffiths Mental Developmental Scales 0-2 years), an overall 
developmental profile is obtained from the five subscales examining the Locomotor 
abilities, Personal-Social abilities, Language abilities, Eye-and-Hand Coordination 
abilities and Performance abilities. In the 2-8 year Scales (Griffiths Mental 
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Developmental Scales Extended Revised), in addition to the above mention five sub-
scales, the profile is expanded to add a Practical Reasoning Subscale. 
A brief description of the Subscales 
Sub-scale A - Locomotor: This sub-scale assesses skills in the gross motor domain. The 
scale tests the ability to balance, coordinate and control movements, walk upright and 
tests the motor tasks which increase in complexity as the child grows (like running, 
jumping, skipping etc.).   
Sub-scale B - Personal-Social:  Initially assesses the interaction with the mother, object 
permanence and as the child becomes older it assesses the competence in activities of 
daily living and interaction with caregivers and other children.  
Sub-scale C - Language:  This scale assesses the Receptive and expressive language. 
Initially this includes the child’s response to familiar and unfamiliar sounds, later ability 
to vocalize, listen to instructions and stories, use of words, phrases and sentences and 
social use of language.  
Sub-scale D - Eye and Hand Co-ordination:  This scale assesses the fine motor skills, 
initially grasping and manipulating objects. Later complex activities of manual dexterity 
and those which require visual-motor coordination (like writing and drawing shapes) are 
assessed. 
Sub-scale E - Performance:  This scale assesses the speed of working, spatial concepts 
and precision in new situations. 
Sub-scale F - Practical Reasoning:  This scale is scored only for children over two 
years of age and checks the ability to solve practical problems 
PATIENTS AND METHODS 
 
 Page 100 
 
The sub-quotient for each of the above sub-scales can be obtained using the appropriate 
Analysis manual. The General quotient (GQ) which is the composite of all the sub-
quotients is then estimated. The GQ is used as an indicator of the child’s overall 
developmental abilities.    
The GMDS scales can only be used by Pediatricians and Psychologists who are certified 
after completing the training course accredited by the Association for Research in Infant 
and Child Development (A.R.I.C.D), UK.  
The GMDS is not standardized for the Indian population. So the children were compared 
to the standards of the norms given in the Analysis manuals.162,370,371 The mean sub-
quotients and their standard deviations are different for the various subscales are shown 
in table 6. Sub quotients which are more than 2 standard deviations below the mean 
indicate significant developmental delay in that particular sub-scale. General quotient of 
more than 2 standard deviations below the mean indicates global developmental delay. 
 
Table 6: Means and Standard Deviations of the Sub-quotients and General Quotient 
of the GMDS 
 
SUB-SCALES (DOMAINS) IN THE 
GMDS 
0-2 YEARS 2-8 YEARS 
Mean SD <2SD Mean SD <2SD 
LOCOMOTOR-Sub-quotient 100.2 15.9 <68 100.41 16.32 <67 
PERSONAL SOCIAL Sub-quotient 101.1 16.3 <67 100.26 16.20 <67 
HEARING & SPEECH Sub-quotient 100.6 16 <68 99.78 17.75 <64 
EYE-HAND COORDINATION Sub-quotient 100.2 15.9 <68 100.46 15.58 <68 
PERFORMANCE Sub-quotient 100.4 16 <68 99.87 17.21 <64 
PRACTICAL REASONING Sub-quotient - - - 99.79 17.43 <64 
GENERAL QUOTIENT  100.5 11.8 <76 100.18 12.76 <74 
 
The Griffiths Mental Development Scales (GMDS) was selected as the assessment tool 
for this study because it  has been used very widely in the assessment of infants and 
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children  for over 30 years.145 The GMDS was administered by Psychologists of the 
Developmental Pediatrics Unit who along with the Principal Investigator are certified to 
use the GMDS and have over seven years of experience in administering it to infants and 
children. Although the GMDS is not standardized in India this was preferred over the 
Developmental Assessment Scale for Indian Infants (DASII)163 predominantly because of 
our experience and competence in using the GMDS. The GMDS has been extensively 
used in infants including in the assessment of ELBW and VLBW infants.372–374 The 
DASII, based on Bayley Scale of Infant Development (BSID) has been standardized only 
on a small population of children from Western India.76,375  
Blinding was not possible because developmental follow of high risk infants is part of 
the regular standard of care. So, the principal investigator, the neonatologists, 
psychologists, occupational therapists and the other clinical specialists were familiar with 
most children.  
 
Categorization of General Quotient: The General quotient (GQ) and the sub-quotients 
of the sub-scales are continuous variables. For the purpose of analysis, the GQ was 
considered a categorical variable with 2 categories 
• Good Neurodevelopmental outcome (GQ >2SD or GQ >76) 
• Poor Neurodevelopmental outcome (GQ <2SD or GQ <76) 
These were the final outcomes of the second phase of the study.  We chose less than 2SD 
as the cut-off to decide between good neurodevelopmental outcome and poor 
neurodevelopmental outcomes since 2SD is accepted as the cut-off level for 
developmental delay in most psychometric tests.   
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Children detected to have developmental delay: If any infant was detected to have 
developmental delay, appropriate therapy was started and the child was asked to come for 
regular developmental monitoring to the Developmental Pediatrics Unit. Although this 
was not part of the study protocol, these children were regularly seen by the members of 
the team and the appropriate intervention was provided.  
 
Correction for gestational age:  Although correcting for prematurity is controversial, in 
our study all infants were corrected for prematurity till 36 months of age as advised by 
Maureen Hack156 There were four infants who were more than 36 months at the time of 
assessment. The oldest infant was 42 months of age. For the sake of uniformity, 
correction of gestational age was done for them as well. There was two to four points 
difference in the General quotient when correction was applied and when correction was 
not applied. The correction did not affect the categorization of three of the four children 
(who had good neurodevelopmental outcome even without the correction for 
prematurity). However for one child if correction had not been applied he would have 
moved to the poor neurodevelopmental outcome group. 
 
Monitoring of anthropometric measures: Weight, length and head circumference were 
recorded during every visit. The measurements of these parameters obtained at the time 
of the final assessment were expressed as Z scores with reference to the WHO 
multicenter growth reference study (MGRS)  using the WHO “ANTHRO” software.376  
The study for was considered as “completed” when the Griffith’s Mental 
Developmental Scales (GMDS) assessment was over. 
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4.8 OPERATIONAL DEFINITIONS OF OUTCOME MEASURES 
 
Normal development: Developmental quotient of   within 2SD of the mean of the 
General quotient. 
Poor Neurodevelopmental outcome (which indicates significant developmental 
delay): General Quotient (GQ) 2SD below the mean on the Griffith’s Mental 
Developmental Scales was considered as the definition for ‘Poor neurodevelopmental 
outcome’. Thus GQ of <76 in the children 24 months and less, and GQ <74 in children 
over 24 months was considered as indicative of Poor neurodevelopmental outcome 
(Table 6). 
Neurological abnormality (decided based on the Amiel-Tison Neurological 
Assessment-ATNA):  Using the scoring system described above the child was graded as 
neurologically abnormal if the child had moderate to severe deficits and normal if the 
child had only mild or no deficits. 
Cerebral Palsy: Non-progressive central nervous disorder characterized by abnormal 
tone in at least one extremity and abnormal control of movement and posture.  
Visual impairment: A vision of less than 6/60 in both eyes with spectacles  
Hearing impairment: Bilateral impairment requiring hearing aids or auditory thresholds 
of above 70 dB in both ears, obtained by using Brainstem auditory evoked response 
(BAER)  
 
THE STUDY WAS APPROVED BY THE INSTITUTIONAL REVIEW BOARD 
(ETHICS COMMITTEE) OF THE INSTITUTION. 
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Table 7:  Brief summary of how the study was conducted 
 Phase 1: Nursery 
 
Data collection (antenatal, perinatal, neonatal stay in NICU)  
Consent for participation 
Phase 2: High risk clinic  and 
Developmental Pediatrics Unit 
Tests administered Interventions (as required) 
Multiple visits to the HRIC for 
follow-up depending on the 
infants’ needs.  
• Growth monitoring 
• Neurologic 
assessment using the 
Amiel-Tison 
Neurological 
assessment  (ATNA)  
1. Address Parental 
concerns 
2. Developmental screening 
3. Treat medical problems 
4. Rule out sensory 
problems 
5. Refer to appropriate 
specialist 
6. Developmental 
assistance by the 
developmental 
Psychologist and 
Occupational Therapist 
(early intervention) 
7. Family counseling and 
support 
8. Anticipatory guidance 
 
  
At one year (Corrected 
gestational age) 
• Growth monitoring 
• ATNA  
• Peabody 
Developmental Motor 
assessment  
After 18 months (corrected 
gestational age) 
• ATNA  
• Neurodevelopmental 
assessment using 
GMDS 
•  Z-scores of weight, 
height and head 
circumference 
obtained using the 
WHO-ANTHRO 
software 
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4.9 STATISTICAL METHODS 
 
4.9.1 CALCULATION OF SAMPLE SIZE 
Sample size to determine the incidence of poor neurodevelopmental outcomes:  
According to Escobar et al’s meta-analysis59 (looking at the outcome of VLBW infants in 
over 100 studies), the median incidence of disabilities was 25%.  
So Sample size (n) = (z 1-α/2)2 x pq 
                                          d2 
Where level of significance (z 1-α/2) is 1.96 (for α of 5%) 
P is 25%,  
q is (1-p) = 75% 
d is the level of precision and is taken as + 5% 
So sample size was calculated as 288 and when adjusted for a drop out of 30% then the 
required sample size was 374 
Sample size to determine the relationship between perinatal and neonatal risk 
factors which lead to poor neurodevelopmental outcomes:   
The sample size for various risk factors is presented in table 8. Risk factors which were 
considered were those known to have a significant association with poor 
neurodevelopmental outcome. These are (1) cranial ultrasound abnormalities particularly 
cystic periventricular leukomalacia and intraventricular hemorrhage (Grades III and 
IV)330
 
(2) severe necrotizing (>Grade 2) enterocolitis279 (3) Maternal chorioamnionitis328 
(4) extremely low birth weight (birth weight of less than 1000 g)212 (5) Hypoglycemia.377
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In infants with cranial ultrasound abnormalities, nearly 92% of have significant 
disabilities.330 Low birth weight infants in general have disability of about 25%. In order 
to show that the difference is statistically significant with alpha and beta errors at 5% and 
20% respectively, we had to study 10 children in each group. Similarly for children with 
the risk factors ELBW, NEC Hypoglycemia and Chorioamnionitis, we required to study 
86, 30, 30 and 83 children in each group (risk present and absent) respectively (table 8). 
Thus we anticipated that the sample size of 374 (obtained for the Objective 1) which 
would have nearly 94 infants with poor neurodevelopmental outcome (given that 25% of 
VLBW have poor outcome) and would be sufficient to meet the sample size of the 
second objective 
Table 8: Sample size calculation for hypotheses testing for risk factors. 
Two-proportion hypothesis 
testing 
Abnormal 
Cranial US 
ELBW 
 
Severe 
NEC 
Hypoglycemia 
 
Chorioamnionitis 
 
Proportion in group I 0.25 0.25 0.85 0.75 .5 
Proportion in group II 0.92 0.49 0.45 0.25 0.25 
Estimated risk difference  -0.67 -0.24 0.4 0.5 0.25 
Power (1- beta)% 80 80 80 80 80 
Alpha error (%) 5 5 5 5 5 
1 or 2 sided  2 2 2 2 2 
Required sample size for 
each arm  7 62 21 14 58 
Drop out Adjusted (30%) 10 86 30 20 83 
 
4.9.2 STATISTICAL PROCEDURES USED FOR THE STUDY 
• Data was collected on a proforma and the information entered into the EPIDATA 
database. All the risk factors were defined using standard definitions obtained from 
renowned textbooks. The operational definitions of each variable are presented in the 
“Appendix section”. 
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• The incidence of the outcomes (death, developmental delay and CP)  are presented 
with 95% confidence interval.  
• Variables are summarized with descriptive statistics (mean, median in cases where 
the distributions are not normal & standard deviations). 
• Continuous variables were checked for normality by visually inspecting the 
histograms and using the tests for normality (Kolmogorov-Smirnov p-values and 
Shapiro-Wilk p-values).  
• Difference in means between continuous variables were tested using independent 
sample t-tests or Mann–Whitney U tests (where normality assumptions were 
violated).   
• Kruskall-Wallis test was used to test multiple groups when the distributions were 
skewed.  Outliers were not included in some of the analyses and are mentioned. 
• Actual p-values were reported.  
• Bi-variate analyses using Chi-square test (or Fisher’s exact test) was done to study the 
significant associations between dichotomous risk factors and outcomes. Relative 
risks were computed to describe the associations.   
• Continuous variables were categorized in certain cases and are mentioned. 95% 
confidence intervals (95% CI) were used to express the precision of relative risks and 
odds ratios. 
• P-values of <0.05 were considered significant on bivariate analyses and the 
associations were explored further using step-wise multivariate logistic regression 
analysis. The final model was one in which the predictors remained in the model if 
the p-value was <0.05. 
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• Model assumptions and fit were evaluated using Hosmer and Lemeshow Goodness of 
Fit statistics and p-value of >0.05 was considered as good fit. The best model is 
presented with adjusted Odds ratios and 95% CI.  
• Kaplan–Meier analysis was used to estimate the survival of the infants in NICU. Risk 
of death was compared between groups with the risk factor and the group without the 
risk factor. Risk of death was compared between the groups using the Log-rank test. 
P-value of <0.05 was considered significant risk. 
• Cox proportional hazard analysis was used to estimate the relation of specific risk 
factors with the time to death.  Cox regression was done after checking 
proportionality of the hazards using the log-log plots. The best model is presented 
with adjusted Hazards ratios and 95% confidence intervals.  
• The subjects who did not come for the final assessment were compared with the 
subjects who came for the final assessment to see if there were any significant 
differences between the groups.  
• Sensitivity analysis was done to see if the subjects who did not come for the final 
assessment would have affected the results using “best case” and “worst case” 
scenarios. For the “best case” scenario, those who did not come for the assessment 
were considered as having a good neurodevelopmental outcome. For the “worst case 
scenario” those who did not come were considered as having a poor 
neurodevelopmental outcome. For both assumptions relative risks with 95% CI were 
calculated. The two groups were then compared with the children who came for the 
final assessment to see if there was any difference between the groups. 
• All analyses were done using the SPSS package 16.0 (SPSS Inc., Chicago, IL, USA). 
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5. RESULTS OF THE STUDY 
 
The Results are arranged in four sections - 
Section 1 - The Results of Phase 1 (the NICU phase):   This section presents the details 
of the maternal characteristics, perinatal risk factors and neonatal complications and 
the outcome of the infants in the NICU. The final outcome of this part of the study was 
death in the NICU. 
Section 2 -The Results of Phase 2 (the follow-up phase): The second section looks at 
the developmental follow-up of those who were discharged alive from the NICU. This 
section addresses the main objectives of the study – the incidence of CP and poor 
neurodevelopmental outcome and the factors which are associated with the poor 
neurodevelopmental outcome. The Neurodevelopmental outcome gauged by the General 
Quotient (GQ) obtained from the Griffith’s Mental Developmental scales (GMDS).  
Section 3 – Comparison of SGA versus AGA infants: This section compares the 
survival and the developmental outcome of children who were born small for gestational 
age (SGA) with those who were appropriate weight for gestational age (AGA). The 
Third percentile of birth weight on the Fenton Charts were used to categorize the 
infants into SGA or AGA.  
Section 4 – Analysis of the children who were lost to follow up:  This section accounts 
for children who were lost to follow-up. This section explores what difference the 
inclusion of those who did not come for the assessment would have made to the study 
results through a sensitivity analysis. 
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5.1 SECTION 1: THE RESULTS OF PHASE 1 - THE NICU PHASE 
 
This section discusses the details of the babies during their stay in nursery, from the time 
of birth till they left the nursery or died. The section is arranged in the following manner - 
5.1.1: Description of the study cohort admitted into the nursery – the sex distribution and 
the distributions of the gestational ages, the birth-weights and the growth status (whether 
small or appropriate for gestational age) is presented. 
5.1.2: Descriptive data of maternal characteristics of the study cohort is presented 
5.1.3: The various neonatal complications in the NICU are described. 
5.1.4: The causes of mortality are described. 
5.1.5:  Presents the bivariate analysis of antenatal, perinatal, and neonatal factors 
5.1.6: The multivariate logistic regression model for predicting death is presented 
5.1.7: Presents the survival analysis – Kaplan Meier graphs and the Cox Proportional 
Hazards model. 
5.1.8: The final outcomes of the study cohort at the time of discharge from the NICU are 
presented 
5.1.9: The survival rate of the cohort is estimated. 
 
 
 
 
 
 
a 
 
FIGURES 1A & 1B  DISTRIBUTION OF BOYS AND GIRLS ACCORDING TO BIRTH WEIGHTS AND 
GESTATIONAL AGES 
 
Fig. 1a BIRTHWEIGHTS Fig 1 b. GESTATIONAL AGE 
 
 
 
 
 
TABLE 9: COMPARISON OF THE GESTATIONAL AGE AND BIRTH WEIGHTS BETWEEN MALE 
AND FEMALE INFANTS 
 
Gestational Age (weeks) Birth weight (grams) 
Boys Girls Boys Girls 
  Mean  31.72 32.18 1271.04 1271.86 
  Median 31.4 32.1 1290.00 1300.00 
  Std. Deviation 2.61 2.47 170.34 189.24 
  Range (Min. to Max. ) 25 - 38  25  - 41  780 - 1500 710 - 1500 
  P-value 0.014 0.486 
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5.1.1 DESCRIPTION OF THE COHORT ADMITTED INTO NURSERY 
 
There were 776 babies with birth weights ≤ 1500 g admitted to the NICU during the 
study period of September 2010 and March 2013. The mean birth weight of the cohort 
was 1270.3g (SD + 180.4 & range 710 g to 1500 g) and the mean gestational age was 
31.9 weeks (SD + 2.5 & range 25.1 weeks to 41.3 weeks). There were 407 (52.45%) boys 
and 368 (47.5%) girls in this cohort. In one child (born at 28 weeks), with ambiguous 
genitalia, the sex could not be confirmed since the child was discharged against medical 
advice on the second day.  
The comparison of boys and girls in terms of the birth weight and gestational age are 
depicted in Figures 1a and 1b and the accompanying table (table 9). The male infants in 
the cohort had a slightly lower gestational age compared to the female infants and this 
was statistically significant (p=0.014). There was no significant difference in the birth 
weights (p=0.486).  
Table 10 (below) shows the distribution of the male and female infants according to their 
gestational ages. Nearly 75% of the infants were between 28 and 33 weeks and 4% were 
term infants. 
Table 10: Distribution of the Male and female infants according to their gestational 
ages. 
 
<28 weeks 
( Extreme 
preterm) 
28-31 weeks 
(Very 
Preterm) 
32-33 weeks 
(Moderate 
Preterm) 
34-36 Weeks 
(Late 
Preterm) 
≥ 37 
weeks 
(Term) 
Total 
 
Boys (%) 15 (62.5) 202 (56.1) 101 (46.5) 70 (48.3) 19 (63.3) 407 (52.4) 
Girls (%) 9 (37.5) 157 (43.9) 116 (53.5) 75 (51.7) 11 (36.7) 368 (47.6) 
Total (%) 24  (3.1) 359 (46.4) 217 (27.9) 145 (18.7) 30 (3.9) 775 (100) 
 
b 
 
FIGURE 2: DISTRIBUTION OF THE VLBW BABIES ACCORDING TO THEIR WEIGHTS 
 
 
FIGURE 3: DISTRIBUTION OF THE INFANTS DEPENDING UPON THEIR GROWTH STATUS AT 
BIRTH 
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Figure 2 shows the distribution of the weights of the infants in clusters of 100 g. Except 
for two clusters (1100-1199 & 1200-1299) the birth weights are almost evenly distributed 
between girls and boys. 
Growth status of the babies at the time of birth 
Figure 3 depicts the distribution of the babies according to their gestational ages and sex, 
if they were small for gestational age (SGA) or if they were appropriate for gestational 
age (AGA).  We used the Fenton’s charts364 to decide if the babies were AGA or SGA. 
Infants whose birth weights were less than the 3rd percentile as per the Fenton charts364 
were considered as small for gestational age.  The 3rd percentile on the Fenton charts 
was used because it corresponds to the 10th percentile of two gestational age-specific 
centile charts for South Indian Infants.378,379 There were 239 (30.7%) infants who were 
small for gestational age (SGA) when the Fenton’s third percentile were used. There were 
more SGA girl babies (53.8%). Majority of the infants (almost 90%) who were <33 
weeks of gestation were appropriate for gestational age. All infants, whose gestational 
age was 34 weeks and more, were small for gestational age, because of the ceiling of 
1500 g in the study.   
 
5.1.2 MATERNAL CHARACTERISTICS OF THE STUDY COHORT  
 
Of the total of 776 infants, 561 (72.3%) were singleton babies. Of the remaining, 200 
(25.8%) were twins and 15 (1.9%) were triplets. After accounting for the multifetal 
gestations there were 713 mothers in the study cohort (table 11).  
c 
 
 
TABLE 11:          CHARACTERISTICS OF THE MOTHERS OF THE INFANTS IN THE COHORT 
Characteristics                                                                                 Number (%) 
Total Mothers (after accounting for multifetal gestations) 713 (100) 
 
Maternal age 
       Between 18 to 35 
       Less than 18  (or) More than 35 (only one mother was <18 years) 
 
686 (96.2) 
27 (3.8) 
 
Maternal Education 
       Less than Std. 8 
       Between 9th -12th standard 
       Graduate & Post graduate 
 
86 (12.1) 
268 (37.5) 
213 (30) 
 
Consanguineous Marriage* 169 (27.9) 
 
Gravida 
      Primi gravida 
      Multi gravida (>3) 
 
388 (54.3) 
56 (7.9) 
 
At least two  Antenatal visits 713 (100) 
 
History of Infertility  
      Conceived after treatment (Clomiphene, IUI, IVF) 
      Conceived spontaneously 
104 (14.6) 
79 (75.9) 
25 (24.1) 
 
Thyroid illness (Hypothyroidism: 31, Hyperthyroidism: 5) 36 (5) 
 
Diabetes complicating pregnancy (Gestational diabetes: 41, Pre-gestational 9) 
 
50 (7) 
Hypertension complicating pregnancy (Pre-eclampsia : 274, Eclampsia:34) 
 
308 (43.2)  
Antepartum Hemorrhage 
      Abruption 
      Placenta previa & Others 
 
 
36 (5.0) 
16 (2.3) 
Antepartum steroids (611  mothers were less than 34 weeks gestation) 
      No steroids at all 
      Steroids given (At least one dose: 217 Two doses given:253) 
 
141 (23.1) 
470 (70.9) 
 
Preterm Premature rupture of membranes (PPROM) 134 (18.8) 
 
Meconium stained amniotic fluid (>Grade 1) 16 (2.3) 
 
Chorioamnionitis 8 (1.1) 
 
Type of Delivery 
     Normal 
     Cesarean section 
     Breech and instrumental (Forceps, vacuum extraction) 
 
235 (32.9) 
435 (61.1) 
43 (6) 
 
Place of birth 
      Inborn 
      Outborn 
 
638 (89.5) 
75 (10.5) 
 
 
Obstetric complications prior to this conception  & Medical complications 149 (20.9) 
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Antenatal check-up: It is heartening to note that all mothers had at least two antenatal 
consultations. Majority (96.2%) of the mothers were between the ages of 18 and 30 years.  
Maternal education level: Most of the mothers (68%) were educated beyond middle 
school, and about one third had completed graduation.  
Preterm premature rupture of membranes occurred in 18.8% of the mothers of the 
cohort  
Pregnancy induced hypertension: The main maternal complication (seen in 43.2%) was 
pregnancy induced hypertension (table 11). Over one third (36.2%) of the babies born to 
mothers with PIH were born SGA. Overall there was 7% mortality in these infants and 
the most common cause of death was septicemia (table 14). Although most children who 
were born to mothers who were pre-eclamptic survived, notably, 20% of children born to 
mothers with eclampsia died (some of them, due to perinatal asphyxia). 
History of infertility: There was history of infertility prior to this pregnancy in 14.6% of 
the mothers (table 11). Of these majority (75.9%) conceived after treatment, while the 
rest conceived spontaneously. More than half of the infants (56.7%) who were born after 
treatment for infertility were born of twin or triplet pregnancies.  
Twins and triplets: Among the 200 children born of multifetal gestations, in 55 twin 
pairs both the twins and in three triplet sets, all the three triplets were part of the study 
cohort since they had birth weight of <1500 g (table 11). In the remaining, only one twin 
or one or two triplets, who were VLBW was included in the study. In our cohort 97.2% 
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of the multifetal gestational babies were premature and 28% of the babies were small for 
gestational age (however, this is because of the birth weight ceiling of 1500 g).  
Significant past obstetric or medical history: About 11.8% of the mothers had previous 
history of adverse pregnancy outcomes (multiple abortions, neonatal death, intrauterine 
death or previous low birth weight infant) and 9.1% of the mothers had medical 
complications (table 11). The medical complications included anemia, chemotherapy for 
malignancies, chronic liver disease, chronic renal failure, rheumatologic problems 
(Systemic Lupus Erythematosus and Rheumatoid Arthritis), hematologic disorders 
(Paroxysmal Nocturnal Hemoglobinuria, Immune Thrombocytopenic Purpura) congenital 
and rheumatic heart diseases, cardiomyopathy, malaria, tuberculosis of spine, seizure 
disorder, HIV sero-positivity (2 patients), Congenital Nemaline Rod Myopathy and 
psychiatric illness on treatment. The presence of these complications did not affect the 
survival of the infants [p=0.249, RR 0.926 (0.83-1.030]. The other less common maternal 
complications were intrapartum hemorrhage (5%), thyroid illness (5%) and 
chorioamnionitis (1.1%). 
Diabetes during pregnancy: There were 50 mothers (7%) with diabetes complicating 
pregnancy (41 had gestational diabetes and 9 had pre-existing diabetes mellitus), 15% of 
the infants of diabetic mothers (IDM) were small for gestation and all the infants were 
preterm (table 11). 
Primi gravida: Almost half of the mothers (54.3%) of the mothers were primi-gravidas 
and about 8% of the mothers had more than 3 previous pregnancies (table 11). 
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Antenatal corticosteroids: It is heartening to note that at least 70% of the mothers (who 
delivered at gestational age of 34 weeks or less) had at least one dose of antenatal 
corticosteroids (betamethasone) (table 11). 
Type of delivery: More than half (67%) of the infants were born by Cesarean or 
instrumental deliveries (assisted breech, forceps or vacuum) (table 11), which is to be 
expected since many mothers had PIH and other complications. 90% of the babies were 
born in this institution and the rest were referred from other centers after the baby was 
born. There was no difference in the outcome between those who were born normally and 
those born by Cesarean section or instrumental delivery (table 14) 
Relationship between the maternal characteristics and survival in the NICU 
None of the above maternal or antenatal risk factors affected the survival of the babies 
in the nursery. This is depicted in table 14 which presents the bivariate analysis of 
these characteristics with death in the NICU. 
 
5.1.3 NEONATAL COMPLICATIONS IN NICU  
Table 12 presents the complications of the infants during the period of admission in the 
NICU. The data are presented according to the gestational age rather than the birth 
weight since many complications in the VLBW are dependent on the gestational age 
rather than on the birth weight. The complications in the extremely preterm (<28 weeks), 
Very preterm (28-31 weeks), moderately preterm (32-33 weeks), late preterm (34-36 
weeks) and term babies are compared between boys and girls. 
 
  
TABLE 12:  PERINATAL RISK FACTORS & NEONATAL COMPLICATIONS ACCORDING TO GESTATIONAL AGE  
  
<28 weeks 
( Extreme preterm) 
28-31 weeks 
(Very Preterm) 
32-33 weeks 
(Moderate Preterm) 
34-36 Weeks 
(Late Preterm) 
≥ 37 weeks 
(Term) 
S.N Variable Boys Girls 
P-
value Boys Girls P-value Boys Girls P-value Boys Girls P-value Boys Girls P-value 
1 
Multifetal 
gestations  (%) 
1 
(26.7) 
3 
(33) 0.728 
66 
(32.7) 
44 
(27.8) 0.324 
27 
(26.7) 
26 
(22) 0.46 
18 
(25.7) 
22 
(29) 0.63 
5 
(26) 
1 
(9.1) 0.25 
2 
Diabetes during 
pregnancy (%) 
1 
(6.7) 
1 
(11) 0.703 
16 
(7.9) 
19 
(12) 0.192 
8 
(7.9) 
8 
(6.9) 0.773 
1 
(1.4) 
3 
(4) 0.345 - - - 
3 
PIH 
 (%) 
0 
(0) 
3 
(33) 0.017 
56 
(27.7) 
64 
(40.5) 0.011 
55 
(54) 
59 
(50.9) 0.597 
30 
(42.8) 
39 
(52) 0.271 
6 
(31.6) 
4 
(36.4) 0.789 
4 
Antepartum 
Hemorrhage (%) 
1 
(6.7) 
0 
(0) 0.429 
18 
(8.9) 
18 
(11.4) 0.383 
4 
(3.9) 
3 
(2.6) 0.568 
2 
(2.8) 
4 
(5.3) 0.454 
1 
(5.3) 
1 
(9.1) 0.685 
5 
Antenatal steroids 
(%) 
5 
(33) 
4 
(55) 0.586 
46 
(22.8) 
30 
(18.9) 0.383 
13 
(12.9) 
15 
(12.9) 0.990 
17 
(24.3) 
22 
(29) 0.493 - - - 
6 
PPROM 
(%) 
5 
(33) 
2 
(22) 0.562 
60 
(29.7) 
26 
(16) 0.003 
17 
(16.8) 
22 
(18.9) 0.683 
11 
(15.7) 
5 
(6.7) 0.082 
0 
(0) 
1 
(9.1) 0.181 
7 
Cesarean & 
Instrumental (%) 
5 
(33) 
1 
(11) 0.224 
113 
(55.9) 
97 
(61) 0.298 
74 
(73) 
85 
(73) 0.999 
55 
(78.5) 
63 
(84) 0.401 
12 
(63) 
10 
(90.9) 0.098 
8 Place of birth  (%) 
3 
(20) 
0 
(0) 0.151 
26 
(12.9) 
17 
(10.7) 0.540 
8 
(7.9) 
8 
(6.9) 0.773 
10 
(14) 
4 
(5.3) 0.068 
4 
(21) 
3 
(27) 0.698 
9 
Perinatal 
Asphyxia (%) 
1 
(6.7) 
0 
(0) 0.429 
11 
(5.4) 
1 
(0.63) 0.012 
4 
(4) 
10 
(8.6) 0.163 
4 
(5.7) 
2 
(2.6) 0.357 
1 
(5.3) 
0 
(0) 
 
0.439 
10 
Acute kidney 
injury (%) 
2 
(13.3) 
1 
(11) 1.000 
10 
(4.9) 
4 
(2.5) 0.248 
2 
(1.9) 
3 
(2.6) 0.758 
0 
(0) 
1 
(1.3) 0.288 
0 
(0) 
2 
(18.2) 
 
0.055 
11 
NEC- Bell stage > 2 
(%) - - - 
4 
(1.98) 
3 
(1.89) 0.956 
0 
(0) 
3 
(2.58) 0.104 
1 
(1.42) 
1 
(1.3) 0.961 - - - 
12 
Apnea 
 (%) 
3 
(20) 
2 
(22) 0.897 
38 
(18.8) 
19 
(12) 0.084 
11 
(10.9) 
14 
(12.1) 0.769 
5 
(7.14) 
2 
(2.67) 0.216 
1 
(5.26) 
0 
(0) 
 
0.439 
13 
RDS  
(%) 
11 
(73.3) 
5 
(56) 0.371 
83 
(41) 
53 
(33.5) 0.155 
10 
(9.9) 
17 
(14.6) 0.279 
6 
(8.6) 
1 
(1.3) 0.044 - - - 
14 
BPD 
 (%) 
2 
 (13.3) 
0 
(0) 0.253 
6  
(2.9) 
2 
(1.26) 0.280 
1 
(0.99) 
1 
(0.86) 0.926 
1 
(1.43) 
0 
(0) 0.302 - - - 
15 
CPAP  
(%) 
10 
(67) 
6 
(67) 1.000 
88 
(43.6) 
54 
(34) 0.078 
16 
(15.8) 
21 
(18) 0.638 
6 
(8.6) 
1 
(1.3) 0.044 - - 
- 
 
 
   
<28 weeks 
( Extreme preterm) 
28-31 weeks 
(Very Preterm) 
32-33 weeks 
(Moderate Preterm) 
34-37 Weeks 
(Late Preterm) 
≥ 37 weeks 
(Term) 
 Variable Boys Girls 
P-
value Boys Girls P-value Boys Girls P-value Boys Girls P-value Boys Girls P-value 
16 Ventilation (%) 
8 
(53) 
1 
(11) 0.039 
52 
(25.7) 
34 
(21.5) 0.368 
5 
(4.9) 
14 
(12.1) 0.061 
3 
(4.3) 
4 
(5.3) 0.755 
1 
(5.3) 
1 
(9.1) 
 
0.685 
17 
Hypotension 
(%) 
11 
(73) 
2 
(22) 0.015 
56 
(28) 
43 
(27) 0.921 
12 
(11.8) 
16 
(13.8) 0.675 
9 
(12.8) 
7 
(9.3) 0.499 
2 
(10.5) 
1 
(9.1) 
 
0.900 
18 
Septicemia 
(%) 
2 
(13.3) 
3 
(33) 0.243 
37 
(18.3) 
36 
(23) 0.292 
16 
(15.8) 
21 
(18) 0.640 
11 
(15.7) 
8 
(10.6) 0.385 
4 
(21) 
0 
(0) 
 
0.092 
19 
Hyper- 
Bilirubinemia (%) - - 0.718 
8 
(3.9) 
6 
(3.7) 0.622 
7 
(6.9) 
5 
(4.3) 0.809 
3 
(4.3) 
1 
(1.3) 0.374 
3 
(15.8) 
0 
(0) 
 
0.311 
21 
Hypo- 
Glycemia (%) 
0 
(0) 
1 
(11) 0.187 
11 
(5.4) 
9 
(5.7) 0.523 
9 
(8.9) 
12 
(10.3) 0.690 
6 
(8.6) 
7 
(9.3) 0.853 
8 
(42) 
5 
(45) 
 
0.858 
22 
Poly- 
Cythemia (%) - - - 
6 
(2.9) 
4 
(2.5) 0.796 
4 
(3.9) 
5 
(4.3) 0.888 
6 
(8.6) 
6 
(8) 0.920 
1 
(5.3) 
3 
(27) 0.100 
23 
Anemia 
(%) 
11 
(73) 
4 
(44) 0.156 
72 
(35.6) 
45 
(28) 0.141 
13 
(12.9) 
18 
(15.5) 0.563 
6 
(8.6) 
5 
(6.7) 0.682 
2 
(10.5) 
1 
(9.1) 0.862 
24 
Thrombo-
cytopenia (%) 
8 
(53) 
3 
(33) 0.375 
78 
(38.6) 
56 
(35) 0.513 
42 
(41.5) 
35 
(30) 0.086 
32 
(45.7) 
28 
(37) 0.338 
8 
(42) 
5 
(45) 0.958 
25 
Abnormal 
Calcium (%) 
5 
(33) 
1 
(11) 0.235 
49 
(24.2) 
30 
(18.9) 0.555 
5 
(4.9) 
13 
(11.2) 0.095 
1 
(1.4) 
4 
(5.3) 0.128 
0 
(0) 
1 
(9.1) 0.227 
26 
Sodium 
(%) 
6 
(40) 
4 
(44) 0.502 
56 
(27.7) 
44 
(27.8) 0.675 
12 
(11.9) 
12 
(10) 0.668 
10 
(14.3) 
9 
(12) 0.973 
5 
(26) 
5 
(45) 0.285 
27 
Potassium 
(%) 
2 
(13) 
2 
(22) 0.423 
31 
(15) 
24 
(15) 0.821 
11 
(10.9) 
8 
(6.9) 0.268 
5 
(7) 
4 
(5.3) 0.838 
1 
(5.3) 
1 
(9.1) 0.693 
28 
PDA 
(%) 
6 
(40) 
4 
(44) 0.405 
36 
(17.8) 
30 
(18.9) 0.772 
6 
(5.9) 
8 
(6.9) 0.779 
4 
(5.7) 
5 
(6.7) 0.796 
1 
(5.3) 
0 
(0) 0.426 
29 
IVH(>Grade2) 
(%) 
1 
(6.7) 
1 
(11) 0.596 
11 
(5.4) 
0 
(0) 0.003 
3 
(2.9) 
1 
(0.86) 0.276 - - - - - - 
30 
Cholestatic 
jaundice (%) 
 
- - - 
9 
(4.4) 
7 
(4.4) 0.972 
8 
(7.9) 
2 
(1.7) 
 
0.029 
2 
(2.8) 
2 
(2.7) 
0.943 
 
3 
(15.8) 
0 
(0) 
0.153 
 
31 
PVL(>Grade2) 
(%) - - - - - - 
0 
(0) 
1 
(0.86) 0.335 - - - - - - 
32 
ROP 
(%) 
2 
(13) 
1 
(11) 0.635 
27 
(13.4) 
31 
(19.6) 0.077 
5 
(4.9) 
2 
(1.7) 0.268 
3 
(4.3) 
0 
(0) 0.092 
1 
(5.3) 
0 
(0) 0.640 
33 
Mortality 
(%) 
6 
(40) 
1 
(11) 0.252 
21 
(10.4) 
18 
(11.4) 0.780 
3 
(2.9) 
7 
(6) 0.296 
3 
(4.3) 
1 
(1.3) 0.310 
0 
(0) 
1 
(9.1) 0.149 
 Total  15 9 24 202 157 359 101 116 217 70 75 145 19 11 30 
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A. RESUSCITATION AND PERINATAL ASPHYXIA   
Among the 776 infants admitted into the NICU, 108 (13.9%) required some form of 
resuscitation at birth (bag and mask ventilation, or intubation) (table 12). However in the 
majority, spontaneous respiration could be established.   
Perinatal asphyxia in this cohort was defined by pH ≤ 7.0 or ABE ≥ -12 in Umbilical cord 
pH or peripheral ABG within one hour or APGAR ≤ 5 at 5 minutes. In 34 infants 
(4.38%) there was evidence of perinatal asphyxia, (characterized by umbilical artery pH 
of less than 7.1 and low APGAR (<3) at 5 minutes requiring assisted ventilation and fluid 
and inotrope support).  There were significantly more boys with perinatal asphyxia in the 
28-31 weeks (very preterm) group and more girls with asphyxia in the 32-33 weeks 
(moderate preterm category).  However when the entire cohort was analyzed there was no 
difference in the occurrence of asphyxia between the girls and boys.   
B. RESPIRATORY DISTRESS SYNDROME (RDS) 
Almost all (96%) the infants with RDS were born before 33 weeks (table 12). Incidence 
of RDS was maximal in the very preterm group (29-31 weeks). Since most of the 
children with RDS required respiratory support, majority of the children who received 
Continuous positive airway pressure (CPAP) or ventilation were also less than 31 weeks 
of gestation.   
As per the Institutional protocol, the first line of treatment for RDS is administration of 
CPAP. Only if CPAP fails would the infant be intubated and surfactant administered 
followed by ventilation. Twenty one out of a total of 186 (11.3%) infants received intra-
tracheal surfactant. Although it appears that the mortality in the RDS group is high 
(18%), most children who died were those who had associated septicemia, or grade IV 
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intraventricular hemorrhage or other conditions. It is likely that these associated 
morbidities worsened the pulmonary function which resulted in increased ventilatory 
requirements and death. 
C. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)  
As mentioned above, CPAP is the first line of management of newborns with RDS in this 
institution. More than a quarter (26%) of the infants required CPAP. As expected 97% of 
these infants were less than 34 weeks (table 12). In about a third (29.7%) the CPAP was 
not sufficient and they required ventilator support (using conventional ventilation or High 
frequency ventilation).  
The mean duration of the CPAP for the entire cohort was 46 hours. There were four 
children who received CPAP for more than one week. The mortality increased with 
duration of CPAP. Mortality according to the duration of ventilation was as follows - 
there was 20% mortality among those who were ventilated for less than 24 hours, 11% 
mortality in those who had CPAP from 1-3 days, 18.5% among those who had CPAP for 
4-7 days and 25% in those who had CPAP for more than one week. The higher mortality 
in those who received CPAP for less than 24 hours was because in these babies these 
babies were sicker. When CPAP failed, they required ventilator support; however they 
still succumbed to the illness. 
D. VENTILATION  
In our cohort 13.4% of the children required ventilation. More than 90% of these were 
less than 34 weeks (table 12). In 20% of the infants who were ventilated, high frequency 
oscillatory ventilation (HFOV) was required due to failure of conventional ventilation.   
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The mean duration of ventilation was 59 hours. There were six children who were 
ventilated for more than one week. The mortality increased with duration of the 
ventilation. There was 62% mortality among those who were ventilated for less than 24 
hours, 32.5% mortality in those who were ventilated for 1-3 days, 56% among those who 
were ventilated for 4-7 days and 67% in those who were ventilated for more than one 
week. The higher mortality in those who were ventilated for less than 24 hours was 
because these were children who were very sick and most of them had multi-organ 
failure. CPAP and Ventilation were not included in the multivariate logistic regression 
model, since CPAP or ventilation per se were not the cause of death. The, underlying 
reason for which the child received CPAP or required ventilation was the cause of death 
and including CPAP or ventilation would therefore confound the model. 
E. NECROTIZING ENTEROCOLITIS (NEC)  
Thirty infants (3.8%) of the 776 infants developed NEC. Nineteen (63%) of the children 
with NEC infants had NEC Bell stage 1, nine children (30%) had NEC stage 2 and two 
children (6.7%) had stage 3 (bowel perforation and required bowel resection). Of the two 
children with NEC stage 3, one child survived and one succumbed after surgery. The 
child who survived came back for the assessment at 18 months.  
The overall mortality in those who had NEC was 17% (5 of 30 died) and all of them had 
severe NEC (stage 2 and beyond). The mortality according the 3 stages was - 0% for 
stage 1, 44% (four out of nine) for stage 2 and 50% (one of two children) for stage 3.  
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F. BRONCHOPULMONARY DYSLASIA (BPD)  
There were 13 children who were diagnosed to have BPD (table 12) and who required 
oxygen therapy for >28 days. Ten of the 13 (77%) were less than 31 weeks gestation; two 
others were between 32 and 33 weeks. There was one baby who was born at 34 weeks 
(gestational age calculated from the last menstrual period) who developed BPD.  
However this child was out-born and the gestational age could not be ascertained 
accurately. In our cohort BPD and post-natal corticosteroid therapy was not associated 
with mortality or neurodevelopmental outcomes. 
G. ANEMIA AND THROMBOCYTOPENIA   
Anemia was a common morbidity (table 12). Anemia can occur due to multiple reasons 
in VLBW infants who are admitted in the NICU. Although the most important reason is 
anemia due to prematurity, iatrogenic bloodletting for diagnostic testing is also a major 
contributor. Anemia was seen predominantly (92.1%) in the infants less than 33 weeks 
gestational age. Thrombocytopenia was another major hematologic morbidity (table 12),  
and 50% of the extremely preterm, 37.2% of very preterm, 36% of moderate preterm, 
41.2% of late preterm and 44% of term infants had low platelets. There are many causes 
for thrombocytopenia in the neonate and since thrombocytopenia is regularly present 
when there are signs of sepsis, it is commonly seen in infants admitted into the NICU.  
H. CALCIUM, GLUCOSE, BILIRUBIN AND ELECTROLYTE ABNORMALITIES 
Abnormal calcium value was present in 109 infants (table 12). Of these two infants had 
hypercalcemia and the rest had hypocalcaemia. Calcium was abnormal primarily (94.4%) 
in infants whose gestational age was less than 33 weeks.  
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Hypoglycemia was an uncommon complication (table 12) and was present in 8.76% of 
the infants. Both premature babies and intrauterine growth retarded babies are prone to 
develop hypoglycemia and so it was seen in all the age groups.   
Almost 547 (70.4%) infants had bilirubin levels more than 8 g% and required 
phototherapy.  Four infants (0.52%) required exchange transfusion. Hyperbilirubinemia 
(bilirubin >15 mg%) was seen in 33 (4.4%)  infants and was present predominantly in the 
preterm babies (table 12). 
The commonest electrolyte abnormality was hyponatremia followed by hyperkalemia. 
Among the 163 infants with abnormal sodium values (<130mEq/L and >150 mEq/L), 
142 (87.1%) had hyponatremia, 14 (8.6%) had hypernatremia and 7 (4.3%) had both 
hypo and hypernatremia. Eighty nine infants had abnormal potassium (<3.5 mEq/L and 
>6 mEq/L). Of these 52 (58.4%) had hyperkalemia, 35 (39.3%) had hypokalemia and two 
children had both hyper and hypokalemia.  Cholestatic jaundice was present in 33 (4.3%) 
infants and was mainly seen in the very preterm and moderately preterm group (table 
12). 
I. INTRAVENTRICULAR HEMORRHAGE (IVH)   
Overall 111 children (72 boys and 39 girls) had IVH (of any grade). Severe IVH (Grades 
III and IV) was a major morbidity in the very preterm (29-31 weeks) infants and was seen 
predominantly in the male infants (15 boys and only 2 girls had severe IVH) (table 12). 
This is very significant and as mentioned in the Literature review section (3.4.11), the 
male infants were particularly prone to develop severe IVH. Of the 17 infants, only two 
infants (one male and one female infant) survived and were discharged alive from the 
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NICU. The rest died or were discharged before completion of treatment in a moribund 
condition. Periventricular leukomalacia was not a very significant morbidity in this 
cohort. Of the 51 children (29 boys and 23 girls) who had periventricular leukomalacia, 
only one girl child had PVL- Grade III (table 12). 
J. MALE PREDISPOSITION TO DEVELOPING NEONATAL MORBIDITIES  
As discussed earlier (Literature Review 3.4.1), male babies are at greater risk than female 
babies in developing neonatal complications. In our study perinatal asphyxia, necrotizing 
enterocolitis, septicemia, periventricular leukomalacia, PDA and acute kidney injury 
were similar between boys and girls.  
The sex predilection for male babies was observed in the occurrence of certain neonatal 
morbidities (table 12) - 
• Boys had a much higher risk of developing severe IVH (Grades III and IV) 
compared to girls. The overall relative risk (across all gestational age) for male 
babies was 4.05 (1.1-14.9 95% CI, p=0.003) compared to girls.   
• Male infants had a higher risk of developing respiratory distress syndrome 
compared to female infants. [Relative risk of 1.213 (1.002-1.47 95%CI, 
p=0.038)].  
• Male babies also were more likely to have received CPAP [Relative risk of 1.23 
(1.02-1.476 95%CI, p=0.025)] and they also had a slightly higher risk (although 
not significant) of being ventilated [Relative risk of 1.24 (.957-1.516 95%CI, 
p=0.094)]. 
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• Preterm premature rupture of membranes resulted in more male babies compared 
to female babies [22.8% male babies vs. 15.2% female babies, p=0.007; RR of 
1.33 (1.06-1.66 95%CI)].  
• Interestingly there were more girls born to mothers with PIH as compared to boys 
[45.6% girls vs. 36.1% boys, p=0.007, RR 1.21 (1.05-1.39 95%CI)]. 
K. SEPTICEMIA  
Septicemia was a major morbidity in the cohort (figures 5 & 6; tables 12 & 13).   
• Total infants with septicemia: 135 of the total of 776 (17.4%) infants had 
septicemia. 
• Septicemia and gestational age: Occurrence of septicemia decreased with 
increasing gestational age. 20.8% of extremely preterm, 20.3% of very preterm, 
17% of moderate preterm, 13.1% of late preterm and 13% of term infants had 
septicemia.  
• Early and late onset septicemia: Septicemia of early onset (onset before 72 
hours) was present in 47 (34.8%) of the infants, 85 (62.9%) had late onset sepsis 
(onset after 72 hours) and three infants (2.2%) had early onset sepsis followed by 
a subsequent episode of late onset sepsis.   
• Organisms causing septicemia: The main organism causing early onset sepsis 
was the Burkholderia species and the predominant causes of late onset septicemia 
were Gram negative organisms like Klebsiella, Acinetobacter and Enterobacter 
species (Figure 4).  
  
 
 
Fig. 5: ORGANISMS CAUSING DEATH DUE TO SEPTICEMIA 
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Figure 4:   EARLY ONSET Vs. LATE ONSET SEPSIS
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TABLE 13:   CAUSES OF DEATH IN THE NICU 
 
 <28 
weeks 
28-31 
weeks 
32-33 
weeks 
34-36 
weeks 
> 37 
weeks 
Total 
Septicemia 3 25 5 2 0 35 
Perinatal asphyxia 0 3 3 2 0 8 
Pulmonary hypoplasia 0 1 0 0 0 1 
RDS with complications (pulmonary  
hemorrhage, pneumothorax, PIE) 
3 1 0 0 1 5 
Intraventricular Hemorrhage 
(Grades  IV) 
1 3 1 0 0 5 
Cardiac causes  (myocardial dysfunction, 
Tetralogy of Falot) 
0 1 1 0 0 2 
Necrotizing Enterocolitis (Grade 3) 0 3 0 0 0 3 
Extremely low birth weight 0 1 0 0 0 1 
Total Mortality (% of the total for the 
GA) 
7 
(29.2) 
38 (10.6) 10 (4.6) 4 (2.8) 1 (3.3) 60 (7.7) 
 
 
10 (42)
290 (81)
194 (89)
126(87)
23(77)
7(29)
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Figure 6:    OUTCOMES OF THE VLBW COHORT IN THE 
NICU
Survived to discharge Expired Discharged before completion of treatment
Numbers (%) 
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• Meningitis: 26 infants (19.3%) developed meningitis.  Twenty one (80.7%) of the 
26 infants were discharged alive from the NICU and five children succumbed to 
meningitis. Four children developed hydrocephalus - two of these underwent 
ventriculo-peritoneal shunt surgery and improved well. The other two were 
among the five infants who died of meningitis.  
• Death due to septicemia (Figure 5): Septicemia was the predominant cause of 
mortality in this cohort.  Thirty five of the sixty (58.3%), of the infants who died, 
died because of septicemia. Gram negative bacilli septicemia was the leading 
cause of septicemia related deaths.  Although in eight children there was no 
growth on the blood culture, sepsis leading on to septic shock was strongly 
suspected in view of the clinical features like sclerema, leukopenia, elevated CRP 
and thrombocytopenia. 
5.1.4 CAUSES OF MORTALITY  
 
Figure 6 and table 13 shows the outcome of the infants after their stay in NICU.  
• Totally sixty children died in the NICU. Of these 33 (55%) were boys and 27 
(45%) were girls. Thus the mortality rate in the NICU was 7.73%. (60/776 
infants)  
• Mortality rate was 8.9% among boys and 8.1% among girls [p= 0.718, RR 0.956   
(0.75-1.22, 95%CI)].  
• The survival rate improved with increasing gestation. Mortality was highest in the 
infants <28 weeks gestation (29.2% of the infants died).. There were 10.6% 
deaths in the 28-31 weeks, 4.6% deaths in the 32-33 weeks category, 2.8% deaths 
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in the 34-36 weeks category and only one death (4.3%) in the >37 weeks category 
(table 13). 
Although the infants who died had multiple complications, each of which could result in 
death, the table 13 depicts the most likely cause of death. For example five children who 
died of septicemia, had severe IVH. Children who died due to respiratory complications 
also had features of septic shock. One ELBW child (825g at 28 weeks gestation), the 
exact cause of death could not be ascertained and the extreme low birth weight is shown 
as the cause of death. 
Like NICUs in other developing countries, unfortunately septicemia was the main cause 
of death in all gestational ages. Klebsiella was the most common cause of septicemia 
(figure 5). Other organisms which contributed to mortality included Acinetobacter 
species, Enterobacter, Burkholderia species and E.coli.  
The mortality rate decreased with increasing gestational age. Among the babies who died 
58.3% were <31 weeks and 91.7% were <33 weeks gestational age.  
Infants who left before completion of treatment (“Discharged against medical 
advice”) 
The percentage of infants who left before completion of treatment are as follows 29.2%  
in the less than 28 weeks category, 8.9% in the 28-31 weeks category, 6% deaths in 32-
33 weeks, 10.3% in the 34-36 weeks  and 20%  in the >37 weeks categories respectively. 
Many of them left the NICU in a moribund state 
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5.1.5 BI-VARIATE ANALYSIS OF ANTENATAL, PERINATAL AND NEONATAL FACTORS    
AND THE RELATIONSHIP TO MORTALITY 
Table 14 shows the bivariate analysis (using Chi-square test) of the various antenatal, 
perinatal and neonatal risk factors. For this analysis the group of infants “discharged 
against medical advice” was not considered. The risk factors which were significantly 
associated (p <0.001)  with death in this cohort were - birth-weight, gestational age, PDA, 
severe IVH, abnormal potassium, sodium and calcium, anemia, septicemia, hypotension, 
ventilation, CPAP, NEC, acute kidney illness and perinatal asphyxia (table 14).  Relative 
risks were also computed. 
Relative risks instead of Odds ratios  
In cohort studies relative risk is more useful than odds ratios.380 When the odds ratios 
were calculated for hypotension, ventilation, severe IVH, NEC, it was very high (the 
odds ratios for death due to hypotension was 59, the OR for IVH was 69.6 the OR for 
ventilation was 74.25) The reason the large distortion is because the event (which is death 
in this case), is especially large in one group (the Expired group) as compared to other 
group. For example there were 9 deaths out of 11 children in those with severe IVH 
(which amounts to 82%) compared to 2 survivors (18%) in those with IVH. This happens 
when hypotension, NEC and ventilation are compared.  
Altman says “The odds ratio should not be interpreted as an approximate relative risk 
unless the events are rare in both groups (say, less than 20-30%)…..In a cohort study 
Relative Risk (RR) rather than odds ratio (OR) is more relevant…. (However) the odds 
ratio remains especially useful when researchers need to adjust for other variables, for 
  
TABLE 14: BI-VARIATE ANALYSIS OF RISK FACTORS VS. MORTALITY IN NICU 
 
MATERNAL AND PERINATAL RISK FACTORS 
Risk Variables Discharged 
alive (%) 
Expired  
(%) 
P value Relative  
Risk 95% CI 
Antepartum H’ge:  No APH 
APH 
602 (92) 
41 (89) 
55  (8) 
5 (11) 
 
0.581 
.028 
0.927-1.140 
PIH: No Hypertension 
PIH present 
371 (90) 
272 (93) 
41 (10) 
19 (7) 
 
0.110 
0.963 
0.922-1.007 
Maternal Diabetes: No Diabetes 
Diabetes  present 
593 (92) 
50 (88) 
53 (8) 
7 (12) 
 
0.318 
1.046 
0.947-1.156 
Multifetal gestation: Singletons 
Multifetal Pregnancy 
468 (93) 
175 (88) 
37 (7) 
23 (12) 
 
0.067 
1.049 
0.991-1.109 
Antenatal Steroid: Received 
No  Steroid received 
520 (92) 
123 (90) 
47 (8) 
13 (10) 
 
0.634 
1.014 
0.955-1.077 
Type of Delivery: Normal  
Cesarean  
211 (91) 
432 (92) 
21 (9) 
39 (8) 
 
0.731 
0.992 
0.944-1.041 
Treated for Infertility: No treatment 
Conceived after treatment 
559 (91) 
84 (91) 
52 (9) 
8 (9) 
 
0.953 
1.003 
0.90-1.11 
Growth (AGA  or SGA): AGA 
SGA 
444 (90) 
199 (94) 
47 (10) 
13 (6) 
 
0.134 
0.963 
0.921-1.008 
PPROM: No PPROM 
Present 
515 (92) 
128 (91) 
47 (8) 
13 (9) 
 
0.745 
1.009 
0.952-1.070 
 
BIRTH DETAILS AND CHARACTERISTICS OF THE BABIES 
Neonatal Characteristics Discharged 
alive (%) 
Expired  
(%) 
P value Relative  
Risk 95% CI 
Place of Birth: Inborn 
Out-born 
575 (92) 
68 (89) 
52 (8) 
8 (11) 
0.511 1.025 
0.946-1.111 
Baby's Sex: Boy 
Girl 
338 (91) 
305 (92) 
33 (9) 
27 (8) 
 
0.718 
0.992 
0.948-1.037 
Birth weight: 1200-1500g* 
1000-1099g 
500-999g 
473 (95.2) 
129 (84.8) 
44 (77.2) 
24 (4.8) 
23 (15.2) 
13 (12.8) 
 
<0.001 
<0.001 
 
Gestational age: 32-33 weeks* 
<31 weeks 
>34 weeks 
194 (95.1) 
300 (87) 
152 (96.8) 
10 (4.9) 
45 (13) 
5 (3.2) 
 
0.003 
0.421 
 
 Table 14 (contd.) NEONATAL COMPLICATIONS 
 
Risk Variables 
Discharged 
alive (%) 
Expired 
 (%) 
P value Relative Risk 
 (95% CI) 
Perinatal Asphyxia:  absent 
Asphyxia present 
624 (93) 
19 (66) 
50 (7) 
10 (34) 
 
<0.001 
1.413 
1.084-1.842 
Septicemia: No Sepsis 
Confirmed Sepsis 
550 (95) 
93 (75) 
29 (5) 
31 (25) 
 
<0.001 
1.267 
1.142-1.404 
Hypotension:  Absent 
Hypotension present 
559 (99) 
84 (61) 
6 (1) 
54 (39) 
 
<0.001 
1.625 
1.422-1.859 
PDA:  Absent 
Present 
571 (94) 
72 (80) 
38 (6) 
18 (20) 
 
<0.001 
1.172 
1.055-1.302 
IVH: Normal to grade 2 
Grade 3 and 4 
   619 (94) 
2 (18) 
40 (6) 
9 (82) 
 
<0.001 
5.166 
1.475-18.1 
Cholestasis: Absent 
Present 
617 (92) 
26 (87) 
51 (8) 
4 (13) 
 
0.285 
1.066 
0.925-1.228 
Potassium: Normal 
Abnormal 
533 (95) 
68 (79) 
30 (5) 
18 (21) 
 
<0.001 
1.197 
1.072-1.337 
Sodium: Normal 
Abnormal 
479 (95) 
124 (84) 
25 (5) 
23 (6) 
 
<0.001 
1.127 
1.048-1.211 
Calcium: Normal 
Abnormal 
467 (94) 
82 (86) 
31 (6) 
13 (14) 
 
0.011 
1.086 
1.000-1.181 
Thrombocytopenia: Absent 
Thrombocytopenia present  
420 (97) 
223 (83) 
12 (3) 
45 (17) 
 
<0.001 
1.168 
1.105-1.236 
Anemia: Absent 
Anemia present 
498 (94) 
145 (84) 
30 (6) 
27 (16) 
 
<0.001 
1.119 
1.045-1.197 
Hypoglycemia: Absent 
Hypoglycemia present 
588 (92) 
55 (92) 
52 (8) 
5 (8) 
 
1.000 
1.002 
0.925-1.085 
CPAP:     No CPAP 
CPAP used 
487 (94) 
156 (84) 
29 (6) 
29 (16) 
 
<0.001 
1.119 
1.048-1.195 
RDS: No RDS 
RDS present 
508 (94) 
135 (82) 
30 (6) 
30 (18) 
 
<0.001 
1.154 
1.071-1.244 
NEC: No or Bell stage 1 
Bell stage 2 & beyond 
637 (92) 
6 (55) 
55 (8) 
5 (45) 
 
0.001 
1.688 
0.984-2.896 
Acute Kidney injury: No AKI  
AKI present 
57 193 
10 (53) 
42 (7) 
9 (47) 
 
<0.001 
1.770 
(1.155-2.713) 
Ventilation: No Ventilation 
Ventilated 
594(91.9) 
52 (8.1) 
8 (13.3) 
52 (86.7)  
 
<0.001 
1.973 
(1.62-2.4) 
Hyperbilirubinemia: Bilirubin < 15 
Bilirubin > 15 
552 (92) 
28 (93) 
45 (8) 
2 (7) 
 
0.018 
0.885 
(0.217-3.586) 
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which logistic regression is the usual approach”.380 Therefore relative risks rather than 
Odds ratios are presented in the bivariate analyses (tables 14 and 23). 
5.1.6 MULTIVARIATE LOGISTIC REGRESSION 
The variables identified as significant at P <0.05 in bivariate analyses were entered into a 
stepwise logistic regression model. Since electrolyte abnormalities, anemia and 
thrombocytopenia were seen in the setting of septicemia they were not entered into the 
model. Ventilation and IVH were also not included because of the very high odds ratios. 
Variables were retained in the adjusted model if they were significant at P <0.05. The 
goodness of fit of the model was checked with the Hosmer-Lemeshow and a p-value of 
>0.05 was considered a good fit.  The discriminatory ability of the model was assessed 
with the area under the receiver operating characteristic (ROC) curve.  
The final model (table 15) for predicting death in the cohort of VLBW babies is 
presented below. The final multivariate analysis indicated that the odds of death was 
more than 3 times with the birth weight of 500 g-999 g and more than twice when the 
birth weight was1000- 1199 g. Chances of death was more than twice in the presence of 
RDS or if the infant had PDA, almost four times in septicemia and five times if the infant 
had asphyxia or NEC. All variables were significantly associated with a p of <0.05. 
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Receiver operator curve: (Figure 7) 
The final predictive model (shown above) yielded an area under the ROC curve of 0.836 
(0.775-0.897 95% CI; p<0.001) indicating good discrimination, and the Hosmer-
Lemeshow statistic indicated a good model fit (p=0.558).    
 
Figure 7: Receiver Operator Characteristics (ROC) Curve for above model 
predicting death in NICU 
 
 
 
 
Table 15: FINAL MULTIPLE LOGISTIC REGRESSION MODEL  FOR PREDICTING 
DEATH IN THE NURSERY 
Predictor B coeff. p-value Adjusted Odds Ratio  
(95% CI) 
Birth weight 1000-1199 g 0.842 .003 2.321 (1.33-4.05) 
Birth weight 500-999 g 1.295 <0.001 3.651 ( 1.782-7.48) 
RDS 0.925 0.003 2.52 (1.5-4.23) 
Septicaemia 1.385 <0.001  3.997 (2.4-6.67) 
NEC (>Grade 2) 1.72 0.011 5.55 (1.49-20.77) 
PDA 0.786 0.009 2.19 (1.22-3.95) 
Perinatal asphyxia 1.569 0.001 4.802 (1.953-11.806) 
Constant -3.844 .000 .034 
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5.1.7 SURVIVAL ANALYSIS 
A. KAPLAN-MEIR GRAPHS 
Kaplan Meier graphs were plotted to look at the survival of the infants with morbidities 
in the NICU. 643 of the total of 776 (82.9%) were discharged alive from the nursery. 
Sixty infants (7.73%) had died during their period of nursery stay and 73 (9.4%) infants 
were discharged prior to completion of treatment against medical advice. The practice in 
the NICU was to keep babies till they reached 1800 g or until they started breast feeding 
well.  32 of the 73 infants who were “discharged against medical advice” were relatively 
stable and left before they reached 1800 g or before breast feeding was well established. 
Forty one of the 73 infants were “discharged against medical advice” were moribund at 
the time of discharge. 
Censored subjects: The Kaplan- Meier survival analysis estimates the probability of the 
subjects surviving a certain time duration taking into account “censoring”.381 For this 
analysis the survival time was chosen as 60 days since almost all patients were 
discharged within 60 days from the nursery. All infants who were alive at the end of 60 
days period and the infants who left the NICU alive before the completion of the time 
duration (60 days) are considered “censored”. In this cohort all 73 infants who left 
“against medical advice before completion of treatment” should have been included in 
the “censored” group. However since 41 of the 73 were moribund and death was certain, 
they are included in the “expired group”. The remaining 32 left the NICU in a relatively 
stable condition are included in the “censored” group.  
The Kaplan Meier graphs are shown in figures (8 a-h) and compare the group with the 
morbidities with the group without the morbidity, as presented below. 
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a. Boys vs. Girls (Figure 8 a) 
b. Infants whose gestational age (<28 weeks and 28-31 weeks) compared with those 
whose gestational age>32 weeks.  (Figure 8 b) 
c. Infants with birth weight (500 g-999 g) and (1000-1199 g) are compared with 
those whose birth weight is >1200 g (Figure 8 c) 
d. Infants with PDA compared to those without PDA (Figure 8 d) 
e. Infants with septicemia compared to those without septicemia (Figure 8 e) 
f. Infants with septicemia compared to those without RDS (Figure 8 f) 
g. Infants with NEC compared to those without NEC (Figure 8 g) 
h. Infants with asphyxia compared to those without asphyxia (Figure 8h) 
Chi-square test using Log rank (Mantel-Cox) was done to look for significant difference 
in survival (p <0.01) between the two groups (those with the morbidity and those without 
the morbidity). From the graphs and the Log-Rank values it is clear that there was 
significant difference in the survival rates in infants with the morbidities as compared to 
the infants without the morbidities. Children with the morbidities (PDS, RDS, NEC grade 
2 and above, birth weights below 1200 g, gestational ages below 32 weeks, asphyxia and 
septicemia) had a poorer survival rates compared to children who did not have these risk 
factors. There was no significant difference in the survival of boys compared to that of 
girls. 
 
 
 
 
  
KAPLAN MEIER SURVIVAL GRAPHS 
8a:  Survival of male infants vs. female infants in the NICU 
 
 Mean survival (days) SE 95% CI p-value (Log Rank) 
Boys 53.043 0.894 51.290- 54.796  
0.307 Girls 53.988 0.883 52.25- 55.719 
Overall 53.486 0.630 52.251-54.722 
 
Figure 8b: Survival of infants based on their gestational age 
 
 
 
Gestational age Mean survival 
(days) 
S.E 95% CI p value on Log-Rank 
32-33 weeks 55.635 1.021 53.633-57.636 
 
P <0.001 31 wks and less 50.662 1.035 48.633-52.691 
>34 weeks 56.776 1.039 54.741-58.812 
Overall 53.421 0.633 52.180-54.661 
  
Figure 8 c: Survival of infants based on the birth weight 
 
Birth wt. 
category 
Mean survival (days) S.E 95% CI p value on Log-Rank 
1200-1500 55.921 .615 54.714-57.127 
 
P<0.001 1000-1199 48.878 1.687 45.573-52.184 
500-999 44.440 2.941 38.675-50.205 
Overall 53.421 .633 52.180-54.661 
 
Figure 8 d: Survival of infants based on presence of PDA 
 
 Mean survival (days) SE 95% CI p value on Log-Rank  
No PDA 55.215 0.598 54.043-56.387 
P<0.001 PDA present 47.882 2.169 43.631-52.133 
Overall 54.237 0.597 53.066-55.408 
 Figure 8 e: Survival of infants based on presence of Septicemia 
 
 
 Mean survival (days) S.E 95% CI Log-Rank p-value 
No septicemia 55.240 .620 54.024-56.456  
<0.001 Confirmed septicemia     46.279 1.891 42.573-  49.986 
Overall 53.622 .625 52.398-  54.847 
 
Figure 8 f: Survival of infants based on presence of Respiratory Distress syndrome 
 
 
 Mean survival (days) S.E 95% CI p value Log –Rank (Mantel-Cox) 
No RDS 55.577 0.612 54.377-56.778  
 
P <0.001 
RDS 
present 
46.665 1.686 43.361-49.969 
Overall 53.421 0.633 52.180-54.661 
 Figure 8 g: Survival of infants based on presence of severe NEC 
 
 Mean survival (days) S.E 95% CI P Value on Log-Rank (Mantel-Cox) 
NEC 
<Stage2 53.607 0.633 52.367-54.847 
P=0.005 NEC >Stage 
2 41.516 6.335 29.098-53.933 
Overall 53.421 0.633 52.180-54.661 
 
 
Figure 8 h: Survival of Infants based on the presence of  Perinatal asphyxia 
 
 Mean survival (days) S.E 95% CI p-value on Log-Rank test 
No Perinatal 
asphyxia 54.202 0.608 53.00-55.39 
 
P<0.001 
Asphyxia present 36.41 4.842 26.92-45.9 
Overall 53.421 0.633 52.180-54.661 
 
 
RESULTS 
 
 Page 130 
 
B. COX PROPORTIONAL HAZARDS MODEL  
The Cox proportional Hazards model was done to explore the relationship between the 
various risk factors (found to be significant in the Kaplan Meier graphs) on the survival 
time of the children in the cohort. The Cox model explores the independent effect of each 
of the risk factors on the time to death after taking into account (“adjusting”) the effects 
of the other risk factors.382,383 Before testing the proportional hazards assumption we 
plotted the “log-log plots”. Since the curves were parallel indicating that the hazards are 
proportional across the groups we went ahead and did the Cox Proportional hazards 
regression model. The log-log plots are shown in the “Appendix section”. 
The Hazard Ratio which is obtained from the Cox model is an estimate of the ratio of the 
hazard rate (of death) between two groups (the group with the morbidity and the group 
without the morbidity) at any given point of time. The group without the morbidity is 
considered as the “reference group”. If the hazard of death is greater than 1, then the 
hazard of death is greater for the individual in that group compared to the hazard of death 
in the reference group. 
 After plotting the Log-log plots a bivariate analysis between the group with the 
morbidity and the group without the morbidity was done using the Cox proportionate 
hazards model to obtain the unadjusted hazards ratio. If hazards ratio was found to be 
significant (p<0.05) then the variables were entered into a step-wise multivariate 
regression model to estimate the independent risk of death. The final model is presented 
in table 16 (below). 
In the final model after adjusting for the other risk factors, gestational age was not found 
to be significant.  
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Table 16: Final model of Cox proportional hazards model on the time to death 
 
Risk Factor 
 
Regression 
Coeff. (SE) 
 
Wald 
 
p-value 
 
Adjusted 
Hazards 
Ratio (HR) 
95.0% CI for HR 
Lower 
 
Upper 
 
 Birth wt. 1000-1199 g .791 (.247) 10.222 .001 2.205 1.358 3.581 
 Birth wt. <1000 g .957 (.303) 9.957 .002 2.604 1.437 4.719 
 NEC .838 (.482) 3.018 .082 2.312 .898 5.953 
 RDS .800 (.231) 12.041 .001 2.226 1.417 3.498 
 Septicemia 1.031 (.221) 21.765 .000 2.803 1.818 4.321 
 PDA .597 (.256) 5.439 .020 1.817 1.100 3.001 
 Perinatal asphyxia 1.421 (.365) 15.144 .000 4.143 2.025 8.475 
 
After controlling the effects of the other variables – 
• at any given point in time, the likelihood of death is 2.6 times in the category 
(500 g-999 g) and two times in the birth weight category (1000 g-1199 g) as 
compared to those whose birth weights were in the category (1200-1500 g).  
• the likelihood of death is  three times more at any given point of time in infants 
with septicemia, compared to infants without septicemia and this is significant (p 
<0.001)  
• the likelihood of death is two times more at any given point of time in infants with 
PDA, compared to infants without PDA and this is significant (p <0.02)  
• the likelihood of death is  two times more at any given point of time in infants 
with RDS, compared to infants without RDS and this is significant  
• the likelihood of death is four times more at any given point of time in infants 
with asphyxia a, compared to infants without asphyxia and this is significant (p 
<0.001).  
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• the likelihood of death is  two times more at any given point of time in infants 
with NEC, compared to infants without NEC and this is moderately significant (p 
= 0.08) 
 
Comparison between Multivariate Logistic regression Model (table 15) and Cox 
proportional Hazard model (table 16):  Significantly the same risk factors – Birth 
weight less <1000 g, Birth weight of 1000-1199 g, NEC, RDS, PDA, Septicemia and 
Perinatal asphyxia predicted mortality independently in both models. 
 
 
5.1.8 OUTCOMES AT THE TIME OF DISCHARGE FROM NICU  
643 of the total of 776 (82.9%) were discharged alive from the nursery. Sixty infants 
(7.73%) had died during their period of nursery stay and 73 (9.4%) infants were 
discharged prior to completion of treatment against medical advice. The practice in the 
NICU was to keep babies till they reached 1800 g or until they breast feeding well. The 
73 infants who were discharged before completion of treatment are not included for 
analysis in the second phase of the study. Forty one of the 73 children were terminally ill 
and left the nursery in a moribund condition. We were able to confirm that twenty of 
them had died. The remaining children were very sick when they left the NICU so it is 
likely they too would have expired.  Thirty two infants among those who went against 
medical advice left in a stable condition. We were able to trace 8 of them. Four of these 
infants survived and came back for the assessment at two years of age.  We were able to 
contact the parents of another four infants over the telephone. They were alive at two 
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years; however the parents were unwilling to bring them for the assessment and were 
apparently developing normally.  
Figure 9 on page 134, shows the outcomes of the infants in the NICU 
 
5.1.9 SURVIVAL in NICU 
Of the 776 children admitted into NICU 60 expired and 73 left before completion of 
treatment. Of the 73, eight children were alive and the outcomes of 65 infants are not 
known, although most of them were very sick when they left the NICU 
The survival rate was 92.26% (89.4-94.54, 95% CI) 
The adjusted survival rate (assuming that those whose outcome is not known had also 
died was  83.89% (80.22-87.14, 95% CI) 
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Figure 9: THE OUTCOMES OF INFANTS WHO WERE ADMITTED IN THE 
NICU 
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5.2 SECTION 2 - THE RESULTS OF PHASE 2 (THE FOLLOW-UP PHASE). 
After excluding the infants who had died and the infants who left the NICU against 
medical advice before the completion of the treatment, the remaining 643 infants were 
scheduled for prospective follow-up of their growth, neurologic status and development, 
till the final neurodevelopmental assessment at 18 - 24 months corrected gestational age.  
These infants were followed up regularly according to the protocols of the High Risk 
Infant follow-up Clinic of the Institution.  As the principal investigator of the study, I saw 
the infants along with the Neonatologists and the Occupational therapist in the High risk 
infant clinic. During these visits the development of the infants were assessed and 
neurologic examination was done using the Amiel-Tison Neurologic assessment tool. 
Hearing and vision were also assessed according to standard protocols as described in the 
“Patients and Methods” section. 
Of the 643 infants who were discharged after completion of treatment in NICU, 190 
infants did not come for any of the assessments. Twenty one of them died within a few 
months after being discharged from nursery. In most of them the cause could not be 
ascertained. Of the remaining 169, the parents of 122 infants refused to give consent to 
come for the follow-up phase, because of the distance and the inconveniences involved. 
Most of them could not be contacted  and so we have no idea about their outcome. 
Parents of forty seven of the 169 infants gave consent but did not come for any of the 
assessments. Some of them came for a few visits to the High risk infant clinic and then 
stopped coming. So eventually only 453 (70.45%) came for at least one assessment 
(motor assessment using the Peabody assessment at one year and/or the final 
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developmental assessment).  422 of the 643 infants came till the final 
neurodevelopmental assessment. So our follow-up rate was 65.6%. For the purpose of the 
analysis, all infants who did not come for the final neurodevelopmental assessment, 
irrespective of the cause are considered lost to follow-up. This group is analyzed further 
in section 4. The figure 10 (below) gives a visual summary of the children during the 
follow-up phase. 
 
Figure 10: Flow chart showing the summary of the children who entered the 
Developmental Follow-up phase  
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This section therefore considers the developmental outcomes of the 422 infants who 
came for the final assessment. The section is arranged in the following manner - 
5.2.1: This sub-section presents the results of the neurodevelopmental assessment  
5.2.2: Objective 1 of the study - the incidence of poor neurodevelopmental outcome 
and CP in this cohort is calculated. 
5.2.3 & 5.2.4 Presents the relationship between the post-natal growth status measured at 
the time of assessment and various factors (sex, gestational age, birth weight). Z scores of 
weight, head circumference and length were calculated using the WHO-ANTRHO 
software  
5.2.5: Briefly compares the ELBW infants with the non-ELBW infants – their mean 
birth-weights, gestational ages and GQs. 
5.2.6: This subsection explores the relationship between perinatal and  neonatal risk 
factors and the final GQ through bivariate analysis and multivariate logistic regression 
model to give a final model which can predict poor neurodevelopmental outcomes 
(Objective 2 of the study) 
5.2.7: As part of measuring the neurodevelopmental outcomes, children with significant 
language delay were analyzed. A logistic regression model to predict poor language is 
presented. 
5.2.8: Discusses the details of the interim motor assessment at one year and considers its 
abilities to predict the results of the final neurodevelopmental assessment.  
5.2.9: This sub-section presents a description of all the children who had neurologic 
abnormalities and those with significant developmental delay (GQ of less than 70). 
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5.2.1 THE RESULTS OF THE NEURODEVELOPMENTAL ASSESSMENT 
 
The final neurodevelopmental assessment was done using the Griffith’s Mental 
Developmental Scales (GMDS) and the General Quotient (GQ) obtained from the GMDS 
was considered the final outcome of the neurodevelopmental assessment. The neurologic 
status of the children was determined using the Amiel-Tison neurologic assessment 
(ATNA). Children with neurologic abnormalities, perform poorly in the developmental 
assessment (as mentioned earlier in 3.2.8, p.47), so a low GQ is also an indicator of the 
presence of neurologic abnormalities in addition to the developmental delay.  
Although initially it was planned that the final assessments using the GMDS would be 
done between 18 and 24 months corrected gestational age, only 348 infants (82.2%) 
could be assessed during this period. Thirteen infants (3%) were assessed between 16 and 
18 months, 46 infants (10.9%) were assessed between 24 and 30 months and 17 infants 
(4.02%) were above 30 months corrected gestational age at the time of the final 
neurodevelopmental assessment. These adjustments had to be done for the convenience 
of the parents, many of whom were coming from faraway places. The mean age of the 
assessment was 20.8 months (+ 4) and median age of assessment was 19 months. 
a) Results of the Final Neurodevelopmental Assessment  
423 of the 643 (65.6%) children came for the final neurodevelopmental assessment. In 
one child the assessment could not be completed because he was very apprehensive. So 
finally 422 children comprising 221 boys (52.4%) and 201 girls (48.6%) were assessed 
completely. 
There were five children with cerebral palsy in the cohort. They are described more in 
detail in 5.2.9.  In four of the five children with CP and in three other children with 
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profound developmental delay, the  GQ could not be quantified accurately in view of 
their disabilities and therefore for the purpose of analysis they were arbitrarily given a 
GQ of <40. These 7 children were not included in the calculation of the mean GQ. 
The mean GQ of the study cohort after excluding these seven children, was 93.6 (SD + 
13.01) and the median GQ was 96. The comparison of the GQs between girls and boys 
are presented in table 17 along with the histogram depicting the distribution of the GQs 
(figure 11). The mean GQ among the boys was 92.9 (+13.08) and among the girls was 
94.97 (+12.8). There was a significant difference between the GQ of  the boys and the 
girls (p = 0.04) with the girls having  marginally better developmental outcomes 
compared to the boys. 
Normality of the GQ distributions of the boys and girls was tested using standard tests (p-
value on Shapiro-Wilk and p-value on the Kolmogorov-Smirnov test).384 Both the tests 
showed that the p-value was below 0.01 which means that the distributions of the GQ in 
both boys and girls were not normally distributed. Visual inspection of the histograms 
also showed that in both boys and girls the distributions were asymmetrical with tail to 
the left (negative skew). The negative skew indicates that there were more children with 
GQs in the higher range, indicating a good neurodevelopmental outcome.  
Good neurodevelopmental outcome:  Indeed there were 374 children (88.6%, 193 boys 
and 181girls) whose GQ was within the normal range of within 2 standard deviations 
(>76) and thus considered to have a good neurodevelopmental outcome. Among the 
children who were within normal limits, there were 292 children (69.2%, 143 boys and 
149 girls) whose GQ was within one standard deviation (>88) and there were 82 children 
(19.4%, 50 boys & 32 girls) whose GQ was between -1SD and -2SD (GQ of 76-87)  
 FIGURE 11:  DISTRIBUTION OF THE GENERAL QUOTIENT OF THE GMDS IN THE BOYS AND GIRLS WHO 
HAD FINAL ASSESSMENT 
  
 
TABLE 17: COMPARISON OF THE GENERAL QUOTIENTS OF THE BOYS AND GIRLS 
 
 
General Quotient on the GMDS* 
Boys Girls 
  Numbers (%) 221 (52.4%) 201 (47.6%) 
  Mean  92.92 94.97 
  Median 94 97 
  Std. Deviation 13.08 12.82 
  Range (Min. to Max.) 50 - 117 (67)  53 – 124 (71)  
  Skewness -0.551 -0.555 
  Kurtosis 0.103 0.343 
 P-value 0.04 
  Normality tests 
 Skewness Z-value -3.32 0.312 
 Kurtosis  Z-value -3.23 0.912 
 Kolmogorov-Smirnov “p” 0.010 <0.001 
 Shapiro-Wilk “p” <0.001 0.003 
*Seven children with Cerebral Palsy and those with severe developmental delay (GQ<50) not included in the 
analysis although included in the total  
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Poor neurodevelopmental outcome: 48 children (11.4%) of the 422 children had poor 
neurodevelopmental outcome (their GQs were more than 2SD below the mean). This 
comprised 28 (12.7%) of the total of 221 boys and 20 girls (9.9%) of the 201 girls.  This 
includes the five children (3 boys and 2 girls) with cerebral palsy. 
b) GQ of the children according to gestational age at birth 
The Figure 12 and table 18 compare the GQ of the 415 children who completed the 
study across various gestational ages. (Five children with CP and two children whose GQ 
could not be quantified are not included which is why there are 415 and not 422 
children). The box-whisker graph (Fig. 12) and its summary are presented in table 20 
(below).  The median GQ was almost the same (96-98) for the four groups (<28 weeks, 
28-31 weeks, 32-33 weeks and >37 weeks) and slightly lesser in the 34-36 weeks group 
(92.5).  However on the Kruskall-Wallis test, the p-value was 0.424, showing that there 
was no significant difference between the five groups.   
c) GQ of children according to birth weights 
Figure 13 and table 19 shows the GQ of the children in the various ages in 5 weight 
categories. The median GQ was almost the same (95-97) between the groups except for 
one group. There was no significant statistical difference between the groups (p= 0.952) 
[The Kruskall Wallis test was used for comparison, rather than the one-way ANOVA, 
because the GQs in each group are not normally distributed]. 
 
 
 FIGURE 12: THE GENERAL QUOTIENT DEPENDING UPON THE GESTATIONAL AGE AT 
BIRTH 
 
 
 
 
 
TABLE 18: GENERAL QUOTIENTS OF CHILDREN IN VARIOUS GESTATIONAL AGE CATEGORIES 
 
 < 28 weeks 28-31weeks 32-33 weeks 34-36weeks  > 37weeks 
Numbers 5 190 126 78 16 
Mean GQ 96.80 93.62 94.94 91.18 92.56 
5% Trimmed Mean 96.94 94.17 95.24 91.53 93.01 
Median GQ 96.00 96.00 96.00 92.50 98.00 
Std. Deviation 5.450 13.124 12.474 13.458 14.814 
Minimum 89 50 61 55 64 
Maximum 102 124 120 117 113 
Range 13 74 59 62 49 
Skewness -.514 -.663 -.428 -.384 -.528 
Kurtosis -.667 .716 -.308 -.195 -.766 
P-VALUE 0.424  (KRUSKALL-WALLIS) 
 
 
 
 
  
FIGURE 13: THE GENERAL QUOTIENT DEPENDING UPON THE BIRTH-WEIGHT AT 
BIRTH 
 
 
 
                          TABLE 19: GENERAL QUOTIENTS OF CHILDREN IN VARIOUS BIRTH-WEIGHT 
CATEGORIES 
 
 <800g 800-999g 1000-1199g 1200-1399g 1400-1500g 
Numbers 4 26 86 155 144 
Mean GQ 95.50 91.96 92.94 93.97 93.72 
5% Trimmed 
Mean 
95.61 92.65 93.30 94.40 94.12 
Median GQ 96.50 95.00 93.00 96.00 97.00 
Variance 69.667 267.958 139.397 165.291 180.093 
Std. Deviation 8.347 16.369 11.807 12.857 13.420 
Minimum GQ 85 55 62 50 53 
Maximum GQ 104 114 115 122 124 
Range of GQ 19 59 53 72 71 
Skewness -.537 -.594 -.395 -.489 -.634 
Kurtosis -1.258 -.549 -.161 .325 .306 
p-VALUE 0.952 (KRUSKALL-WALLIS) 
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d) Comparing the sub-quotients between girls and boys among the subscales of 
the GMDS.  
The GQ is a composite score based on the sub-quotients (SQ) obtained on five subscales 
(in children less than 24 months) and six subscales in older children. As mentioned 
earlier the GQ of the girls (table 17) was significantly better than the boys. Table 20 
shows the mean sub-quotients between girls and boys in all the 6 subscales. The median 
SQ in all the subscales except for the “Performance” subscale was better in girls as 
compared to the boys. This was statistically significant (p<0.05) in three of the subscales. 
  
5.2.2 INCIDENCE OF POOR NEURODEVELOPMENTAL OUTCOME AND CEREBRAL 
PALSY 
One of the main objectives of the study was estimation of the incidence of poor 
neurodevelopmental outcome (GQ <2SD). 
From the information presented above, the incidence of poor neurodevelopmental 
outcome was estimated to be: 
 48/422 - 11.37% (8.6%-14.9% 95% CI) (This includes the children with cerebral palsy) 
To calculate the incidence of cerebral palsy, the 31 children who had the one year 
assessment but did not come for the final assessment were also included. Although the 
developmental outcome in terms of their GQ cannot be ascertained from the one year 
assessment, they were neurologically normal at one year without any signs of CP.  
So the incidence of cerebral palsy is 5/453 is 1.10%. (0.4%-2.63%, 95%CI).  
 
 
  
 
 
 
 
Table 20: COMPARING THE SUB-QUOTIENTS (SQ) of the VARIOUS DOMAINS OF THE GMDS BETWEEN BOYS AND GIRLS 
 
 
 
 
 LOCOMOTOR PERSONAL -
SOCIAL 
HEARING & 
LANGUAGE 
EYE-HAND PERFORMANCE PRACTICAL 
REASONING 
 Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls 
Mean of SQ 105.36 106.03 92.06 97.04 84.58 88.30 98.32 102.35 89.32 88.72 86.14 87.58 
5% Trim’d  Mean 106.45 107.17 92.31 96.99 85.23 88.79 98.49 102.70 89.80 89.02 85.96 86.75 
Median of SQ 107.00 112.00 94.00 96.00 88.00 91.00 98.00 103.00 92.00 90.00 87.00 87.00 
Variance 425.71 376.19 258.34 311.41 308.46 263.38 239.084 226.61 244.15 234.16 138.03 160.2 
Std. Dev. 20.633 19.396 16.073 17.647 17.563 16.229 15.462 15.054 15.625 15.302 11.749 12.657 
Minimum SQ 50 39 45 58 31 34 50 58 45 49 66 65 
Maximum SQ 154 142 132 144 128 122 140 145 123 122 110 129 
Range of SQ 104 103 87 86 97 88 90 87 78 73 44 64 
P-VALUE 0.732 0.003 0.026 0.008 0.693 0.993 
RESULTS 
 
 Page 142 
 
5.2.3 GROWTH of THE BABIES 
The growth parameters (weight, length and head circumference) of the children in the 
cohort were monitored during every visit to the High Risk Infant Clinic (HRIC). The Z- 
scores of the final weight, length and head circumference at the time of the 
neurodevelopmental assessment was computed using the World Health Organization 
“ANTHRO” software.376  
Infants were classified as -  
• underweight if the  Z- score of weight for age was if they were more than 2SD 
below the mean, 
• microcephaly if the  Z- score of head circumference for age was more than 2SD 
below the mean,  
• short if the  Z- score of length for the age was more than 2SD below the mean. 
Table 21 compares the Z-scores of the various growth parameters of boys with that of the 
girls. Although the distributions of weight for age, weight for length and head 
circumference seem to be similar, the boys are significantly shorter than the girls 
(p=0.004). Another worrying aspect is that 36.3% of the children were underweight, 44% 
were short and 43.8% had microcephaly on comparing to the WHO standards.  
 
5.2.4 RELATIONSHIP BETWEEN GQ AND BIRTH WEIGHT & GESTATIONAL AGE. 
The scatter plots shown in Figure 14 explore if there was any linear relationship between 
the GQ & gestational age and GQ & birth-weight. It is very obvious that there is no 
relationship between the final GQ and the gestational age or birth weight. The R2 for GQ 
vs. gestational age was 0.001 and for GQ vs. birth-weight was 0.003. This means that 
  
 
 
TABLE 21: ANTHROPOMETRIC (GROWTH) PARAMETERS OF THE STUDY COHORT ESTIMATED AT THE TIME OF ASSESSMENT 
 Weight for length Weight for age Head circumference for 
age 
Length for age 
Boys Girls Boys Girls Boys Girls Boys Girls 
Mean (of the Z-scores) 
95% CI 
-1.0383 
-1.186 to -.89 
-1.0247 
-1.158 to-.89 
-1.8462 
-2.0  to-1.689 
-1.6551 
-1.81 to -1.50 
-1.8804 
-2.04-1.723 
-1.8426 
-1.98 -1.695 
-2.1243 
-2.30 to-1.946 
-1.7098 
-1.901 to 1.52 
5% Trimmed mean -1.0440 -1.0180 -1.8417 -1.6203 -1.8569 -1.8136 -2.1247 -1.6715 
Median (of Z- scores) -1.0500 -.9200 -1.8000 -1.6550 -1.8300 -1.8450 -2.0900 -1.7100 
Variance 1.487 1.122 1.666 1.490 1.679 1.375 2.158 2.317 
Std. Deviation 1.21949 1.05903 1.29080 1.22071 1.29594 1.17280 1.46900 1.52205 
Minimum -4.07 -4.93 -6.94 -5.93 -7.85 -6.79 -8.68 -9.83 
Maximum 2.20 1.65 1.91 1.61 2.07 1.56 2.58 7.27 
Range 6.27 6.58 8.85 7.54 9.92 8.35 11.26 17.10 
% of children <2 SD 22% 21% 39.3% 33% 43.2% 44.5% 49.5% 38% 
p-value  0.868(-0.215-0.181) 0.137 (-0.388-0.052) 0.751 (-0.253-0.183) 0.004 (-0.657-0.126) 
 
 
 
 
 
  
 
FIGURE 14: SCATTER PLOTS EXPLORING THE RELATIONSHIP BETWEEN GQ &  GESTATIONAL AGE  AND  GQ & BIRTH-WEIGHT 
 
 
 
Pearson’s correlation coefficient ‘r’ is -0.036 
R2 is 0.001 
 
 
 
Pearson’s correlation coefficient ‘r’ is 0.055 
R2 is 0.003 
 
 
RESULTS 
 
 Page 143 
 
gestational age accounts only 0.1% and birth weight accounts 0.3% of the variance in the 
General quotient in this cohort. 
 
5.2.5 COMPARISON OF ELBW (<1000 g) vs. non ELBW (1000-1500 g) 
The table 22 (below) shows the results on comparing the GQ of the ELBW children with 
the GQ of children whose birth weights >1000 g.  
Table 22: Comparison of ELBW infant with non-ELBW (>1000 g) children 
 ELBW (<1000 g) Non ELBW (1000-1500 
g) 
p-value 
Number 30 392  
Sex (Boys %) 43% 53%  
Mean GQ  (SD) 92.4 (15.5) 93.6 (12.8) 0.918 
Children with GQ <2SD (%) 20% 11% 0.123 
Children with CP 0 5/392 (1.3%)  
Mean Gestational age 32.7 30.4 <0.001 
There was a predominance of girls in the ELBW group. There was no significant 
difference in the mean GQ between the groups, although there is a slightly higher 
proportion of children with developmental delay in the ELBW group. The mean 
gestational age in the ELBW group in this cohort is significantly high (30 weeks), 
compared to Western cohorts where the ELBW babies are usually less than 27 weeks. 
Although the incidence of CP increases with decreasing birth weight, all the children with 
CP weighed more than 1000 g at birth, so ELBW was not a cause of CP in this cohort. 
 
 
 
  
Table	23:	BIVARIATE	ANALYSIS:	PERINATAL	&	NEONATAL	CHARACTERISTICS	AND	
GROWTH	WITH	POOR	DEVELOPMENTAL	OUTCOME	GQ	<2SD	
Risk Variables Normal GQ 
  No. (%) 
GQ<76 (2SD) 
  No(%) 
P value Relative Risk 95% 
CI 
MATERNAL and PATERNAL CHARACTERISTICS 
PIH:  No PIH 
PIH 
209(87) 
165(90) 
30(13) 
18(10) 
 
0.384 
0.970 
0.906-1.038 
Diabetes: No Diabetes 
Diabetes in pregnancy 
342(88) 
32(94) 
46(12) 
2(6) 
 
0.404 
0.937 
0.855-1.026 
Twins:    Singletons 
Multifetal Pregnancy 
271(89) 
103(89) 
35(11) 
13(11) 
 
0.947 
0.997 
0.924-1.076 
Antenatal steroids: Received 
No steroids given 
307(89) 
67(87)  
38(11) 
10(13) 
 
0.622 
1.023 
0.931-1.123 
Delivery: Normal Delivery 
Cesarean or instrumental 
 118(85) 
256(90.4) 
  21(15) 
27(9.6) 
 
0.090 
0.938 
0.867-1.016 
Infertility treated: No treatment 
Conceived after treatment 
314(87) 
60(94) 
44(13) 
4(6) 
 
0.161 
.916 
0.832-1.001 
Mother’s Education: >8
th
 std.  
< 8
th
 Standard 
313(89) 
51(84) 
38(11) 
10(16) 
 
0.211 
1.067 
0.949-1.199 
Fathers’ Education: >8
th
 Std  
< 8
th
 Standard 
302(89) 
62(84) 
           36(11) 
12(16) 
 
0.177 
1.066 
0.958-1.187 
NEONATAL COMPLICATONS 
PDA: No PDA 
PDA Present 
335(89) 
39(89) 
43(11) 
5(11) 
 
0.998 
0.998 
0.373-2.67 
Asphyxia:  No asphyxia 
H/o asphyxia 
362(89) 
12(80) 
45(11) 
3(20) 
 
0.284 
1.12 
(0.861-1.435) 
IVH: Normal to grade 2 
Grade 3 and 4 
363(88) 
2(100) 
48(12) 
0(0) 
 
1.000 
0.883 
0.853-0.915 
Septicemia:  No Sepsis 
Confirmed Sepsis 
327(89) 
47(89) 
42(11) 
6(11) 
 
0.990 
0.999 
0.902-1.108 
Hypoglycemia: Absent 
H/o Hypoglycemia present 
342(89) 
32(86) 
43(11) 
5(14) 
 
0.594 
1.027 
0.900-1.172 
RDS: No RDS 
H/o RDS present 
295(88) 
79(92) 
41(12) 
7(8) 
 
0.290 
0.956 
0.887-1.030 
NEC: No or Bell stage 1 
Bell stage2 & beyond 
370(89) 
4(80) 
47(11) 
1(0) 
 
0.455 
1.109 
0.715-1.72 
Hypotension: Absent 
Hypotension present 
332(89) 
42(82) 
39(11) 
9(18) 
 
0.132 
1.087 
0.953-1.240 
Any NICU morbidity: Absent 
NICU morbidity present 
138 (87.3) 
236 (89.4) 
20 (12.7) 
28 (10.6) 
 
0.52 
0.997 
(0.91-1.05) 
 Table 23 (contd.) INFANT CHARACTERISTICS AND POST NATAL GROWTH PARAMETERS 
 
Risk Variables Normal GQ 
No. (%) 
GQ <76 (-2SD) 
  No. (%) 
 
P value 
Relative Risk 95% 
CI 
Boys 
Girls 
193(87) 
181(90) 
28(13) 
20(10) 
 
0.380 
0.970 
0.906-1.038 
Growth:    AGA 
SGA 
264(90) 
110(85) 
28(10) 
20(15) 
 
0.083 
1.068 
0.984-1.160 
Birth weight: 1200-1500g 
1000-1199g 
500-999g 
272 (89.2) 
78 (89.6) 
24 (75) 
33 (10.8) 
9 (10.4) 
8 (25) 
 
0.301 
 
Gestational age: 32-33 weeks  
> 34 weeks 
< 31 weeks 
115 (91.3) 
82 (83.7) 
177 (89.4) 
11 (8.7) 
16 (16.3) 
21 (10.6) 
 
0.185 
Weight for age  
Z score within + 2 SD 
Z score >-2SD 
 
249(93) 
124(81) 
 
19(7) 
29(19) 
 
 
<0.001 
 
1.146 
1.055-1.246 
Length for age 
Z score within + 2 SD 
Z score >-2SD 
 
217(92) 
155(84) 
 
18(8) 
30(16) 
 
 
0.006 
 
1.102 
1.024-1.186 
Head Circumference 
Z score within + 2 SD 
Z score >-2SD 
 
218(92) 
154(84) 
 
18(8) 
30(16) 
 
 
0.006 
 
1.104 
1.025-1.188 
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5.2.6 BIVARIATE and MULTIVARIATE ANALYSIS OF POST-NATAL RISK FACTORS 
In order to look at the antenatal, neonatal and perinatal factors which were associated 
with poor neurodevelopmental outcome (GQ <2SD), bivariate analysis (Chi-square) was 
done (table 23). On the bivariate analysis no antenatal or neonatal factors were 
associated with poor neurodevelopmental outcome. The maternal and paternal education 
levels were also not associated with poor neurodevelopmental outcome.  
However the z-scores of anthropometric measurements at the time of assessment - 
weight for age (p <0.001) at the time of assessment, length for age at the time of 
assessment (p = 0.006), and head circumference (p = 0.006) were significantly associated 
with poor neurodevelopmental outcome.  
The above factors were entered into a stepwise multivariate regression model. The best 
model to predict the GQ <2SD is presented table 24 (below).  
 
 
Table 24: Final Multiple logistic regression model for predicting low GQ (<2SD) at the 
time of neurodevelopmental assessment 
 
 
 
 
Predictor B 
coefficient 
p-value Adjusted Odds Ratio 
(95% CI) 
Weight for age 0.918 .007 2.504 (1.281-4.89) 
Head circumference for age 1.295 0.149 1.646 (0.836-3.24) 
Constant -2.736 .000 .065 
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The model predicts that the odds of having a poor neurodevelopmental outcome is two 
and half times more in children whose Z-scores for weight is >2SD below the mean as 
compared to those who have Z-score weight in the normal range (+2SD of the mean 
weight for age). Children whose Z-score for head circumference is less than 2SD have 
1.6 times the chance of having poor neurodevelopmental outcome as those with normal 
head circumference (+2SD of the mean HC for age).  Hosmer and Lemeshow Test p-
value was.614 (>0.05) indicating that the model is a good-fit. The Area under the curve 
(AUC) on the Receiver operator characteristic curve was 0.655 (0.569-0.741 95%CI, p 
<0.001). 
5.2.7 SOCIAL QUOTIENT OF THE LANGUAGE SUBSCALE (H&L-SQ) ON THE GMDS AND 
ITS RELATIONSHIP TO GQ. 
In this cohort it was observed that there were children who performed badly in the 
Hearing and language subscale, but had done well in the other scales, thus their final GQ 
was within normal limits. According to Ruth Griffiths “Hearing and Language subscale is 
the most intellectual of the scales and most intellectual children do well in this 
subscale”.161 Thus language abilities is a good indicator of intelligence as well. The 
correlation between the sub-quotient on the Language scale (SQ-HL) and the overall 
GQ was very high (Pearson’s correlation coefficient “r” was 0.859, p <0.001).  
On the bivariate analysis (Chi square) the following risk factors were significantly 
associated with low sub-quotient on the Hearing and language scale (SQ- H&L <2SD) -  
• Perinatal asphyxia (p=0.018), 
• Twin pregnancy (p=0.036),  
• Weight for age below 2SD (p=0.005),  
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• Head circumference below 2SD (p=0.044),  
• Maternal education less than Std. 8 (p=0.012), and  
• Male sex (p=0.048).  
Except for weight and head circumference, the other variables which are related to poor 
sub-quotient in the language scale are not significantly related to poor GQ as evident 
from Table 23. This may be because of the larger sample size of children with poor 
language (SQ-HL <2SD) compared to the sample of children with poor overall 
development (GQ <2SD). There were more children (59 children) with SQ-HL <2SD 
compared to the 48 children with GQ <2SD.  
The above variables were entered into a multivariate logistic regression model to obtain a 
model which could predict a low language sub-quotient. In the model below, in addition 
to the weight at 2 years which had predicted a low GQ (table 25), perinatal asphyxia and 
low maternal education were also independent predictors of low language sub-quotient.  
 
 
Hosmer and Lemeshow Test p-value was >0.05 (p=0.810) implying the above model was 
good fit. The model predicts that the odds of having a poor language outcome is more 
than two times if the maternal education is less than the 8th standard, twice if the Z-score 
Table 25 : Final Multiple logistic regression model  for predicting language sub-
quotient of <2SD (SQ-HL< 2SD) 
Predictor B 
coefficient 
p-value Unadjusted 
OR (95%CI) 
Adjusted Odds 
Ratio 
(95% CI) 
Maternal education below 
8
th
  
0.764 0.029 2.31 (1.9 -4.5) 2.15(1.083-4.26) 
Z- Weight for age below 2SD 0.694 0.017 2.2 (1.3-3.8) 2.00 (1.13-3.54) 
Perinatal asphyxia 1.526 0.014 3.6 (1.66-11.2) 4.59 (1.36-15.41) 
Constant -2.285 .000  .102 
RESULTS 
 
 Page 147 
 
for weight is less than 2SD weight at two years of age, and more than 4 times if the child 
had perinatal asphyxia. 
Although the language scores of boys were significantly lesser than the girls and male sex 
was significantly associated to low Hearing and Language sub-quotient on the bivariate 
analysis, in the final multivariate logistic regression model,  male sex  and the Z-score for 
HC less than 2SD did not predict  poor language outcome thus were not included in the 
final model. 
 
5.2.8 INTERIM ASSESSMENT USING THE PEABODY DEVELOPMENTAL MOTOR 
SCALES 
 
At the end of one year, an interim motor assessment was done using the Peabody 
Developmental Motor Scales [2nd edition] (PDMS) by the Occupational therapist. 354 
infants had the motor assessment at 12-14 months corrected gestational age. The Total 
Motor Quotient (TMQ) obtained on the PDMS is a composite score of the fine motor and 
gross motor abilities of the child. 
 Of the 354 children, 323 infants returned for the final assessment. The mean TMQ of the 
children was 101.9 (+8.3) and the mean of the TMQ of the boys was 101.3 (+8.6) and 
that of the girls was 102.6 (+8). Unlike the GQ, there was no statically significant 
difference between the boys and girls (p=0.129) in the TMQ scores. The PDMS was done 
to assess the motor developmental progress and to provide therapy for those who had 
motor delay.  
There were 31 infants who came for the motor assessment at one year but did not come 
for the final developmental assessment. The motor development of 29 of these 31 infants 
was within normal limits but two of the infants had low TMQ scores. None of the 
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children had any neurologic abnormality, thus ruling out cerebral palsy. However since 
these 31 children did not have a developmental assessment there is no certainty about 
their final neurodevelopmental outcome.  
Can the developmental outcome at 18 - 24 months be predicted depending on the motor 
outcome at one year of age? 
As mentioned earlier 323 children had both the one year motor assessment using PDMS 
and the final neurodevelopmental assessment using the GMDS. So using the TMQ and 
GQ scores of these infants the linear regression technique was used to look for the 
relationship between the TMQ and the GQ, to see if the TMQ at one year could be used 
to predict the GQ.  
Both Pearson’s correlation coefficient “r” and R2 obtained from the linear regression were 
highly significant (p <0.001) indicating that there was definite association between TMQ 
and GQ. The Pearson’s correlation coefficient “r” was 0.665 indicating that there was a 
moderate correlation between TMQ and GQ. On doing the linear regression to quantify 
the association between TMQ and GQ the R2 was 0.442. This means that only 44.2% of 
the variation in GQ could be explained by the TMQ and so the TMQ only partially 
predicts the final GQ.  
The final regression equation to predict GQ using the TMQ is -  
GQ = -1.342 + 0.939*TMQ. 
The rather poor ability of the TMQ to predict the GQ is not surprising, because the 
PDMS only looks at the motor abilities of the child and domains like language and 
cognition cannot be predicted using the PDMS scores at one year. Another reason is that 
RESULTS 
 
 Page 149 
 
rate of development is dissimilar in the different domains. So children who have a normal 
motor development need not have a normal language development and vice versa.  
This being the case,  it was not possible to accurately predict the neurodevelopmental 
outcome based on the motor abilities at one year. These children who came for the 
assessment at one year but did not come for the final neurodevelopmental assessment 
were considered as “lost to follow-up”. However the data of these children have been 
used in the subsequent Sensitivity Analysis section. 
 
5.2.9 INDIVIDUAL DESCRIPTIONS OF THE CHILDREN WITH SEVERE 
DEVELOPMENTAL DELAY AND NEUROLOGIC ABNORMALITIES (including 
CEREBRAL PALSY) 
Among the 48 children with poor neurodevelopmental outcome (GQ <2SD or GQ <76), 
there were 31 children who were the most affected and had GQ <70. The Table 26 
presents a comprehensive record of the complications of these children.  
Children were classified as neurologically normal or abnormal based on the Amiel-Tison 
neurologic examination. Fifteen children had neurologic abnormalities. The scoring is 
described in “Patients and methods section” (4.6.3). So the incidence of neurologic 
abnormalities in the cohort was 3.6% (15 out of 422).   
All the neurologically abnormal children had significant developmental delay (their GQ 
was less than 70) and microcephaly.  Nine of the 15 children had abnormalities in the 
tone. Five children had cerebral palsy and four children had hypotonia. The remaining six 
 TABLE  26: BRIEF DESCRIPTION OF PATIENTS WHO WERE PROFOUNDLY DELAYED (GQ < 70) 
 
S.no 
 
GQ 
 
SEX 
 
Birth 
Wt. 
 
G.A 
 
OBSTETRIC, MEDICAL AND 
FAMILY HISTORY 
 
COMPLICATIONS 
IN N.I.C.U 
ABNORMAL 
ATNA 
Z 
score 
Wt. 
Z 
score 
HC 
COMPLICATIONS 
AFTER N.I.C.U 
DISCHARGE 
 
FINAL DIAGNOSIS 
1. <40 Boy 1350  30  PREVIOUS LOW BIRTH 
WEIGHT (1.66 kg) 
NIL YES -2.64 -2.78 NONE SPASTIC  BILATERAL C.P 
(QUADRIPARETIC) - GMFCS 5 
2. <40 Boy 1260 31  TWIN PREGNANCY H.M.D Required CPAP  
For 4 days, CYSTIC 
P.V.L 
YES -1.22 -3.78 SYMPTOMATIC 
EPILEPSY 
SPASTIC  BILATERAL C.P 
(QUADRIPARETIC) – GMFCS-5 
3. <40 Boy 1280 35 ABNORMAL DOPPLER, 
IUGR, OLIGOHYDRAMNIOS 
 NIL YES -3.02 -4.63 NONE MICROCEPHALY, HYPOTONIC, 
SEVERE G.D.D, AUTISTIC 
4. <40 Boy 1230 28  NONE ASPHYXIA, RECURRENT 
APNEA D15 
YES -3.08 -2.66 NONE HYPOTONIA, SEVERE  G.D.D 
5. <40 Boy 1440 31 ABNORMAL DOPPLER, 
INFERTILITY, TRIPLET 
PREGNANCY 
SUSPECTED SEPSIS, 
HEARING IMPAIRMENT 
YES -2.47 -2.8 NONE SPASTIC  BILATERAL C.P 
(QUADRIPARETIC) - GMFCS 5 
HEARING IMPAIRED 
6. <40 Boy 1460 36 PRE-ECLAMPSIA ASPHYXIA,  YES -4.66 -4.12 NONE NEURONAL MIGRATION 
DISORDER, SEVERE G.D.D 
7. <40 Girl 1030 35 ABNORMAL DOPPLER, 
Primary INFERTILITY 
HYPOGLYCEMIA 
MYOCARDIAL 
DYSFUNCTION.  
SEPSIS,  CHOLESTASIS 
YES -2.33 -6.09 LATE H.D.N with 
INTRACRANIAL  
HEMORRHAGE 
SPASTIC  UNILATERAL C.P  
(GMFCS 1), EPILEPSY 
MICROCEPHALY 
8. 50 Boy 1220 
 
 
30 
 
 
PRE-ECLAMPSIA 
 
 
VENTILATION FOR RDS, 
PNEUMOTHORAX, A.K.I 
CARDIAC ARREST, 
NFNB SEPSIS, 
HYPOGLYCEMIA,  
 
YES 
 
 
-1.14 -3.15 NONE SEVERE  G.D.D WITH  
CORTICAL VISUAL 
IMPAIRMENT DUE TO HYPOXIC 
BRAIN DAMAGE 
9. 53 Girl 1500 31 POLYHYDRAMNIOS 
Primary INFERTILITY 
FACIAL DYSMORPHISM 
NOTED 
YES -2.24 -2.88 NONE SUSPECTED  DYSMORPHISM, 
HYPOTONIA, SEVERE  G.D.D 
10. 63 Girl 1500 34 PREECLAMPSIA 
Both Parents <8
th
 standard 
NIL NO -2.9 -1.2 NONE HYPOTONIA, 
SEVERE G.D.D 
11. 55 Boy 940 28 MATERNAL  BRONCHIECTASIS 
Both Parents <8
th
 standard, 
E.L.B.W, ACUTE KIDNEY   
INJURY 
NO -3.12 -4.85 NONE MICROCEPHALY,  
SEVERE G.D.D 
12. 58 Boy 1480 30 PRE-ECLAMPSIA NIL NO -0.85 -1.14 NONE AUTISM 
13. 58 Boy 1280 36 ABNORMAL DOPPLER RECURRENT 
HYPOGLYCEMIA 
NO -2.86 -2.49 NONE SEVERE G.D.D 
14. 61 Girl 1480 32 ECLAMPSIA, 
MATERNAL S.L.E 
Both Parents <8
th
 standard, 
NIL YES -1.89 -2.22 NONE SPASTIC  BILATERAL C.P 
(DIPLEGIC)  C.P  (GMFCS 3) 
EPILEPSY 
 
  
S.no 
 
GQ 
 
SEX 
 
Birth 
Wt. 
 
G.A 
 
OBSTETRIC, MEDICAL AND 
FAMILY HISTORY 
 
COMPLICATIONS 
IN N.I.C.U 
 
 
 
Z 
score 
Wt. 
Z 
score 
HC 
COMPLICATIONS 
AFTER N.I.C.U 
DISCHARGE 
 
FINAL DIAGNOSIS 
 
15. 62 Boy 1110 28 P.P.R.O.M RECURRENT APNEA NO -2.94 -1.59 NONE SEVERE G.D.D 
16. 62 
 
Boy 
 
1150 
 
29 
 
ABRUPTION PLACENTAE, 
P.P.R.O.M for 10 days 
RECURRENT APNEA 
 
YES -1.99 
 
-2.21 
 
RESPIRATORY 
ARREST  at 2 m.  
SEVERE G.D.D 
 
17. 64 Boy 1300 37 NIL FACIAL DYSMORPHISM 
NOTED 
SEVERE I.U.G.R 
YES -6.94 -7.85 NONE SUSPECTED SECKEL 
SYNDROME 
18. 65 Boy 1200 36 I.U.G.R  NIL NO -1.96 -1.94 NEPHRECTOMY 
(L) DYSPLASTIC 
KIDNEY 
DEVELOPMENTAL DELAY 
19. 66 Girl 1240 34 TWIN PREGNANCY PDA NO -2.68 -2.91 PERSISTENT PDA DEVELOPMENTAL DELAY 
20. 67 Boy 1220 32 PREECLAMPSIA 
INFERTILITY (TUBAL BLOCK) 
NIL NO -3.69 -4.14 NONE MICROCEPHALY WITH 
DEVELOPMENTAL DELAY 
21. 68 Boy 840 28 PRE-ECLAMPSIA E.L.B.W NO -0.81 -0.33 SUSPECTED 
AUTISM 
DEVELOPMENTAL DELAY WITH 
HYPERACTIVE BEHAVIOUR 
22. 69 Girl 910 33 TWIN PREGNANCY 
(Other twin is No.23) 
E.L.B.W YES -5.7 -3.22 NONE SEVERE GROWTH DELAY WITH 
DEVELOPMENTAL DELAY 
23. 70 Girl 850 33 TWIN PREGNANCY 
(Other twin is No.22) 
E.L.B.W YES -5.7 -3.3 NONE SEVERE GROWTH DELAY WITH 
DEVELOPMENTAL DELAY 
24. 70 Girl 1420 31 NIL RDS REQUIRED 
VENTILATION 
NO -2.57 -0.25 NONE DEVELOPMENTAL DELAY 
25. 70 Boy 900 29 PRE-ECLAMPSIA E.L.B.W, R.O.P with 
PLUS disease 
NO -1.67 -0.54 NONE DEVELOPMENTAL DELAY 
26. 70 Boy 1300 29 Primary 
 
INFERTILITY, 
TWIN PREGANCY. 
NIL NO -1.59 -0.85 NONE DEVELOPMENTAL DELAY 
27. 70 Boy 1000 28 P.P.R.O.M for 1 day SEPTICEMIA NO -1.18 -1.04 NONE DEVELOPMENTAL DELAY 
28. 70 Boy 1400 31 NIL NIL NO -2.18 -1.04 NONE DEVELOPMENTAL DELAY 
29. 70 Boy 1440 32 ABNORMAL DOPPLER, NIL NO -1.98 -1.24 NONE DEVELOPMENTAL DELAY 
30. 70 Girl 1500 38 I.U.G.R, OUTBORN and 
HYPOGLYCEMIA  on arrival 
HYPOGLYCEMIA NO -2.95 -1.38 NONE DEVELOPMENTAL DELAY 
31. 70 Boy 1420 33 OLIGOYDRAMNIOS, 
ABNORMAL  DOPPLER 
CYTOMEGALOVIRUS 
(CMV) ELISA POSITIVE 
NO -3.04 -4.65 HEARING 
IMPAIRMENT 
CMV INFECTION SEQUELAE - 
MICROCEPHALY, HEARING 
IMPAIRED, Dev. DELAY 
 
(Grey Filling indicates children with Cerebral Palsy)
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had normal tone; however they had significant deficits when scored on the Amiel Tison 
neurologic examination. 
The children have been individually described below- 
1) CHILDREN WITH INCREASED TONE (CEREBRAL PALSY)  
Cerebral palsy was diagnosed using the Surveillance of Cerebral Palsy in Europe (SCPE) 
algorithm.366 There were 5 children with definite features of cerebral palsy (Children 
nos. 1,2,5,7 and 14 in table 26). All these children were detected to have abnormal tone 
in the latter half of the first year. The functional motor outcomes for children with 
cerebral palsy were graded using the five levels defined in the Gross Motor Function 
Classification System (GMFCS)367 from 1 for minimal motor impairment to 5 for severe 
motor impairment with dependence on others for most daily activities. 
• Four of these children (80%) had Spastic Bilateral Cerebral Palsy. Three of the 
bilateral spastic children (Children nos. 1,2 & 5) both upper and lower limbs were 
involved (quadriparetic) and they were GMFCS level-5. Their GQ could not be 
quantified in view of the extensive involvement. 
• Fourth child with bilateral spastic CP had Diplegia and was GMFCS level 3. 
• Fifth child with CP had Spastic unilateral CP (Left hemiplegic CP) and she was 
GMFCS level 1. 
The children with CP are described below - 
First child: Child 1 had an uneventful period in NICU and he did not have any infection 
in the NICU. The mother’s antenatal period was also normal. The neurosonogram at 2 
months did not shown any ventriculomegaly or evidence of PVL or IVH. His older 
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sibling was also born with low birth weight (1.66 kg).  However he was brought for his 
first check up at seven months corrected GA and was detected to have spasticity. He was 
severely disabled and was GMFCS level V. His MRI (Figure 15) showed a paucity of 
white matter with periventricular hyperintensities and “wavy margin” of the ventricles 
suggestive of periventricular leukomalacia.  
Second child: Child no. 2 was the second of twin gestation. His neurosonogram done at 
2 months showed extensive cystic lesion in the periventricular region (Figure 16). The 
twin sister is normal. He was severely disabled and was GMFCS level V. 
Third child: Child no. 5 was one of triplets and his siblings were normal. His 
neurosonogram at two months showed mild ventriculomegaly. In addition to spastic 
bilateral CP (Quadriplegic CP) he also had cortical visual impairment and bilateral 
hearing impairment.. He was severely disabled with GMFCS level V.  His MRI (Figure 
17) shows extensive periventricular hyperintensities. 
The fourth child: Child no. 7 had spastic Unilateral (Left side) CP. This child had 
cholestasis when she was discharged from the NICU. This was unfortunately resulted in 
late hemorrhagic disease and intracranial hemorrhage (Figure 18). She went on to have 
Left sided hemiplegia and microcephaly. In spite of the severe cognitive and 
communication compromises she was independently ambulant and was GMFCS level I. 
It could be argued that the cause of the CP in this child is post-natal. However she is 
included because she had multiple co-morbidities in the Neonatal period, which could 
have predisposed to the intracranial hemorrhage postnatally. 
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The fifth child: Child no.14 had spastic bilateral (diplegic type) and she was able to 
move her upper limbs and was able to crawl on her hands and knees without a reciprocal 
movement (GMFCS level III). Her mother was on corticosteroids for Systemic Lupus 
Erythematosus. She had reasonably good verbal skills and her low GQ is primarily 
because of her difficulties in ambulation. Her early neurosonogram were normal and 
unfortunately she did not return for the neurosonogram at 6 weeks. The mother brought 
the child only at one year with seizures and signs of spasticity. Her MRI (Figure 19) 
shows periventricular white matter loss with ventriculomegaly and mildly wavy 
ventricular margins. 
2) CHILDREN WITH HYPOTONIA 
There were four children who were detected to have significant hypotonia without any 
other signs like ataxia or extrapyramidal symptoms. These children also had decreased 
age appropriate social interactions, delayed parachute reflexes and profound global delay. 
In two of these children the developmental delay was  very profound and it was difficult 
to score them on the GMDS. 
First child: Child no 4 - This child had birth asphyxia and multiple apneic episodes in 
NICU. He had profound developmental delay with hypotonia.  
Second child: Child no. 9 - This child had hypotonia with significant developmental 
delay. She was noted to have some abnormal facial features like hypertelorism, small 
palpebral fissure, and large ears and was therefore suspected to have an underlying 
dysmorphic state. 
  
 
Figure 15: MRI showing a paucity of white matter with periventricular hyperintensities 
and a “wavy margin” of the ventricles 
 
 
 
Figure 16: Cranial ultrasound showing cystic changes in the bilateral periventricular 
white matter 
 
 
  
 
Figure 17:MRI showing hyperintensities in the periventricular region 
 
 
 
 
Figure 18: CT scan subdural hematoma over right frontal and temporal and occipital 
regions causing midline shift 
  
 
 
 Figure 19: MRI showing mildly enlarged ventricles with wavy margins. Paucity of 
periventricular white matter 
 
 
 
 
 
Figure 20: MRI showing bilateral pachygyria-polymicrogyria complex with callosal 
dysgenesis 
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Third child: Child no. 10 - This boy child had a relatively uneventful NICU stay. He had 
hypotonia and profound developmental delay. MRI was not done and so the etiology is 
not known. 
Fourth child: Child no. 3 - This child had autistic traits with profound delay and he is 
described below (along with the other autistic children). His MRI of the brain was 
normal. 
3) CHILDREN WITH NORMAL TONE, BUT HAD NEUROLOGICALLY 
ABNORMAL ON AMIEL-TISON NEUROLOGIC ASSESSMENT. 
These children had normal tone, but they had microcephaly, their social interactions were 
not age appropriate, parachute reflexes were absent and they had much delayed motor 
skills, so they were considered abnormal on the ATNA. 
First child: Child no.6 had perinatal asphyxia at birth. However after that he had a 
relatively uneventful stay in the NICU. He was detected have bilateral micro-cornea and 
bilateral cataract which was operated in the first year. His muscle tone was normal but he 
had microcephaly with profound developmental delay (we could not quantify his GQ). 
MRI showed features of Neuronal migration disorder – polymicrogyria and pachygyrias 
and dysgenesis of corpus callosum (Figure 20). He may be having sequelae of TORCH 
infection (in view of the small for gestational age status, eye finding, neuronal migration 
disorder and profound developmental delay). 
Second child: Child no.8 - This child had multiple neonatal complications (RDS, 
pneumothorax, and hypoglycemia). He had a cardiorespiratory arrest in NICU. On 
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follow-up he was detected to have profound developmental delay and cortical visual 
impairment. 
Third child: Child no.17 was born severely growth retarded and was suspected to have 
features of Seckel syndrome. He has remained profoundly microcephalic, growth 
retarded and had severe developmental delay in his motor and language milestones. 
Fourth child: Child no. 16 - This child had recurrent apnea in the NICU and at 2 months 
had a respiratory arrest from which he was resuscitated. He had profound delay in his 
motor milestones, although his head circumference was almost normal. 
Fifth and sixth children: Children 22 and 23 were twins. They were born with severe 
IUGR and subsequent growth continued to have post-natal growth retardation. Both the 
children have significant motor delay.   
 
4) CHILDREN WITH AUTISM 
Three children did not satisfy the criteria for moderate or severe deficits on the ATNA 
and were neurologically normal; however they were positive on the Modified Checklist 
for Autism in Toddlers (M-CHAT). 
Child no.3: This child was conceived after the mother was treated for infertility. He did 
not have any complications in the neonatal period and the neurosonogram were normal. 
His vision and hearing are also normal. However he had microcephaly and profound 
developmental delay. He also had autistic features, exacerbated by the profound delay 
and is currently on developmental therapy and follow-up. 
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Child no. 12 was brought for the neurodevelopmental assessment at 18 months of age. 
He was noted to have features of autism like poor eye contact, abnormal interest in 
rotating objects, hyperactivity and poor communication and fulfilled the criteria for 
autism on the DSM-IV. Interestingly the parents did not think he was abnormal and they 
were reluctant to accept that he had a significant problem. Unfortunately they did not 
return and so we could not do any more formal tests for the confirming the diagnosis of 
autism. 
Child no. 21: When this child was brought for the assessment at 19 months of age he was 
detected to have features suspicious of autistic spectrum. He fulfilled 5 of the 6 “critical” 
items on the Modified Childhood autism tool (M-CHAT). He was started on early 
intervention and he started improving. At 3 years of age, his language and 
communication had improved and he displayed considerable improvement in his social 
behavior. However he continues to be very hyperactive and is on regular follow-up for 
his behavior. 
5) CHILD WITH PERINATAL CMV INFECTION SEQUELAE 
Child no. 31 was born small for gestational age and CMV IgM was positive at birth. His 
hearing report on the Neonatal ABR was “bilateral referred”. He was suspected proved to 
have bilateral deafness on the BAER and the OAE.  Although his motor milestones were 
normal, he was very delayed in the language milestones. 
There were factors in the other children such multifetal gestation, absent end diastolic 
uterine artery flow, hypoglycemia, antepartum hemorrhage, pre-eclampsia and 
intrauterine growth retardation which would affect the neurodevelopmental outcome. 
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5.3 SECTION 3 - ANALYSIS OF THE SMALL FOR GESTATIONAL AGE 
INFANTS 
One of the secondary objectives of the study was to determine if the survival and 
neurodevelopmental outcomes of the small for gestational age babies were different from 
those who were born appropriate for gestational age. The third percentile of Fenton’s 
charts was used to decide if the infant was small or appropriate for gestational age.  
Of initial 776 infants who were admitted in the NICU, 239 (30.7%) of the infants were 
small for gestational age (SGA). There were more SGA girl babies (53.8%) than SGA 
boys. Majority of the infants (almost 90%) who were less than 33 weeks of gestation 
were appropriate for gestational age. All infants whose gestational age was 34 weeks and 
more were small for gestational age, because of the ceiling of 1500 g in the study   
This section is arranged in the following manner - 
5.4.1: The range of gestational age in a given weight category is depicted. This was 
done to emphasize the heterogeneity of the children in this cohort 
5.4.2: Compares all the SGA babies with all AGA babies. However this results in a 
comparison between late preterm and term SGA babies and AGA preterms, as explained 
in the section 
5.4.3: Compares the neonatal morbidities and survival of SGA babies <34 weeks (PT-
SGA) with AGA babies of <34 weeks (PT-AGA).  
5.4.4: Compares the growth and developmental outcomes between PT-SGA and PT-
AGA who are <34 weeks. 
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5.5.5: Since many preterms were underweight (Z- score of weight for age was <2SD) at 
the time of assessment, this section reviews the factors which could predict a preterm 
infant being underweight at 2 years. 
 
5.3.1 RELATIONSHIP BETWEEN BIRTHWEIGHT AND GESTATIONAL AGE 
Table 27 (below) depicts the relationship between the birth weight and the gestational 
age  distribution in this cohort. It is obvious that for a given birth-weight there is a wide 
variation in the gestational age. So infants in the category 750-1000 g could have a 
gestational age anywhere from 26 weeks to 34 weeks. This severe intrauterine growth 
retardation explains why many infants continued to remain severely underweight even 
after two years. 
Table 27: Relationship between Birth-weight categories and Gestational age 
 750-999 g 
(ELBW) 
1000-1199 g 1200-1500 g 
Mean  GA (95% CI) 30.9 (29.8-31) 30.9 (30.5-31.3) 32.3 (32.3-32.7) 
Median GA (weeks) 30.4 30.4 32.3 
Std. Deviation 1.9 2.3 2.3 
Minimum GA (weeks) 26 26 28 
Maximum GA (weeks) 34 38 40 
Range of GA (weeks) 8 12 12 
 
 
5.3.2 COMPARING BETWEEN SGA AND AGA INFANTS 
Among the 643 children who were discharged alive from the NICU, 201 (31.3%) were 
small for gestational age at birth. There were 98 boys and 103 girls in this group. Of the 
final 422 children who came for the assessment, 131 (31%), 66 boys and 65 girls came 
for the assessment were SGA.  
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Comparisons between SGA and AGA in this cohort will predominantly be a 
comparison between “small for gestational age late preterms and term babies” and 
“appropriate for gestational age preterms”. This is because of the birth-weight ceiling of 
1500 g in this study, so all infants who were above 34 weeks were small for gestational 
age and majority of the less than 33 week babies were appropriate for gestational age.  
Table 28 shows the results of the comparison the AGA babies with the SGA babies. 
Morbidities in NICU 
Only the perinatal and neonatal factors which are significantly different between the two 
groups are presented.  
• Diabetes in pregnancy resulted in more premature births so there are more AGA 
babies.  
• PIH resulted in more growth retarded babies. 
• The higher rate of Cesarean among the SGA group is related to the higher 
incidence of PIH.  
• As expected there was higher incidence of RDS in the AGA group, because of 
prematurity and this explains the greater incidence of CPAP and ventilation in the 
AGA group.  
• Other complications of premature infants like PDA, hypocalcaemia and ROP 
were also more common among the AGA infants.  
• Although not statistically significant severe IVH (Grades III and IV) was also 
more common among the AGA babies.  
• Hypoglycemia was more common among the small for gestational babies.  
 TABLE 28: COMPARISON OF THE INFANTS WHO WERE SGA WITH THOSE WHO WERE AGA 
 AGA SGA p-value 
Perinatal and Neonatal risk factors (among the initial 776) 
1.  Diabetes in pregnancy 8.8% 3.8% 0.013 
2.  Hypertension in pregnancy 38.8% 48.9% 0.002 
3.  Cesarean section 60.6% 79.6% <0.001 
4.  Acute kidney injury 4.6% 0.9% 0.045 
5.  RDS 32.2% 5.1% 0.001 
6.  Ventilation 18.9% 8.5% 0.001 
7.  Hypotension 23.4% 14% 0.003 
8.  Hypoglycemia 5.7% 15.9% < 0.001 
9.  Hypocalcaemia 20.8% 7.1% <0.001 
10. PDA 16% 6.5% <0.001 
11. Severe IVH (Grade 3 and 4) 2.9% 0.9% 0.122 
12. ROP 17.9% 10.6% 0.099 
13 Deaths 14.8% 5.7% 0.014 
Developmental outcome (GQ) (Children whose GQ could not quantified not included) 
% of children with GQ <76 9.6% 15.3% 0.091 
GQ- Mean [+2SD] 94.2 (+12.8) 92.1 (+13.3)   
1.000 Median GQ 96 93.5 
Range of GQ 50-124 58-117 
Cerebral Palsy (no. of children) 4 1 0.591 
Weight at assessment 
% of children with weight < 2SD below mean  27.1% 56.9% <0.001 
Mean Z-score (+2SD) of Weight -1.56 (1.14) -2.47 (1.35) <0.001 
Length at assessment 
% of children with length < 2SD below mean 38.3% 63.6% <0.001 
Mean of Z-Score (+2SD) of Length -1.74 (1.24) -2.64 (1.72) <0.001 
Head Circumference (HC) at assessment 
% of children with HC  < 2SD below mean 27.1% 56.9% <0.001 
Mean of Z-Score (+2SD) of HC -1.79 (1.08) -2.28 (1.6) <0.001 
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• The AGA group had significantly more neonatal complications like hypotension, 
thrombocytopenia and acute kidney injury.  
• Because the AGA group had more life threatening complications it is not 
surprising that the AGA group had greater mortality.  
• Some complications like perinatal asphyxia, NEC and septicemia were not 
statistically different between the groups.  
Neurodevelopmental outcomes 
At the time of the neurodevelopmental assessment there was a significantly higher 
proportion of babies with a lower GQ among SGA babies. The mean GQ between the 
two groups however was not statistically significant (table 28). Cerebral palsy, although 
the numbers were very small was more among the infants who were AGA  
Growth 
The growth parameters (weight, length and head circumference) at the time of the 
assessment were significantly more affected among the SGA infants, than among the 
AGA infants. Almost 60% of the SGA babies continued to have growth retardation while 
only about 27% of the AGA infants were underweight.  
So in AGA infants, neonatal mortality and morbidity mainly due to the complications 
of prematurity contribute to their outcomes. While neonatal morbidities and mortality 
are less in the SGA infants, they are more likely to be affected in their growth, head 
circumference and their developmental outcomes. 
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5.3.3 COMPARISON OF PRETERM AGA AND PRETERM SGA   
As mentioned above the comparison of all the AGA babies with all SGA babies was 
invariably a comparison between the preterm babies and moderately preterm intrauterine 
growth retarded & term growth retarded babies. Therefore to make a comparison between 
SGA and AGA, it was necessary to study the infants who were less than 34 weeks to look 
for differences between the babies who were preterms and small for gestational age (PT-
SGA) and the babies who were preterm and appropriate for gestational age (PT-AGA). 
The results of this analysis are presented in table 29.  
Of the initial sample of 776 babies there were 600 infants who were less than 34 weeks 
gestational age, of these 538(89.7%) infants were AGA and 62 (10.3%) infants were 
SGA. The neonatal morbidities and survival is estimated based on this group 
Of the 422 who came for the final assessment, 324 infants were less than 34 weeks 
gestational age. Of these 290 (89.5%) infants were AGA and 34 infants (10.5%) were 
SGA babies. The growth and developmental outcomes are estimated based on this 
group. 
A. Morbidities of PT-SGA compared with PT-AGA 
On comparing the two groups (Preterm AGA with Preterm SGA) - 
• There were more girls in the preterm SGA group compared to the preterm AGA 
group 
• Maternal PIH was more common in the SGA group and as mentioned the growth 
retardation may be the result of the PIH.  
• There were more babies who were born Cesarean in the SGA group, possibly 
because of the PIH.  
 TABLE 29: COMPARISON OF PRETERM SGA BABIES WITH PRETERM AGA BABIES 
 PT- AGA PT-SGA p-value 
Perinatal and Neonatal risk factors  
1. Girls 44.4% 66.1% 0.001 
2. Hypertension in pregnancy 37% 59.7% 0.001 
3. Cesarean section 60.8% 75.8% 0.012 
4. RDS 47.8% 8.8% 0.001 
5. CPAP 34.5% 14.5% 0.001 
6. Hypoglycemia 5.8 % 18 % 0.001 
7. Thrombocytopenia 32.2% 54.1% <0.001 
8. Mortality in NICU 10.5% 14.5% 0.368 
Developmental outcome (GQ)  
% of children with GQ <2SD 9.6% 11.8% 0.696 
GQ- Mean [+2SD] 93.4 (+14.7) 93.8 (+12.9)   
0.769 Median GQ 96 93.5 
Cerebral Palsy (no. of children) 4 0  
Weight*  
% of children with weight < 2SD below mean  26.2% 60.6% <0.001 
Mean Z-score (+2SD) of Weight -1.41 (1.09) -2.30 (1.41) <0.001 
Length* 
% of children with length < 2SD below mean 38.1% 54.5% 0.06 
Mean of Z-Score (+2SD) of Length -1.59 (1.20) -2.31 (1.66) 0.002 
Head Circumference (HC)* 
% of children with HC  < 2SD below mean 34.8% 63.6% <0.001 
Mean of Z-Score (+2SD) of HC -1.66 (1.07) -2.36 (1.12) <0.001 
                                             *At the time of the neurodevelopmental assessment 
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• RDS was five times more common in the AGA preterms. It is well known that 
conditions like pregnancy induced hypertension which results in chronic 
intrauterine stress induces lung maturity in preterms and protects against 
developing RDS 385. This may be reason why SGA babies had much lesser 
incidence of RDS 
• CPAP use was also higher among the preterm AGA babies.  
• Hypoglycemia was more common in the preterm SGA group possibly because of 
the combination of prematurity and growth retardation which can both 
independently cause hypoglycemia.  
• Thrombocytopenia was more common in the preterm AGA group..  
• Other factors like maternal history of infertility, twin gestation, perinatal 
asphyxia, NEC, septicemia, hypotension, hypercalcemia, PDA, severe IVH, ROP 
were not significantly different between the two groups 
• Though proportionately the mortality among the PT-SGA babies were more than 
the PT-AGA babies, this difference was not significant (p=0.368) 
• The mean GQ was similar between the two groups indicating that there was not 
much difference in the development of preterm SGA as compared to preterm 
AGA 
• Significantly the growth parameters were more affected in the SGA group. About 
56-64% of the SGA babies continued to be growth retarded (in their weight, 
length and head circumference) as compared to about 30-35% of the AGA babies. 
Thus in conclusion there are significant differences in the morbidities between PT-AGA 
and PT-SGA in the neonatal period. Because they are more advanced in gestational age, 
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PT-SGA infants are protected from the complications of prematurity. However PT-SGA 
babies are significantly more growth retarded,  
 
5.3.4 NEURODEVELOPMENTAL & GROWTH OUTCOMES OF PT-AGA vs. PT-SGA  
There are more infants with GQ less than 2SD in the PT-SGA group, but this was not 
statistically significant. The mean GQ between the two groups appear almost similar. 
Although all the children with CP were in the PT-AGA group, because of the small 
numbers no inference of any association can be made out. 
At the time of assessment, there was a significant difference in the post-natal growth. The 
SGA babies were more affected and majority of them did not catch up by 2 years 
Did the GQ differ significantly between those who remained underweight (<2SD of 
Z score for weight) and those who had caught up in their weight? 
Among the preterm SGA (PT-SGA) there were 13 (39.4%) who caught up and 20 
(60.6%) who continued to have poor post-natal growth and remained underweight. The 
mean GQ of those who caught up was 97.9 (+13.8) and in those who continued to have 
post-natal growth retardation was 91.2 (+12). However this was not significantly 
different (p=.191). 
Among the preterm infants who were appropriate for gestation at birth (PT- AGA) there 
were 26.2% infants who had post-natal growth retardation and the remaining 73.8% were 
within the normal range. The mean GQ of those who weight was normal was 95.9 
(+11.9) and the mean of the infants who had post-natal growth retardation was 89.45 
(+13.9). This difference was statistically significant.(p<0.001).  
These findings are shown in table 30.  
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Table 30: Comparison of GQ of infants who had adequate catch-up growth and 
those who had inadequate post-natal growth 
 Adequate catch-up 
growth 
Inadequate post-natal 
growth 
p-value 
PT-AGA %. of infants: 73.8% 
GQ(SD): 95.9 (11.9) 
%. of infants: 26.2% 
GQ(SD): 89.45(13.9) 
 
<0.001 
PT-SGA %. of infants: 39.4% 
GQ(SD): 97.9 (13.8) 
%. of infants: 60.6% 
GQ(SD): 91.2 (12) 
 
<.191 
 
So in the SGA group although there was a difference in the developmental outcome 
(mean GQ) between those who had caught up and those still remained underweight, 
this was not significant. But in the babies who were AGA at birth, those who had 
inadequate post-natal growth the developmental outcome was significantly worse than 
those whose post-natal weight gain was within normal limits. 
So, are the NICU and neurodevelopmental outcomes of the SGA infants worse than 
that of the AGA infants ? 
• There are definite differences in the neonatal complications between SGA and 
AGA infants however there is no difference in the survival  
• Developmental outcomes (mean GQ) appear similar between SGA and AGA 
• More SGA babies have post-natal growth restriction compared to AGA babies. 
• In both groups the developmental outcome is worse in the infants who have post-
natal growth restriction compared to those whose post-natal growth is normal 
• The developmental outcome of AGA babies who have post-natal growth 
restriction is worse that SGA babies who have post-natal growth restriction 
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5.3.5 POST-NATAL GROWTH RESTRICTION IN THE PREMATURE INFANTS. 
About one third of the preterm babies remained underweight at two years. Are there any 
factors which could predict the infant being underweight at two years? 
In order to answer this question the bivariate analysis of the perinatal, neonatal and post-
natal factors of the preterm (<34weeks) babies was done to see if there were any 
predictors for being underweight (Weight of <2SD below the mean) after 18 months 
corrected gestational age. There were 225 (69.6%) the infants who had a normal weight 
(weight within 2SD of the mean) and 98 babies who were underweight (weight more than 
2SD below mean) at the time of assessment.  
From the bivariate analysis the following predictors in premature babies were associated 
with being underweight – being SGA at birth (p <0.001), maternal education below Std. 8 
(p=0.003), neonatal hypoglycemia (p = 0.018), and, Retinopathy of prematurity (p = 
0.047), severe IVH (p = 0.033). These were entered into a multivariate regression model.  
The best multivariate prediction model for being underweight at two years is given 
below: 
 
Table 31: Multivariate logistic regression model predictive for the study children 
being underweight at the time of assessment 
Variable B coeff. p-value Adjusted OR (95%CI) 
Small for gestation at birth 1.427 .000 4.165  (1.89-9.18) 
Low maternal education (less than Std.8) 1.030 .003 2.802  (1.42-5.53) 
Neonatal hypoglycemia .791 .088 2.206  (0.89-5.48) 
Constant -1.219 <.001 0.295 
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The final predictive model (shown above) yielded an area under the ROC curve of 0.654 
(0.584-0.723 95% CI; p<0.001) and the Hosmer-Lemeshow statistic indicated a good 
model fit (p=0.473).  
The model predicts that being small for gestational age increases the odds by four times, 
low maternal education increases the odds by nearly three times and neonatal 
hypoglycemia increases the odds by two times of being underweight at two years. 
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5.4 SECTION 4 - ANALYSIS OF THE CHILDREN WHO DID NOT COME 
FOR FOLLOW-UP.  
Although 422 children were followed up until the final neurodevelopmental assessment, 
and this is probably the largest VLBW cohort which has been followed up, there was still 
a drop out of over 30%.  Thirty of these children did not come for the final assessment 
but were seen at one year for the interim motor assessment. The majority of the “lost to 
follow-up” group did not come for any developmental assessment and therefore the 
developmental status of these children is not known. In many children we do not even 
know if they have survived. Although some of the parents did not give consent to join the 
study, for the sake of analysis, they are considered among the patients who were lost to 
follow-up. 
COMPARING THE “LOST TO FOLLOW-UP” INFANTS WITH THOSE WHO 
UNDERWENT NEURODEVELOPMENTAL ASSESSMENT 
In order to see if there was any significant differences between the children who were 
followed up and those who did not come for the follow-up and assessment the bivariate 
analysis by using the Chi-square test on the usual 2-way cross tabulations was done to 
look for any significant differences between perinatal and neonatal risk factors between 
the two groups. Associations were considered to be significant if the p-value was <0.05. 
The results are presented in table 32. There were 453 children who had at least one of the 
two assessments and 169 children who had no assessments. The children (21 children) 
who died after discharge from the nursery are excluded from the analysis. 
  
Table 32: BIVARIATE COMPARISON OF THOSE WHO HAD ASSESSMENT WITH THOSE DID 
NOT COME FOR ASSESSMENT (DIED, DID NOT GIVE CONSENT AND LOST TO FOLLOW UP)  
S. No Characteristic/Risk factor Assessment 
done (453)  
No assessment 
(169) 
P-value OR (5% CI) 
1. Boys  
Girls 
237 (52) 
216 (47.6) 
90 (53) 
79 (46.7) 
 
0.835 
0.963 
(0.676-1.372) 
2.  Antepartum 
 Hemorrhage (%) 
53 
(11.7) 
24 
(14.2) 
0.399 1.249 
(0.744-2.098) 
3. Pregnancy induced 
hypertension (%) 
193 
 (42.6) 
78 
 (46) 
0.427 1.155 
(0.810-1.647) 
4. Twins (%) 128 
(28.2) 
39 
(23) 
0.195 0.762 
(0.504-1.150) 
5. Antenatal steroids (%) 86 
(18.9) 
32 
(18.9) 
0.989 0.997 
(0.635-1.535) 
6. Cesarean or Instrumental 
delivery (%) 
305 
(67) 
115 
(68) 
0.865 1.033 
(0.708-1.509) 
7. Infertility (%) 87 
(19.2) 
21 
(12.4) 
0.047 0.597 
(0.357-0.997) 
8. PPROM (%) 94 
(20.7) 
29 
 (17) 
0.317 0.791 
(0.499-1.253) 
9. Ponderal index > or < 2 (%) 84 
(18) 
23 
(13.6) 
0.203 0.723 
(0.438-1.194) 
10. Birth weight less than 
1200g (%) 
126 
(27.8) 
36 
(21) 
0.100 0.702 
(0.461-1.071) 
11. Gestational age less than 32 
weeks (%) 
214 
(47) 
70 (41) 0.195 0.790 
(0.552-1.129) 
12. Mothers Education below Std  
8 (%)* 
64 
(14.5) 
21 
(19.6) 
0.193 1.435 
(0.831-2.476) 
13. Perinatal asphyxia (%) 
  
15 
 (3.3) 
3 (1.8) 0.309 0.528  
(0.151-1.84) 
14. IVH Grades III & IV 9%) 2 (0.44) 0 
(0) 
0.398 - 
15. Septicemia (%) 56 
(12.4) 
31 
(18) 
0.056 1.593 
(0.986-2.573) 
16. Ventilation (IPPV & HFOV) (%) 54 
(11.9) 
24 
(14.2) 
0.445 1.223 
(0.729-2.051) 
17. Gestational Age (<28 weeks) 
 (%) 
6/453 
(1.4) 
3/169 
(2) 
0.675 0.743 
(0.184-3.004) 
18. Respiratory Distress Syndrome 
(%) 
93 
(20.5) 
34 
(20) 
0.910 0.975 
(0.628-1.513) 
19. Necrotising enterocolitis  
 (>Bell stage 2) (%) 
5 
(1.1) 
1 
(0.59) 
0.561 0.533 
(0.062-4.599) 
20. Acute kidney illness (%) 8  
(1.96) 
1 
 (0.65) 
0.272 0.329 
(0.041-2.652) 
21. Hypoglycemia 38 
(8.4) 
17 
(10) 
0.514 1.221 
(0.669-2.229) 
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The analysis presented in table 32 shows that, except for maternal history of infertility, 
there is no significant difference between the two groups in the occurrence of perinatal or 
neonatal risk factors.   
SENSITIVITY ANALYSIS 
Sensitivity analysis was done to assess what impact the “lost to follow-up” would have 
on the results obtained from the present cohort of 422 children. This was done by 
considering two extreme possibilities – a “worst case scenario” and a “best case scenario" 
(table 33). 
The “worst case scenario” was where all the children who were lost to follow-up had a 
poor neurodevelopmental outcome (GQ <2SD) and the “best case scenario” was one in 
which all the children who were lost to follow-up had a good neurodevelopmental 
outcome (GQ of >2SD). For this analysis the children who had the one year motor 
assessment using the Peabody developmental Motor scales (PDMS), but did not come for 
the final neurodevelopmental assessment were included. Of the 31 children who came for 
the PDMS but did not come for the GMDS, 29 had Total motor quotient of more than 90 
and hence using the Regression equation mentioned above (see 5.2.8, p.147 comparing 
TMQ with GQ) they would have a GQ of >2SD (normal developmental outcome). The 
other two children had TMQ in the “below average” (TMQ <90) category and therefore 
were classified as poor neurodevelopmental outcome (GQ <2SD). Children who had died 
after discharge from the nursery (21 children) were excluded. 
 Thus in the “worst case scenario” there were - 
219 children with poor neurodevelopmental outcome (169 children who had no 
assessment, 48 children who had GQ <2SD and the 2 children who had low TMQ) 
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 403 children (374 children with GQ >2SD and 29 children with normal TMQ) with good 
neurodevelopmental outcome. 
 In the best case scenario there were 
 572 (374 children who had GQ of >2SD, 169 children who had no assessment and 29 
children who had a normal TMQ) with good neurodevelopmental outcome and 
50 children (48 children with GQ <2SD and 2 children who had low TMQ) who had poor 
neurodevelopmental outcome 
These were compared with the children of the study cohort (374 children with GQ >2SD 
and 48 children with poor neurodevelopmental outcome GQ <2SD) 
The results are presented in table 33. 
From table 33, it is clear that the relative risks in the three situations [“worst case 
scenario” or the “best case scenario” and the study cohort] are quite similar and the p-
value is not significant in any the neonatal and perinatal factors in all the three scenarios. 
Thus it seems that the study cohort is not different from either of the extreme 
scenarios, so the children who were lost to follow-up are unlikely to affect the results 
obtained from this study cohort.  
 
The influence of the growth parameters on the developmental outcome, could not be 
estimated since the anthropometric measurements were collected only at the time of the 
neurodevelopmental assessment.   
 
 
 
 Table 33: SENSITIVITY ANALYSIS - Comparing the “Best-case” and “Worst case” 
 
 
 
 
S. No Risk Factor Worst Case scenario  
p-value; OR(95%C.I) 
 
Study cohort 
p-value; RR (95% C.I) 
Best case scenario 
p-value; RR (95% C.I) 
N Number Children with GQ <76: 219 
Children with GQ >76: 403 
Children with GQ <76: 48 
Children with GQ >76: 374 
Children with GQ <76: 50 
Children with GQ >76: 
572 
1. Perinatal 
Asphyxia 
0.866 0.918 
(0.340-2.480) 
0.284 
 
1.112 
(0.861-1.435) 
0.172 1.107 (0.89-
1.36) 
2. Acute Kidney 
illness 
0.901 0.915 
(0.226-3.700) 
0.226 
 
2.691 
(0.526-13.774) 
0.114 1.87 (0.835-
1.68) 
3. Hypotension 0.133 1.448 
(0.891-2.351) 
0.132 1.824 
0.826-4.030 
0.208 1.047 (0.962- 
1.14) 
4. Antenatal 
steroids 
0.756 1.068 
(0.704-1.622) 
0.622 
 
1.023 
(0.931-1.123) 
0.569 1.017 (0.955-
1.084) 
5. PPROM 0.050 0.648 
(0.420-1.002) 
0.050 0.395 
(0.152-1.030) 
0.070 0.95 (0.91-
0.993) 
6. History of 
Infertility 
0.045 0.626 
(0.395-0.993) 
0.524 0.973 
(0.899-1.053) 
0.791 0.992 
(0.955-1.052) 
7. Twins 0.272 0.809 
(0.555-1.181) 
0.947 0.997 
0.924-1.076) 
0.848 1.005 
(0.953-1.06) 
8. Type of Delivery 0.487 0.883 
(0.623-1.253) 
0.090 
 
0.938 
0.867-1.016 
0.134 0.962 
(0.912-1.02) 
9. NEC 0.923 0.919 
(0.167-5.060) 
0.455 1.109 
(0.715-1.72) 
0.435 1.105 
(0.776-1.58) 
10. PIH  0.789 1.046 
(0.751-1.458) 
0.384 0.970 
0.906-1.038 
0.408 0.98 
(0.936-1.027) 
11. Septicemia 0.123 1.435 
(0.905-2.276) 
0.990 0.994 
(0.401-2.465) 
0.673 0.986(0.93-
1.04) 
12. RDS 0.439 0.849 
(0.561-1.285) 
0.290 0.956 
(0.887-1.030) 
0.240 0.97 
 (0.92-1.02) 
13. Ventilation 0.370 1.249 
(0.768-2.032) 
0.573 1.280 
(0.541-3.029) 
0.745 1.149 
(0.498-2.652) 
14. Hypoglycemia 0.436 1.252 
(0.711-2.206) 
0.594 1.027 
(0.90-1.172) 
0.764 1.01 
(0.94-1.06) 
15. Intraventricular 
Hemorrhage 
0.303 - 1.000 - 0.670 - 
16. Low maternal 
education  
0.085 1.531 
(0.941-2.491) 
0.211 1.067 
(0.949-1.199) 
0.361 1.035(0.953-
1.124) 
17. Baby's Sex  
Boys vs. Girls 
0.413 0.871 
(0.626-1.212) 
0.380 0.970 
(0.906-1.038) 
0.273 0.974 (0.93-
1.02) 
RESULTS 
 
 Page 169 
 
REASONS FOR ATTRITION OF THE INFANTS FROM THE STUDY 
There are many reasons for the non-compliance of parents of those infants who were lost 
to follow-up.  
a. The institution where this study was done is a tertiary referral center and patients 
come from all over South India and the eastern part of India and Bangladesh visit 
the Centre. Many of those who were lost to follow-up and many of those refused 
consent were from far-off places.  
b. Many mothers came to Vellore for delivery because their homes are located here. 
After the child was discharged they went back to their regular places of stay and 
therefore could not come for the assessments.  
c. Although all assessments were done free of charge, there was still loss incurred 
(in terms of cost of transportation, loss of wages) in bringing children for the 
assessment, which resulted in the attrition.  
d. Some mothers refused to bring their children since they felt that their child was 
doing well and so did not require any assessments.  
e. The converse could also be true. Other studies have shown that children who 
were are lost to follow-up especially those from the lower socio-economic status 
are likely to have higher rates of disability.221,222 
 
 
 
 
                                                          DISCUSSION 
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6 DISCUSSION 
Western studies have shown that the survival of VLBW infants have consistently 
improved since the early 1990s.386 The survival of VLBW babies in India is about 68-
86%.91,92 The incidence of developmental delay from these studies range from 10-
17%,71,76,81 and that of cerebral palsy from 3-5%.76,82–84 This is less than the  incidence of 
7.8%  for CP and 25% obtained from Escobar’s the meta-analysis of over 100 studies 
which looked at the outcomes of the VLBW infants.59  
The hypotheses of this study were: (a) the occurrence of CP and developmental delay 
would be different from that of the Western countries (b) that risk factors in the perinatal 
and neonatal period would affect the developmental outcome at 18 months corrected 
gestational age. This hypothesis was tested on a large Indian cohort of very low birth 
weight infants who were followed up beyond 18 months of age. The primary questions 
that were answered are - how many of the VLBW survive? What is the developmental 
outcome after 18-24 months of life and do the complications in the perinatal influence 
their developmental outcome?  
The Discussion of the study is divided into 3 sections:  
Section 1:   incidence of poor neurodevelopmental outcomes (cerebral palsy and 
developmental delay) in this cohort.  
Section 2: The influence of the perinatal and neonatal morbidities on survival and the 
developmental outcome. 
Section 3: The findings of the Developmental follow-up and the Neurodevelopmental 
assessment 
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6.1 SECTION 1 - INCIDENCE OF CEREBRAL PALSY AND 
DEVELOPMENTAL DELAY 
This section comprises the following:  
6.1.1: The incidence of poor neurodevelopmental outcome and cerebral palsy in the 
cohort  
6.1.2: The neurodevelopmental outcomes among the ELBW babies of the cohort in 
comparison to other ELBW cohorts. 
6.1.1 INCIDENCE OF POOR NEURODEVELOPMENTAL OUTCOME (CP AND 
DEVELOPMENTAL DELAY) 
As mentioned earlier the results of outcomes (mortality in NICU) and poor the 
neurodevelopmental outcomes in the follow up phase study were - 
• Incidence of Poor Neurodevelopmental Outcome: 48 out of 422 children had 
GQ less than 2SD below the mean) and so the incidence of poor 
neurodevelopmental outcome was 11.37% (8.6%-14.9% 95% CI). (This 
includes the children with CP also) 
• Incidence of Cerebral Palsy: There were 5 children with Cerebral palsy in this 
cohort was and so the incidence of Cerebral palsy was 1.1% (0.4%-2.63%, 
95%CI). 
• Incidence of Hearing loss: There were 2 children (0.47%) with hearing loss, one 
of whom was suspected to be secondary to CMV infection and the other child had 
spastic quadriparetic cerebral palsy.  
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• Visual impairment: There were 2 children (0.47%) with blindness both due to 
cortical visual impairment, secondary to the brain damage and not due to 
Retinopathy of prematurity. 
• Mean General quotient of the cohort was 93.56 + 13.5.   
The results of this cohort were  compared with that of a similar cohort of 77 VLBW 
babies from Malaysia, another developing country.387 In this Malaysian study the VLBW 
infants had neurodevelopmental assessment at 2 years using the Griffith’s Mental 
Developmental Scales. The mean GQ of the VLBW infants was 94 (SD 15.7). The GQ of 
3.9% of the children in this cohort was 2SD below the mean, 2.6% were blind and 3.9% 
had cerebral palsy.  
The results were also comparable to a Western meta-analysis  which showed that the 
mean developmental quotient of 1461 VLBW infants was 95.8 (SD 8).388 (In this meta-
analysis many different neurodevelopmental assessment tests were used).  
The table 34 (below) shows the comparison of the results of this study cohort with that of 
VLBW cohorts from other developing countries as shown in 34. 
Table 34: Comparison of the results of this cohort with that of other developing 
countries  
 No. of 
children  
CP (95%CI) Developmental delay 
(95%CI) 
Study Cohort 422 1.1% (0.4%-
2.9%). 
11.37% (8.6%-14.9%) 
Mukhopadhyay et al (India)
76
 71 3% 16% (MeDQ <70), 
Ho et al (Malaysia)
387
 77 3.9% 3.9% 
Sangtawesin  et al (Thailand)
199
 30 3.3% 23.3% 
Ballot (South Africa)
200
 106 3.7% 8.5% 
Escobar et al (meta-analysis)
59
 Over 9,000 7.7% (5.3-9) 25% (20.9-30.0) 
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Therefore the incidence of 1.1% for cerebral palsy and 11.37% for developmental delay 
obtained from this cohort is likely to be right for the following reasons - 
1. Because of the sample size, the confidence intervals are within a narrow range 
[Incidence of CP: 1.1% (95% CI - 0.4%-2.9%) and the incidence of 
developmental delay: 11.37% (95% CI is 8.6%-14.9% 95% CI)]. This adds 
certainty to the results obtained and therefore we can state that we are 95% 
confident that the incidence of CP and developmental delay lie within these 
confident intervals.389,390 
2. The incidence is quite comparable to what is obtained from the other studies on 
VLBW babies (table 34). 
3. The sensitivity analysis (Section 4 of Results, table 33) showed that the infants 
who did not come for the final assessment are unlikely to have changed the 
results obtained. 
 
6.1.2 DEVELOPMENTAL DELAY AND CP in ELBW INFANTS - COMPARING WITH 
OTHER COHORTS.  
In this cohort - among the 422 children, there were 30 children with ELBW and their 
mean birth weight was 867g, mean gestational age was  30.7 weeks and mean GQ was 
92.4 (+15.5) (table 22).  Six (20%) of these children had developmental delay although 
none of them had cerebral palsy. None of the ELBW babies had hearing or visual 
impairment.    
The ELBW babies of  this cohort were compared to another cohort of 49 ELBW babies 
from Hong Kong.391 who were followed up till 2 years of age. The mean gestational age 
of the ELBW babies from Hong Kong was 26.2 weeks and mean birth weight was 789 g, 
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six (12%) of the ELBW infants had CP, eight (16%) had significant developmental delay 
on the Griffith’s Mental developmental Scales. 
The ELBW babies of this cohort were also compared to  a cohort from the NIHHD (data 
on ELBW during the period 2000-2002).104  The ELBW infants in the NICHHD had a 
mean gestational age of 25.5+ 2.2 weeks, their mean birth-weight was 750 g + 144. The 
neurodevelopmental sequelae in the NICHHD cohort was that 5% of the infants had CP 
and 21% of the infants had MDI of <70 and 15% of the infants had PDI of <70 on the 
BSID, 1% of the infants were blind and 1% of the infants were hearing impaired.  
Compared to the other cohorts, ELBW babies in this cohort are more mature at birth 
Since many of them are growth restricted there are fewer extremely preterm or very 
preterm babies. The mean gestational age in this cohort among the ELBW was 30 weeks 
while that of the NICHHD cohort was 25.5 weeks.   
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6.2 SECTION 2 - INFLUENCE OF ANTENATAL, PERINATAL AND 
NEONATAL RISK FACTORS OF SURVIVAL AND DEVELOPMENTAL 
OUTCOME. 
 
This section is about the influence of the antenatal, perinatal and neonatal risk factors on 
the survival of the babies in the NICU and their influence on the neurodevelopmental 
outcomes. 
This section is arranged in the following manner - 
6.2.1: The rationale of using the third percentile of the Fenton’s curves to classify 
infants into SGA and AGA. 
6.2.2: The influence of antenatal and perinatal risk factors on the neurodevelopmental 
outcomes 
6.2.3: The influence of neonatal complications on neurodevelopmental outcomes 
6.2.4: Comparison of the neonatal morbidities of this cohort with that of a large 
Western cohort, to highlight the differences between the two cohorts.  
6.2.5: Why the neurodevelopmental outcomes were not influenced by the neonatal 
complications in the NICU. 
 
 
6.2.1 CLASSIFYING THE INFANTS AS SGA OR AGA BASED ON THE 3RD 
PERCENTILE OF THE FENTON CURVES  
 
Although there are some growth charts from India,378,379,392,393 the sample  sizes used for 
obtaining these curves are small and they are based on infants of a certain region which 
may not be representative of infants from other parts of the country. The Fenton’s 
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curves364 are  the most commonly used intrauterine and post-natal growth curves in 
neonatal units internationally.394 Although by definition, SGA babies are those who are 
less than the 10th percentile of birth weight-for-gestational age, the 3rd percentile on 
Fenton’s curves was chosen. This is because, the 3rd percentile on the Fenton curves 
corresponds to the 10th percentile of the chart developed by Mathai. M378 which is from 
this institution and the 10th percentile of the growth chart developed by Kandraju et al379 
which is most recent Indian growth chart and also has the largest sample size.  
A global review looking at the rate of SGA found that nearly 50% of South Asian babies 
were SGA when the 10th percentile was considered the cut-off and 23%  were SGA when 
the 3rd percentile was used as the cut-off.5 Another study found that depending on the 
reference population used, the prevalence of SGA in India can vary from 12% to 
74.8%.395 Similarly, in this cohort, when the 3rd percentile of Fenton curves were used, 
30.3% of the infants of the infants in our cohort were small for gestational age, and when 
the 10th percentile was used, 49.4% of the infants were small for gestational age.   
The data about the intrauterine and post-natal growth which was compiled to draw the 
Fenton’s curves were from large population based surveys from four Western countries 
(Sweden, Canada, Australia and the Center for Disease Control (CDC), USA).396–399  The 
intrauterine weights used to obtain the curves were from the Canadian study with its large 
sample of over 600,000 babies born between 22 and 43 weeks. The Australian and 
Swedish databases were used to compile the intrauterine head circumference and length 
curves. The CDC data was used to derive the growth curves after 40 weeks. The pooled 
data for these various datasets were used to derive the percentiles and create a single 
growth chart that combined both sexes394,400. Even though it has been criticized, since the 
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curves are drawn using different databases, all being from developed countries, the 
Fenton curves were chosen for this cohort since it is an internationally accepted growth 
curve.  
6.2.2 INFLUENCE OF MATERNAL & PERINATAL CHARACTERISTICS ON THE 
SURVIVAL AND NEURODEVELOPMENTAL OUTCOME  
 
Some of the positive features in the mothers of this cohort were that 100% of the mothers 
had antenatal check-ups during pregnancy (table 11), there was only one teenage 
pregnancy and majority of the mothers had completed 10th standard. However this may 
not be representative of the mothers in Tamil Nadu. According to the National Family 
Health Survey-3 (NFHS-3), 22.3% of the women in Tamil Nadu were less than 18 years 
at the time of marriage and only 31.1% had 5-9 years of education. However the survey 
also showed that during the same period, 96.5% of the mothers receive antenatal care and 
90% of the deliveries were institutional deliveries.401  
A. MATERNAL COMPLICATIONS PRECEDING THIS PREGNANCY  
About 20.9% of the mothers of the cohort had history of obstetric and medical 
complications (table 11).   The data of the mothers of  this cohort is similar to other 
studies from this country done on VLBW cohorts,402,403 where a significant proportion of 
the mothers had antenatal complications (like PIH, antepartum hemorrhage, preterm 
premature rupture of membranes (PPROM) and Gestational diabetes). (5.1.2, p.112-115 
tables 14 and 23) 
Two maternal morbidities which lead to birth of VLBW or premature babies are maternal 
anemia and a previous history of delivering a low birth weight infant.94,403 Both preterm 
DISCUSSION 
 
 Page 178 
 
and IUGR are commoner in mothers with severe anemia.404 There were only few mothers 
with anemia (probably because of the good antenatal care) in this cohort, and only about 
8% of the mothers had previous history of having a low birth weight child. In this study 
the antenatal complications and maternal risk factors did not affect the survival or 
neurodevelopmental outcomes of the VLBW infants. 
B. PREGNANCY INDUCED HYPERTENSION  
As mentioned earlier (table 11) 
• PIH was a major maternal complication in this cohort and more than one third of 
the babies, born to these mothers were growth restricted.   
• The mortality rate in the babies born to PIH mothers was 7%.  
• PIH did not influence the survival or neurodevelopmental outcomes of the infants 
in this study (table 23) 
The results of this cohort have been supported by other studies which have shown that 
intrauterine growth restriction is a major complication of PIH.405 Perinatal mortality due 
to PIH ranges from 6%  in developed countries to about 30% in developing counties.406 
Although PIH was not significantly related to mortality in this cohort (section 5.1.2, 
p.112 and table 14), other studies have shown the mortality is higher in infants born to 
mother with PIH.407  
However there are conflicting studies on the effects of PIH on the neurodevelopmental 
outcomes, which is to be expected given the heterogeneity of the condition.405 One study 
showed that PIH did not affect the IQ or school performance of children at 9-10 years of 
age.408 Another  large study on VLBW infants showed that those born to PIH mothers 
had similar GQ scores and lesser incidence of cerebral palsy as compared to VLBW 
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babies who were born to normotensive mothers.409 Other studies have shown that infants 
born to pre-eclamptic mothers had significantly better MDI and PDI scores on the 
Bayley’s scales at 18 months, although their growth was significantly lesser than the 
infants born to mothers with normal blood pressure.410  However in contrast one study 
showed babies who are have significant growth retardation following PIH are worse  in 
their cognition, visuo-spatial and motor skills.411 
C. MULTIFETAL GESTATIONS (5.1.2) 
In this cohort – 
• More than a quarter of the babies in the cohort were twins or triplets and almost 
all of them (97%) were premature and in addition, about a quarter were preterm 
and SGA. (however because of the weight ceiling of 1500 g for inclusion into the 
study, this is not truly representative of the babies born of multifetal gestations).  
• There was slightly greater mortality among the twins [p=0.067, RR 1.05 (.99-1.1 
95% CI)] compared to the singletons (table 14) and the main causes of death 
among the twins was septicemia followed by asphyxia. 
• Multi-fetal gestation did not influence neurodevelopmental outcomes (table 23) 
although two children with CP were born of multi-fetal gestations. 
It has been shown that twins have a relative risk of 5.4 and triplets have a relative risk of 
9.4 of being premature compared to singletons.412 Another major complication of 
multiple gestations is intrauterine growth retardation.413  
There are conflicting reports about the mortality of twins compared to singletons. Some 
studies have shown that the mortality in twins is higher,416  while  a large cohort study 
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from the NICHHD-NRN registry which compared twins with matched singletons, 
showed that the risks of death, IVH and CLD were similar between the two groups.417  
Studies which have compared the neurodevelopmental outcomes of premature twins to 
premature singletons including an Indian study, have not found any difference in the 
developmental quotients between twins and singletons.418–420 However data from a large 
NICHHD cohort which looked at the outcomes of ELBW twins  and triplets and 
compared them with singletons showed an increased risk of death ,neurodevelopmental 
impairment among the infants born of twin and triplet pregnancies.421,422 
D. BIRTH AFTER ASSISTED CONCEPTION  
In this cohort –  
• There was no significant difference in the mortality or neurodevelopmental 
outcomes between those who were spontaneously conceived and those who were 
born by assisted conception techniques (tables 14 and 23). 
• Many mothers were treated for infertility and many of these pregnancies resulted 
in multifetal gestations.  
Systematic reviews have shown that multifetal  pregnancies are a known risk when 
assisted conception techniques are used and that perinatal morbidity and mortality are 
more common in these infants.423,424  
The information about neurodevelopmental outcomes after assisted conception is 
conflicting. A systemic review of eighty studies found that the developmental outcomes 
of children born through assisted conception was comparable to those who were 
conceived normally.425 Another study however found that the developmental outcomes of 
children less than 26 weeks gestation, born after AC, were worse than gestation matched 
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peers who were conceived normally. However this was not seen in infants born after 27 
weeks gestation.426 
E. DIABETES COMPLICATING PREGNANCY  
In this study – 
• 7% of the mothers had diabetes complicating pregnancy and 15% of the infants 
were SGA. 
• Maternal diabetes during pregnancy did not affect the survival or 
neurodevelopmental outcomes of the infants in this cohort (tables 14 and 23) 
Gestational diabetes is prevalent in up to 18% of Indian mothers427 as compared to 4% in 
European mothers.428 A study from this institution showed that 4.7% of infants born to 
diabetic mothers were small for gestational age and 15.8% were preterm.429 while 
Western studies have shown that 2% of infants born to diabetic mothers are small for 
gestational age.430 Prematurity is known to be five times more common in diabetic 
mothers.431 Unlike the results of this cohort infants of diabetic mothers are at higher risk 
of mortality.432  
There are studies which show neurodevelopmental outcomes and the cognitive outcomes 
of infants born to diabetic mothers are worse compared to mothers without diabetes. 
However these studies were on term babies and none of them were done on VLBW 
infants.433–435 
F. ANTENATAL CORTICOSTEROIDS  
In this study there was no relationship between antenatal corticosteroids and the survival 
or the neurodevelopmental outcomes of the infants in this study (tables 14 and 23).  
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Antenatal corticosteroids have been shown to significantly improve survival and decrease 
incidence of intraventricular hemorrhage and respiratory distress syndrome in preterm 
infants.436 Antenatal corticosteroids have also been shown to improve the 
neurodevelopmental outcomes.212  
 
6.2.3 NEONATAL MORBIDITIES – THEIR INFLUENCE ON THE SURVIVAL AND THE 
NEURODEVELOPMENTAL OUTCOMES 
One of the objectives of the study was to look at the neonatal complications which 
occurred in this cohort of VLBW babies and their effect on the eventual outcomes.  
A. BIRTH WEIGHT AND GESTATIONAL AGE 
In this study –  
• Lower birth weight and lower gestational age was significantly associated with 
higher mortality. (Tables 14. 15 and 16, figures 8 b and 8c) 
• However there was no relationship between birth weight or gestational age and 
the final neurodevelopmental outcome. (Figure 14 and tables 18 and 23) 
The results of this study are in concurrence with other studies which have shown that 
lower gestational age and lower birth weight result in greater mortality (these studies 
have been reviewed in 3.1.1 and 3.1.2  p21-28) 
In contrast to results of this study, lower birth-weights and lower gestational ages are 
associated with poorer neurodevelopmental outcomes and cerebral palsy (tables 3A & 4). 
Even late preterms (>34 weeks) have a poorer outcome compared to normal term 
babies.437 Bhutta et al438 in a meta-analysis demonstrated that there was a very significant 
linear relationship between cognitive test scores and the birth-weight (R2= 0.51; p 
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<0.001) and gestational age (R2 = 0.49. p <0.001). The greater rates of 
neurodevelopmental impairment in smaller and less mature babies are because of the 
vulnerability of the immature brain and other organs to injury. Brain growth occurs 
linearly as gestation progresses439 and at 34 weeks gestation the premature infants’ brain 
is only 65% of that of the term infant.437 The major organizational events in the 
development of the cerebellum, neurons and glia occur in the latter half of gestation. 
Complications of prematurity like RDS, apnea, hypoglycemia cause neuronal cell death 
which damage the preterm brain440 and manifest later as neurodevelopmental 
impairments and behavior disorders.  
The reason why gestational age and birth weights did not affect the neurodevelopmental 
outcomes in this cohort may be because the babies in this cohort were more mature at the 
time of birth and had lesser complications compared to babies from Western countries. 
B. DIFFERENCES IN THE NEONATAL MORBIDITIES BETWEEN BOYS AND 
GIRLS 
 In this study – 
• There was a significantly higher incidence of intraventricular hemorrhage and 
respiratory distress syndrome in the male infants compared to the female infants 
(p.121). Hence rates of CPAP and ventilation were also higher in the male infants 
(table 12).  
• Premature preterm rupture of membranes was associated with birth of male 
infants (p=0.007), but PIH in the mother resulted in the higher incidence of birth 
of female infants (p=0.007) (table 12 & 5.1.3, p115) 
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• In spite of the differences in the neonatal complications, there was no difference 
in the mortality between girls and boys (p=0.718) (5.1.4, p.123). 
Findings similar to this cohort have been described in other studies. Premature male 
babies (especially <800 g) also have a higher risk of RDS and BPD442,443 and 
intraventricular hemorrhage.444  
However unlike this cohort many studies have shown the male infants have a poorer 
survival compared to girl babies of the same gestational age. This is particularly true in 
extremely premature male infants who have higher mortality.226,230 Survival of female 
infants was significantly better than male infants in many studies.445,446 Studies have 
shown that Preterm premature rupture of membranes (PPROM) and pre-eclampsia in the 
mothers are also associated with birth of male babies.447  
However the unusual finding in this study was that, very significantly, PIH was 
associated with the birth of girl babies. The reason for this finding is not known and 
therefor it is speculated that it may be because the girl babies born to mothers with PIH in 
this cohort were heavier - the median birth weight of girl babies was 1300 g compared to 
the median birth weight of 1280 g in male babies (however since the p-value was 0.783 
for the difference between the weights, this finding may not be significant).  
There were differences in the neurodevelopmental outcomes between boys and girls, 
which are discussed in Section 3 (6.3.2, p.197) of the Discussion. 
C. PERINATAL ASPHYXIA  
• Asphyxia was significantly associated with mortality in this cohort (tables 13- 16) 
• Although asphyxia did not affect the overall neurodevelopmental outcomes since 
it did not show a significant association with the General Quotient (table 23), the 
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multivariate logistic regression analysis showed that asphyxia was significantly 
associated with language delay (table 25). 
Perinatal asphyxia is characterized by acidosis. The results in this cohort were similar to a 
large study which looked at the neurodevelopmental outcomes in ELBW infants with 
acidosis at birth (defined as pH <7.0 and Base excess >−12 mEq/L), which showed that 
acidosis was strongly related to death (OR=2.1, p <0.001).448 In addition acidosis was 
predictive of poor neurodevelopmental impairments and cerebral palsy in the study, but 
as mentioned this was not a finding in the study cohort. 
D. NECROTIZING ENTEROCOLITIS  
In this study - 
• Severe NEC was significantly associated with mortality (tables 12-16)  and 
mortality increased with the severity of NEC and was 0% for stage I to 50% for 
stage 3 (5.1.3, p.118) 
• However severe NEC was not associated with poor neurodevelopmental 
outcomes (table 23) 
The findings in the study cohort have concurred with the findings from another cohort 
from South India which showed worsening mortality as the severity of NEC increased, 
with 0% mortality in stage 1, 15.4% mortality in Stage 2 was and 79.6% mortality in 
stage 3.449 Although other studies have shown that  NEC also significantly affected 
growth and neurodevelopmental outcomes,276–278 this was not observed in this cohort. 
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i.  RESPIRATORY DISTRESS SYNDROME  
• Presence of RDS was strongly related to death in this cohort (tables 13-15, figure 
8f) but only few children who died because of pulmonary complications related to 
RDS and most of the deaths were because of associated co-morbidities like 
septicemia, coagulopathy or severe IVH.   
• RDS was not associated with neurodevelopmental outcomes in this cohort (table 
23) 
The findings similar to the study cohort were also reported from another Indian study, 
which showed that the mortality in RDS was related to other co-existing conditions like 
IVH and septicemia.450 
As mentioned earlier (5.1.3, p116), the use of surfactant is very low in this cohort since 
CPAP is the first line of management of RDS in this institution. It has now been 
recommended, that surfactant be used only when CPAP has failed in low-income 
countries.451,452  
E. INTRAVENTRICULAR HEMORRHAGE  
In this cohort severe IVH was seen predominantly in the male infants, the mortality due 
to severe IVH was nearly 90% and it occurred only in infants less than 34 weeks (tables 
12-14). Only two children survived after severe IVH and both of them had good 
neurodevelopmental outcome, so severe IVH did not influence the neurodevelopmental 
outcomes in this cohort (table 23). 
The incidence of IVH increases with decreasing gestational age and it has been shown 
that for every week of increasing gestational age, the rates of IVH come down by 
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3.5%.453 Like the findings in this study, many studies have documented that it is more 
common in male children.  
Although not evident in this cohort, children who survive IVH in the neonatal period 
usually have significant neurodevelopmental sequelae (neurodevelopmental impairment, 
hydrocephalus, cerebral palsy and cortical visual impairment).454,455  
F. SEPTICEMIA  
In this study 
• Septicemia was the main cause of mortality and majority of the deaths were 
because of Gram negative organisms (figures 4 & 5, table 13) 
• In more than two-thirds of the babies the onset of septicemia was after 72 hours 
(late onset), so it is likely to be of nosocomial origin.  
• Septicemia did not influence the neurodevelopmental outcomes (table 23) 
The predominance of Gram negative organisms seen in this cohort is  similar to what has 
been observed in other developing countries.91,93,456–458 However these findings are in 
contrast to Western reports which show Gram-positive organisms to be the main cause of 
late-onset septicemia.288,459,460  Septicemia in VLBW infants  can result in periventricular 
leukomalacia which is major cause of cerebral palsy and significant neurodevelopmental 
impairment.54,461  
SURVIVAL OF THE INFANTS IN THE NICU 
• The survival rate was in this cohort was 92.26% (89.4-94.54, 95% CI). The 
adjusted survival rate (assuming that those whose outcome is not known had also 
died was 83.89% (80.22-87.14, 95% CI) (5.1.9, p.133).   
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• The survival improved with increasing gestational age 
The survival in this study is better than other Indian studies (3.1.1, p.22-25).  Almost all 
studies on VLBW infants from India and abroad have shown that survival improves as 
the birth weight and gestational age increases. 
 
COMPARISON OF THE STUDY COHORT WITH THAT OF A NICHHD COHORT 
The table 35 (below) compares the perinatal and neonatal morbidities which occurred in 
this cohort with that of a cohort of VLBW infants from the NICHHD database.96 (This 
particular article was chosen, since the infants are classified according to the weight. In 
the later studies from NICHHD the infants are classified according to their gestational 
age.)34   
The use of antenatal corticosteroids and the rate of Cesarean section seem to be similar 
between the two cohorts. The proportion of the infants born of multifetal gestation who 
are more than 1000 g is almost similar between both the cohorts.  
However there are many differences between the two cohorts.  
• There is a much greater proportion of twins who weigh less than 1000 g. This 
may be because of the large number of twins who are born following assisted 
reproductive technology in Western countries. 
• Not surprisingly there is a higher proportion of SGA babies in this cohort as 
compared to the NICHHD cohort.  
• Septicemia being a major cause of neonatal morbidity and mortality in developing 
countries is more in the study cohort.  Septicemia tends to increase with 
decreasing birth-weights in both the cohorts. 
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However the striking differences between the NICHHD study and the study cohort is that 
the incidence of RDS, surfactant use, CLD, severe IVH, severe NEC and PDA is much 
lesser in the study cohort. This is because all these are primarily complications seen in 
preterm babies and there is a larger proportion of SGA babies in our cohort. As shown in 
table 27 for a birth-weight of less than 1000 g, the gestational age ranges from 25-36 
weeks in our cohort, while in the NICHHD cohort the gestational age is more 
homogeneous and babies who weigh less than1000 g are usually less than 26 weeks.  
There is a lower survival rate in the babies of the study cohort, especially in the lower 
birth-weight category. This could be because of the effect of septicemia, which is the 
main cause of death in the study cohort (table 13). However it is heartening to note that 
the survival seems almost equal in the highest birth-weight category.  
 
Table 35: Comparison of the results of this study cohort with that of the NICHHD. 
 
Risk Factors 
751-1000 g 1001-1250 g 1251-1500 g 
NICHHD 
Cohort (%) 
Study 
Cohort (%) 
NICHHD 
Cohort (%) 
Study 
Cohort (%) 
NICHHD 
Cohort (%) 
Study 
Cohort (%) 
Antenatal Steroids 76 72.5 74 72.4 70 62.5 
Multiple births 79 28.8 21 25.9 25 28.7 
SGA 17 35 24 25.9 29 31.8 
Late septicemia 33 13.8 18 23.5 7 13.9 
Cesarean section 60 61.3 60 55.5 50 66.5 
RDS 63 38.8 44 32.5 26 16.8 
Surfactant 68 0 47 25.4 28 7 
BPD 34 0.5 15 2.1 7 0.7 
IVH  Grades III & IV  12 4.3 8 3.5 3 1.5 
NEC >Grade 2 9 1.3 5 2.1 3 1.3 
PDA 39 21 25 19.7 13 8.24 
Survival 86 75 94 89.7 97 95.1 
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6.2.4 WHY DIDN’T NICU MORBIDITIES INFLUENCE NEURODEVELOPMENTAL 
OUTCOMES? 
Why is that, even though the Western studies have shown that significant 
neurodevelopmental impairments and cerebral palsy are related to neonatal risk 
factors, these risk factors did not seem to affect the neurodevelopmental outcomes in 
this cohort of babies? 
First, compared to the Western cohorts as shown in table 35, although the incidence of 
septicemia is higher among the babies in the study, the incidence of neonatal 
complications like severe IVH, NEC, PDA and RDS is much lesser in this cohort because 
of the higher proportion of SGA babies.   
Second, as displayed in the table 36 below, for each neonatal complication (other than 
severe IVH) only 32-50% of the babies, who had that particular complication, came for 
the assessment. (Except for severe IVH where only 12% of the babies who had severe 
IVH came for the assessment). The majority of the infants died in the nursery or after 
discharge and a smaller proportion were lost to follow-up. Moreover at the time of 
assessment, as shown in table 36, less than 20% of the survivors of each neonatal 
complication had poor neurodevelopmental outcomes.   
So in conclusion the study babies had a lesser incidence of some complications, higher 
mortality rate because of the complication, but better neurodevelopmental outcomes if 
they survived. Because of these reasons the number of children who had poor 
neurodevelopmental outcomes was not large enough to demonstrate a statistically 
significant association between neonatal complications and the neurodevelopmental 
outcomes 
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Table 36: Proportion of children who were alive after neonatal morbidities 
Neonatal risk factor Alive at the 
time of 
assessment 
Died in Nursery 
or after 
discharge 
Lost to follow 
-up 
 
Among the 
assessed whose  
GQ <2SD*  
ELBW  49% 31% 20% 6/30 (20%) 
Perinatal asphyxia 32% 56% 12% 3/15 (20%) 
NEC (>Grade 2) 42% 42% 17% 1/5 (20%) 
RDS 50% 30% 20% 7/86 (8.1%) 
Hypotension 33% 50% 17% 9/51 (17.6%) 
PDA 50% 30% 20% 5/44 (11.4%) 
Septicemia 41% 33% 26% 6/53 (11.3%) 
Severe IVH  12% 88% 0 0/2 (0%) 
* Estimated from table 23 
However it must noted, that from the above table, it appears that the mortality because of 
PDA or RDS is very high (30%). That is not true. It is well known that in a VLBW infant 
multiple complications co-exist. A child with RDS who required ventilation, may have 
developed ventilator associated sepsis, which resulted in the release of pro-inflammatory 
cytokines and prostaglandins. This further leads to the opening of the ductus venosus 
resulting in PDA. This same child could have necrotizing enterocolitis and IVH. Thus the 
mortality in this child can be due to any of these causes and the child’s mortality is 
included in RDS, Septicemia, PDA, NEC and IVH. So a child who had RDS at the time 
of death, probable died of septicemia or some other cause and not because of the RDS 
per se.  In conclusion to this Section many neonatal risk factors were significantly 
associated with the death in the NICU. However despite the relatively large cohort, for 
the reasons mentioned above, none of neonatal factors affected overall 
neurodevelopmental outcome of the babies in our cohort. Only perinatal asphyxia was 
significantly associated with poor language outcome. 
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6.3 SECTION 3 - OBSERVATIONS DURING THE DEVELOPMENTAL 
FOLLOW-UP 
 
In this section the findings of the developmental follow-up phase are discussed. The 
section is arranged in the following manner - 
6.3.1: The concept of “causal pathways” which lead to CP 
6.3.2 The topography and the co-morbidities associated with CP. 
6.3.3: Differences in the neurodevelopmental outcomes between girls and boys. 
6.3.4: Impact of being small for gestational age on the survival and neurodevelopmental 
outcome of the children in our cohort. 
 6.3.5: Effect of the post-natal growth on the developmental outcomes.  
6.3.6: Language skills predictors of poor language in the study cohort.  
6.3.7: Influence of some social factors particularly maternal educational level on the 
developmental and language outcomes.  
 
6.3.1 CEREBRAL PALSY and “CAUSAL PATHWAYS” 
There were five children with CP and their clinical summary is presented in table 26.  
Since their numbers were small there was no risk factor which was found to be associated 
with cerebral palsy. However, in many children, it may be a confluence of adverse 
antenatal, perinatal and neonatal events which leads to cerebral palsy rather than a single 
event. This has led to the concept of “causal pathway” – which is a sequence of multiple 
antecedents which are interdependent but finally confluences in neurodevelopmental 
impairment and cerebral palsy.36 Thus looking at table 26 it is clear that many children 
had factors which could have led to their impaired neurodevelopmental outcome. Some 
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of the risk factors which were seen in the children with CP and are known to be 
associated with cerebral palsy are considered below.  
A. MULTIPLE GESTATIONS  
Two of the five children were born of multifetal gestation (one was of twin pregnancy 
and the other child was one of triplets). Studies have consistently shown that multifetal 
gestations are associated with cerebral palsy.462,463 A study from Australia showed that 
the prevalence for CP at one year of age was 28 per 1000 in triplets, 7.3/1000 in twins 
and 1.6/1000 in singleton pregnancies.464 The causes of brain damage in multifetal 
gestation could be abnormal anastomoses, thrombogenesis following thromboplastin 
release after the death of the co-twin, prematurity and associated intrauterine growth 
retardation.465  
B. CYSTIC PVL  
Cystic changes on ultrasound are the strongest predictors for cerebral palsy in preterm 
infants.356  One of the children was detected to have cystic PVL (Figure 16) on the 
neurosonogram taken at two months of age. The early scans (done on day 3 and day 7) 
were normal. De Vries in her seminal study showed that serial cranial ultrasonography till 
40 weeks post-menstrual age is required to diagnose cystic PVL, since about a third of 
the cystic lesions are detected only after day 28330 and these will not be picked up in the 
first two weeks..  
Later in life the sequelae of PVL on the MRI are periventricular hyperintensities 
(representing glial scars), periventricular loss of white matter, distortion of the ventricular 
margins (leading to “wavy margins” on the MRI) and focal ventricular enlargement 
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adjacent to the regions of signal hyperintensities.466 These MRI findings were observed in 
this child and two other children who had CP. (Figures 15, 16 & 19). 
C. ABNORMAL UTERINE ARTERY DOPPLER  
Some of the mothers of the children in table 26 (including two of the children with CP) 
had absent or reversed end diastolic uterine artery velocity (AEDV or REDV).  AEDV 
and REDV are ominous findings seen in fetal growth retardation and pre-eclampsia and 
result in fetal hypoxia; many  studies have shown that abnormal uterine artery  blood 
flow is associated with adverse neurodevelopmental outcomes including CP,467–469 . This 
has been documented from an Indian study as well.197  
D. MATERNAL SLE  
The mother of one of the children with cerebral palsy (child no. 14 in table 26) had 
Systemic Lupus Erythematosus (SLE). Children born to mothers with SLE are known 
have higher risk of developing neurodevelopmental disorders, probably because of  high 
level of circulating autoantibodies and cytokines, which in animal models, have been 
shown to affect the fetus.470 Infants born mothers with SLE have much higher risk of 
perinatal arterial stroke which results in hemiplegic cerebral palsy.471 However this is 
unlikely in this child because she had the spastic bilateral (diplegic) form of CP.  This 
child’s mother also had PIH and eclampsia which could have contributed to the “causal 
pathway” which finally led to CP.  
E. CEREBRAL PALSY AS A CONFLUENCE OF MULTIPLE RISK FACTORS 
As mentioned earlier CP is the culmination of multiple risk factors. This was probably 
the case in child 7 (table 26). She was born severely growth retarded and had multiple 
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complications in NICU (acidosis at birth, RDS, septicemia, hypoglycemia and 
cholestasis). Each of the risk factors is associated with neurodevelopmental impairment 
and cerebral palsy. At two months of age she developed intracranial hemorrhage 
(probably due to hemorrhagic disease because of persisting cholestasis) which finally 
resulted in left hemiplegic cerebral palsy (figure 18). It could be argued that the child’s 
CP was because of post-natal causes and not because of the VLBW. However she is 
included in view of the multiple risk factors which could have culminated to result in the 
final event which led to CP.   
Post-natal causes like septicemia, meningitis, cerebral malaria, and intracranial 
hemorrhage account for a sizeable proportion of children with cerebral palsy. 472,473  In 
developing countries it is likely that these post-natal cases can affect the already 
vulnerable VLBW infant and result in CP.  
F. CEREBRAL PALSY DESPITE NORMAL SERIAL CRANIAL ULTRASOUNDS 
In one of the children with cerebral palsy (Child 1, table 26) the only risk factor was 
probably low birth weight since there were no other complications.  However the older 
sibling was also low birth weight and so there are likely to be unidentified maternal, 
antenatal and possibly genetic causes which could have contributed to the child’s 
neurodevelopmental impairment. Of particular importance is that the child’s cranial 
ultrasound at 6 weeks was normal and there were no cystic changes. It has been shown 
that, some children with cerebral palsy have multiple normal cranial ultrasounds without 
any hyper-echoic lesions (indicative of hemorrhagic lesions) or hypo-echoic lesions 
(indicative of cystic lesions). It may be that these children have diffuse periventricular 
leukomalacia which cannot be detected even by high resolution ultrasound scans. But 
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they subsequently go on to develop ventriculomegaly and other signs of PVL.474 Figure 
15 shows features of PVL in the MRI this child, which supports this point. 
 
TOPOGRAPHY OF CEREBRAL PALSY AND THE CO-MORBIDITIES IN THE 
CHILDREN WITH CEREBRAL PALSY 
In this cohort, there were – 
• three children (60%) with spastic bilateral CP (spastic quadriplegia with all four 
limbs involved and all three were GMFCS level 5),  
• one child (20%) with spastic unilateral CP (left hemiplegia - GMFSC level 1)  
• One child (20%) with spastic bilateral CP (Diplegic CP - GMFCS level 3).  
Initially spastic diplegia (“Little’s disease”) was the topographic type of CP described in 
preterm infants.475  However in the study cohort the quadriplegic form seems to the most 
predominant. Data form a  large CP registry from the UK showed  that the topographic 
distribution of the CP in the birth weight group 1000-1499 (the birth weight category in 
which all the five CP children in the study cohort belonged) was as follows - Spastic 
Hemiplegia – 20%, Diplegia - 29.2%  and Quadriplegia  was 37.8%.476  Therefore it 
seems that spastic quadriplegia is the more common topographic manifestation of 
cerebral palsy in the very low birth weight infants. 
In addition to the children with spasticity, there were many children with hypotonia 
(table 26). Although initially classified among children with cerebral palsy, children with 
“central hypotonia” (hypotonia due to a cortical cause, manifesting with brisk tendon 
reflexes) are absent from contemporary CP classifications.36  As seen in this cohort, 
hypotonia is commonly associated with significant developmental delay and intellectual 
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disability.477 Although 1.5% of the children in the Cerebral palsy register of Victoria, 
Australia had hypotonia, they were not considered as CP.478  
According to the definition of cerebral palsy348 proposed by Bax and colleagues, “the 
motor disorders of cerebral palsy are often accompanied by disturbances of sensation, 
cognition, communication, perception, and/or behavior and/or by seizure disorder”. 
Children with CP in this cohort, particularly the children with quadriplegic CP, in 
addition to the significant developmental delay, had multiple associated co-morbidities 
like visual and hearing impairment, microcephaly and epilepsy (table 26). In a study 
done in Canada, 80% of children with GMFCS level IV and V had a visual impairment, 
40% had  hearing impairment and 47% had epilepsy.479 
 
6.3.2 DIFFERENCES IN NEURODEVELOPMENTAL OUTCOMES BETWEEN BOYS & 
GIRLS  
The differences between boys and girls in the neurodevelopmental outcomes in the study 
cohort were - 
• The mean GQ of the boys were slightly but significantly lower than that of the 
girls (Mean GQ of boys was 92.92 and that of girls was 94.97, p=0.04) (table 17) 
• The boys fared worse than the girls in some domains of development like 
personal-social skills, hearing and language skills and eye-hand coordination 
activities (table 20).  
• There was a larger proportion of boys than girls with GQ of less than 2SD (GQ 
<76) [12.7% boys to 9.9% girls] although this was not significant (table 23, see 
5.2.1)  
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• Among children whose GQ was less than 70 (table 26), 23 of the 31 (74.2%) 
children were boys as compared to 9 girls (25.8%)  
• Among the children with CP there were 3 boys and 2 girls. All the 3 boys were 
more severely affected (GMFCS level V) compared to the girls with CP (one was 
GMFCS level I and the other GMFCS level II) (table 26). 
• There were three boys with autistic symptoms while there were no girls with 
autistic features (table 26, see 5.2.9, p.154) 
The findings in this cohort have been corroborated by other studies. Recent studies have 
shown that preterm boys were more likely to have moderate to severe CP, and low 
Bayley MDI and PDI scores compared to the girls, even when the neonatal neurosograms 
are normal.480 The gender differences in the cognitive performance persist even when 
assessed at six years of age.481 The language abilities of male VLBW infants are much 
less than female VLBW infants and normal children.482 Similar to what was found in this 
study (see table 20), a study from Australia which looked at the neurodevelopmental 
outcomes of ELBW infants using the GMDS,  showed that the performance on  the 
Hearing and language scales and the overall GQ in boys were significantly lesser when 
compared to the girl children483  
The reason for this male disadvantage in the developmental outcomes of VLBW children 
is not known. It has been shown in a study which, compared the white matter and grey 
matter (on the MRI) of eight year old preterm boys and girls with age and gender-
matched controls, that the white matter volumes are significantly lesser in boys who were 
preterm compared to the normal male controls, while in girls who were preterm there was 
no difference when compared to the normal girl controls. Thus preterm boys may be 
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more vulnerable to brain injury.484 Another reason why preterm boys are more vulnerable 
than girls is the “lung maturity hypothesis” which was mentioned earlier in the Literature 
review section (3.4.1.). Even after adjusting for perinatal, neonatal, post-natal factors, 
gestational age and birth weight, studies have shown that male sex remained an 
independent risk factor for adverse neurodevelopmental outcomes. Therefore there may 
be a still unknown constitutional reason for the gender specific brain susceptibility.226,227 
 
6.3.3 CHILDREN WITH AUTISM IN THE COHORT  
The Personal-Social subscale of the GMDS assesses the child’s abilities of social 
interaction and independence in daily living skills. According to Ruth Griffiths 
“emotionally disturbed children” do poorly on this sub-scale.161 Another study using the 
GMDS showed that the Hearing and Language sub-scales and Personal-Social sub-scales 
are the scales which are most affected in autism.485 Even in our cohort these two sub-
scales were significantly more affected in boys compared to the girls (table 20).  There 
were three children (all males) who had symptoms of autism (table 26), and were 
positive on the Modified Checklist for Autism Toddlers (M-CHAT). Their clinical 
features have been described in 5.2.9 (p.154).   
Findings in this cohort are supported by other studies.  It is well known that in the general 
population, autism is four times more common in male children than female children.486 
Male preterm infants are more also likely to have symptoms suggestive of autistic 
spectrum disorder.487 The difficulties in the social and communicative domains and 
presence of autistic features are commoner in premature infants, who have had neonatal 
complications like RDS.488 Autism is associated with the poor cognitive abilities as 
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demonstrated in the study by Kuban and associates, who showed that that in the ELBW 
babies, cognitive and neurosensory impairment was strongly associated with testing 
positive on the M-CHAT.489 This could explain why the child with profound 
developmental delay (child no.3 in table 26) in this cohort had autistic symptoms.  
The symptoms of autism in VLBW infants are likely to persist through life. The 
adolescents who were VLBW at birth have a higher risk of having autism and other 
psychiatric manifestations.490 In VLBW children, autistic symptoms are associated with 
cognitive impairment even later in life. In a long term follow-up of preterm infants, it was 
shown that cognitive impairment was strongly related to  autistic symptoms at 11 years of 
age.491  
 
6.3.4 IMPACT OF BEING SMALL FOR GESTATIONAL AGE 
In this study the survival and neurodevelopmental outcomes of the small for gestational 
age infants were compared to the infants who were born AGA. Among the infants 
admitted into the nursery about one third were SGA and among the 422 infants who came 
for the developmental follow-up, 131 infants (31%) were SGA.  
Effect of SGA status on survival and developmental outcomes 
From the tables 28 and 29 the following facts are apparent:  
• Being SGA did not affect the survival of the infants, neither was there any 
significant difference in the neurodevelopmental outcomes.  
• In this cohort there was no significant difference in the neurodevelopmental 
outcomes of the SGA and the AGA babies since (a) the proportion of children 
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with GQ <2SD in both groups is not statistically different (b) mean GQ between 
the SGA and AGA groups are not statistically significant 
• All the children with CP were AGA at birth (however this may be because of the 
much larger number of AGA babies).  
However the findings in the study cohort are different from that of a study from the 
Vermont Oxford Network database which looked at the morbidities and mortality of  the 
IUGR babies in a large cohort of nearly 20,000 VLBW babies who were less than 32 
weeks.492 They found that being small for gestational age was significantly associated 
with death [Odds ratio 2.77 (2.59-3.3 95%CI)]; necrotizing enterocolitis (OR, 1.27, 1.05-
1.53, 95% CI); respiratory distress syndrome (OR 1.19; 1.03-1.36 95%CI) and severe 
IVH (OR 1.25, 0.98-1.59 95%CI). Other Western cohorts have also found that the 
mortality of SGA babies are higher than that of AGA babies.493,494 This difference in the 
findings may be explained by the fact that the SGA babies in the study cohort had a 
higher gestational age and therefore did not have the complications of prematurity unlike 
the babies of the Western cohorts. 
Western studies have also shown that the neurodevelopmental outcome of infants born 
SGA are worse than those born AGA.  A retrospective study from the NICHHD cohort 
showed that SGA status was significantly associated with low MDI the Bayley’s scales 
(odds ratio 2.08, p=0.018) and occurrence of CP (OR 2.55) compared to AGA babies61 
Other studies have shown that children who are born small for gestational age have lower 
school achievements and more behavioral problems (particularly inattention and 
hyperactivity).495,496  
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Effect of SGA status on the post-natal growth 
The growth of SGA babies remain significantly affected at two years of age. In a study 
by Mukhopadhyay et al497 who followed up a cohort of ELBW babies, at two years of 
age 41% were underweight, 68% were short and 32% had microcephaly. In another 
Indian study which followed up VLBW infants till 18 months 30.9% were underweight, 
59% were short and 25% had microcephaly.498 In the study cohort nearly 60% of the 
babies were underweight, 54.5% were short and 63.6% were microcephalic (table 29). 
Long term follow-up studies have shown that children who are born SGA are likely to be 
shorter than their peers in adolescence.229,499 Therefore a significant proportion of SGA 
babies remain growth restricted throughout life.  
 
6.3.5 POST-NATAL GROWTH AND NEURODEVELOPMENTAL OUTCOMES 
This study also looked at the post-natal growth of the VLBW babies in the cohort and the 
relationship between the post-natal weight growth and developmental outcomes. The 
post-natal growth was estimated by the Z-scores of weight, length and head-
circumference at the time of assessment estimated using the WHO-ANTHRO software. I 
will briefly discuss two important findings of our study pertaining to post-natal growth. 
A. Developmental outcome is dependent on the post-natal growth 
In this cohort it was found that the growth status (whether the baby was SGA or AGA) at 
birth was not significantly related to the developmental outcome at the time of 
assessment (p=0.083, table 23). The weight, length and head-circumference at the time of 
assessment were significantly related to the developmental outcomes (GQ). On the 
multivariate logistic regression, the Z-score or the weight at the time of assessment was 
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significantly associated with the final GQ. The Z-score of the head circumference also 
showed an association although this was not significant (table 24). 
Other studies have supported these findings. It is a well-established fact now, that 
impaired post-natal growth is associated with poor cognitive performance. A prospective 
study by Latal-Hajnal500 showed results similar to what was found in this study, that 
appropriateness of weight for gestational age at birth (whether SGA or AGA at birth) did 
not affect the neurodevelopmental outcome at two years, but the post-natal growth, 
assessed by the Z-scores for weight at two years, significantly affected the 
neurodevelopmental outcome. Ehrenkranz501 showed poor growth during the NICU 
period was significantly associated with inadequate post-natal growth at 22 months and 
furthermore the rate of growth in the ICU significantly correlated with the 
neurodevelopmental outcomes at 18- 22 months. The study also showed that infants 
whose NICU weight gain was in the lowest quartile were the most likely to have 
neurodevelopmental impairment at 18-22 months. Other studies have shown that  poor 
weight gain due to inadequate nutrition during the period of brain development in VLBW 
children, results in decreased brain cells which later leads to significant deficits in 
behavior and learning.502 
B.  Developmental outcomes in AGA and SGA are different depending upon their 
post-natal weight gain 
On considering the developmental outcome depending on the post-natal growth of AGA 
and SGA babies the following findings were observed:  .  
• SGA infants who had adequate catch up growth had developmental outcomes 
similar to AGA infants whose weight remained appropriate for age (In this study 
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the GQ for the SGA babies who caught up was 97.9 vs. GQ of  95.9 for the AGA 
babies whose weight remained appropriate) 
• Infants who were AGA at birth but had inadequate post-natal growth were the 
most affected. Their development was worse than the SGA babies who had 
inadequate post-natal growth. (In this study GQ of AGA babies with poor post-
natal growth was 89.4 compared with the GQ of  91.2 for SGA babies who 
continued to have inadequate post-natal growth) (table 30) 
Significantly both these findings have concurred with that of Latal-Hajnal and 
associates.500 who have reported that the post natal growth status influences 
neurodevelopmental outcomes and not the growth status at birth.  
The phenomenon of AGA infants having poor weight gain and having poor growth post-
natally to the point of falling below the 2SD of the mean of the weight, later in life is 
termed “Weight catch down”. The possible explanations for this “Weight catch down” is 
that the preterm AGA children who exhibit it, were already probably in a process of 
“catch down” even during the intrauterine period, but they were born before their weights 
fell below 10th percentile and hence their birth- weight was appropriate for gestational 
age. So, in these babies their post-natal growth restriction was just a continuation of their 
insufficient intra-uterine growth. These preterm AGA children who were likely to 
become IUGR had pregnancy continued, are probably more sensitive to restrictive extra-
uterine environments than the SGA infants and so exhibit weight catch down with time. 
The implication of this phenomenon is that preterm AGA infants require strict growth 
and developmental monitoring like SGA children.503,504 
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Head circumference and developmental outcomes 
In this study the Z-score for head circumference less than 2SD (microcephaly) was 
related to the poor developmental outcome on the bivariate analysis (table 23), although 
it was not significant in the multivariate analysis (table 24). Similarly microcephaly was 
also related to low scores on the language sub-scales on bivariate analysis.(see 5.2.7 
p.145). Head circumference (Occipito-frontal circumference) is a very good predictor of 
brain volume in children who are less than 6 years of age505 and a smaller head size at 
birth, below 33.5 cm indicates smaller brain volume.506  Subnormal head circumference 
in VLBW children is associated with poorer IQ, academic skills and adaptive behavior in 
the school going age.507 A large study has shown that subnormal head circumference (HC 
<2SD) is strongly related to lower MDI and PDI scores and cerebral palsy at two years of 
age in VLBW children.508 These studies, thus, concur with the findings that subnormal 
head circumference in the post-natal period (at the time of assessment) is associated with 
adverse neurodevelopmental outcomes. 
 
6.3.6 LANGUAGE OUTCOMES IN THE VLBW CHILDREN  
Language skills in VLBW children: Speech and language are core skills in a child’s 
development and markers of  cognitive and social development.509 Children with global 
developmental delay will have delayed language development and will use words only 
much later in life.509 Acquisition of expressive and receptive language skills is thus a 
good indicator of a child’s cognitive abilities.510 
In this cohort we found that both boys and girls who scored low on the Hearing and 
Language subscale were most likely to have a poor GQ (see 5.2.7 p145). The Sub-
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quotient on the “Hearing and Language” sub-scale showed very good correlation to the 
GQ. Although it is too early, it is speculated that the children with low language abilities 
are likely to have difficulties in their learning and would be more delayed than their 
peers. On multivariate analysis it was found that maternal education, Z-score for weight 
below 2SD and perinatal asphyxia independently predicted poor language outcome 
indicated by Sub-quotient of Hearing and Language subscale below 2SD.  
VLBW and preterm infants are known to have much reduced expressive and receptive 
language skills compared to normal control infants,511 VLBW babies have lesser 
vocabulary size and poorer quality of word use, as well as lesser morphological and 
syntactic complexity.512 In many preterm infants the language delays are because of 
cognitive impairment rather than any specific language impairment.513 The language 
difficulties in VLBW babies persist through childhood and often lead to educational, 
behavioral and social problems.514,515 
There are many biological, social and environmental factors which are believed to 
influence language development in VLBW infants. These include socio-economic status 
of the family, maternal education, gestational age, birth-weight, neurosensory deficits and 
complications like asphyxia, IVH, BPD, PDA which disrupt the oxygen regulation and 
cause hypoxic damage to specific language areas of the brain.516–518 
Perinatal asphyxia is the only neonatal complication which showed association with 
developmental outcome. Although it was not associated with overall developmental delay 
(indicated by GQ) it was independently associated with poor language outcomes (table 
25).  Other studies have also shown that perinatal asphyxia results in specific speech and 
language deficits519 and in cognitive deficits  which also result in language difficulties.520  
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6.3.7 MATERNAL EDUCATION LEVEL AND ITS INFLUENCE ON THE 
NEURODEVELOPMENTAL OUTCOMES 
This study was not designed to look for the effects of post-natal factors; particularly the 
influence of social factors on the developmental outcome but it occurred during the 
course of the study that the social and environmental factors can influence even early 
developmental outcomes. One social factor which was shown to be associated with the 
outcomes was low maternal education (in this study defined as educational level less than 
Std.8). Although low maternal education was not related to poor neurodevelopmental 
outcome (GQ <2SD) on the bivariate (table 23) or the multivariate analysis (table 24) 
which may be because of the small number of babies with GQ <2SD, low maternal 
education was significantly related to poor language outcomes (SQ-HL <2SD) on the 
bivariate and multivariate analyses (table 25). Maternal education was also an 
independent predictor for the child remaining underweight at the time of assessment 
(table 31).  In table 24, it was shown that being underweight at the time of assessment 
was associated with poor neurodevelopmental outcome. So in short low maternal 
education is related to poor language outcomes and the child remaining underweight; and 
the child remaining underweight can lead to poor overall developmental outcome (GQ) 
Developmental outcomes of VLBW infants are dependent on the “biologic factors” - 
antenatal & perinatal risk factors and the neonatal complications especially in the first 
two years. From early childhood, social factors like socio-economic factors, home 
environment, and parental education level play an important role in the subsequent 
development of the child.521 VLBW infants who are likely to have developmental 
impairment because of their biologic risk factors are especially vulnerable in an adverse 
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social environment.522 A study on VLBW infants showed that biological factors 
particularly cerebral ultrasonography findings (presence of ventriculomegaly, IVH or 
PVL) in the neonatal period was related strongly to the adverse developmental outcomes 
at one year of age. However as the age progressed, at 3.6 years, although the biologic 
factors were associated with outcome, social factors (occupational status of parents, 
maternal education and home environment) strongly influenced the developmental 
outcomes.521  
The effect of social factors in the development of children was demonstrated in a seminal 
longitudinal study which showed that, even more than the various biological and medical 
factors, parental socio-economic status and particularly maternal education were the 
factors most predictive of intellectual performance at four years of age.523 The 
relationship between maternal education and the developmental outcome of very low 
birth infants is multifactorial. Maternal socio-economic status has a close and direct 
association with maternal education level and women who are less educated are most 
likely to come from poor socio-economic background.524 Furthermore women from the 
lower socio-economic status have a higher risk of having low birth weight babies.525 
Studies from the NICHHD cohort have shown that neurodevelopmental impairment  
(MDI of <70 on the Bayley’s scales) are associated with lower  maternal education level 
(less than high school).212 Lower level of maternal education is also shown  to be related 
poor IQ at 8 years of age in those who were VLBW.526  
There may be many reasons why maternal education level influences the developmental 
outcome. Since a mother with low educational status is most likely exposed to more 
deprived social conditions, there may be many environmental risk factors like 
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malnutrition, repeated infection, environmental toxins (lead poisoning) which can further 
compromise her already compromised VLBW infant.527 VLBW infants will require 
frequent hospital visits for developmental monitoring and better educated mothers are 
more likely to utilize health services and have greater autonomy in health related 
decisions regarding the child which are likely to have positive influence on the child’s 
developmental outcome.528  
Maternal educational level also influences the language development in children as 
shown in this cohort (table 25).  Other studies have supported this finding since, maternal 
educational level has been shown to have a linear correlation with the child’s expressive 
and receptive language capabilities and children whose mothers have lower education 
have early language delays.529,530  
In conclusion, the major objective of medical practice is prevention of neonatal 
complications and amelioration of the developmental outcomes. The implication 
therefore is that with time, it may not be the neonatal complications which will influence 
the developmental outcome; but the socio-demographic factors.  This was demonstrated 
in a study by Siegal et al  who showed that infants who were classified “at risk” because 
of their neonatal morbidities but who were looked after by parents in a highly stimulating 
home environment, had scores in the normal range, compared to children who did not 
have any neonatal risk factors but was brought up in under-stimulating environments.531 
The initial efforts to improve developmental outcomes of infants should focus rightly on 
maternal wellbeing, providing good perinatal care and prevention of preterm birth. 
However, after the birth of the VLBW baby, the major preventive measures consist of 
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protecting the fragile brain and the other organs. Neonatal morbidities are likely to have 
long lasting impact. Nevertheless in infants with significant biologic risks, a stimulating 
home environment may compensate partly for the damage in the perinatal period.521 But 
in situations where there were significant biologic risks or in the absence of a stimulating 
home environment a comprehensive early intervention program is required to prevent 
further developmental impairment. A Cochrane review has shown that early intervention 
in premature babies has a positive influence on the cognitive and motor development.532 
The Child development Centre, Trivandrum has developed a simple early intervention 
package which can be taught to the mother. They have also shown that low birth weight 
and other high risk infants who have been administered this intervention model are 
comparable in their development to normal birth weight babies.77,174 Therefore neonatal 
care does not end when the child is discharged from the Nursery. A stimulating home 
environment and a dedicated early intervention program is required to prevent the infant 
being trapped in a vicious cycle which can be counterproductive to his future growth and 
to attain the best neurodevelopmental outcomes.  
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7 SUMMARY OF THE FINDINGS OF THE STUDY 
This study was done to ascertain the survival and neurodevelopmental outcomes of very 
low birth infants who were admitted in to the NICU of a tertiary level center. The study 
was done in two phases. Phase 1 dealt with the survival and the morbidities of the infants 
in the NICU and Phase 2 dealt with the neurodevelopmental outcomes of the infants who 
came for follow-up. 
There were 776 infants who were admitted into the NICU. Of these 643 infants survived 
till discharge and were advised to come for follow-up. A final cohort of 422 infants 
completed the final developmental assessment. The results of the study are summarized 
below. The significant findings are highlighted. 
7.3 RESULTS OF PHASE 1 
• There was a slight preponderance of male babies in the study (52.4%). Among the 
babies of the cohort 30.7% were small for gestational age.  
• The major antenatal risk factors was PIH in the mother and because of this 
majority of the infants were born by Cesarean section 
• There were significant differences between boys and girls in the neonatal co-
morbidities. Male infants had a significantly higher incidence of severe IVH 
and RDS. 
• Septicemia was the major cause of morbidity and was the cause of 58.3% of the 
deaths. Gram negative organisms predominated as the cause of neonatal 
septicemia and mortality 
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• The mortality rates improved with increasing gestational age and besides 
septicemia, the other main causes of death were asphyxia and  complications 
which are mainly seen in preterm babies (RDS, severe IVH and NEC) 
• Sixty of the 776 babies died and 73 left before completion of treatment. The 
survival rate was 92.26% (89.4-94.54, 95% CI). The adjusted survival rate 
(assuming that those whose outcome is not known had also died was 83.89% 
(80.22-87.14,  95% CI) 
• On multivariate analyses the risk factors that predicted death were – birth weight, 
perinatal asphyxia, septicemia, RDS, NEC and PDA. Although lesser gestational 
age was associated with death in NICU, in the multivariate model it was not 
independently related to death.  
7.4 RESULTS OF PHASE 2 
• Of the 643 who left the nursery and were advised to come for follow-up, twenty 
babies died. Of the reminder 422 completed the final assessment (Follow-up of 
65.6%). Thirty one babies who came for assessment at one year but did not come 
for the final assessment so 70.5% had at least one assessment. 
• 221 boys (52.4%) and 201 girls (48.6%) completed the developmental follow-up 
• The mean GQ of the study cohort was 93.6 (SD + 13.01).  The mean GQ among 
the boys was 92.9 (+13.08) and among the girls was 94.97 (+12.8). There was a 
significant difference between the boys and the girls (p = 0.04) 
• There were 48 children who had poor neurodevelopmental outcome (GQ of less 
than 2SD) below the mean and five children developed Cerebral Palsy. The 
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incidence of poor neurodevelopmental outcome (GQ <2SD) is 11.37% (8.6%-
14.9% 95% CI)  and incidence of Cerebral palsy in this study is 1.1 (0.39-2.63) 
• Gestational age or birth-weight did not correlate with the General quotient  
• None of the antenatal, perinatal or neonatal risk factors were related to the 
neurodevelopmental outcome. However perinatal asphyxia in the neonatal 
period predicted low Hearing and Language sub-quotient. 
• There were differences between girls and boys in the neurodevelopmental 
outcomes.  
• The mean GQ of the boys was significantly less than that of the girls (mean GQ 
in boys was 92.92 compared to the GQ of 94.97 in girls, p=0.04) 
• Although sex of the baby was not related to the GQ on bivariate or multivariate 
analyses, larger proportion of boys had poor neurodevelopmental outcome 
compared to girls - 12.7% of the boys had poor neurodevelopmental outcome 
compared to 9.9% of the girls.  There were also more boys (23 boys compared to 
9 girls) who were profoundly delayed (GQ of <70)  
• Boys fared significantly worse than the girls in certain sub-scales of the GMDS  - 
(Personal –Social subscale, Hearing and language subscale and Eye-Hand 
coordination) 
• There were more boys with cerebral palsy (3 boys compared to 2 girls). The boys 
were more disabled and all of them had quadriplegic cerebral palsy. 
• There were three boys with signs of autism, while there were no girls with 
autism. 
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• Weight Z-score below 2SD at the time of assessment independently predicted 
low GQ. Head circumference below 2SD at the time of assessment was also 
related with low GQ although not significantly  
• The language development of the boys was significantly worse than the girls 
• Weight Z-score below 2SD, low level of maternal education, perinatal asphyxia, 
at the time of assessment independently predicted a low language sub-quotient 
(<2SD on SQ-H&L). 
• There was no difference in the survival or neurodevelopmental outcome of SGA 
babies compared to AGA babies.  
• The post-natal growth of the AGA and SGA influenced their developmental 
outcomes. AGA and SGA babies who had good weight gain and whose Z-scores 
of the weight were in the normal limits at the time of assessment had the best 
neurodevelopmental outcomes. However AGA babies whose post-natal growth 
was poor (who had “weight catch down”) had the worse neurodevelopmental 
outcome compared to  SGA & AGA babies whose post-natal  growth was 
adequate and SGA babies who had inadequate post-natal growth. 
• Low maternal education, being small for gestation and neonatal hypoglycemia 
were significantly related to being underweight (Z-score of weight<2SD) at the 
time of assessment 
•  Low maternal education was a significant predictor for both poor post-natal 
growth (Z-score of weight<2SD) and for poor language outcomes (<2SD on 
SQ-H&L) 
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• Sensitivity analysis using “Best case” and “Worse case scenarios” showed that 
the exclusion of those who did not come for the final assessment (those who did 
not give consent, those who died and those who were lost to follow-up) did not 
affect the final results. 
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8 LIMITATIONS OF THE STUDY 
 
This is the largest cohort of Very Low birth weight babies followed up from the time of 
birth till 18-24 months of corrected gestational age. Yet the following limitations of the 
study must be considered – 
1. Although this was the largest follow-up study of VLBW form India we were not 
able to determine the perinatal and neonatal risk factors which lead to poor 
developmental outcome. The reasons for this are clearly explained in 6.2.4 
(p.190). However it has become clear from the study that neurodevelopmental 
outcomes are dependent not only on biologic factors, but also on the post-natal 
growth of the infants and social factors like maternal education and socio-
economic status. 
2. The final follow-up was only 65.6% who came for the final developmental 
assessment and 70.45% of the infants came for at least one assessment. The 
reasons for the loss to follow up has been discussed earlier in (section 4 (5.4) of 
the Results section).  However in spite of the attrition rate, the sensitivity analysis 
showed that the results of the study were not affected because of the loss to follow 
up.   
3. In the absence of a locally validated developmental assessment scale the results of 
the General Quotient obtained on the GMDS can be questioned. It would have 
also been good to have a local control population to interpret the test scores better. 
But it was very difficult to convince mothers of “normal” children to bring their 
children as controls. Although the Developmental Assessment Scale for Indian 
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Infants (DASII) is considered an Indian developmental assessment tool, it has 
been standardized only in Maharashtra. However the GMDS has been used for 
many years in the assessment of VLBW and ELBW infants. The psychologists 
and the Principal Investigator have many years of experience in using this tool 
and are confident of its efficacy.  Despite all its limitations 88.6% of the infants in 
this study were within two standard deviations and 69.2% were within one 
standard deviation of the Western norms. Thus the GMDS appears to have served 
its purpose in the developmental assessment of infants between 18-36 months.  
4. It is likely that the results obtained in this study may not reflect the true reality of 
the neurodevelopmental outcomes of the VLBW infants in this country since this 
was conducted in premier tertiary health center with excellent infrastructure and 
staffing for maternal and neonatal care. However the study proves beyond doubt 
that dedicated follow up can enhance the development of VLBW infants in this 
country, so that their neurodevelopmental outcomes are comparable to those from 
Western cohorts. 
5. Long- term predictions in terms of future cognition may not be possible since the 
developmental follow-up was only till 18- 24 months in most babies and up till 36 
months in a few babies.  However, during the course of the study, it was possible 
to identify the babies who were at risk for developmental problems and 
commence early intervention and developmental therapy based on the results of 
the neurodevelopmental assessments.  
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9 RECOMMENDATIONS AND CONCLUSIONS 
 
1. Since long term outcomes determine the success of the NICU care, it is 
mandatory that each tertiary level center invests in a multi-disciplinary 
developmental follow-up program. As the infants get discharged from the NICU 
their parents may have to continue developmental monitoring with their local 
pediatricians who may not recognize the risks the infant was exposed to, in the 
NICU or well informed about the guidelines of following up these children. 
Therefore the developmental follow-up programs should include networking with 
the local doctors, allied health workers, the schools, early intervention centers and 
community organizations who are involved in the care of these children after their 
discharge. There should be a system of getting feedback from the professionals 
who look after the child after discharge so that the NICUs are also aware about 
the child’s progress and are aware of long term sequelae (if any) of these 
children.69  
2. Research data and guidelines about neonatal practices from the Western countries 
cannot be extrapolated to this culturally diverse country. It is time to develop 
guidelines specific for this country. Therefore what is required are multicenter 
research networks like the National Institute of Child Health and Human 
Development (NICHHD) Neonatal Network, the Victorian Infant Collaborative 
Study (VICS) or the Vermont Oxford Neonatal Network. Multicenter networks 
result in partnership between academic centers and facilitate sharing of 
information. The results of the Networks may be more generalizable than the 
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results obtained by a single clinical center.149,533 In India the NNF can be the 
umbrella body which coordinates multi-centric research and each center could 
contribute to a national database like the Neonatal Perinatal database.  
Information from the various centers around the country could make the National 
database equipped to reflect the neonatal practices from all over India. This would 
be useful in preparing guidelines, and for allocation of resources 
3. There are different neurodevelopmental assessments done around the country. A 
uniform but versatile developmental assessment tool is the pressing need of the 
day. The DASII requires re-standardization to bring it up to date with the “I-pad” 
generation. This must be done in various sites and will require meticulous 
translation into multiple languages before it can truly considered the “gold 
standard” assessment tool. Many centers have started adapting the Bayley’s Scale 
of Infant development (3rd edition) according to the local culture. However this 
has to be done in coordinated manner to reflect the practices of the entire country. 
“All psychological tests need revision from time to time. Changes in the behavior 
and activities of young children, in rearing practices, standards and expectations, 
throughout the whole social and material environment in which babies grow and 
develop take place over time and must be reflected in the content and standards of 
a test that purports to assess that development in a reliable, currently meaningful 
and valid way”162 
4. Every follow-up study should have a concurrent component of intervention, even 
during the progress of the study. Many children will be identified to have 
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neurologic, sensory and developmental deficits and therapy should be started as 
soon as possible. 
5. Since India has the largest number of high-risk (including VLBW) babies, there 
should be affordable, accessible and simple intervention models of developmental 
stimulation and early intervention. Like the Gadchiroli model for improving 
survival, there should be models for improving outcomes. A right step in this 
direction is the intervention package based on the Trivandrum Developmental 
Screening Chart. This package was shown to be very effective recently in 
providing home-based developmental stimulation77,174 in high risk infants. 
6. Neurodevelopmental follow up should go on till the child enters school. Before 
the school entry, these children should have a detailed evaluation, in order to 
identify those who are at risk of difficulties in the scholastic performance. 
Subsequently the school authorities should also be involved, so that the child can 
receive the appropriate educational support. 
7. This study has revealed that poor neurodevelopmental outcome is closely 
associated with risk factors like low maternal education and poor post-natal 
weight gain which are modifiable to a great extent in order to yield better 
developmental outcomes. Although beyond the scope of this study it is well 
known that there are other social factors which are associated with long term 
outcomes of high risk infants - lack of social and emotion support to the mother, 
unemployment, large families etc. Improving prenatal care by educating mothers, 
promoting institutional deliveries, encouraging breast feeding and kangaroo 
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mother care and providing support to the mothers are very simple measure which 
will go a long way in improving outcomes. Unless these modifiable risk factors 
are identified and appropriate intervention provided the child’s long term outcome 
may be poor.   
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10 IMPACT OF THE STUDY  
 
Very Low birth infants are a heterogeneous group in terms of their etiology and their 
prognosis. These infants are exposed to multiple biologic, medical and social risks. Their 
developmental outcomes can range from normal development to profound developmental 
delay, neurosensory impairments and cerebral palsy.  They are also likely to have long 
term problems in their growth, cognition, behavior and school performance. Thus 
information about their developmental progress is of utmost importance. 
Despite all its limitations, this study is the report of the largest cohort of the VLBW 
babies who have been followed up in India till date. The incidences of 
neurodevelopmental impairment (Cerebral Palsy-1.10% and significant developmental 
delay-11.37%) are comparable to the best reports from Western countries and other 
developing countries. This study has also demonstrated that the VLBW infants in India 
are very different from the VLBW infants in Western cohorts in terms of the perinatal 
and neonatal risk factors. Another important finding from this study is that social factors 
play a very important role in the neurodevelopmental outcomes.  
This study has substantiated that good perinatal care and dedicated follow-up can 
significantly influence the outcome of VLBW and bring it at par with the Western 
standards. Furthermore because of the appropriate tools of assessment which were used, 
the duration of follow-up and the multi-disciplinary team involved, this study can be a 
reference for future studies on neurodevelopmental outcomes of high risk infants.  
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DEFINITIONS OF THE VARIOUS CONDITIONS 
FACTOR/CONDITION DEFINITION 
MATERNAL 
Gestational hypertension BP >  140/90 mmHg first detected during pregnancy, No proteinuria, 
postpartum (within 12 weeks) BP becomes normal 
Pre-eclampsia Minimum criteria: 
BP >  140/90 mmHg after 20 weeks gestation;  Proteinuria > 300 mg/24 
or > 1+ dipstick 
Increased certainty of pre-eclampsia: 
BP> 160/110 mmg Hg 
Proteinuria 2g/24hours or > 2+ dipstick 
Serum creatinine >1.2 mg/dL , Platelets < 100,000/mm
3
,  
Microangiopathic hemolysis (increased LDH), Elevated ALT or AST, 
Persistent headache or other cerebral or visual disturbance 
Persistent epigastric pain  
Eclampsia Seizures that cannot be attributed to other causes in a woman with 
preeclampsia 
Pre-gestational hypertension 
(chronic/essential/secondary) 
BP >  140/90 mmHg before pregnancy  or Hypertension 
Pre-gestational /overt 
Diabetes 
Diabetes existing before pregnancy  
Overt diabetes — A diagnosis of overt diabetes can be made in women 
who meet any of the following criteria at their initial prenatal visit:  
• Fasting plasma glucose ≥126 mg/dL [7.0 mmol/L], or 
• HbA1C ≥6.5 percent using a standardized assay, or 
• Random plasma glucose ≥200 mg/dL [11.1 mmol/] that is 
subsequently confirmed by elevated fasting plasma glucose or 
A1C, as noted above 
Gestational Diabetes Mellitus Diabetes not known to be present before pregnancy 
Fasting plasma glucose ≥92 mg/dL [5.1 mmol/L], but <126 mg/dL [7.0 
mmol/L] at any gestational age  
At 24 to 28 weeks of gestation: 75 gram two hour oral glucose 
tolerance test (GTT) with at least one abnormal result: fasting plasma 
glucose ≥92 mg/dL [5.1 mmol/L], but <126 mg/dL [7.0 mmol/L] or one 
hour ≥180 mg/dL (10.0 mmol/L) or two hour ≥153 mg/dL (8.5 mmol/L) 
Preterm premature rupture 
of membranes (PPROM) 
Rupture of  membranes when the pregnancy is less than 37 completed 
weeks of gestation 
Antepartum hemorrhage Uterine bleeding after 20 weeks of gestation that is unrelated to labor 
3
and delivery 
Stillbirths/ Intra-uterine 
death (IUD) 
Fetal death after 20 weeks of gestation prior to expulsion or extraction 
from the mother 
Early still birth: death  between 20 to 27 weeks gestation or late still 
birth ≥28 weeks gestation. 
Neonatal death Infant death after birth before 28 days of age.  
Early neonatal deaths occur within the first 7 days of birth,  
Late neonatal deaths occur between 8 and 27 days of age 
Post-neonatal death  Death of infant between 28 to 365 days of age 
Abortion Termination of pregnancy, spontaneously or by intervention prior to 20 
weeks of gestation or less than 500 grams birth weight 
Threatened abortion Bloody vaginal discharge or bleeding appearing through a closed 
cervical os during the first half of pregnancy 
Induced abortion Medical or surgical termination of pregnancy before the time of fetal 
viability 
Anemia Anemia in pregnant women: Hemoglobin   less than11 g/dL or 
hematocrit  < 33 percent) 
Severe anemia in pregnancy : Hb <7 g/dL  
Very severe anaemia: Hemoglobin <4 g/dL. (WHO definition) 
HELLP syndrome The diagnosis is established by the presence of preeclampsia and the 
following criteria: 
• Microangiopathic hemolytic anemia with characteristic 
schistocytes on blood smear  
• Platelet count <100,000 cells/µL  
• Serum lactate dehydrogenase >600 IU/L or total bilirubin >1.2 
mg/dL  
• Serum aspartate aminotransferase (AST) >70 IU/L  
Chorioamnionitis Fever > 38
o
C or 101.4
o
F with accompanying ruptured membranes ( 
additional features: uterine tenderness, fetal tachycardia and 
malodorous amniotic fluid) 
Oligohydramnios Amniotic fluid index [AFI] <5  on ultrasound examination 
Polyhydramnios  Amniotic fluid index greater than 25 cm on ultrasound examination 
Abrutio placenta Premature separation of a normally implanted placenta prior to 
delivery of the infant confirmed by ultrasound 
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NEONATAL CONDITIONS – DEFINITIONS 
Respiratory distress syndrome • RR > 60, grunting expiration, in-drawing of sternum, 
intercostal spaces and lower ribs during inspiration, cyanosis 
without added oxygen,  
• CXR characteristic of RDS,  
• Surfactant used (help in corroborating not diagnosing the 
condition) 
• ABG – hypoxemia, mixed metabolic and respiratory acidosis, 
hypercarbia 
Acidosis Respiratory Acidosis: ( pCO2 >= 60 mmHg, pH < 7.25) 
Metabolic Acidosis: (HCO3 < 17 mmol/L or B.E. < minus 6.0 mEq/L, pH 
< 7.30) 
{Source: Neonatal handbook} 
Alkalosis Metabolic Alkalosis: (e.g. HCO3 > 28 mmol/L or B.E. > plus 4.0 mEq/L, 
pH > 7.40) 
Respiratory alkalosis: (e.g. pCO2 < 35 mmHg, pH > 7.40) 
{Source: Neonatal handbook} 
Hypercapnia PaCO2 > 60 mmHg (Avery)  
Hypocapnia PaCO2  < 30 mmHg (Avery p.968) 
Shock • Mean BP (diastolic pressure + 1/3 systolic pressure) less than 
10
th
 percentile for gestational age and postnatal age  
• Capillary refill time of > 3 seconds 
• Other signs which may help – increased heart rate (>120/min), 
pallor, cool peripheries, lethargy,  low urine output,  acidosis 
Sepsis/bacterial 
sepsis/septicemia 
• Systemic signs of infection (fever, lethargy, jitteriness, poor 
perfusion, accompanied by bacteremia (blood culture positive) 
Risk of sepsis Any of the following: 
• Prolonged rupture of membranes (>24 hours) 
• Prematurity (especially in association with PROM) 
• Preterm labour with no adequate explanation 
• Fetal distress without adequate explanation (fetal heart rate 
abnormalities especially fetal tachycardia, passage of 
meconium) 
• Maternal fever  during labour (100.4
o
F)or other evidence of 
infection 
• Foul smelling amniotic fluid (Chorioamnionitis) or malodorous 
baby 
• GBS colonization not give prophylaxis during labour, previous 
baby with GBS sepsis 
• Multiple vaginal examinations (>3) after ROM  
5
• Indwelling vascular catheter            
Probable sepsis Systemic signs of infection with sterile blood culture and any 2 of the 
following: 
• CRP >10 
• Total WBC count <5,000/mm
3
 
• Absolute Neutrophil count  < 1500/mm
3
 
• I:T ratio >0.2 
• CRP  >10 
Fever Rectal or axillary temperature > 100.1
0
F or 37.8
0
C for more than one 
hour  
Pneumonia Respiratory rate > 60 and signs of respiratory distress (dyspnea, 
grunting, coughing, nasal flaring, irregular respirations, cyanosis, 
intercostal and subcostal retractions, rales and decreased breath 
sounds with  
• Fever 
• Associated signs of sepsis 
• Radiologic features: hyper expansion, atelectasis, parahilar 
peribronchial infiltrate, consolidation, air bronchograms, 
pneumatoceles, pleural effusion   
• Tracheal aspirates or other sites (blood, CSF, urine) culture 
positive  
Meningitis • CRP >10 or bacteremia along with CSF findings  (CSF Protein > 
100 mg% and/or WBC  > 20/ mm
3
)                        
• Gold std: Organism isolated from the CSF 
UTI Positive urine culture in a urine specimen obtained by suprapubic 
culture 
In the absence of bacteriuria  then 
• Any bacterial colony count in a SPC sample with features of 
sepsis or failure to thrive 
• Colony count of 10
3
/ml in a catheter sample with features of 
sepsis 
• Bacteriuria in a catheter obtained sample with features of  
sepsis 
Renal failure  Creatinine > 1.5 g% regardless of rate of urine output  
Hypoglycemia (symptomatic, 
asymptomatic, persistent) 
Plasma glucose level  < 46 mg%  
Persistent hypoglycemia when dextrose infusion of  > 10 mg/kg/min is 
used 
Hypocalcemia (early,late) Calcium levels < 7 mg% .Early hypocalcemia if within less than 48 
hours. Late hypocalcemia if > 48 hours  
Hyponatremia At least one reading of S. sodium less than 130 mEq/L   
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Hypokalemia Serum potassium less than 3.5 mEq/l 
Hyperglycemia Plasma glucose concentration >145 mg%  
Hypercalcemia Serum calcium >11 mg%  
Hypomagnesemia Serum magnesium <1.4 mg %  
Hypernatremia At least one reading of S. Sodium more than 150 mEq/L  
Hyperkalemia Serum potassium > 6 mEq/L  
Small for gestational age Infants whose birth weight are more than 2SD below the mean or less 
than the 10
th
 percentile of the  mean for the gestational age (using 
AIIMS growth charts).   
Very low birth weight infants Less than 1500 grams at birth  
Extremely low birth weight 
infants 
Less than 1000 grams at birth  
Prematurity Infant whose birth occurs before 37 completed weeks  
(before 260
th
 day)  following onset of the last menstrual period  
Fetal distress/ Non reassuring 
fetal status 
Three tier diagnosis based on the ACOG guidelines published by 
Macones et al in OBSTETRICS & GYNECOLOGY VOL. 112, NO. 3, 
SEPTEMBER 2008 p.661-68 
Apnea of prematurity Cessation of breathing for more than 20 seconds with accompanying 
bradycardia (HR<100/min)in infants born before 37 weeks 
Diaphragmatic hernia Prenatal diagnosis by antenatal ultrasounds 
Postnatal – Respiratory distress, decreased breath sounds, scaphoid 
abdomen, signs of mediastinal shift 
X-ray features of diaphragmatic hernia   
Transient tachypnea of 
newborn 
• Radiologic features: streaky, perihilar opacities, lung over 
inflation 
• Respiratory distress – grunting, nasal flaring, retractions, 
tachypnea (>60/min) within few hours after birth in term or 
near term infant. Requirement of oxygen of FiO2 of <40% 
• Clinical and radiologic features resolve within 72 hours 
• All other causes of respiratory distress have been ruled out   
Persistent pulmonary 
hypertension or Persistent 
fetal circulation 
• Respiratory distress and cyanosis within 12 hours 
• Clinical features: RV impulse, single second heart sound 
and/or systolic murmur consistent with tricuspid regurgitation 
• A 10% or greater difference in oxygen saturation between the 
preductal (right upper extremity) and postductal( lower limbs) 
in the absence of structural heart disease suggests PPHN   
• ECHO findings  Chest X-ray may be normal                             
• Exclude all other causes of respiratory distress  
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Pneumothorax • Sudden onset of respiratory distress with or without signs of 
circulatory compromise 
• Radiologic features of pneumothorax  
Chronic lung disease of 
prematurity or 
Bronchopulmonary dysplasia 
Treatment with FiO2 greater than 0.21 for at least 28 days PLUS failure 
of room air challenge test at 36 weeks post-menstrual age 
Radiologic features of BPD on chest X-ray 
Patent ductus arteriosus • Systolic murmur 
• Hyperdynamic precordium 
• Wide pulse pressure, bounding pulse 
• Worsening respiratory status 
• ECHO- Diameter of LA : Aortic root > 1.4  
Osteopenia of prematurity • Serum phosphorus < 4 mg% 
• Alkaline phosphatase > 800 IU 
• Radiologic features: decreased lucency of bones with or 
without epiphyseal changes 
• Clinical features: failure to wean from ventilator, hypotonia, 
decreased linear growth with sustained head growth, widened 
cranial sutures, frontal bossing, craniotables, large anterior 
fontanel, rachitic rosary, enlarged wrists/ knees/ ankles, 
Harrison’s groove  
Late onset metabolic acidosis Metabolic acidosis after 4 days 
Perinatal asphyxia • Umbilical cord ABG or or peripheral ABG within 1 hour: pH ≤  
7.0 or ABE ≥ -12 
• APGAR ≤ 5  at 5 minutes 
• History of acute perinatal event 
 Intrapartum fetal distress 
 Cord prolapsed 
 Placental abruption 
 Uterine rupture/dehiscence 
• If outborn – resuscitated for >10 mins/did not cry at birth with 
signs of encephalopathy 
HIE (1,2,3) 
 
Features of Perinatal asphyxia plus encephalopathy as defined by 
Sarnat and Sarnat staging (see table below) 
Intraventricular hemorrhage 
(1,2,3,4) 
Using Papile’s grading using  Ultrasound findings 
Periventricular leukomalacia Infarction of deep white matter adjacent to the trigones and frontal 
horns of the lateral ventricles  
Staged using de Vries classification based on the ultrasound findings 
Retinopathy of prematurity Vasoproliferative disorder of the retina in premature babies caused 
due to interruption in normal vasculogenesis and due to abnormal 
neo-vascularization in extra-retinal tissues, finally resulting in retinal 
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detachment and scarring of the macula, and significant visual loss. 
Graded using International  Classification of ROP 
NEC (1,2,3) Using modified Bell’s criteria 
Recurrent feed intolerance 
(without NEC) 
Feed intolerance  - (abdominal distension, large aspirate - >50% of 
feeds in the previous 6 hours, vomiting) necessitating discontinuing 
feeds and starting anti-reflux medications 
Anemia Hb < 9 g% any time during the nursery stay   
Polycythemia Hct > 65% or Hb > 22 g%   
Thrombocytopenia Platelet count  < 150,000/mm
3 
 
Hyperbilirubinemia 
(physiologic or pathologic) 
• Clinical jaundice in the first 24 hours of life 
• Serum TB conc. Increasing more than 0.2 mg%/hour or 
5mg%/day 
• S. TB exceeding the 95
th
 percentile for age in hours 
• Direct bilirubin exceeding 1.5-2 mg% 
• Clinical jaundice persisting for more than 2 weeks in full term 
infant 
• Total bilirubin more than 15 mg% 
Meconium aspiration 
syndrome 
Respiratory distress in a infant born through meconium stained 
amniotic fluid  
Radiologic signs of air trapping, atelecasis, patchy opacities 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9
Sarnat Clinical Stages of Perinatal Hypoxic Ischemic Brain Injury 
 State 1 Stage 2 Stage 3 
Level of 
Consciousness 
Hyperalert Lethargic or obtunded Stuporous 
Neuromuscular Control 
Muscle tone Normal Mild hypotonia Flaccid 
Posture Mild distal 
flexion 
Strong distal flexion Intermittent decerebration 
Stretch reflexes Overactive Overactive Decreased or absent 
Segmental myoclonus Present Present Absent 
Complex Reflexes 
Suck Weak Weak or absent Absent 
Moro Strong; low 
threshold 
Weak; incomplete; high 
threshold 
Absent 
Oculovestibular Normal Overactive Weak or absent 
Tonic neck Slight Strong Absent 
Autonomic Function Generalized 
sympathetic 
Generalized 
parasympathetic 
Both systems depressed 
Pupils Mydriasis Miosis Variable; often unequal; 
poor light reflex 
Heart Rate Tachycardia Bradycardia Variable 
Bronchial and Salivary 
Secretions 
Sparse Profuse Variable 
GI Motility Normal or 
decreased 
Increased; diarrhea Variable 
Seizures None Common; focal or multifocal Uncommon (excluding 
decerebration) 
EEG Findings Normal (awake) Early: low-voltage 
continuous delta and theta 
Later: periodic pattern 
(awake) 
Seizures: focal 1-to 1-Hz 
spike-and-wave 
Early: periodic pattern with 
Isopotential phases 
Later: totally isopotential 
Duration 1-3 days 2-14 Hours to weeks 
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 Classification of periventricular leukomalacia, according to de Vries  
Grade Definition 
I Transient periventricular echodensities persisting for 7 days or longer 
II Periventricular echodensities evolving into small localized frontoparietal cystic 
lesions 
III Periventricular densities, evolving into extensive periventricular cystic lesions 
IV Densities extending into the deep white matter evolving into extensive cystic 
lesions 
 
 
Grading of the severity of germinal matrix-intraventricular haemorrhages from US scan, 
adapted from Volpe  
Grade Extension of haemorrhage 
I Germinal matrix haemorrhage with minimal or no intraventricular haemorrhage 
(<10% of ventricular area in parasagittal view) 
II Intraventricular haemorrhage (10–50% of ventricular area in parasagittal view) 
III Intraventricular haemorrhage (>50% of ventricular area in parasagittal view; usually 
distends lateral ventricle) 
Separate 
notion 
Periventricular echodensity (location and extent) 
 
Bell clinical staging of NEC: 
Stage I: Suspect: Infant with suggestive clinical signs but Xray non-diagnostic. 
Stage II: Definite: Infant with pneumatosis intestinalis. (IIA: mildly ill - IIB: 
moderately ill (acidosis, thrombocytopenia or ascites)) 
Stage III: Advanced. (IIIA: Critical with impending perforation - IIIB: Critical with 
proven perforation) 
 
(1–11)(12)(13)(14) 
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INFORMATION BROCHURE AND CONSENT FORM 
 
Dear parents of _______________________________________________ 
As you know, your baby was born preterm (born before the due date) and therefore required to 
be in the Nursery for many weeks. Now that your baby is stable, putting on weight and is 
feeding well, he/she is being discharged. However babies who are born prematurely (especially 
those who have a birth weight of less than 1.5 k.g) will need special care during their first 2 
years and constant monitoring after that. 
What are the problems which premature babies can have after leaving Nursery? 
Although many preterm babies grow to be normal children, some preterm infants can have 
complications. 
The usual complications which premature babies can have: 
1. The development of a preterm infant can be slower than children who are born with 
normal birth weight. Some of these children will require help in walking, speaking, and 
understanding.  
2. Hearing problems:  Hearing can be affected in babies who are born with a low birth 
weight. When your baby was in the nursery his/ her hearing would have been checked. 
However if you feel that your child is not responding to sounds or to your voice please 
show the child to the doctors. 
3. Eye problems: Some preterm babies can have eye problems. If detected early, this can 
be treated. All preterm babies have eye check up in the Nursery. If the baby’s eyes were 
not checked, he will have to be shown to the Ophthalmologist at Schell eye hospital, 
Vellore. 
4. Some premature infants can have seizures and will require medicine. 
5. In some preterm infants brain may be affected and they may develop cerebral palsy 
which will require long term treatment. 
How can you help your baby’s development? 
Even in those who seem to be standing and walking normally, there may be minor impairments 
in their language, understanding and other functions. Regularly showing your baby to the 
doctors can help in early detection and immediate treatment of complications. 
 
How can I help my child develop to his best potential? 
In order to regularly follow up and help infants who are born with a low birth weight we have a 
special clinic for Very Low Birth weight babies on Wednesday mornings in the Developmental 
Pediatrics Unit. We will see these babies till they are 2 years old. When problems are detected, 
your child will then receive help from a dedicated team of doctors, psychologists and 
occupational therapists in the Very Low birth Infants Clinic and the Developmental Pediatrics 
Unit. 
13
  
When your child is discharged from the Nursery, the doctors will inform when you have to bring 
the child to the Very Low Birth weight infant clinic.  You will be seen by Dr. Sridhar or Dr. 
Niranjan Thomas (Neonatologists), Dr. Samuel P Oommen (Developmental specialist) and the 
Occupational therapist Ms. Hima in the clinic. Your child’s development will be monitored and 
appropriate help will be given. Sometimes you may require to see a specialist (if he has any 
hearing or eye problems, if there are seizures), in which case the doctors will refer you to the 
concerned specialist.  
How frequently should I bring my child? 
This depends on your child’s developmental progress. For the first 3 months it is advisable to 
bring your child at least once a month and after that, once in 2 months will be sufficient. 
However please ask the doctors about the date of your next visit.  At one year of age and at 1 
½   years of age we will check the child’s complete development using a test called the Griffith 
Mental Developmental Scales. This will tell us how the child is developing as compared to other 
children of the same age. 
 
Will my child require any special blood tests or brain scans? 
All preterm babies will require ultrasound scans of the brain at 6 weeks of age. After that if your 
child is developing normally there is no need for any tests. However if the doctor feels that 
there is some problem with your child’s development, he will require special blood tests and 
brain scans. 
 
If you would like to take part in this regular follow up program as mentioned above for the next 
1 ½ years kindly sign in attached form. You are welcome to stop coming at any time, but for 
reasons mentioned above, we would encourage you to come regularly. 
If you have  clarifications you can contact any one of the following doctors: 
1. Dr. Samuel P Oommen, Developmental Pediatrics Unit (above the Well baby clinic) 
Phone: 0416 228 3260 
2. Dr. Sridhar, Neonatology,  Phone: 0416 228 3311 
3. Dr. Niranjan Thomas, Neonatology, Phone: 0416 228 3311 
4. Ms. Hima, Occupational Therapist, Neonatology  
Phone: 0416 228 3311 
Details about your appointment are written in the blue colour card (Very Low Birth 
weight clinic card) which is given at the time of discharge from the nursery.  
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CONSENT FORM 
I, __________________________________________________________ 
(printed name of parent/guardian signing the form) 
• confirm that I have read (or the information has been read to me) and understood the 
written informed consent form for the parent/guardian for study.  Study conduct and 
purpose has been explained to me. 
• confirm that I have been given enough of time to consider participation in the study, I 
have had the opportunity to ask questions and I have been provided with satisfactory 
answers. 
By signing this consent form I voluntarily agree to bring my child for regular developmental 
monitoring and take part in the early intervention programme as advised, during the study 
period. 
I understand that I can withdraw my consent at any time without having to give any reason. 
This will not have any impact on my child’s right to receive the medical care he/she is entitled 
to. 
Child’s name: _________________________________________________ 
Hospital Number: ______________________________________________ 
Signature of parent/guardian: ___________________________  
Date:____________ 
Note: only the signature of a legal guardian is valid.  
Person obtaining consent: 
Dr. Samuel P Oommen, Developmental Pediatrics Unit 
(or) Dr. S. Sridhar (or) Dr. Niranjan Thomas (or) Ms. Hima (Neonatology) 
 
Signature: ___________________________ 
 
Date: __________________ 
CMC Hospital, Vellore 
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PROTOCOL FOR LBW STUDY 
NICU PHASE 
 
 
PERSONAL DETAILS 
 
 
Mother 
 
Name 
 
 
Hosp. No 
 
Age  Occupation Literacy : (illit/ <5/5-8/9-
10/+2/grad or PG/prof) 
Father       
 
Address: Phone Nos.: 
 
 
 
Baby’s H. No: Date of Birth: SEX: B/G 
 
 
 PAST OBSTETRIC HISTORY 
 
Years  of Marriage: 
 
Consanguinity:           Y/N 
 
Gravida:   1/2/3/>3                           
Para:   0/1/2/3/>3                          
Living:    0/1/2/3/>3                                                              
Neo/END:  0/1/2/3/>3                          
 
Abortions:   0/1/2/>2                                                         
Still births:  0/1/2/>2                          
IUDs:   0/1/2/>2                        
 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
 
 
 
 
 
Year 
 
 
 
 
Sex GA 
 
Delivery 
(n/I/C) 
 
 
 
 
 
 
 
 
 
 
 
 
N-normal 
I-Instrum 
C-Cesar 
Weight ANC 
 
Neonatal 
 
Currently 
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Maternal Risk Factors (previous pregnancy):  
 
Second  stage complications: 
 
Family History                               
 
PRESENT PREGNANCY. 
 
AN visits:  <3 / >3 (booked) 
 
LMP                                                            Not known                                                         Gest. Age (Weeks) 
MATERNAL RISK FACTORS (PRESENT PREGNANCY) 
 
Elderly/Teenaged primi:   Y/N                                  Grand Multipara: Y/N                                 Height <140: Y/N                                  
Threatened abortion/Spotting:  Y/N 
Infertility treated:     Y/N                                            
Pregestational Thyroid disorder:  Y/N                              Thyroid disorder during pregnancy: Y/N 
 
Max. TSH                              Treatment 
 
Multifetal pregnancy:    Y/N                        Amnion                                              Chorion  
Drugs: Y/N                          Details: 
 
Infections: Y/N                   Details: 
Pregestational Hypertension: Y/N 
 
PIH: Y/N                                                                     Max. BP:                                 Complications:  Y/N 
                                                                                                               
Albuminuria (≥3+) y/N           Seizures: Y/N                       Bleeding: Y/N                        HELLP: Y/N 
 
Diabetes:  Pregestational  DM: Y/N                                                                             GDM: Y/N                                                        
 
HbA1C:<7/>7                                                                                    Treatment for GDM : Diet/OHA/Insulin 
       
 
Fetal Movements: 
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Ultrasound scans: 
Date GA ANOMALY AFI DOPPLER IUGR 
      
      
      
      
      
Summary of above: 
Fetal anomaly: Y/N                     if yes then Head (size, structure): N/AbN                  Limbs: Y/N                   Viscera: Y/N 
Growth: N/AbN 
AFI: N/AbN 
Antepartum Bleeding: Y/N                                               Details: 
  
 
Antepartum steroids:  0/1/2 
 
 
Drugs during pregnancy: Y/N                                           Details: 
 
INVESTIGATIONS 
 
 Hb <10/>10 Blood Group 
 
Rh ICT at 
HIV: Y/N Urine alb      
 
VDRL : Y/N        HBsAg:Y/N        
GTT: N/abN AC/PC HbA1C 
 
Uric acid 
 Creat UTI Urine c/s – organism:  Y/N 
 
LFT 
 
Other obst.comp Y/N 
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 LABOUR 
Duration of labour : <6 /6-12 />12  
 
Spontaneous                                Induced – Indication  Oxytocin     +      - Others 
  
Vaginal examinations after ROM:  
 
Membranes ruptured: Spontaneously                                                       Artificially:  
 
Hrs before delivery : <12 />12h                           
Amniotic  Meconium stained:  Nil/Gr 1/Gr 2/Gr 3 
 
Foul smelling                                                                                      Chorioamnionitis (fever) 
Sedation in previous 6 hrs before delivery:  Y/N                                         Sedative: 
 
 
Drugs in labour (specify):  Antibiotics/ Tocolytics/Mg 
 
    
 
CTG record: Nature of foetal distress : N/NRFS/FD/Nd 
 
 
DELIVERY 
Type:  Normal/CS/ Breech/Forceps/Suction           
 
Indication (if abnormal):  
 
Placenta:  N/AbN                                       If Abn:                        Anatomic defect:                                Retroplacental clot                                                               
 
Infarction;                              Calcification:                                                             Umbilical Blood vessels:           
 
Maternal Complications during labour and delivery: Y/N 
 
If yes give details: 
 
 
BABY 
Born (time and day)                                                          Inborn/Outborn 
Birth weight (checked within 4 hours):                                                   
Length Head circumference after 48 hours 
22
  
Gestational age:                                                          LMP:                                              Dubowitz /clinical:     
APGAR SCORE:  1 min 5 min. 10 min 20 min 
 
Umbilical Cord pH:                                                    bicarb:                                           Base ex: 
 
RESUSCITATION DETAILS 
IPPV:  Y/N                       
 
Chest compression 
 
Drugs: NS/adrenalin/naloxone                                                                         Ventilation: Y/N 
 
EXAMINATION 
AF 
 
Ears Eyes 
Mouth 
  
Throat  Heart  
Abdomen 
  
Femorals  Skin  
Hips 
  
Anus  Genitalia  
Scalp 
 
Summary:   
Normal examination:        Y/N (Abnormality in any of above) 
 
 
NEONATAL MORBIDITY 
Respiratory distress (Tachypnoea, Grunting, Retractions,apnea): Yes/No 
Time of onset: 
Diagnosis:                                                                              Treatment: 
X-ray: 
ABG at onset: 
Duration: 
VENTILATION: Y/N                                    Duration:                     Type                                                                         
Surfactant therapy;                                  PIP:                                PEEP: 
Diagnosis: RDS/TTN/Pneumothorax/ Pneumothorax/MAS 
 
Shock: Y/N 
Time of onset: 
Diagnosis: 
Duration 
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Septicemia:   Y/N                        Onset of first symptom:                       Poor feeding                   Length           Y / N                 
Fever                                    Y / N                   clinical features                 Y / N                    DURATION OF ABX 
Organism 
Duration: 
Diagnosis:                                                        CRP pos/neg 
Dx: SEPSIS/MENINGITIS/SEPTIC ARTHRITIS/OTHERS 
 
Renal failure :                     Y / N 
Maximum creatinine 
Dialysis 
Diagnosis : 
Anemia/Polycythemia 
 
Thrombocytosis/Thrombocytopenia 
Seizures : Y/N                                                                    
Diagnosis:  
EEG                          
Jaundice (>8 mg%):  Y/N                                                                         
If yes:  
Highest bilirubin: 
Treatment: Phototherapy/Exchange transfusion:  
 
Hypoglycemia: Y/N 
If yes  
Seizure: Y/N                                                                                                                     Onset:                                                       
Duration: <24 h?                                                                       Max dextrose reqd. g/kg/d:  
 
Hypocalcemia: Y/N 
If yes: 
Seizures: Y/N                                                                                                                  Onset:                                                         
Duration: < 24 h                                       
 
Electrolyte imbalances:  
Hypernatremia: Y/N                      Hyponatremia: Y/N 
 
Hyperkalemia: Y/N                        Hypokalemia: Y/N 
 
PDA: Y/N 
If yes: 
          CCF: Y/N 
          Day  of Onset 
           Treatment: Indo/Ibupr./Ligation 
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Necrotising enterocolitis: Y/N 
If yes:                                                             
          Stage: 0/1/2/3                 
          Surgery: Y/N 
 
NEUROSONOGRAM :Normal/ ICH/ PVL 
 
1. 
2. 
3. 
 
IF ICH then Grade: 1/2/3/4 
If PVL : Flare/Cystic/ Non cystic  
VP shunt : Y/N 
 
CNS infection: Y/N 
If yes:    
Onset: 
CSF cells                                                         CSF sugar                                                             CSF protein 
CSF culture 
Treatment given 
Other complications: Y/N 
Onset 
Duration 
Treatment 
 
Eye Involved: Y/N 
Etiology: ROP/ Cataract/ Others 
 
Hearing difficulty:  Passed/Referred 
 
NEUROLOGIC EXAMINATION (ATNAT): Normal or mild/moderate/severe 
 
 
 
AT DISCHARGE:  Duration of stay:                       
Discharge Weight: 
Discharge length: 
Discharge HC: 
 
Feeding at discharge: 
DBF/ others 
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AMIEL TISON NEUROLOGICAL EXAMINATION SHEET (0 - 18+ months) 
 
NAME: Hosp. No: DOB: Notes: 
Mother’s Name: EDC: B wt.                 Gest. Age: 
Father’s Name:  Sex: Contact no.:  
   
Visit A B C D E F G H I J K L M N O 
Exmn. Date                
Corrected 
Gest. Age   
               
Chron. Age                
 
1. GROWTH (N ± 2SD (0); <2SD (2); >2SD (2) 
 
GROWTH 
A B C D E F G H I J K L M N F 
Head 
circumference 
               
Weight 
 
               
Height  
 
              
HC : Ht: Y/N 
 
               
VP Shunt 
 
               
A.F:  Open=0 
Closed =2 
Closed >9m=0 
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CRANIOFACIAL EXAMINATION 
SUTURES 
Edge- edge:0  
Overlapping:1 
Squamous:  
Frontal: 
Coronal: 
Sagittal: 
Occipital 
A                    
    
SKULL SHAPE  
Normal(0): 
Abnormal (1): 
Describe 
               
PALATE  
Flat (0):                                                  
High arched-1  
 
               
 
2. SOCIAL INTERACTIONS & NEUROSENSORY EXAMINATION 
SEIZURES: 
Absent-0, 
Focal/Short:1 
Prolonged -2, 
Febrile –X 
A B C D E F G H I J K L M N O 
               
ALERTNESS & 
ATTENTION 
Normal age: 0  
 Mod. Deficit:1  
Sev. Deficit: 2 
               
HYPER- 
EXCITABILITY  
No signs: 0                 
Compatible: 1 
Uncontrolled:2 
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NEUROSENSORY EXAMINATION    
 A B C D E F G H I J K L M N O 
 
HEARING 
(Normal:0.  
Mod. HL:1;  
Severe HL:2) 
               
VISION - Fix & 
Track: 
Easy to obtain: 0 
Difficult: 1   
No response: 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NYSTAGMUS 
Absent : 0                                    
Present: 2 
 
               
EYE 
MOVEMENTS 
Synchrnous: 0     
Erratic: 2 
 
               
STRABISMUS - 
Absent : 0:                                            
Present : 1 
 
               
SUNSET SIGN - 
Absent : 0                                   
Present: 2 
 
               
Diagnostic tests:  
Hearing (Audiogram, BERA, Tympanogram): 
Vision (VEP) 
 
 
28
 4 
 
 
                                                                  MOTOR DEVELOPMENTAL MILESTONES 
 
Head Control:   
<4 months: 0    
5-6 months: 1 
After  6 m: 2 
 A B C D E F G H I J K L M N O 
               
SITTING:  
< 9 m: 0            
10-12 m: 1  
>12m: 2 
               
WALKING:  
<18 m : 0        
18-24 m: 1  
>24m :2 
               
CUBE in CUP: 
<10 m: 0 
 11-14 m: 1  
>14m:  2 
               
Grasp pellet  
 <12 m: 0  
13-15 m: 1     
>15m: 2 
               
3-cube tower: 
  <21 m: 0 
  22-24 m: 1    
>24m: 2 
               
Turns over                
Reach & 
Mouth 
               
Knee-hand                
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3.  PASSIVE MUSCLE TONE  
 A B C D E F G H I J K L M N O 
ADDUCTOR 
ANGLE 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asymmetry  (R>L/R<L) Present: X              
POPLITEAL 
ANGLE  
 
R               
L 
 
 
 
             
Slow Dorsi- 
Flexion 
 
R 
 
 
 
             
L               
Rapid 
Dorsiflex. 
 
R 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L 
 
 
 
 
 
 
 
 
 
 
 
         
 
  0-3 m 4-6 months 7-9 months 10-18 months 19-24 months 
Adductor angle 0 ≥40 ≥70 ≥100 ≥110 ≥110 
1 ≤30 ≤60 80-90 80-100 80-100 
2 No resistance  (NR) NR ≤70  or NR ≤70     ≤70    or  NR = 2 
X    NR  
Popliteal angle 
(Left or right) 
0 ≥80 ≥90 ≥110 ≥110 ≥110 
1 ≤70 ≤80 90-100 90-100 90-100 
2 NR NR ≤80  or NR ≤80     ≤80   or NR = 2 
X    NR  
Slow dorsiflexion 
(R or L) 
0  
NOT SCORED 
≤80 ≤80 ≤80 ≤80 
1 90-100 90-100 90-100 90-100 
2 ≥110 ≥110 ≥110 ≥110 
Rapid 
dorsiflexion 
0  
NOT SCORED 
Identical (I) Identical Identical Identical 
1 Phasic stretch (P) Phasic stretch Phasic stretch Phasic stretch 
2 Tonic stretch (T) Tonic stretch Tonic stretch Tonic stretch 
SCARF SIGN 0 EBM,ECM ECM, EPM ECM, EPM ECM, EPM ECM, EPM 
1  EBM    
2 EPM, NR NR EBM, NR EBM EBM, NR 
X    NR  
                                                                EBM: elbow before midline; ECM: elbow crosses midline; EPM: Elbow well past midline   No resistance - NR 
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 A B C D E F G H I J K L M N O 
Candlestick 
Absent:0 
Present:X 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINGERS 
MOVE: 0  
CLOSED: 1 
Thumb Inactive/ 
Cortical :2   
R               
L 
 
 
 
             
SCARF Sign 
(See above for 
score) 
 
R 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L 
 
 
 
 
 
 
 
 
 
 
 
         
 
 
 A B C D E F G H I J K L M N O 
Dorsal extension 
Absent to 
moderate: 0 
Opisthoton:2 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ventral flexion 
Moderate to 
absent: 0 
Excessive: 2 
  
 
             
Comparison of 
curvature 
Flex≥Extn:0 
Flex<Extn:1 
Ragdoll: 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RIGID diffusely 
None: 0 
Lead pipe:2  
               
Asymmetry of 
tone Absent:0 
R>L or R<L: 1  
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4.  MOTOR ACTIVITY 
FACIAL 
EXPRESSIONS 
Symmetrical.(0)   
Insufficient (1) 
 A B C D E F G H I J K L M N O 
               
DROOLING 
Absent::0; 0-1y:X  
Present:1  > 1yr  
               
FACIAL 
PARALYSIS 
 Absent (0) 
 Present (2)  
               
TONGUE 
FASCICULATIONS 
Absent (0) 
Present (2) 
               
LIMBS 
SPONTANEOUS 
MOVEMENTS 
Coordinated and 
varied (0) 
Insuff/uncoord/ 
stereotypic(1) 
Absent/uncoordin
ated (2) 
               
INVOLUNTARY 
MOVEM. 
 Absent (0) 
 Present  (2)                            
Describe: 
               
Dystonia  -
Absent (0) 
Present (2) 
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DEEP TENDON & CUTANEOUS REFLEXES  
BICIPITAL REFLEX 
Normal:0 
Brisk:1 
Clonus/Absent:2   
 A B C D E F G H I J K L M N O 
               
PATELLAR JERK 
Normal:0 
Brisk:1 
Clonus/Absent:2   
               
PLANTAR REFLEX 
Flexion: 0  
Extension < 1Yr.:X 
Extension > 1 yr:2 
               
5. PRIMITIVE REFLEXES  - Except ATNR, rest not scored after 9 months ( DNS> 9m) 
SUCKING:DNS>9m 
Present (0) 
Insufficient(1) 
Absent (2) 
               
MORO- DNS>9m 
0:Presnt<3&Absnt>6 
2:Absnt<3&Presnt>6 
X:Prsnt or absnt 3-6 
               
GRASP- DNS>9m 
0:Presnt<3&Absnt>6 
2:Absnt<3&Presnt>6 
X:Prsnt or absnt 3-6 
               
WALKING DNS>9m 
0:Presnt<3&Absnt>6 
2:Absnt<3&Presnt>6 
X:Prsnt or absnt 3-6 
               
ATNR 
0: Absent > 6 months 
2: Present > 6 mnths 
X:Prsnt or absnt 0-6 
               
R/L asymmetry 
(which side) 
               
Moro, Grasp, Walking reflex score  2 only if other signs of CNS depression are present. 
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POSTURAL REACTIONS (Scored after 6 months) 
Lateral Propping
#
 
0: Present > 6 m  
1:Incomplete > 9 m 
2:Absent>9 m 
X: Incom/Absnt 6-9m 
 A B C D E F G H I J K L M N O 
R               
L               
PARACHUTE   
0: Present > 6 m  
1:Incomplete > 9 m 
2:Absent>9 m 
X: Incom/Absnt 6-9m 
R               
L               
                                                                                                                                                                                #
Lateral propping done while baby is sitting 
 
 
Qualitative Abnormalities in Gross Motor Function and Acquired Deformities 
Holding head 
behind axis 
Abnormal.  Absent: 0 
Abnormal. Present: X  
               
Poor head control  
Abnormal. Absent: 0 
Abnormal. present  X 
               
Sitting  (score >6m)*  
Normally: 0 
Falls forward/back  
 (1:6-12/, 2: 12-18) 
               
Standing position 
Normal standing:0  
Opisthotonos(2)  
               
Lower limb  
Deformity absent (0) 
Scissoring (2) 
 
               
                                                                       * Falls forward (global hypotonia); Falls backward (hypertonia of extensor muscles)   
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ROP Screening (Schell)  
 
 
6 weeks Neuro-sonogram 
(Radiology) 
 
 
 
 
Others (Hearing etc.) 
 
 
 
Any significant medical 
concerns,  
 
 
INTERPRETATION OF ATNA (0 - 6 MONTHS) 
(Severe: score of 2 in ≥ four of  five sections / Moderate: mostly 1, some scores of 2 are acceptable) 
Date of visit          
Corrected Gest. Age          
1. Head growth (HC, growth profile, 
fontanels, sutures) (Severe 2;  Mod. 1) 
         
2. Social interactions (alertness & 
attention, visual tracing, excitability) 
         
3. Passive muscle tone  
                  (limbs and trunk) (Severe 2;  Mod. 1) 
         
4. Motor activity  
                  (quality and quantity) (Severe 2;  Mod. 1) 
         
5. Primitive reflexes (absent /insufficient, 
especially sucking) (Severe 2;  Mod. 1) 
         
FINAL INTERPRETATION OF NEUROLOGIC 
STATUS 
(Normal/moderate/Severe) 
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INTERPRETATION OF ATNA (7 - 9 MONTHS) 
 
(Severe: score of 2 in ≥ four of six sections 
 Moderate: Scores of 1 in at least 4 of six sections, some scores of 2 are acceptable) 
 
Date of visit      
Corrected Gest. Age      
1. Head growth (HC, growth profile, 
fontanels, sutures) 
(Severe  2;  Moderate 1) 
     
2. Social interactions (alertness & 
attention, visual tracing, excitability) 
(Severe  2;  Moderate 1) 
     
3. Passive muscle tone  
                (limbs and trunk) 
                (Severe 2;  Moderate 1)   
     
4. Motor activity  
                 (quality and quantity) 
               (Severe 2;  Moderate 1) 
     
5. Head control (scored according to age 
of acquisition)  
(Severe 2;  Moderate 1) 
     
6. Evident ATNR 
               (Severe 2; Moderate 0) 
     
FINAL INTERPRETATION OF NEUROLOGIC 
STATUS 
(Normal/moderate/Severe) 
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INTERPRETATION OF ATNA (10 - 24 MONTHS) 
Severe deficit: a score of 2 in at least 6 of 7 sections, including inability to walk.  
Moderate abnormality:  a score of 1 in at least 5 of 7 sections, some scores of 2 are acceptable.  
Minor abnormality: a score of 1 in at least 3 of 7 sections 
Date of visit          
Corrected Gest. Age          
1. Head growth ( insufficient HC, all 
structures abnormal or an isolated 
abnormality with squamous sutures)    
      (Severe - 2;  Moderate - 1 or 2; Minor - 0 or 1) 
         
2. Social interactions (alertness & 
attention, visual tracing, excitability) 
                (Severe - 2;  Moderate - 1 ; Minor -  0) 
         
3. Passive muscle tone  
Trunk Imbalance (Sev:2, Mod:1, Minor:1) 
Stretch reflex in limbs (Sev:2, Mod:1/2, Minor:1) 
Hypotonia or rigidity (Severe:2,  Mod &, Minor:0) 
         
4. Involuntary movements 
                (Severe - 2;  Moderate &  Minor -  0) 
         
 
5. Parachute reaction (scored 
according to age of acquisition) 
                (Severe - 2;  Moderate - 1 ; Minor -  0) 
         
6. Gross  motor skills (scored according to 
age of acquisition) 
Head control 
Sitting position 
(Severe - 2;  Moderate - 1 ; Minor -  0) 
         
7. Independent walking 
(Severe - 1;  Moderate - 1 ; Minor -  0/1) 
         
FINAL INTERPRETATION OF NEUROLOGIC 
STATUS 
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ARE WE OVERESTIMATING THE INCIDENCE OF RETINOPATHY OF 
PREMATURITY ?
RESULTS OF A LONGITUDINAL COHORT OF VLBW BABIES
Saban Horo1, Samuel P Oommen2, Santhanam Sridhar3, Niranjan Thomas3, Manish Kumar3, Atanu Kumar Jana3
Departments of Ophthalmology1, Developmental Pediatrics2 & Neonatology3, Christian Medical College, Vellore, India.
BACKGROUND
AIMS AND OBJECTIVES
METHODOLOGY
RESULTS
CONCLUSIONS
HIGHLIGHT OF THE STUDY
Retinopathy of prematurity is a potential
cause of blindness in preterms and low birth
weight infants
Wide variation in incidence of ROP
reported across different centers in India
 There are multiple risk factors associated
with ROP.
 Study design: Prospective, follow up of
a cohort of VLBW babies
 Setting: Tertiary Neonatal center in
South India
 Period: September 2010- March 2013
 Inclusion Criteria: Infants <34 weeks GA
and/or < 1500 g birth weight.
Statistical Analysis:
 Antenatal and perinatal factors and
morbidities were collected prospectively
 Association between the variables/ risk
factors and the outcome (ROP) were
calculated.
 Univariate analysis was done using Chi-
square and Odds ratio.
 Risk factors that were significant on
univariate analysis were entered into logistic
regression to assess their independent
effect.
 Analyses were done using SPSS 16.0
 
Variable 
Univariate analysis Multivariate analysis 
p-Value Unadjusted odds 
(95% CI) 
p-Value Adjusted odds 
(95% CI) 
Gestational Age 0.004 0.81 (0.69-0.94) 0.028 0.813 (0.676-0.978)  
Birth weight 0.001 0.997 (0.996-0.999) 0.088 0.998 (0.996-1.000) 
Septicemia 0.001 3.097 (1.52-6.31) 0.004 3.12 (1.45-6.69) 
Respiratory Compl. 0.057 1.766 (0.97-3.18) 0.14 1.65 (0.85-7.405) 
Hypotension 0.003 2.797 (1.407-5.58) 0.29 1.53 (0.7-7.35) 
Abnormal sodium 0.003 2.57 (1.36-4.8) 0.47 1.32 (0.64-2.74) 
Sex 0.489 1.229  (0.685-2.20) 0.67 1.15 (0.61-2.21) 
 
REFERENCES
• To estimate the incidence of ROP in a 
cohort of premature, VLBW babies
• To identify risk factors that are significantly 
associated with ROP
 Incidence of ROP requiring treatment is only 3/59
(5%) which is much less than the incidence from
other centers in India (1-4)
• 258 infants were examined as per the protocol
• Mean Birth weight was 1190g (SD+184)
• Mean Gestational age was 31 weeks 
(SD+ 2.14)
• 59 (22.9%) infants had ROP
32 (54.4%) were boys and 
27 (45.7%) were girls
• Stage 1 ROP: 25 babies (42.7%)
Stage 2 ROP: 27 babies (45.7%)
Stage 3 ROP: 7 babies (11.9%) of which 
3 babies required  Laser photocoagulation.
• In the other babies ROP regressed  
spontaneously.
• In Univariate analysis (table below) the 
following variables showed  significant
association with ROP – Gestational age,
Birth weight, Septicemia, Respiratory
. complications,  Hypotension and Low  sodium 
• On Multivariate analysis septicemia alone
was independently  associated with ROP. 
There was a trend to develop ROP with
decreasing birth weight and gestational age.
 This cohort was predominantly inborn and
therefore incidence of ROP is likely to differ with
quality of neonatal care
 The etiology and risk factors for developing ROP
may be heterogeneous in various parts of country.
1.. Chaudhari S, Patwardhan V, Vaidya U, Kadam S, Kamat A. Retinopathy of prematurity in a tertiary care center--incidence, risk factors and 
outcome. Indian Pediatr. 2009 Mar;46(3):219–24. 
2. Vinekar A, Dogra MR, Sangtam T, Narang A, Gupta A. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at 
birth: ten year data from a tertiary care center in a developing country. Indian J Ophthalmol. 2007 Oct;55(5):331–6. 
3. Gupta VP, Dhaliwal U, Sharma R, Gupta P, Rohatgi J. Retinopathy of prematurity--risk factors. Indian J Pediatr. 2004 Oct;71(10):887–92. 
4. Kumar P, Sankar MJ, Deorari A, Azad R, Chandra P, Agarwal R, et al. Risk factors for severe retinopathy of prematurity in preterm low birth 
weight neonates. Indian J Pediatr. 2011 Jul;78(7):812–6.
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GENERAL MOVEMENT ASSESSMENT IN VERY LOW BIRTH WEIGHT 
INFANTS IN SOUTH INDIA AND MOTOR OUTCOMES AT ONE YEAR 
Hima B John*, Lars Adde***, Samuel P Oommen**, Toril Fjørtoft***, Ragnhild Støen*** Niranjan Thomas* *Department of 
Neonatology,**Developmental Paediatrics Unit, Christian Medical College, Vellore, ***Department of Laboratory Medicine, 
Women’s and Trondheim and St. Olavs University Hospital, Trondheim, Norway. 
BACKGROUND
•Very Low Birth weight  infants are at risk of adverse 
neurodevelopmental outcomes1
•Early identification is important to offer intervention 
programs to minimize the functional consequences of 
cerebral palsy (CP)2
•Assessment of general movements (GMA) appears to have 
the potential for predicting the development of CP with a 
high degree of certainty at an early stage3,4
•There are no studies which have looked at GMs in Indian 
infants
AIMS AND OBJECTIVES
• To evaluate the applicability of GMA in Indian infants
• To evaluate the association between  GMA  and  
motor function at one year.
METHODOLOGY
• Design: Prospective, observational cohort study
• Setting: Tertiary care neonatal unit in south India.
• Participants and Methods:
• Video recordings of a cohort of 327 VLBW babies born in
Christian Medical College, Vellore was taken between 9-15
weeks post term age (The Fidgety movements period) and
analyzed according to Assessment of Motor Repertoire (AMR)
by two observers masked for the infants’ medical history.
• Fidgety movements (FMs) were classified as abnormal if
absent, sporadic or exaggerated and as normal if continuously
or intermittently present. Movement character was classified as
normal if smooth and fluent and abnormal if monotonous, stiff
or jerky. Motor function at 1 year corrected age was assessed
using the Peabody Developmental Motor Scales (PDMS-2)
• Statistical Analysis: The variables Gross Motor Quotient
(GMQ), Fine Motor Quotient (FMQ) and Total Motor Quotient
(TMQ) were transformed using logarithmic transformation in
parallel with reversing the data due to zero or below zero
values. Hence, to get mean values, statistics were performed
using a General linear model and the GMQ, FMQ and TMQ
Reversed Ig10 were used to get p- values.
RESULTS
N=22 
(9%)
N=178
(73%)
N=42
(18%)
REFERENCES
Absent 
N=11
Sporadic
N=31
Intermittent 
N=209
Continual 
N=71
Exaggerated
N=5
Abnormal / high risk
N= 47 (14%)
Normal / low risk
N= 280 (86%)
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General movement assessment 
(GMA) in very low birth weight 
infants in south India 
General Movement Assessment in India (Lars Adde) 
2 
Quality of general movements are 
associated with cerebral palsy (1,2) 
General Movement Assessment in India (Lars Adde) 
Cerebral palsy status: yes/no 
 
3 
GMA needs higher quality evidence (3) 
General Movement Assessment in India (Lars Adde) 
• Larger, heterogeneous and representative samples 
• Studies originated outside Europe to expand 
generalizability to other parts of the world 
 
AND 
 
The fact that GMA is done purely through observation of 
video recordings should make it feasible for clinical use in 
low resource settings 
4 
The aim of this study 
General Movement Assessment in India (Lars Adde) 
To evaluate the applicability of GMA during the fidgety 
movement’s period in India 
 
And to describe fidgety movements and movement 
character in a cohort of Very Low Birth Weight (VLBW) 
infants in India 
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The study site 
General Movement Assessment in India (Lars Adde) 
Christian Medical 
College, Vellore, India 
(Tamil Nadu) 
6 
Participants 
General Movement Assessment in India (Lars Adde) 
345 VLBW infants (<1500 g) (170 boys and 157 girls) from a 
two year cohort were included from the NICU 
7 
Participants 
General Movement Assessment in India (Lars Adde) 
• 327 out of 345 had corresponding video 
recordings  
• Mean gestational age 32 (range 26-39) weeks 
• Mean birth weight 1275 grams (range 760-1500) 
N=5 N=29 
8 
Methods – video recordings 
General Movement Assessment in India (Lars Adde) 
All participants (n=327) were video recorded during the fidgety 
movement’s period  
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Methods – video recordings 
General Movement Assessment in India (Lars Adde) 
Video recordings were 
performed using a standard 
mobile set-up  
    
10 
Methods – FMs classification 
General Movement Assessment in India (Lars Adde) 
Video recordings were classified by two certified and experienced 
observers using the Prechtl’s approach for GM assessment  
    
Absent 
(FM-) 
Sporadic 
(FM +/-) 
Intermittent 
(FM+) 
Continual 
(FM++) 
Exaggerated
(Fa) 
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Methods – FMs classification 
General Movement Assessment in India (Lars Adde) 
Video recordings were classified by two certified and experienced 
observers using the Prechtl’s approach for GM assessment  
    
Absent 
(FM-) 
Sporadic 
(FM +/-) 
Intermittent 
(FM+) 
Continual 
(FM++) 
Exaggerated
(Fa) 
Abnormal / high risk Normal / low risk 
12 
Results  
General Movement Assessment in India (Lars Adde) 
Fidgety movements  
    
FMs N (%) Risk for adverse development 
Exaggerated (Fa) 5 (2) High risk 
Absent (-) 11 (3) High risk 
Sporadic (+/-) 31 (9) High risk 
Intermittent (+) 209 (65) Low risk 
Continual (++) 71 (22) Low risk 
Total 327 
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5, 2% 
11, 3% 31, 9% 
209, 64% 
71, 22% 
FMs 
Exaggerated (Fa)
Absent (-)
Sporadic (+/-)
Intermittent (+)
Continual (++)
Results 
14 
Methods – movement character 
classification 
General Movement Assessment in India (Lars Adde) 
The global movement character were classified as smooth & fluent or as 
monotonous, stiff or jerky  
    
Smooth & 
Fluent 
Abnormal / at risk Normal / low risk 
Monotonous, 
stiff or jerky 
15 
206, 63% 
121, 37% 
Global movement character 
Smooth & Fluent
Monotonous, jerky, stiff
Results 
16 
Discussion: participants 
General Movement Assessment in India (Lars Adde) 
• Vellore, India: VLBW (Mean gestational age 32 weeks) 
• Norway: ELBW (Mean gestational age 26 weeks)  
Vellore, India Norway 
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17 
Discussion: participants 
General Movement Assessment in India (Lars Adde) 
• Vellore, India: VLBW (Mean birth weight 1275 grams) 
• Norway: ELBW (Mean birth weight 816 grams) 
Vellore, India Norway 
18 
Discussion: FMs classifications 
General Movement Assessment in India (Lars Adde) 
Vellore, India: 
VLBW (n=327) 
Norway: 
ELBW (n=73) 
2% 3% 9% 
64% 
22% Exaggerated (Fa)
Absent (-)
Sporadic (+/-)
Intermittent (+)
Continual (++)
4% 10% 
11% 
70% 
5% 
Exaggerated (Fa)
Absent (-)
Sporadic (+/-)
Intermittent (+)
Continual (++)
19 
Discussion: Global movement character 
General Movement Assessment in India (Lars Adde) 
Vellore, India: 
VLBW (N=327) 
Norway: 
ELBW (N=73 
63% 
37% Smooth & Fluent
Monotonous,
jerky, stiff
42% 
58% 
Smooth & Fluent
Monotonous,
jerky, stiff
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